Effects of moderate maternal energy restriction on the offspring metabolic health, in terms of obesity and related diseases, and identification of determinant factors and early biomarkers by Torrens García, Juana María & Departament de Biologia Fonamental i Ciències de la Salut
 
 
 
DOCTORAL THESIS 
2014   
 
 
 
 
EFFECTS OF MODERATE MATERNAL ENERGY 
RESTRICTION ON THE OFFSPRING METABOLIC 
HEALTH, IN TERMS OF OBESITY AND RELATED 
DISEASES, AND IDENTIFICATION OF 
DETERMINANT FACTORS AND EARLY 
BIOMARKERS 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Juana María Torrens García 
 
 
 
 
 
 
 
 
DOCTORAL THESIS 
2014  
Doctoral Programme of Nutrigenomics and 
Personalized Nutrition  
 
 
EFFECTS OF MODERATE MATERNAL ENERGY 
RESTRICTION ON THE OFFSPRING METABOLIC 
HEALTH, IN TERMS OF OBESITY AND RELATED 
DISEASES, AND IDENTIFICATION OF 
DETERMINANT FACTORS AND EARLY 
BIOMARKERS 
 
 
Juana María Torrens García 
 
 
Thesis Supervisor: Catalina Picó Segura, PhD 
Thesis Supervisor: Andreu Palou Oliver, PhD 
 
 
 
Doctor by the Universitat de les Illes Balears 
 
  
 
 
 
With the consent of the directors 
 
 
 
 
 
 
 
 
 
 
 
The doctoral candidate 
 
 
 
Juana María Torrens García 
 
 
 
 
 
Catalina Picó Segura, PhD 
Professor of Biochemistry and Molecular 
Biology, UIB 
Andreu Palou Oliver, PhD 
Professor of Biochemistry and Molecular 
Biology, UIB 
 
 
 
 
Dr Catalina Picó Segura, Professor of Biochemistry and Molecular Biology from the University 
of the Balearic Islands 
 
and 
 
Dr Andreu Palou Oliver, Professor of Biochemistry and Molecular Biology from the University 
of the Balearic Islands 
 
 
WE DECLARE: 
 
That the thesis entitled Effects of moderate maternal energy restriction on the offspring 
metabolic health, in terms of obesity and related diseases, and identification of determinant 
factors and early biomarkers, presented by Juana María Torrens García to obtain a doctoral 
degree, has been completed under our supervision and meets the requirements to opt for an 
European Doctorate Mention. 
 
 
For all intents and purposes, we hereby sign this document. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Palma de Mallorca, 18
th
 November 2014 
 
Catalina Picó Segura, PhD 
Professor of Biochemistry and Molecular 
Biology, UIB 
Andreu Palou Oliver, PhD 
Professor of Biochemistry and Molecular 
Biology, UIB 
 
  
 
 
 
 
 
 
 
 
 
 
A mis padres 
 
I 
 
Agradecimientos 
Quiero expresar mi agradecimiento a todas las personas que han contribuido, de una forma u otra, en la 
realización de esta tesis. 
Recuerdo perfectamente el día en el que me preguntaron si quería ser alumna colaboradora del 
laboratorio. Yo estaba en segundo de carrera y la verdad es que por aquel entonces no había pensado en 
nada de doctorados ni en investigación, simplemente me hacía muchas ganas conocer cómo se trabaja 
en un laboratorio, así que lo probé. Empecé un verano ayudando básicamente a Ona en el estabulario 
con las “ratitas” y  como tanto el trabajo como la gente del laboratorio me engancharon, verano tras 
verano volví a repetir hasta que, al acabar la carrera, decidí empezar el doctorado y continuar con lo que 
me gustaba, la investigación. Y aquí estoy ahora, escribiendo unas líneas para agradecer a todas las 
personas que han hecho posible que haya conseguido llegar hasta el final de esta etapa. La redacción 
nunca se me ha dado bien y mucho menos reflexionar sobre mis sentimientos, ―siempre he dicho que 
soy de números y no de letras―, pero haré lo posible para que todo el agradecimiento que siento quede 
reflejado en estas líneas. 
Mi especial agradecimiento a mis dos directores de tesis: el Prof. Andreu Palou y la Prof. Catalina Picó 
por su contribución en mi formación investigadora. Al Prof. Andreu Palou, quiero agradecerle la 
oportunidad que me brindó para formar parte y para realizar el doctorado en su grupo de investigación, 
el Laboratorio de Biología Molecular, Nutrición y Biotecnología (LBNB) de la Universidad de las Islas 
Baleares. También quiero agradecerle la supervisión y los consejos aportados a mi tesis, así como 
también la oportunidad que me ofreció para realizar mis dos estancias predoctorales en la Universidad 
de Warwick, en el Reino Unido. A la Prof. Catalina Picó quiero agradecerle muy especialmente, toda la 
confianza,  paciencia y comprensión que ha tenido conmigo en todos los momentos (porque sé que soy 
muy cabezota, y cuando me encierro en una cosa, soy muy difícil de sacar de ahí). Quiero agradecerle 
toda la ayuda que me ha dado durante todos estos años, y especialmente durante estos últimos meses, en 
los que la redacción de la tesis ha sido un camino duro y complicado.  
A los demás profesores del grupo: Dra. Paula Oliver, Prof. Francisca Serra, Dra. Ana María Rodrídrez, 
Dr. Joan Ribot y Dra. Lluïsa Bonet, quiero agradecerles sus consejos, su ayuda y la proximidad de su 
trato.  
Muchísimas gracias Dra. Mariona Palou y Dra. Joana Sánchez, por vuestra amistad, por escucharme, 
por comprenderme y por vuestras enseñanzas; sin vosotras no estaría en estos momentos a punto de 
terminar el doctorado. Me guiasteis en mis primeros pasos en el laboratorio: a trabajar con los animales 
(santa paciencia tuvisteis conmigo que siempre me desmayaba cuando teníamos que sacar sangre!!), a 
manejar las máquinas del laboratorio, a rellenar papeles administrativos, a escribir resultados…. 
Sinceramente, las dos habéis estado desde el principio siempre a mi lado y me habéis ayudado tanto a 
nivel profesional como personal en todos los obstáculos que han ido apareciendo a lo largo de estos 
años.  
A la Dra. Teresa Priego, al Dr. Pep Mercader y a la Dra. Nuria Granados, gracias por vuestro apoyo, por 
vuestros ánimos y consejos. 
Thank you to the Prof. Paul Thornalley and Dr. Naila Rabanni for giving me the opportunity to work 
with them, for all their advices and for treat me as another one of the group. Thanks to all the members 
of the Protein Damage group: Fozia, Dr. Amy, Dr. Ming, Dr. Makoto, Alla, Amal, Dr. Attia Dra. Zhera, 
and especially to Dr. Jinit for his patience understanding and advices (also thanks to all “Costa time”).  
Quiero agradecer especialmente a Enzo por hacerme sonreír siempre que he estado triste y por hacerme 
reír cuando sólo quería llorar. Gracias por enseñarme morfología e histología y por ayudarme siempre 
que lo he necesitado.  
II 
 
A todos mis compañeros de laboratorio, quiero daros las gracias: Rubén y Xisco, gracias por convertir el 
despacho en el Polo Norte!!!, voy a añorar no discutir con vosotros por el aire acondicionado; Estefanía, 
simplemente gracias por todos tus detallitos; Nora, gracias por escucharme y darme consejos; Raúl, 
gracias por hacerme reír y saber escuchar; Petar, gracias por ser cómo eres; Madhu, gracias por 
cuidarnos tan bien con tus postres; Heriberto; gracias por deleitarnos con la comida mejicana; Nara, 
gracias por tu alegría y vitalidad; Alice, gracias por escucharme cuando lo he necesitado.  
Especialmente quiero agradecer a la Dra. Jadwiga Konieczna por ayudarme siempre y por aguantarme 
tantas horas en el estabulario y en laboratorio.  
A los nuevos becarios Cati Dora, Marga Cifre, Andrea, Alba y Sebastián, gracias, mucha suerte y 
muchos ánimos. 
A los demás compañeros del laboratorio, Bea; al personal del estabulario, Teresa de Francisco y Miquel, 
gracias. 
A los antiguos compañeros del laboratorio, Dr. Toni Caimari, Dr. Jaume Amengual, Dra. María Servera, 
Dra.Ana Paula García, Dra. Hana Musinovic y especialmente a la Dra. Pilar Parra, gracias por acogerme 
tan bien cuando llegué al grupo.  
Quiero agradecer muy especialmente a las Pingüinas: Bárbara, Marina, Ona y Joana. Gracias por 
vuestros ánimos pero sobre todo por haberme aguantado (sé que estos últimos meses he sido la niña del 
exorcista y “mordía” por todo, pero a pesar de ello habéis seguido ahí), gracias por escucharme, por 
vuestro apoyo, por vuestros consejos, por reír conmigo, por llorar conmigo…por todo, gracias!!. 
Quiero agradecer la ayuda de todos los alumnos colaboradores, en especial a Cristina Cabrer, Cati Joy, y 
Bel Mora. Gracias Cati Joy por ser mi mejor amiga (aunque hayamos estado semanas sin saber la una de 
la otra), gracias por aguantarme cuando he estado agobiada y por reñirme por mis tonterías. Gracias Bel, 
por tu amistad, por tu cariño y por tu gran ayuda, porque estos últimos meses no lo hubiese podido 
conseguir sin ti.  
A mi prima Natalia, muchas gracias por escucharme siempre, por animarme, apoyarme y sobre todo por 
hacerme reír cuando he estado triste. 
Finalmente, y no por ello menos importante, quiero darles las gracias a mis padres, Miguel y Antonia. 
Lo sois todo para mí, y todo lo que pueda decir de vosotros se quedaría corto. Os quiero mucho y si he 
llegado hasta aquí has sido gracias a vosotros. Gracias por vuestro esfuerzo y sacrificio incondicional 
para que yo pudiese estudiar. Gracias por todas las facilidades que me habéis dado. Gracias por 
ayudarme a estudiar y por estar a mi lado en todo momento. Gracias por aguantar mis enfados, mis 
lloros y mi estrés durante toda la vida y especialmente durante estos últimos meses. Os quiero agradecer 
todo lo que me habéis enseñado desde pequeña y que me han formado como la persona que ahora soy, 
solo espero no defraudaros nunca. Ahora, lo que más deseo es compartir con vosotros todo lo que he 
conseguido gracias a vuestra ayuda, apoyo, confianza, esfuerzo, comprensión y dedicación. Gracias 
mami!!. Gracias papi!!! Esto es por y para vosotros!!!. Os quiero!!!. 
Guty, esta recta final no hubiese sido posible tampoco sin ti. Gracias por tu comprensión y por tu 
enorme paciencia estos últimos meses. Gracias por escuchar mis preocupaciones, por aguantar mis 
lloros y mis tonterías. Gracias por tus consejos, por tus abrazos, tus mimos, por tu ayuda, por todo. Te 
ha tocado conocerme en una época de mucho estrés para mí, pero a pesar de ello, sigues aguantándome. 
Simplemente gracias por ser cómo eres, por confiar en mí y por quererme tal y como soy. Te quiero.  
 
 
 
Index 
III 
 
 
Index 
Abbreviations ............................................................................................................................... VII 
Abstract/Resumen/Resum .............................................................................................................. IX 
List of original articles ................................................................................................................. XV 
I. Introduction ................................................................................................................. 1 
1. Obesity ..................................................................................................................... 3 
2. Energy balance regulation ....................................................................................... 4 
2.1 Main tissues involved in maintenance of energy homeostasis  ......................... 5 
2.1.1. Hypothalamus ......................................................................................... 5 
2.1.2. White adipose tissue ............................................................................... 7 
2.1.3. Liver ....................................................................................................... 8 
2.1.4. Skeletal muscle ..................................................................................... 10 
2.2 Main hormones involved in maintenance of energy homeostasis  .................. 11 
2.2.1. Leptin ................................................................................................... 11 
Leptin during the perinatal period ........................................................ 12 
Leptin resistance ................................................................................... 14 
2.2.2. Insulin ................................................................................................... 15 
Insulin resistance .................................................................................. 16 
2.3 Calorie restriction  ........................................................................................... 20 
3. Developmental origins of obesity: importance of early life nutrition ................... 21 
3.1. Programming effects of maternal calorie restriction during gestation  .......... 22 
3.2. Programming effects of maternal calorie restriction during lactation  ........... 24 
Breast milk ............................................................................................ 25 
4. Biomarkers of metabolic health ............................................................................ 26 
4.1. Gene expression analysis in PBMCs  ............................................................. 27 
4.2. Quantitative screening of protein damage biomarkers.  ................................. 28 
II. Aim and experimental design................................................................................... 33 
III. Materials and methods ............................................................................................. 43 
1. Experimental animals ............................................................................................. 45 
2. PBMC isolation ...................................................................................................... 45 
3. RNA isolation and quantification ........................................................................... 46 
3.1. Tripure reagent method for RNA isolation ..................................................... 47 
Juana María Torrens García – Doctoral Thesis 
 
 
IV 
 
 
 
3.2. E.Z.N.A total RNA kit I for RNA isolation .................................................... 47 
3.3. RNA quantification and assessment of its integrity ........................................ 48 
4. Gene expression analysis by RT-qPCR  ................................................................ 49 
4.1. Reverse transcription ....................................................................................... 49 
4.2. Real Time quantitative Polymerase Chain Reaction (RT-qPCR).................... 49 
5. Determination of circulating parameters  .............................................................. 50 
5.1. Insulin .............................................................................................................. 50 
5.2. Glucose ............................................................................................................ 51 
5.3. Homeostatic model assessment for insulin resistance (HOMA-IR) ................ 51 
5.4. Leptin ............................................................................................................... 51 
5.5. Triglycerides (TGs) ......................................................................................... 52 
5.6. Non-esterified fatty acids (NEFAs) ................................................................. 53 
5.7. β-hydroxybutirate (BHB) ................................................................................ 53 
5.8. Adiponectin ..................................................................................................... 53 
5.9. Tumor Necrosis Factor alpha (TNFα) ............................................................. 54 
6. Measurement of hepatic glycogen content  ........................................................... 54 
7. Total hepatic lipid content measurement  .............................................................. 55 
8. Measurement of hepatic triglyceride content  ....................................................... 56 
9. Histological analysis  ............................................................................................. 57 
10.  Confocal microscopy for Green Fluorescent Protein detection in liver samples  58 
11.  Isolation of mitochondria from liver  ................................................................... 58 
12.  Western blot analysis  ........................................................................................... 59 
12.1. Sample preparation ....................................................................................... 59 
12.2. Electrophoresis ............................................................................................. 60 
12.3. Electroblotting .............................................................................................. 60 
12.4. Labelling and detection ................................................................................ 61 
12.5. Scanning and quantification ......................................................................... 62 
12.6. Loading control ............................................................................................ 62 
13.  Indirect gas calorimetry and locomotive activity measurements  ........................ 62 
14.  Blood pressure measurement  ............................................................................... 63 
15.  Liquid chromatography-tandem mass spectrometry (LC-MS/MS)  .................... 63 
15.1. Sample preparation ....................................................................................... 64 
15.2. Ultrahigh Performance Liquid Chromatography (UPLC) ............................ 64 
Index 
V 
 
 
15.3. MS/MS detection .......................................................................................... 64 
15.4. Calculation .................................................................................................... 64 
16.  Statistical analysis  ............................................................................................... 65 
 
IV. Results and discussion .............................................................................................. 67 
1. Impaired insulin and leptin sensitivity in the offspring of moderate caloric-
restricted dams during gestation is early programmed ........................................ 69 
2. Enhancing hepatic fatty acid oxidation as a strategy for reversing metabolic 
disorders programmed by maternal undernutrition during gestation ................... 95 
3. Moderate caloric restriction in lactating rats protects offspring against obesity 
and insulin resistance in later life ....................................................................... 121 
4. Moderate caloric restriction in lactating rats programs their offspring for a better 
response to HF diet feeding in a sex-dependent manner.................................... 141 
5. Early biomarkers identified in a rat model of a healthier phenotype based on early 
postnatal dietary intervention may predict the response to an obesogenic 
environment in adulthood .................................................................................. 163 
6. Identification of early transcriptome-based biomarkers related to lipid 
metabolism in peripheral blood mononuclear cells of rats nutritionally 
programmed for improved metabolic health ...................................................... 185 
7. Moderate maternal calorie restriction in lactating rats affects markers of protein 
damage by glycation and oxidation in breast milk  ........................................... 209 
V. Recapitulation.......................................................................................................... 227 
VI. Conclusions/Conclusiones ....................................................................................... 235 
VII. Bibliography ............................................................................................................ 241 
 
 
  
 
 
 
 
 
 
Abbreviations 
 
VII 
 
 
Abbreviations 
3DG-H: 3-deoxyglucosone 
3-NT: 3-Nitrotyrosine  
AAV: adeno-associated virus 
ACC: acetyl-CoA carboxylase 
ACOX: acyl-CoA oxidase 
AdipoR1: adiponectin receptor 1 
AdipoR2: adiponectin receptor 2 
AGEs: advanced glycation endproducts  
AgRP: Agouti-related peptide 
AKT: protein kinase B (PKB) 
AMPK: AMP-activated protein kinase 
α-MSH: alpha-melanocyte-stimulating hormone 
ARC: arcuate nucleous 
ATGL: adipose tissue triglyceride lipase 
BMI: body mass index 
cAMP: cyclic adenosine monophosphate 
CART: cocaine and amphetamine-regulated transcript 
CEL: Nε-carboxyethyl-lysine 
CKM: creatine kinase 
CMA: Nω-carboxymethylarginine 
CML: Nε-carboxymethyl-lysine 
CNS: central nervous system 
CPT1: carnitine palmitoyltransferase 1 
CPT1A: carnitine palmitoyltransferase 1 liver isoform 
CPT1AM: mutant form of carnitine palmitoyltransferase 1 liver isoform 
CRH: corticotropic releasing hormone 
DEX: dexamethasone 
DMN: dorsomedial nucleous 
FABP: fatty acid binding protein  
FAO: fatty acid oxidation 
FASC: fatty acid synthase complex 
FASN: fatty acid synthase 
FATP: fatty acid binding protein 
FL: Fructosyl-lysine 
FTO: fat mass and obesity associated 
GCK: glucokinase 
G-H1: Nδ-(5-hydro-4-imidazolon-2-yl)ornithine  
GLUT4: glucose transporter 4 
GPAT: glycerol-3-phosphate acyltransferase 
GSA: glutamic semialdehyde 
HDL: high-density lipoprotein 
HF: high fat 
HSL: hormone-sensitive lipase 
IDL: intermediate density lipoproteins 
IL-6: interleukin-6 
InsR: insulin receptor 
Juana María Torrens García – Doctoral Thesis 
 
VIII 
 
 
 
IRS: insulin receptor substrate 
IRX3: iroquois homeobox 3 gene 
iWAT: inguinal white adipose tissue 
JAK2: janus-activated tyrosine kinase 2 
LCAS: long chain acyl-CoA synthetase 
LC-MS/MS: liquid chromatography with tandem mass spectrometry detection    
LDL: low-density lipoprotein 
LH: lateral hypothalamus 
LPL: lipoprotein lipase 
MC3R: melanocortin receptor subtype 3 
MC4R: melanocortin receptor subtype 4 
MCH: melanin-concentrating hormone 
MetSO: methionine sulfoxide 
MG-H1: Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl)ornithine 
MOLD: bis(lysyl) crosslink derived from methylglyoxal 
NEFAs: non-esterified fatty acids 
NFK: N-formylkynurenine 
NPY: neuropeptide Y 
ObRb: long form of leptin receptor 
PBMCs: peripheral blood mononuclear cells 
PCK1: phosphoenolpyruvate carboxykinase 
PDK1: 3-phosphoinositide-dependent protein kinase 1 
PGC1α: peroxisome-proliferator-activated receptor gamma co-activator 1 alpha  
PI3K: phosphatidylinositol-3-kinase 
PIP2: phosphatidylinositol-4,5-biphosphate 
PIP3: phosphatidylinositol-3,4,5-triphosphate 
PKA: protein kinase A 
PKL: liver pyruvate kinase 
POMC: pro-opiomelanocortin 
PPARα: peroxisome-proliferator-activated receptor alpha  
PPARɣ2: peroxisome-proliferator-activated receptor gamma-2 
PVN: paraventricular nucleous 
rWAT: retroperitoneal white adipose tissue 
SOCS3: suppressor of cytokine signaling 
SREBP1c: sterol-regulatory-element-binding protein 
STAT3: signal transducer and activator of transcription 3 
TCA: tricarboxylic acid 
TG: triglyceride 
TNFα: tumor necrosis factor alpha 
TRH: thyrotropin releasing hormone 
VLDL: very low density lipoprotein  
VMN: ventromedial nucleous 
WAT: white adipose tissue 
WHO: World Health Organization 
Abstract 
 
IX 
 
 
Effects of moderate maternal energy restriction on the 
offspring metabolic health, in terms of obesity and related 
diseases, and identification of determinant factors and early 
biomarkers 
Department of Fundamental Biology and Health Sciences.  
University of the Balearic Islands. 
Juana María Torrens García 
Abstract 
A growing body of evidence, from epidemiological studies in humans and animal models, 
indicate that maternal health and nutritional status during gestation and lactation can program 
the propensity to develop obesity in their offspring. Huge efforts are now being directed toward 
understanding the molecular mechanisms underlying this developmental programming. 
Identification of these mechanisms could give some clues about potential strategies to prevent 
or revert programmed propensity to develop obesity, as well as may help in the identification 
of early biomarkers. Therefore, the main aim of this PhD Thesis has been: To characterize in 
rats the programming effects of moderate maternal energy restriction during pregnancy or 
lactation on the metabolic health of their offspring in terms of obesity and related metabolic 
alterations, as well as to identify new preventing strategies against programmed obesity and 
early biomarkers of metabolic health. 
We have characterized an animal model previously described to exhibit higher propensity to 
develop obesity and related metabolic alterations ― the offspring of rat dams exposed to 
moderate food restriction during gestation (CRG) ― to find out some of the potential 
mechanisms underlying their negative metabolic outcomes. Expression levels of key energy 
homeostasis-related genes in the hypothalamus and adipose tissue, as well as the measurement 
of some circulating parameters, showed that these animals were programmed, already from 
early stages of life, for a lower capacity to respond to insulin and to central leptin action. This 
could explain the hyperphagia observed in these animals (both genders) and the higher body 
weight occurring particularly in males. Some of these programmed metabolic disturbances, 
such as the impaired insulin and leptin sensitivity, and the increased systolic blood pressure, 
characteristic of CRG animals, were reverted by enhancing hepatic fatty acid oxidation at early 
ages, through adeno-associated virus (AAV)-mediated gene transference of the cDNA of 
Cpt1am (encoding for a permanently active form of CPT1A insensitive to its physiological 
inhibitor malonyl-CoA). AAV-Cpt1am injection in CRG animals was also able to ameliorate 
inflammatory state and restored the locomotive activity that was diminished in these animals in 
comparison to their controls. 
Unlike calorie restriction during gestation, we show here that moderate calorie restriction in rat 
dams during lactation protects their offspring (CRL) against diet-induced obesity and related 
metabolic alterations, such as dyslipidemia, insulin resistance and hyperleptinemia. This 
condition during lactation determines early changes in WAT and liver, affecting lipogenic and 
oxidative capacity and increasing their sensitivity to the peripheral effects of leptin and insulin, 
which suggests a better control of energy metabolism. These adaptations occurring in early 
ages were partially maintained in adulthood and were particularly evident when animals were 
exposed to an obesogenic environment. Adult CRL animals showed gender-dependent changes 
at gene expression level in adipose tissue and hypothalamus, suggesting that males were more 
protected against HF-diet induced peripheral insulin resistance and also showed improved 
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capacity to respond centrally to leptin, while CRL females were programmed for a better 
sensitivity to the peripheral actions of leptin and to the central action of insulin. We used this 
animal model to identify early transcriptome-based biomarkers of improved metabolic health 
by whole-genome microarray analysis in peripheral blood mononuclear cells (PBMCs); these 
cells may be easily obtained by low invasive techniques and hence represent an attractive 
source for identifying biomarkers and to extrapolate such biomarkers from animals into 
humans. Concerning the factors potentially involved in the benefits of maternal calorie 
restriction during lactation, the analysis  by liquid chromatography with tandem mass 
spectrometry detection  of protein damage biomarkers in breast milk from CRL dams, 
suggests that the diminished content of glycation and oxidation free adducts during the second 
part of the lactating period, in comparison to control milk, could contribute to the health 
benefits observed in their adult offspring. 
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Efectos de una restricción energética moderada en las madres 
sobre la salud metabólica de las crías, en relación a la 
obesidad y las alteraciones metabólicas asociadas, e 
identificación de factores determinantes y biomarcadores 
tempranos.   
Departamento de Biología Fundamental y Ciencias de la Salud 
Universidad de las Islas Baleares 
Juana María Torrens García 
Resumen 
Numerosas evidencias, procedentes tanto de estudios epidemiológicos en humanos como de 
modelos animales, indican que la salud materna y su estado nutricional durante la gestación y 
la lactancia pueden programar la propensión a desarrollar obesidad en la descendencia. Se 
están llevando a cabo grandes esfuerzos para entender los mecanismos moleculares 
responsables de dicha programación metabólica. La identificación de los mecanismos 
responsables podría dar ciertas pistas para el desarrollo de estrategias que permitan prevenir o 
revertir dicha propensión a desarrollar obesidad, así como también podría ayudarnos en la 
identificación de biomarcadores tempranos de salud metabólica. Por consiguiente, el principal 
objetivo de esta tesis doctoral ha sido: Caracterizar en ratas los efectos de una restricción 
energética materna moderada durante la gestación o la lactancia sobre la salud metabólica 
de la descendencia, en relación a la obesidad y las alteraciones metabólicas asociadas, así 
como también identificar nuevas estrategias de prevención frente la programación de la 
obesidad y nuevos biomarcadores tempranos de salud metabólica.   
Hemos caracterizado un modelo animal, que previamente se había descrito que presentaba una 
mayor propensión a desarrollar obesidad y alteraciones metabólicas asociadas – las crías de 
ratas sometidas a una restricción calórica moderada durante la gestación (CRG) – para 
identificar algunos de los posibles mecanismos responsables de sus efectos negativos. Los 
niveles de expresión de genes claves relacionados con la homeostasia energética en el 
hipotálamo y en el tejido adiposo, así como el análisis de ciertos parámetros circulantes, 
revelaron que estos animales estaban programados, ya desde etapas tempranas de la vida, para 
una menor respuesta a la insulina y a la acción central de la leptina, en relación con los 
animales control. Esto podría explicar la hiperfagia observada en estos animales (en ambos 
sexos), y el mayor peso corporal que presentan, particularmente los machos. Algunas de estas 
alteraciones metabólicas, tales como la alteración de la sensibilidad a la insulina y a leptina, así 
como la elevada presión sistólica, característica de los animales CRG, se vieron revertidas al 
favorecer el incremento de la oxidación hepática de ácidos grasos, en edades tempranas, a 
través de la transferencia génica mediada por vectores virales adeno-asociados (AAV) del 
ADNc de la Cpt1am (que codifica para una forma permanentemente activa de la CPT1A, 
insensible a su inhibidor fisiológico malonil-CoA). La inyección de AAV-Cpt1am en animales 
CRG también fue capaz de mejorar el estado de inflamación y de restaurar la actividad 
locomotora que estaba disminuida en estos animales en comparación con los controles.  
A diferencia de la restricción calórica durante la gestación, observamos que la restricción 
calórica moderada en ratas madre durante la lactancia, protege a su descendencia (CRL) frente 
al desarrollo de obesidad inducida por la dieta y el desarrollo de alteraciones metabólicas 
asociadas, tales como la dislipidemia, la resistencia a la insulina y la hiperleptinemia. Esta 
condición durante la lactancia determina cambios tempranos en el tejido adiposo y el hígado, 
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afectando la capacidad lipogénica y oxidativa, e incrementando la sensibilidad a la acción 
periférica de la insulina y la leptina, lo que sugiere un mejor control del metabolismo 
energético. Dichas adaptaciones, que ocurrieron en edades tempranas, se mantuvieron 
parcialmente en edad adulta y fueron particularmente más evidentes cuando los animales 
fueron expuestos a un ambiente obesogénico. Los animales CRL adultos mostraron cambios a 
nivel de expresión génica en el tejido adiposo y en el hipotálamo que fueron dependientes del 
sexo, sugiriendo que los machos estaban más protegidos frente a la resistencia periférica a la 
insulina inducida por una dieta hiperlipídica, así como también mostraron una capacidad 
mejorada para responder a la leptina a nivel central; en cambio, las hembras CRL estaban 
programadas para una mejor sensibilidad a la acción periférica de la leptina y a la acción 
central de la insulina. Utilizamos este modelo animal para identificar marcadores tempranos de 
transcripción indicadores de salud metabólica mejorada mediante el análisis por microarray de 
células mononucleares de sangre periférica (PBMCs); estas células se pueden obtener 
fácilmente mediante técnicas poco invasivas por lo que representan una fuente atractiva para la 
identificación de biomarcadores y para extrapolar tales biomarcadores de animales a humanos. 
Con respecto a los factores que podrían estar potencialmente implicados en los efectos 
beneficiosos de la restricción calórica durante la lactancia, el análisis  por cromatografía 
líquida con sistema de detección por espectrometría de masas en tandem  de biomarcadores 
de daño proteico en la leche de madres CRL, sugiere que el menor contenido de aductos libres 
de glicación y oxidación durante la segunda mitad de la lactancia, en comparación con la leche 
de madres control, podría contribuir a explicar los efectos beneficiosos observados en las crías 
de estos animales en edad adulta.  
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Efectes d’una restricció energètica moderada a les mares 
sobre la salut metabòlica de les cries, en relació a l’obesitat i 
les alteracions metabòliques associades, i identificació de 
factors determinants i biomarcadors primerencs. 
Departament de Biologia Fonamental i Ciències de la Salut 
Universitat de les Illes Balears 
Juana María Torrens García 
Resum 
Nombroses evidències, procedents tant d’estudis epidemiològics en humans com de models 
animals, indiquen que la salut materna i el seu estatus nutricional durant la gestació i la 
lactància, poden programar la propensió de la descendència per desenvolupar obesitat. S’estàn 
duent a terme grans esforços per entendre els mecanismes moleculars responsables d’aquesta 
programació metabòlica. La identificació d’aquests mecanismes podria donar-nos certes pistes 
per al desenvolupament d’estratègies que permetin prevenir o revertir la propensió programada 
per al desenvolupament d’obesitat, així com també podria ajudar-nos en la identificació de 
biomarcadors primerencs de salut metabòlica. Per això, el principal objectiu d’aquesta tesis 
doctoral ha estat: Caracteritzar en rates els efectes d’una restricció energètica moderada a les 
mares durant la gestació o la lactància sobre la salut metabòlica de la descendència, en 
relació a l’obesitat i les alteracions metabòliques associades, així com també identificar 
noves estratègies de prevenció enfront a la programació de l’obesitat i nous biomarcadors 
primerencs de salut metabòlica.  
Hem caracteritzat un model animal, que prèviament se va veure que exhibia una major 
propensió a desenvolupar obesitat i alteracions metabòliques associades – les cries de rates 
sotmeses a una restricció calòrica moderada durant la gestació (CRG) – per identificar alguns 
dels possibles mecanismes responsables dels seus efectes negatius. Els nivells d’expressió de 
gens clau relacionats amb la homeòstasi energètica a l’hipotàlem i al teixit adipós, així com 
també l’anàlisi de certs paràmetres circulants, varen mostrar que aquests animals estaven 
programats, ja des d’etapes primerenques de la vida, per una menor resposta a la insulina i a la 
acció central de la leptina respecte dels animals control. Això podria explicar la hiperfàgia 
observada en aquests animals (en ambdós sexes), i el major pes corporal, que presenten 
particularment els mascles. Algunes d’aquestes alteracions metabòliques, com ara l’alteració de 
la sensibilitat a la insulina i a la leptina, així com l’elevada pressió sistòlica, característica dels 
animals CRG, es van veure revertides en afavorir l’increment de la oxidació hepàtica dels àcids 
grassos, a edats primerenques, a través de la transferència gènica mitjançant vectors virals 
adeno-associats (AAV) de l’ADNc de la Cpt1am (que codifica per una forma permanentment 
activa de la CPT1A, insensible al seu inhibidor fisiològic, el malonil-CoA). La injecció de 
AAV-Cpt1am en animals CRG també va ser capaç de millorar l’estat d’inflamació i va 
restaurar la activitat locomotora que estava disminuïda en aquests animals en comparació amb 
els controls.    
 
A diferència de la restricció calòrica durant la gestació, observarem que la restricció calòrica 
moderada en rates mare durant la lactància, protegeix a la seva descendència (CRL) enfront del 
desenvolupament d’obesitat induïda per la dieta i el desenvolupament d’alteracions 
metabòliques associades a l’adultesa, com ara la dislipèmia, la resistència a la insulina i la 
hiperleptinèmia. Aquesta condició durant la lactància determina canvis primerencs en el teixit 
adipós i en el fetge, afectant la capacitat lipogènica i oxidativa, i incrementant la sensibilitat a 
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la acció perifèrica de la insulina i la leptina, el que suggereix un millor control del metabolisme 
energètic. Aquestes adaptacions en edats primerenques se varen mantenir parcialment en edat 
adulta, i varen ser particularment més evidents quan els animals es varen exposar a un ambient 
obesogènic. Els animals adults CRL varen mostrar canvis en els nivells d’expressió gènica en 
el teixit adipós i a l’hipotàlem, que varen ser dependents del sexe, suggerint que els mascles 
estaven més protegits enfront a la resistència perifèrica a la insulina induïda per una dieta 
hiperlipídica, així com també mostraren una capacitat millorada per respondre a la leptina a 
nivell central; en canvi, les femelles CRL estaven programades per a una millor sensibilitat a 
l’acció perifèrica de la leptina i a la acció central de la insulina. Utilitzarem aquest model 
animal per a la identificació de biomarcadors primerencs de transcripció, indicadors de salut 
metabòlica millorada, mitjançant l’anàlisi per microarray en cèl·lules mononuclears de sang 
perifèrica (PBMCs); aquestes cèl·lules se poden obtenir fàcilment mitjançant tècniques poc 
invasives, pel que representen una font atractiva per a la identificació de biomarcadors i per 
extrapolar tals biomarcadors d’animals a humans. Pel que fa als factors que podrien estar 
potencialment implicats en els efectes beneficiosos de la restricció calòrica materna durant la 
lactància, l’anàlisi  per cromatografia líquida amb sistema de detecció per espectrometria de 
masses en tadem  de biomarcadors de dany proteic a la llet de mares CRL, suggereix que el 
menor contingut d’adductes lliures de glicació i d’oxidació durant la segona mitat de la 
lactància, en comparació amb la llet de mares control, podria contribuir a explicar els efectes 
beneficiosos observats en les cries d’aquests animals en edat adulta. 
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Introduction 
1. Obesity 
According to World Health Organization (WHO), overweight and obesity are defined as 
abnormal or excessive fat accumulation that presents a risk to health. Clinicians and 
epidemiologist usually rely on body mass index (BMI) that is considered a simple index of 
weight-for-height and commonly used to classify overweight and obesity in adults 
(WHO·2013).  BMI is defined as a person's weight in kilograms divided by the square of his 
height in meters (kg/m
2
). The WHO defines: a BMI of 30 or more is obesity; and a BMI equal 
to or more than 25 is overweight. Nowadays, it is calculated that 400 million adults have a BMI 
exceeding 30 kg/m
2
 and this number is forecast to rise to 700 million by 2030, especially in 
developed countries (Shaw, et al. 2010). 
Overweight and obesity are the fifth leading risk for global deaths. At least 2.8 million adults 
die each year as a result of being overweight or obese (WHO·2013). It is due to the fact that 
obesity is a central factor in development of insulin resistance, Type 2 diabetes and metabolic 
syndrome, and all of which create an increased risk of cardiovascular disease (Rask-Madsen 
and Kahn 2012). Metabolic syndrome itself is characterized by central obesity plus a cluster of 
key risk factors of obesity-related disorders, including impaired glucose tolerance, diabetes 
mellitus, hypertension and dyslipidemia (Alexander, et al. 2003). The WHO defines that 44% 
of the diabetes burden and 23% of the ischemic heart disease burden are attributable to 
overweight and obesity (WHO·2013). Furthermore, a very worrisome fact is the hugely 
increased level of childhood obesity, that is rising with the same pattern that of the adult 
population. In the USA, 10% of preschool children are obese and half of these are thought to 
have impaired glucose tolerance (Rocchini 2002). As childhood obesity is a major risk factor 
for adult obesity, 20% incidence of childhood obesity portents a further increase in the 
prevalence of the also early appearance of Type 2 diabetes [reviewed by (Desai, et al. 2013)]. 
Therefore, obesity and its associated illnesses not only are a rising worldwide health problem, 
but they are also placing nowadays an enormous financial burden on society for the care and 
treatment of patients. It has been calculated that over the next 20 years, the healthcare costs 
attributable to obesity will rise to about 16% of the total of those costs in Western countries 
(Wang, et al. 2011). In this sense, many attempts have been done by researchers to understand 
the biology, aetiology and pathogenesis of obesity. 
The pathogenesis of obesity is very complex. Evidences from twin studies and from adoption 
and family studies strongly support the concept that genes play a central role in the 
determination of BMI and, consequently, in the pathogenesis of obesity [reviewed by (Xia and 
Grant 2013)]. By 2011, nine loci have been recognized to be involved in monogenic forms of 
obesity (Choquet and Meyre 2011). Among these loci, those that encode for leptin, leptin 
receptor, proopiomelanocortin (Pomc) and melanocortin 4 receptor (Mc4r) are relevant because 
a single gene mutation in one of these loci, with a recessive or dominant mode of inheritance, 
has been associated to extremely severe phenotypes of obesity in childhood (Mutch and 
Clement 2006). However, genetic predisposition to obesity for most individuals has a polygenic 
basis, and hence, each single polygene makes a small contribution to the development of 
obesity. Concretely, until know, 58 loci have been described to contribute to polygenic obesity 
(Choquet and Meyre 2011). Among them, common genetic variants with replicable effects on 
obesity susceptibility are: catenin beta like (Ctnnbl1), fat mass and obesity associated (Fto), 
Mc4r, proprotein convertase subtilisin/kexin type 1 (Pcsk1) and insulin-induced gene 2 
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(Insig2). Particularly, the receptor variant with the amino acid isoleucin (wildtype: valine) at 
position 103 of the MC4R represents the first confirmed polygenic variant with an influence on 
body mass index. Moreover, variants in the first intron of the gene Fto confer the most 
pronounced polygenic effect on obesity (Hinney and Hebebrand 2008). Interestingly, recent 
studies in mice have demonstrated that obesity-associated noncoding sequences within Fto are 
functionally connected with the iroquois homeobox 3 gene (Irx3). This finding suggests that 
Irx3 is a functional long-range target of obesity-associated variants within Fto, representing a 
novel determinant of body mass and composition (Smemo, et al. 2014). 
However, over the past few years, obesity in developed countries has been increased too rapid 
to be accounted for only by genetics. Nowadays, it is known that the recent acceleration of 
obesity and overweight incidence is due to a complex interaction among behavioural, 
environmental, and genetic factors which ultimately lead to a chronic energy imbalance that 
favours energy accumulation and excessive weight gain. Obesity is positively associated with 
dietary patterns of western societies, such as increased fat intake, lower fibre consumption, 
increased hidden sugars in prepared foods, reduced amounts of unrefined sugars and an 
inadequate fruit and vegetable intake (Chantel, et al. 2002). Physical activity pattern also plays 
an important role in obesity. Sedentary behaviours, such as prolonged TV watching, video 
game playing, computer use, sedentary nature of many forms of work and increasing 
urbanization have been expanded rapidly in developed countries contributing to obesity 
development (Ogunbode, et al. 2011). Indeed, technological inventions have created many 
time- and labor-saving products. As a result, people have reduced the overall energy 
expenditure in their daily lives, which also contributes to obesity development (Verduin, et al. 
2005).  
In addition to the mentioned interacting factors that lead to obesity development, climbing 
evidence in human and animal models indicate that certain stimuli experienced during early life 
may have an important role programming the risk of obesity and its related metabolic disorders 
(Guilloteau, et al. 2009; Martin-Gronert and Ozanne 2013; Picó, et al. 2012). In particular, it 
has become apparent that early life environment, especially nutrition during critical periods of 
development, such as pregnancy and lactation, can have long-lasting effects programming the 
susceptibility of an individual to develop obesity and other features of the metabolic syndrome 
in adult life. Such programming causes permanent alterations in the development and 
organization of energy balance-related tissues and organs that leads to irreversible changes in 
the structure and function of the body influencing the propensity to obesity and related 
metabolic alterations in adult life (Martin-Gronert and Ozanne 2013). 
Therefore, knowing the consequences of obesity for quality of life, morbidity and health costs, 
it becomes very important to understand the aetiology of obesity as well as to elucidate the 
mechanisms underlying the threatening increase in obesity rates among the adult population, 
and even among children. In this regard, identification of these mechanisms could be the basis 
for the description of early biomarkers which may serve as biological indicators of the 
propensity of an individual to develop obesity later in life. Moreover, identification of the 
mechanisms involved in obesity development could be the tool for developing new strategies to 
prevent or revert the increased risk for obesity. 
 
2. Energy balance regulation  
As described above, obesity results from a prolonged imbalance between energy intake and 
energy expenditure, in favour of energy intake. Energy homeostasis is defined as a coordinated 
balance among food intake, energy expenditure and storage, which maintain stability of the 
 Introduction 
- 5 - 
 
metabolic state. It is under the control of an integrated system that has the capacity to rapidly 
respond to metabolic changes.  
Energy homeostasis is mainly regulated by the central nervous system (CNS), especially by the 
hypothalamus that plays an important role in central regulation of appetite and body 
composition (Brenseke, et al. 2013). In addition, a set of peripheral tissues, such as liver, 
adipose tissue and skeletal muscle, has also been described as metabolic tissues with an 
important role in global energy balance regulation under the control of the CNS (Lee, et al. 
2003; Pang and Han 2012).  
 
2.1. Main tissues involved in maintenance of energy homoeostasis 
2.1.1. Hypothalamus  
The hypothalamus is the portion of the brain located below the thalamus, just above the 
brainstem, that contains a number of small nuclei that produce neuropeptides involved in 
numerous physiological and behavioural functions (Figure 1A). Among them, one of the most 
important functions of the hypothalamus is to link the nervous system to the endocrine system 
via the hypophysis. This connection allows the hypothalamus to be informed about the 
nutritional, energetic and environmental status of the body through peripheral and central 
orexigenic or anorexigenic messages (Valassi, et al. 2008).  
Experimental efforts have been made to understand how the brain regulates energy homeostasis 
and how impaired brain functions contribute to the pathogenesis of obesity, diabetes and related 
metabolic disorders. The specific hypothalamic structures that are directly involved in energy 
homeostasis were identified when a set of systematic lesion experiments were performed in rats 
(Brobeck 1946). In several experiments, various hypothalamic nuclei, including the 
hypothalamic ventromedial (VMN), paraventricular (PVN) and dorsomedial (DMN) nuclei, 
were destroyed. The lesion of these nuclei induced hyperphagia and obesity, whereas lesions in 
the lateral hypothalamus (LH) led to hypophagia. These studies led to the proposal of a “dual 
center model” that identified the hypothalamic VMN as the “satiety center”, and the LH as the 
“hunger center” [reviewed by (Gao and Horvath 2008)].  
The hypothalamic arcuate nucleus (ARC) is located at the base of the hypothalamus around the 
third ventricle and is considered a critical region in food intake and energy homeostasis 
regulation due to various reasons (Elmquist, et al. 1999). Firstly, their neurons, known as “first-
order neurons” have their nerve endings anatomically placed in close proximity to fenestrated 
capillaries at the base of the hypothalamus, giving them access to humoral signals that are 
restricted from other regions of the brain. Indeed, they respond rapidly to fluctuations in 
nutrients and metabolic hormones. Finally, they project broadly to the brain and periphery both 
directly as well as indirectly [reviewed by (Gao and Horvath 2008)].  
ARC neurons are separated in two populations of neurons with opposite effects on feeding 
behaviour. In this sense, there is a family of anorexigenic neurons that co-express cocaine and 
amphetamine-regulated transcript (CART) and pro-opiomelanocortin (POMC), which is the 
precursor for many active neuropeptides including melanocyte-stimulating hormone (α-MSH). 
These, in turn, reduce food intake and body weight as well as increase energy expenditure in 
animals and humans by acting on melanocortin receptor subtypes 3 and 4 (MC3R and MC4R, 
respectively), found to be abundant in the ARC, PVN, LH and DMN. In contrast, there is a 
family of orexigenic neurons that co-express neuropeptide Y (NPY) and Agouti-related peptide 
(AgRP). NPY potently stimulates food intake and reduces energy expenditure. AgRP acts as a 
Juana María Torrens García – Doctoral Thesis 
 
- 6 - 
 
natural antagonist of MC3R and MC4R, and hence reduces the anorectic effect of α-MSH 
[reviewed by (Gao and Horvath 2008)].  
 
Figure 1. A. Anatomical localization of the arcuate nucleus (ARC) and the surrounding hypothalamic nuclei: 
DMN, dorsomedial nucleus; LHA, lateral hypothalamic area; PVN, paraventricular nucleus and VMN, 
ventromedial nucleus.  B. Schematic diagram of the ARC. Two populations of “first-order” neurons, with opposite 
effects on food intake regulation and energy expenditure, are located in the ARC. Anorexigenic neurons, which 
release the neuropeptides Proopiomelanocortin (POMC) and Cocaine and Amphetamine-regulated transcript 
(CART); and the orexigenic neurons, which release the neuropeptides Agouti-related peptide (AgRP) and the 
Neuropeptide Y (NPY). The axons of these neurons project to “second-order” neurons, located mainly in PVN and 
other hypothalamic regions.  Both insulin and leptin are secreted into the bloodstream in direct proportion to body 
fat stores, and both interact with neurons in the ARC. Insulin and leptin activate POMC and CART neurons via 
their respective receptors, insulin receptors (InsR) and leptin receptor (ObRb). This results in the activation of 
downstream catabolic neurons which in turn reduce food intake and increase energy expenditure. Conversely, the 
NPY and AgRP expressing neurons are inhibited by insulin and leptin, reducing the secretion of NPY and AgRP 
which potently stimulate food intake and reduce energy expenditure. Adapted from (Niswender and Schwartz 
2003). 
The axons of ARC neurons project to “second-order” neurons located in various parts of the 
brain, such as PVN and LH, where there are substantial numbers of MCR3 and MCR4. The 
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projection from the ARC to the PVN is important for the regulation of neurons that produce the 
anorexigenic substances, such as corticotropic and thyrotropin releasing hormones (CRH and 
TRH respectively), and for the modulation of sympathetic activity, both of which are 
significant mechanisms in energy metabolism. The projection from the ARC to the LH is 
important for the production of orexant molecules, such as melanin-concentrating hormone 
(MCH) and orexines (Valassi, et al. 2008). 
Hypothalamus, and particularly the hypothalamic ARC structure, integrates the peripheral 
information of hormones (insulin, ghrelin and leptin) and nutrients, such as glucose, to maintain 
energy balance (Breton 2013; Morton, et al. 2006). Concretely, leptin and insulin act at 
hypothalamic level by binding to its respective receptors, the long form of leptin receptor 
(ObRb) and insulin receptor (InsR) respectively, which  have been localized in the ARC 
(Baskin, et al. 1998). Both receptors are linked to the phosphatidylinositol 3-kinase (PI3K) 
pathway and reduce the expression and release of the orexigenic peptides (NPY and AgRP) and 
activate anorexigenic peptides (CART and POMC) (Figure 1B). 
In addition, other hypothalamic nuclei, especially the PVN, may in turn also modulate energy 
expenditure such as lipolysis and/or thermogenesis in adipose tissue, via the sympathetic 
autonomic nervous system (Fliers, et al. 2003). 
 
2.1.2. White adipose tissue  
White adipose tissue (WAT) is the major body’s energy storage. The main form of energy 
storage is represented by high amounts of triglycerides (TGs) in adipocyte lipid droplets 
(Daval, et al. 2006). The stored TGs are derived from fatty acids which can be either taken up 
from the diet or synthesized within adipocytes by de novo synthesis from non-lipid substrates 
(Fliers, et al. 2003). In order to take up fatty acids from plasma, adipocytes synthetize a specific 
insulin-stimulated enzyme called lipoprotein lipase (LPL), which is exported to the luminal 
side of vascular endothelium where it can hydrolyse TG-rich lipoproteins such as chylomicrons 
and very low density lipoproteins (VLDLs) to yield fatty acids and free glycerol. Fatty acids 
enter into the adipocytes through transporters and are re-esterified with glycerol phosphate to 
form TGs stored in a single lipid droplet in white adipocytes (Daval, et al. 2006). In addition, 
glucose also provides the glycerol backbone for TG (Aguilera, et al. 2008). Fatty acids can also 
be de novo synthesized from glucose, however, the rate of synthesis of fatty acids from glucose 
in humans is lower than in rodents (Aguilera, et al. 2008). When food is available, via lipogenic 
pathways, adipocytes store excess of energy as TGs to guarantee the survival in periods of 
increased energy expenditure or decreased energy availability. Conversely, when energy is 
needed, TGs are hydrolysed into fatty acids and glycerol, which are exported back into the 
blood, via activation of lipolytic pathways mainly driven by noradrenergic innervation (Breton, 
2013). The key enzymes of norepinephrine-stimulated lipolysis are adipose tissue triglyceride 
lipase (ATGL), which is the main protein involved in the catalysis of the initial step in TG 
hydrolysis in adipocyte lipid droplets, and hormone-sensitive lipase (HSL), which hydrolyses 
stored TGs to free fatty acids as well as several other lipids stored in WAT. Particularly, HSL is 
regulated by numerous factors and hormones through several mechanisms, including reversible 
phosphorylation via noradrenergic innervation. This phosphorylation stimulates adenylate 
cyclase and increases intracellular levels of cyclic adenosine monophosphate (cAMP). Then, 
cAMP activates protein kinase A (PKA) which in turn phosphorylates and activates HSL. 
Although ATGL works in conjunction with HSL, its activity is not dependent on PKA 
phosphorylation (Daval, et al. 2006).  
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In addition to its functions related to energy storage and release, WAT plays a key role as an 
endocrine organ controlling energy homeostasis and substrate partitioning (Daval, et al. 2006). 
WAT is involved in steroid hormone metabolism and glucocorticoid metabolism. Moreover, 
WAT produces adipocytokines, such as leptin and adiponectin; other hormones, like resistin; 
appetite-regulating related peptides, and proteins from the renin-angiotensin system. Among all 
of them, resistin has been linked with insulin resistance induction while adiponectin has been 
associated with insulin sensitivity enhancement (Fliers, et al. 2003). Some of these circulating 
factors act in an autocrine/paracrine manner as adipocyte lipid metabolism regulators, while 
some of them act as peripheral endocrine signals to regulate energy homeostasis at 
hypothalamic level, as leptin (Breton 2013). 
Finally, adipose tissue also secretes other proteins that may be of interest in view of the 
association between obesity and cardiovascular risk inflammatory. Among them, there are 
cytokines such as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNFα), and several 
coagulation and complement factors, such as plasminogen activator inhibitor-1 (the key 
modulator of the fibrinolytic pathway), tissue factor (the most powerful activator of the 
coagulation system) and fibrinogen-angiopoietin-related protein (a regulator of angiogenesis 
and modulator of tumorigenesis) (Fliers, et al. 2003; Trayhurn and Beattie 2001). Concerning, 
IL-6 and TNFα, these cytokines are involved in systemic inflammation and also appears to 
participate in the induction and maintenance of the subacute inflammatory state associated with 
obesity. Moreover, TNFα is overproduced in fatty liver and participates in the development of 
insulin resistance (Shoelson, et al. 2006) and IL-6 can also favour insulin resistance in insulin 
sensitive tissues.  
 
2.1.3. Liver 
Liver is recognized as a metabolic, endocrine and exocrine organ that is responsible for many 
vital functions, including formation of bile salts, excretion of bilirubin and cholesterol, blood 
detoxification and purification, immunological processes and production of critical coagulation 
factors, serum proteins and hormones. In addition, due to the fact that all the blood coming 
from the digestive system passes through the hepatic portal vein, liver also plays an important 
role in storage of energy and nutrients obtained from blood, as well as in the metabolism of 
lipids, proteins and carbohydrates. In this sense, alterations in the ability of the liver to properly 
regulate lipid metabolism and glucose homeostasis are the heart of the deleterious 
consequences of obesity and insulin resistance (Brock and Dorman 2007). 
Regarding lipid metabolism and transport, liver is considered the most dynamic organ of the 
body and the key site of metabolic integration (Brock and Dorman 2007). Liver is able to 
acquire fat and cholesterol from the diet. Concretely, dietary TGs and cholesterol are 
transported from the intestine in the form of chylomicrons. Rapidly, the TGs in the lipid core of 
the chylomicrons are hydrolysed at the capillary surface by the enzyme LPL, which yields 
smaller particles known as chylomicrons remnants. The released free fatty acids are used either 
for storage in adipose tissue or for oxidation in other tissues, while dietary cholesterol is 
transported in the chylomicrons remnants to liver (Gotto 1990; Sandhofer 1994). Cholesterol 
and TG are also synthesized in the liver and then secreted into the blood in the form of VLDL. 
TGs from VLDL particles are also hydrolysed by the enzyme LPL, to yield intermediate 
density lipoproteins (IDL) which are either taken up by the liver or further catabolized to low-
density lipoprotein (LDL). These LDL are bound and taken up by specific receptors in the liver 
and many other tissues; by this pathway, cholesterol is transported from the liver to peripheral 
tissues (Sandhofer 1994). Moreover, when hepatic glycogen stores are in a state of excess, liver 
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synthetises de novo fatty acids by deviation of acetyl-CoA to the fatty acid synthase complex 
(FASC), located within the cytoplasm of hepatocytes. Hepatic fatty acids are stored in the form 
of TGs, by esterification of acetyl-CoA with glycerol-3-phosphate. Once formed, these TGs are 
packaged to form VLDL, which are transported out of the liver and back to peripheral 
adipocytes. In general, there is an equilibrium of fatty acids between the peripheral adipocytes 
and the liver without any appreciable accumulation of lipids [reviewed by (Brock and Dorman 
2007)].  
Furthermore, liver influences strategically glucose homeostasis through a delicate balance 
between hepatic glucose production through glycogenolysis and gluconeogenesis during the 
fasted state, and hepatic glucose uptake, storage and utilization in the fed state. Transitions 
between the two states in liver are possible due to the joined physiological action of insulin and 
glucose promoting the expression of genes normally induced during the fed state and down-
regulating the expression of genes normally activated during the fasted state (Collier and Scott 
2004). On the one hand, representative genes expressed during the fed state are: glucokinase 
(Gck), liver pyruvate kinase (Pkl), 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 
(Pfkfb2), acetyl-coenzyme A carboxylase (Acc), and fatty acid synthase (Fasn). On the other 
hand, the representative genes that are activated during the fasted state are: 
phosphoenolpyruvate carboxykinase (Pck1), fructose-1,6-bisphosphatase (Fbp1), and carnitine 
palmitoyl transferase 1 and 2 (Cpt1 and Cpt2) [reviewed by (Collier and Scott 2004)]. The 
transcription factor, peroxisome proliferator-activated receptor alpha (PPARα) plays an 
important role in liver regulating directly the expression of genes involved in fatty acid uptake, 
such as the gene encoding the fatty acid transport protein (Fatp) and fatty acid binding protein 
(Fabp). In addition, PPARα also regulates the genes involved in plasma VLDL TG hydrolysis, 
such as Lpl, and also β-oxidation-related genes, such as Cpt1a and acyl-CoA oxidase 1 (Acox1) 
(Lee, et al. 2003; Martin, et al. 2009; McIntosh, et al. 2013). 
While in the fed state the fuel source are carbohydrates and fats, in the fasted state, the main 
fuel source shift to fats. Fatty acids that were stored during feeding are released from the 
adipocyte and taken up by the liver. There, they are either reestirified to TGs and assembled 
into VLDL or broken down through mitochondrial hepatic fatty acid oxidation (FAO) and used 
to generate ketone bodies (Lee, et al. 2003). 
Mitochondrial FAO represents a crucial process in energy metabolism. Hepatic FAO is tightly 
regulated by interaction between the key enzyme CPT1A and the ACC via intermediate 
malonyl-CoA (McGarry, et al. 1977). Malonyl-CoA, derived from glucose metabolism, is the 
first intermediate in lipogenesis and regulates FAO by inhibiting CPT1A. CPT1A is localized 
in the outer mitochondrial membrane and expose its active site at the cytosolic face of the 
mitochondria (Schreurs, et al. 2010). CPT1A regulates the transfer of long-chain acyl-CoAs 
from the cytosol into the mitochondria, where they are oxidized. Considering this and taking 
into account that obesity results from a chronic imbalance between energy intake and energy 
expenditure, which leads to fat accumulation in lipid deposits, strategies able to tilt the energy 
balance towards FAO could be considered as potential ways  to treat or prevent obesity and 
related metabolic disorders. In this regard, genetic studies that increased hepatic FAO have 
been already developed. On the one hand, in vitro studies showed that hepatocytes transduced 
with adeno-associated viruses (AAV) encoding carnitine palmitoyltransferase 1a (CPT1a) 
increased the rate of β-oxidation that, in turn, led a decrease in TG content in liver (Stefanovic-
Racic, et al. 2008). In other studies, the gene of Cpt1a was transferred into obese mice by 
injecting AAV vectors into the tail vein. This led to a nonimmunoreactive long-term increase in 
lipid oxidation. Concretely, Orellana-Gavaldà et al. used a mutant but permanently active form 
of CPT1A, the CPT1AM, which is insensitive to malonyl-CoA and therefore leads to a 
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permanent increase in the rate of FAO, independently of the glucose-derived malonyl-CoA 
levels. The results of this study showed than an increased hepatic FAO through AAV-mediated 
gene transference of Cpt1a or Cpt1am reduced obesity-induced hepatic steatosis, weigh gain, 
inflammation, diabetes, glucose levels and insulin resistance in mice consuming a high-fat (HF) 
diet (Orellana-Gavaldà, et al. 2011).  
 
2.1.4. Skeletal muscle 
Skeletal muscle is a major mass peripheral tissue that accounts for approximately 40% of the 
total body mass. Skeletal muscle serves for overlapping functions, such as movement, posture, 
stability, communication, heat production, and cold tolerance (Smith and Muscat 2005). As the 
motor of the body, muscle requires considerable amounts of energy in the form of ATP. Muscle 
can burn energy faster than can be produced within the cell necessitating a buffer system that 
uses creatine kinase (CKM) to transfer a high-energy phosphate from phosphocreatine stores to 
ADP to form ATP. For short bursts of activity, skeletal muscle relies upon glycolysis for ATP 
production, which is the primary form of energy obtaining (Smith, et al. 2013).  
In addition to these functions, skeletal muscle is being recognized also as an endocrine organ 
because expresses and releases into the circulation several cytokines that exert their effect in 
other parts of the body (Tomas, et al. 2004). These cytokines have been coined “myokines” and 
are for example, IL-6 and IL-15 (Smith and Muscat 2005). Concretely, IL-6 is able to sense the 
energy demands in muscle and signal to central and peripheral organs to maintain energy 
supply. In this sense, sustained and intense exercise induces skeletal muscle to express and 
release IL-6 into the circulation, especially when glucose and glycogen stores are low. Then, 
IL-6 stimulates 5' adenosine monophosphate-activated protein kinase (AMPK) activity which 
activates lipolysis in adipose tissue, inhibits TNFα, and also improves insulin sensitivity 
[reviewed by (Smith and Muscat 2005)].  
Skeletal muscle is also a metabolic flexible tissue and has an essential role in energy balance 
because is the primary tissue of insulin stimulated glucose uptake, disposal, and storage in form 
of glycogen, even four-fold the glycogen content of liver. Moreover, skeletal muscle regulates 
cholesterol efflux and highly influences metabolism via modulation of circulating and stored 
lipid flux (Smith and Muscat 2006).  
Fatty acids and glucose are the main energy sources in muscle. Particularly, during initial 
aerobic exercise, skeletal muscle uses as energy fuel the stored muscle glycogen which is 
broken down back into glucose via the enzyme glycogen phosphorylase; then, glucose is 
broken down into pyruvate during glycolysis providing the required energy in the form of ATP. 
If exercise continues, then, glucose from glycogen and stored muscle TGs become important 
energy substrates, and muscle must utilize the more efficient oxidative phosphorylation 
process. In this regard, pyruvate conversion to acetyl-CoA by pyruvate dehydrogenase allows 
progression through the tricarboxylic acid (TCA) cycle and subsequent oxidative 
phosphorylation to obtain energy. Concerning stored muscle TGs, the enzyme HLS is 
responsible for triglyceride breakdown to free fatty acids in muscle; the released free fatty acids 
are then transported into the mitochondria to undergo β-oxidation and produce acetyl-CoA and 
NADH (Smith, et al. 2013).  If exercise is prolonged over long periods, then fatty acids and 
lipid mobilization from other tissues are increasingly needed (Smith and Muscat 2005).  
Therefore, given the fact that skeletal muscle can utilize both carbohydrate and lipid energy 
substrates and considering the relative mass of the tissue, it is hardly surprising that normal or 
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abnormal skeletal muscle metabolism has an important impact on insulin sensitivity, on blood 
lipid profile and on the pathogenesis of metabolic diseases (Smith and Muscat 2006).  
 
2.2. Main hormones involved in maintenance of energy homoeostasis  
A growing body of evidence suggest that hormones produced by adipose tissue, such as the 
adipocytokine leptin, and other hormones, such as the pancreatic insulin, play a critical role in 
the regulation of energy intake, energy expenditure and lipid and carbohydrate metabolism 
(Havel 2004). Understanding the biological actions, regulation and signalling mechanisms of 
these hormones will provide insights into the pathogenesis and treatment of obesity and its 
related metabolic disorders, particularly insulin and leptin resistance.  
 
2.2.1. Leptin 
Leptin, the ob gene product, is a protein of 167 amino acids. It is synthesized mainly by white 
adipocytes, but low levels are also produced in the stomach (Cinti, et al. 2001), placenta 
(Masuzaki, et al. 1997), skeletal muscle (Wang, et al. 1998) and mammary epithelium (Smith-
Kirwin, et al. 1998). The concentrations of leptin in adipose tissue and plasma are closely 
parallel to the mass of adipose tissue and adipocyte size and TG content. Thus, leptin increases 
in obesity and falls with weight loss (Ahima, et al. 2000).  
Circulating leptin plays a pivotal role in control of body weight and energy metabolism by 
communicating the body fuel availability to the CNS to adapt energy homeostasis (Pang and 
Han 2012). Leptin is secreted into blood, enters the brain in proportion to its plasma levels and 
reaches neuronal targets via a saturable transport mechanism across the blood-brain barrier 
(Banks, et al. 1996). Once in the CNS, leptin binds its receptors, ObRb, in the ARC and 
regulates energy homeostasis by stimulating the expression of the anorexigenic neuropeptides 
(POMC and CART) and by inhibiting the expression of the orexigenic neuropeptides (NPY and 
AgRP). These ARC neurons project on to “second-order” neurons, in the PVN and DMN 
(Schwartz, et al. 2000), to modulate glucose homeostasis, suppress feeding, stimulate 
thermogenesis and enhance lipid oxidation and insulin sensitivity in peripheral organs (Ahima 
and Lazar 2008). This leads to prompt appropriate regulation of food intake and energy 
expenditure processes and help our body to maintain the amount of fat stores within a certain 
range (Martin-Gronert and Ozanne 2013).  
Concerning leptin signal transduction pathway (Figure 2), when it binds to the extracellular 
domain of the leptin receptor, activates Janus-activated Tyrosine Kinase 2 (JAK2) which leads 
to autophosphorylation of tyrosine residues on JAK2 and phosphorylation of Tyr
985
, Tyr
1077
, 
and Tyr
1138
 on leptin receptor. Phosphorylation of Tyr
1138
 mediates the activation and nuclear 
translocation of the signal transducer and activator of transcription 3 (STAT3), which induces 
the transcription of neuropeptides in the hypothalamus as well as of the suppressor of cytokine 
signalling 3 (SOCS3), which terminates leptin signalling (Ahima and Lazar 2008). Leptin also 
activates PI3K, which induces the synthesis of phosphatidylinositol-3,4,5-triphosphate (PIP3) 
from phosphatidylinositol-4,5-biphosphate (PIP2). Accumulation of PIP3 leads to 3-
phosphoinositide-dependent protein kinase 1 (PDK1) activation, and thus activates protein 
kinase B (PKB, also known as AKT). Activation of both pathways has been shown to be 
required for proper regulation of energy and glucose homeostasis (Konner and Bruning 2012) 
In addition to its central anorexigenic actions, leptin also has a peripheral role as a mediator of 
energy expenditure acting in a paracrine/autocrine way in a range of cell types (Margetic, et al. 
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2002). Particularly, leptin receptors have been found in liver, adipose tissue, heart, kidneys, 
lungs, small intestine, pituitary cells, testes, ovaries, spleen, pancreas and adrenal gland 
[reviewed by (Margetic, et al. 2002)]. Then, when leptin binds to its cell-membrane receptors, 
induces the phosphorylation of STAT3 via the same signal transduction pathway as in the 
hypothalamus. Hence, once STAT3 is activated, it penetrates into the nucleus and regulates the 
transcriptional activity of leptin-controlled genes in the target tissues (Aguilera, et al. 2008). 
Leptin is currently considered the major liporegulatory hormone, maintaining the normal 
intracellular lipid homeostasis (Aguilera, et al. 2008). Leptin avoids accumulation of TGs 
outside the adipose tissue, increasing glucose uptake, glycogen synthesis and lipid partitioning 
at skeletal muscle (Ahima and Lazar 2008; Houseknecht, et al. 1998). Particularly, leptin limits 
accumulation of TGs in muscles and liver, at least in part, stimulating FAO through AMPK 
activation (Daval, et al. 2006). In this sense, AMPK, activated by leptin, phosphorylates the 
enzyme malonyl-CoA decarboxylase and the lipogenic enzyme ACC, which is involved in the 
initial phase of fatty acid synthesis. These phosphorylations result in the activation of malonyl-
CoA decarboxylase and the inhibition of ACC, leading to decreased levels of malonyl-CoA. 
Inhibition of malonyl-CoA formation, in turn, increases the activity of the CPT1, because 
malonyl-CoA is the physiological allosteric inhibitor of the CPT1. This results in the inhibition 
of lipid synthesis and in the enhancing of the mitochondrial FAO (Ahima and Lazar 2008).  
In addition, leptin also down-regulates the activity of lipogenic transcription factors, mainly 
peroxisome-proliferator-activated receptor-gamma2 (PPARɣ2), which is essential for 
adipogenesis, and, in liver cells, the sterol-regulatory-element-binding protein (SREBP1c), 
which regulates cholesterol and lipid synthesis (Sampath and Ntambi 2006). Hence, down-
regulation of these transcription factors results in a decreased expression of the Acc and Fasn, 
and an increased expression of key enzymes involved in FAO, such as Acox and Cpt1, 
particularly in adipose tissue. Moreover, AMPK activation in skeletal muscle by leptin also 
appears to be related with enhancement of the intracellular expression of PPARɣ co-activator 
1α (PGC-1α), which facilitates glucose entry and ensures its effective utilization by increasing 
the expression of genes involved in oxidative phosphorylation. In addition, PGC-1α has 
emerged as a key regulator of mitochondrial biogenesis along with AMPK [reviewed by 
(Roman, et al. 2010)].  
Furthermore, another physiological effect of leptin is the inhibition of insulin secretion in 
pancreatic β-cell by activation of cyclic nucleotide phosphodiesterase 3B through the PIP3 
signalling transduction pathway (Zhao, et al. 1998). In addition, leptin also exerts multiple 
autonomic and cardiovascular effects, including activation of sympathetic nerve activity, 
increasing levels of endothelium-derived nitric oxide, and promoting angiogenesis [reviewed 
by (Konner and Bruning 2012)]. 
All in all, leptin is a peripheral hormone that acts centrally, at hypothalamic level, as an 
anorexigenic hormone modulating feeding patterns and energy expenditure. Besides of its 
central effects, leptin also acts peripherally regulating the entire body weight, and has 
antisteatotic effects by maintaining lipid homeostasis (Huan, et al. 2003).  
 
Leptin during the perinatal period 
As above mentioned, the main source of leptin in adults is the adipose tissue and its principal 
role is energy balance regulation. In neonates, serum leptin levels vary dramatically, because 
their mothers are contributing to the supply of leptin through the placenta during the gestational 
period and through breast milk during lactation (Cinti, et al. 2001; Palou and Picó 2009; Pico, 
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et al. 2011). However, neonatal leptin is not fully functional in the regulation of energy balance 
but has basically a developmental role, acting as an important neurotropic factor that facilitates 
the development of the neuronal hypothalamic circuits that govern metabolism, adipose tissue 
distribution and food intake (Keen-Rhinehart, et al. 2013; Remmers and Delemarre-van de 
Waal 2011).  
At birth, circulating leptin levels in rodents are very low. However, several studies have shown 
that there is a surge in plasma leptin concentration, with a 5- to 10-fold increase in leptin, 
occurring around postnatal days 4-10 (Ahima, et al. 1998), the time when connections between 
hypothalamic neurons are developing. Nevertheless, despite this elevation in plasma leptin 
levels, neonates maintain a high level of food intake, and the responses to exogenous leptin 
administration are absent, until around the time of weaning. This is due to the fact that during 
this period leptin has no effect on appetite, but it seems to exert direct neurotropic actions, 
promoting neurite outgrowth and the establishment of hypothalamic circuitry, instead of 
regulating energy balance (Cottrell, et al. 2010).  
Recent studies provide convincing evidence that leptin specifically promotes the development 
of axonal projections from ARC to PVN since day 4 of postnatal life, increasing inhibitory 
synapses and reducing excitatory synapsis in the hypothalamus, and hence, affecting sensitivity 
to this hormone in adulthood [reviewed by (Keen-Rhinehart, et al. 2013)]. In this sense, a 
disruption in the postnatal leptin surge can alter the formation of neuronal pathways and can 
contribute to the later development of obesity (Martin-Gronert and Ozanne 2013). In fact, in 
leptin-deficient ob/ob mice, the aforementioned projection pathways regulating appetite are 
permanently disrupted causing reducing ARC axonal densities (Ahima, et al. 2000) and 
reducing AgRP and α-MSH fibre density in the PVN. This effect is reversed by chronic leptin 
injection during the first week of life (Bouret 2009).  
Besides the role of leptin promoting the development of ARC neuronal projections, leptin is 
also required for normal neuronal and glial maturation in the mouse nervous system (Ahima, et 
al. 1999), adult neuronal hippocampal neurogenesis (Garza, et al. 2008) and dendrite formation 
(O'Malley, et al. 2007). In this sense, neonatal leptin surge has been related with neuron 
differentiation and migration, whereas low leptin levels have been associated with the 
maintenance of neural progenitor cells (Udagawa, et al. 2007). 
Magnitude and timing of the leptin surge can be changed by maternal and neonatal nutritional 
environment during the perinatal period, such as maternal nutrient restriction (Martin-Gronert 
and Ozanne 2013). On the one hand, perinatal undernutrition, especially during fetal life, has 
been shown to result in a drastic reduction or even lack of plasma leptin surge in rats and 
increased hypothalamic ObRb protein expression at birth. This leads to permanent changes in 
hypothalamic ingestive behaviour circuits (Cottrell, et al. 2010; Delahaye, et al. 2008; Keen-
Rhinehart, et al. 2013). Moreover, maternal isocaloric low-protein diet during gestation, which 
is associated with intrauterine growth retardation of their offspring, has also been described in 
rats to reduce and delay normal leptin surge in offspring from dams fed an isocaloric low-
protein diet (Bautista, et al. 2008). On the other hand, subcutaneous injection of leptin (2.5 μg/g 
body weight/day), from 5.5 to 10.5 days of age, has been shown to induce a premature leptin 
surge in intrauterine normal nourished mice. This unexpectedly led to accelerate weight gain of 
these animals under HF-diet feeding conditions (Yura, et al. 2005). Therefore, a premature 
leptin surge seems to be associated with an early-onset ARC leptin resistance, which can 
permanently alter central regulation of food intake, leading to accelerated HF-diet-induced 
obesity [reviewed by (Picó, et al. 2012)]. 
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Leptin resistance 
A majority of obese individuals are leptin resistant because they have increased levels of leptin, 
however, they do not respond to rising endogenous leptin levels, concerning its anorexigenic 
action via the ARC of the hypothalamus. Hence, leptin resistance is defined as the reduced 
ability of leptin to suppress appetite and weight gain (Ahima, et al. 2000; Zhou and Rui 2013). 
Therefore, leptin resistance has been considered as the main risk factor for the pathogenesis of 
overweight and obesity and may represent an integrated marker for the inextricably linked 
disease states of obesity, metabolic syndrome, insulin resistance, type II diabetes, hypertension, 
atherothrombosis and myocardial disease (Martin, et al. 2008) 
Several mechanisms have been proposed to explain leptin resistance, among them, are of 
interest: genetic mutations, impairment in leptin transportation across the blood-brain barrier, 
reduction of leptin-mediated JAK2-STAT3 signalling, reduction of the levels of leptin receptor 
in the cell surface and induction of negative regulators such as SOCS3 (Martin, et al. 2008; 
Zhou and Rui 2013).    
Concerning genetic mutations, a mutation in the ob gene producing leptin that is secreted but is 
ineffective at the signalling level, can lead to hyperleptinemia and leptin resistance. Similar 
results are observed if mutations in the gene encoding for the leptin receptor occur. In this 
sense, Zucker rats have dysfunctional leptin receptors, fact that causes hyperleptinemia and 
leptin resistance (Chen, et al. 1996). Such mutations in a single gene are uncommon in the 
typical obese population, although some cases have been found in humans. However, 
polygenetic inheritance patterns in other gene products, exerting influence on the leptin axis, 
are significantly contributing to the genetic predisposition to leptin resistance (Martin, et al. 
2008). In this sense, deficiency of leptin, leptin receptor and STAT3 in POMC neurons induces 
hyperphagia and impairs thermogenesis leading to morbid obesity (Ahima, et al. 2000). In 
contrast, the loss of orexigenic peptides, attenuates obesity in leptin-deficient ob/ob mice 
(Ahima and Lazar 2008).  
Most recently, the concept of “leptin resistance” has been challenged by an alternative concept, 
the “hypothalamic leptin insufficiency” (Rabe, et al. 2008). The major assumption of this 
postulation is that the blood-brain barrier restricts the leptin transport between the bloodstream 
and the brain neurons in response to hyperleptinemia, resulting in leptin insufficiency at 
multiple target sites in the brain (Rabe, et al. 2008) 
Attenuation of leptin sensitivity in the brain leads to excess lipid accumulation in adipose 
tissue, muscle, liver and also in pancreas. This results in impaired insulin sensitivity and 
secretion (Rabe, et al. 2008). This lipid storage, as it occurs in obesity and the metabolic 
syndrome, is promoted because AMPK fails to inhibit ACC; this results in elevation of 
malonyl-CoA levels and in a simultaneous blockage of the FAO through inhibition of CPT1, 
leading to an increase in the synthesis of TGs and fatty acids [reviewed by (Aguilera, et al. 
2008)]. Moreover, excess lipid accumulation also leads to formation of ceramide and various 
lipid metabolites that ultimately impair insulin sensitivity in liver and muscle, as well as insulin 
secretion (Ahima and Lazar 2008). 
In addition, hyperleptinemia also can contribute to the development of hypertension with 
simultaneous resistance to the metabolic actions of leptin. In this sense, transgenic mice 
overexpressing leptin (whose elevated plasma leptin levels are comparable to those seen in 
obese subjects) exhibit elevated systolic blood pressure and urinary catecholamine excretion 
[reviewed by (Konner and Bruning 2012)]. 
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2.2.2. Insulin  
Insulin is a polypeptide of 51 amino acids produced by pancreatic β-cells in the islets of 
Langerhans. Insulin is secreted in response to an increase in glucose concentration and acts 
principally in peripheral organs regulating glucose homeostasis, lipid homeostasis, synthesis of 
proteins and gene expression (Niswender and Schwartz 2003). In addition to its peripheral 
functions, it has been more recently discovered that insulin, like leptin, is also involved in 
energy homeostasis, through their central action in the ARC [reviewed by (Pang and Han 
2012)].  
Insulin acts peripherally regulating glucose homeostasis by inhibiting endogenous glucose 
production and stimulating glucose uptake in liver, skeletal muscle and WAT. Concretely, 
insulin action on hepatocytes suppresses gluconeogenesis and glycogenolysis, and increases 
glycolysis and glycogen synthesis, resulting in decreased glucose output from the liver (Konner 
and Bruning 2012).  
Insulin also regulates lipid homeostasis. Particularly, insulin is an antilipolytic agent and the 
main activator of energy storage in WAT, up-regulating lipogenesis (Cripps, et al. 2005). In 
this sense, mice with adipocyte-specific knockout of the Insr gene have a decrease in the ability 
of insulin to suppress lipolysis, as well as impaired insulin-stimulated glucose uptake and TG 
synthesis in adipocytes; therefore, these mice showed a reduction in fat mass and protection 
against obesity induced by a HF-diet or hypothalamic injury (Bluher, et al. 2002). Insulin 
effects on hepatic lipogenesis are predominantly mediated by SREBP1c, which in turn 
increases transcription of genes required for cholesterol, fatty acid, TG and phospholipid 
synthesis, such as Acc and Fasn  (Rask-Madsen and Kahn 2012).  
Furthermore, insulin also plays an important role in myeloid cells (monocytes, macrophages 
and neutrophils) regulating macrophage invasion in WAT and the development of obesity-
associated insulin resistance. Therefore, deletion of the InsR in myeloid cells has shown to 
cause reduced accumulation of macrophages in WAT during HF feeding; as consequence, 
animals with deletions of the Insr gene have reduced circulating levels of TNFα, reduced 
activation of stress kinases in muscle, and are protected from the development of insulin 
resistance upon HF-diet feeding (Rask-Madsen and Kahn 2012).  
In addition to its multiple peripheral functions, insulin, like leptin, also plays a pivotal role in 
the CNS, concretely, at hypothalamic level, regulating body weight, energy homeostasis, 
peripheral fat and glucose metabolism (Konner and Bruning 2012; Pang and Han 2012). 
Circulating insulin is transferred to the CNS using a receptor-mediated mechanism across the 
blood-brain barrier in proportion to its circulating levels (Baura, et al. 1993). Once in the CNS, 
insulin acts via its receptor (InsR) in the ARC, and regulates energy homeostasis by stimulating 
the expression of the anorexigenic neuropeptides (POMC and CART) and by inhibiting the 
expression of the orexigenic neuropeptides (NPY and AgRP) (Pang and Han 2012). 
Insulin triggers its transduction pathway by activating its intrinsic tyrosine kinase activity 
(Figure 2), after binding its receptor, leading to tyrosine phosphorylation of the insulin receptor 
substrate (IRS) (Baskin, et al. 1998; Valassi, et al. 2008; Varela and Horvath 2012). 
Interestingly, insulin signalling pathway converges here with the leptin signalling pathway, the 
activation of PI3K (Havel 2004). Therefore, PI3K pathway is likely to mediate common actions 
of insulin and leptin as peripheral signals that converge on the CNS in the hypothalamic 
regulation of energy balance, metabolic homeostasis and feeding and neuroendocrine functions 
(Davis, et al. 2010). In addition, PI3K pathway of insulin signalling also results in AKT 
activation, which leads to prompt several cellular events, such as stimulation of glycogen 
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synthesis, inhibition of gluconeogenesis, and stimulation of glucose uptake (Konner and 
Bruning 2012) . 
 
Figure 2. Schematic insulin and leptin intracellular signal transduction. Insulin receptor (InsR) is a disulfide-
bonded dimer with two α and β subunits. Upon insulin binding to the extracellular portion of α subunits, a tyrosine 
kinase intrinsic to the intracellular β subunit is activated leading to phosphorylation of multiple tyrosine residues 
on β subunits. Phosphorylation of these residues creates a binding site for insulin receptor substrate (IRS) proteins. 
Then, IRS proteins bind to and activate the enzyme phosphatidylinositol 3-kinase (PI3K) which phosphorylates 
phosphatidylinositol (4,5) bisphosphate (PIP2) to phosphatidylinositol (3,4,5) triphosphate (PIP3). PIP3 in turn 
recruits and activates numerous other downstream molecules including phosphor-inositide dependent kinase 1 
(PDK1), protein kinase B (PKB/AKT), and protein kinase C (PKC). The leptin receptor (ObRb) belongs to the 
cytokine receptor family and consists of a single membrane spanning domain. When leptin binds to its receptor, it 
induces activation of Janus Kinase 2 (JAK2) by autophosphorylation of tyrosine residues on JAK2, allowing 
receptor dimerization. Then, JAK2 phosphorylates residues of Tyr
985
, Tyr
1077
, and Tyr
1138
 on the intracellular 
portion of the ObRb. Signal transducer and activator of transcription 3 (STAT3) molecules are then recruited via 
phosphotyrosine binding, and are, in turn, activated by tyrosine phosphorylation mediated by JAK2. Activated 
STAT3 dimerizes, translocates to the nucleus, and activates the transcription of target genes. Suppressor of 
cytokine signalling 3 (SOCS3) molecules are synthesized in response to STAT3 activation and terminates leptin 
signalling. Leptin also activates PI3K signalling via JAK2 mediated phosphorylation of IRS proteins. Adapted 
from (Niswender and Schwartz 2003). 
 
Insulin resistance 
Insulin resistance is a term that describes the inability of the pancreatic hormone insulin to 
maintain glucose homeostasis. Insulin resistance has been linked to obesity and other several 
clinical conditions such as hypertension, increased adiposity in the visceral region, 
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dyslipidemia, atherosclerosis, cardiovascular disease, polycystic ovaries syndrome and cancer 
[reviewed by (Konner and Bruning 2012)].  
The link between obesity and insulin resistance is well recognized (Figure 3). A positive 
energy balance leads to increased storage of fat in adipose tissue; however, with the 
development of obesity the ability of adipocytes to store TGs is impaired or exceeded. As 
consequence, fat is stored in other cell types, including liver and skeletal muscle. Ectopic lipid 
and their metabolites or increased concentrations of circulating free fatty acids cause insulin 
resistance in muscle and other peripheral tissues (Rask-Madsen and Kahn 2012). Moreover, 
WAT is infiltrated with mononuclear cells and other immune cells because adipocytes express 
monocyte chemoattractant protein-1 and other cytokines. This infiltration can also be produced 
in response to adipose tissue hypoxia or adipocyte death. Consequently, it is established a 
chronic inflammatory state and hence, proinflammatory cytokines, such as TNFα and IL-6, are 
released promoting insulin resistance in skeletal muscle, liver and other tissues (Rask-Madsen 
and Kahn 2012; Sell, et al. 2006).  
Resistance to the effects of insulin represents a key process in the development of type II 
diabetes mellitus. In the prediabetic state, pancreatic β-cells can increase insulin secretion in 
order to compensate for insulin resistance and to maintain glucose homeostasis (compensatory 
hyperinsulinemia). Nevertheless, if this condition persists, β-cell dysfunction occurs and insulin 
secretion is suppressed, hence, glucose homeostasis gets impaired and type II diabetes mellitus 
becomes established (Konner and Bruning 2012). 
In skeletal muscle, insulin resistance decreases receptor binding and phosphorylation of the 
insulin receptor and IRS1. There is also a dramatic reduction of insulin signalling through PI3K 
and AKT, fact that ultimately results in a decrease in translocation of the glucose transporter 
GLUT4 to the plasma membrane and impaired insulin-stimulate glucose transport into the cell 
(Konner and Bruning 2012; Rask-Madsen and Kahn 2012). 
In liver, insulin fails to adequately suppress hepatic glucose production, fact that represents a 
hallmark of progression from insulin resistance to overt diabetes mellitus (Rask-Madsen and 
Kahn 2012). At the molecular level this is represented by an increased expression of the 
gluconeogenic enzymes phosphoenolpyruvate carboxykinase and glucose 6-phosphatase and a 
decreased expression of enzymes that regulate glycogen synthesis and glycolysis, including 
glucokinase and pyruvate kinase (Michael, et al. 2000). Although the insulin suppression of 
glucose production is completely lost in liver due to insulin resistance, insulin continues 
promoting lipid synthesis increasing circulating levels of free fatty acids and TG, fact that leads 
to hypertriglyceridemia. In addition, hepatic insulin resistance also contributes to 
hyperlipidemia by downregulation of the LDL receptor. Therefore, it is well recognized that 
hepatic insulin resistance contributes to the classical hyperglycemia, hyperinsulinemia and 
hypertriglyceridemia observed in humans with type II diabetes mellitus (Konner and Bruning 
2012).  
In the brain, impaired insulin signalling contributes to obesity by failing to suppress appetite. 
Moreover, brain insulin resistance also leads to glucose intolerance by impairing the ability of 
insulin to suppress hepatic glucose output through innervation of the liver (Rask-Madsen and 
Kahn 2012).  
Furthermore, clinical studies indicate that insulin resistance at the vascular wall could be 
important in the development of cardiovascular pathologies in insulin-resistant and diabetic 
patients due to the acceleration of atherosclerosis (Konner and Bruning 2012). Normally, 
insulin acts on vascular endothelial cells affecting endothelial function beyond regulating blood 
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flow or capillary recruitment; hence, insulin activates both antiatherosclerotic and 
proatherosclerotic mechanisms in vascular endothelial cells. It has been suggested that the lack 
of insulin actions mediated by the activation of IRS1/PI3K/AKT pathways, in vascular 
endothelial cell, could be the main cause for the development and progression of atherogenesis 
and microvascular disease in type II diabetes mellitus patients. In addition, insulin resistance in 
smooth muscle cells may also contribute to the development of diabetes-associated 
cardiovascular disease (Konner and Bruning 2012; Rask-Madsen and Kahn 2012) 
In the context of insulin resistance, adiponectin is a hormone of particular interest. Concretely, 
adiponectin is produced exclusively by the adipose tissue and its plasma levels correlate 
negatively with BMI, insulin and TG levels, and positively with high-density lipoprotein 
(HDL) cholesterol, in obese adults (Fliers, et al. 2003). Adiponectin has multiple beneficial 
effects on a cluster of obesity-related metabolic and cardiovascular dysfunctions. Like leptin, 
adiponectin displays antisteatotic activity in non-adipose tissues, but the most important role of 
adiponectin is its ability to improve insulin sensitivity through stimulation of the insulin 
receptor tyrosine kinase activity (Wang, et al. 2009).  
Two adiponectin receptors have been identified: adipoR1 (abundantly expressed in skeletal 
muscle) and adipoR2 (present predominantly in the liver) (Wang, et al. 2009).  Adiponectin 
contributes to enhance insulin sensitivity through binding its receptors, adipoR1 and adipoR2, 
prompting the phosphorylation and activation of AMPK. Activation of AMPK in its major 
target tissues, including skeletal muscle, liver, heart, endothelium, adipocytes and brain, leads 
to stimulate glucose utilization and FAO, and hence, to enhance whole-body insulin sensitivity 
(Rabe, et al. 2008). Concretely, AMPK attenuates by phosphorylation ACC activity, which 
results in a reduction of lipid synthesis and an enhancing of FAO by blocking the production of 
malonyl-CoA. In addition, activation of AMPK downregulates the expression of Srebp1c, 
which in turn leads to downregulate the expression of genes involved in lipogenesis, including 
Acc, Fasn, and glycerol-3-phosphate acyltransferase (Gpat) [reviewed by (Wang, et al. 2009)]. 
Therefore, considering this upregulation of adiponectin/adiponectin receptors, enhancing 
adiponectin receptor function may represent a potential strategy to treat obesity-linked insulin 
resistance (Rabe, et al. 2008). 
Additionally, adiponectin has been also described to have anti-atherogenic and anti-
inflammatory properties (Wang, et al. 2009).  
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Figure 3. Overview of the pathophysiology of obesity-related insulin resistance. Obesity is characterized by a 
chronic positive energy balance which leads to an increased storage of fat in adipose tissue. With the development 
of obesity, the ability of adipocytes to store triglycerides (TG) is impaired or exceeded. Consequently, fat is stored 
in other ectopic tissues, including liver and skeletal muscle. Moreover, circulating TG and free fatty acid (FA) 
levels are also increased in obesity due to a defect in the postprandial dynamic adjustment of lipoprotein lipase 
(LPL) and due to a postprandial impairment of the normal ability of adipose tissue to buffer FA excess. Under 
these conditions, all tissues are chronically exposed to very high concentrations of FAs and TGs; this situation is 
known as “lipotoxicity”. Lipotoxicity gradually impairs insulin action on the liver and muscle, aggravating insulin 
resistance. As long as pancreatic β-cells can adapt to insulin resistance in peripheral tissues with an appropriate 
increase in insulin secretion, normal glucose homeostasis can be maintained. However, lipotoxicity on pancreas 
can also produce β-cell disfunction, which results in a defect in insulin secretion. Concurrently, fat tissue is 
infiltrated with macrophages and other immune cells. Adipose macrophages release pro-inflammatory cytokines, 
such as TNFα and IL-6 that also contribute to insulin resistance in muscle, liver and other tissues. In the brain, 
impaired insulin signaling and compromised nutrient sensing contributes to obesity by failing to suppress appetite. 
Brain insulin resistance also leads to glucose intolerance by impairing the ability of insulin to suppress hepatic 
glucose output through innervation of the liver Adapted from (Rask-Madsen and Kahn 2012). 
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2.3. Calorie restriction  
Calorie restriction is a dietary intervention defined as a reduction in macronutrient intake, 
bellow the amount of calories that would be consumed ad libitum, with maintenance of a 
sufficient micronutrient intake (Minor, et al. 2010). In general, calorie restriction is set at 
around ≥ 10% reduction of energy consumption in human studies and 20% or higher in rodent 
species (Bales and Kraus 2013). 
The balance between energy (calorie) consumption and energy expenditure is critical for the 
quality of life across the lifespan. A clear example of this observation is the fact that an 
increased calorie intake together with a sedentary lifestyle is responsible for the epidemic of 
obesity and for the deterioration of the health span because obesity, in turn, also increases the 
risk for chronic inflammatory disorders such as hypertension, type II diabetes, coronary heart 
disease and other related metabolic alterations (Gonzalez, et al. 2012). However, in contrast to 
the detrimental effects of eating an excess of energy, a restriction of calorie intake below the 
amount required for weight maintenance appears to have a wide range of benefits. Particularly, 
calorie restriction has shown to slow the aging process, extend lifespan and improve the health 
span (Bales and Kraus 2013).  
Mammalian experimental studies and also preliminary studies on humans have shown that 
calorie restriction, in addition to its commonly accepted effect on increasing lifespan, also 
benefits other processes that contribute to overall health. In this regard, calorie restriction has 
been considered the most efficient way to promote weight loss in the population. Moreover, 
moderate calorie restriction has been shown to prevent or reverse the damaging effects of type 
II diabetes, hypertension, cardiovascular disease, chronic inflammation and other age-
associated metabolic diseases, such as blood glucose regulation [reviewed by (Gonzalez, et al. 
2012)].  
Another benefit of calorie restriction is the prevention of free radical formation. Concretely, 
long-term calorie restriction reduces the age-associated accumulation of oxidative damage to 
proteins, lipids and DNA (Sohal and Weindruch 1996). This reduction can be due to several 
processes, including a decrease in the generation of reactive oxygen molecules, an increased 
efficiency of protective processes, an increase in repair activity, or a combination of these 
processes. In this sense, calorie restriction has been shown to enhance autophagy and DNA 
repair systems, and up-regulates endogenous enzymatic and non-enzymatic antioxidative 
defense mechanisms (Omodei and Fontana 2011). 
The biological mechanisms by which calorie restriction decreases insulin resistance and 
improves glucose metabolism are still not fully elucidated. However, it has been proposed that 
calorie restriction may reduce plasma levels of pro-inflammatory cytokines, peptides and other 
factors produced normally by the adipose tissue (Gonzalez, et al. 2012).  
At gene expression level, calorie restriction may induce the activity of genes that protect cells 
from the damaging action of harmful agents. In this sense, it has been shown that calorie 
restriction increases the induction of the gene encoding one of the hepatic scavenging proteins 
(Hsps70) in response to heat stress (Heydari, et al. 1993). Moreover, several observations 
suggest that a low-calorie diet also has an impact on the expression of inflammatory genes in 
peripheral mononuclear cells (PBMCs) of obese patients (Crujeiras, et al. 2008). 
All in all, it has been assumed that calorie restriction is a low intensity stressor that provokes a 
survival response in the organism, helping it to tolerate adversity by activating longevity 
pathways (Omodei and Fontana 2011). Moreover, the antioxidant and anti-inflammatory 
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properties of calorie restriction make this nutritional intervention approach as an interesting and 
promising alternative to prevent and control cardiovascular disease (Gonzalez, et al. 2012).  
Despite the fact that calorie restriction is the only intervention known to date that consistently 
decreases the biological rate of aging and increases both average and maximal lifespan, some 
detrimental effects have also been observed. In this sense, studies with rodents suggest that 40-
60% calorie restriction has detrimental effects on the innate immune response with impaired 
ability to control infections by monocytes/macrophages (Jolly 2004). Another worrisome 
concern about calorie restriction, especially in humans, is the potential development of 
symptoms of eating disorders. It was observed that calorie restriction or the intent to restrict 
intake has been associated with the onset of eating disorders, such as anorexia, bulimia nervosa 
and binge eating disorder. Hence, there is a need to examine both the benefits and potential 
harms of calorie restriction in humans [reviewed by (Redman and Ravussin 2011)]. 
Another important fact to take into account is the moment of life in which the calorie restriction 
is imposed, because it is already accepted that certain stimuli experienced during critical 
periods of development, such as pregnancy and lactation, may cause permanent alterations in 
the development and organization of tissues and organs that can lead to irreversible changes in 
the structure and function of the body, programming the metabolic health of an individual in 
adult life (Martin-Gronert and Ozanne 2013; Picó, et al. 2012). Further information about the 
effects of the exposure of calorie restriction either during pregnancy or lactation will be given 
in the next section (section 3).  
 
3. Developmental origins of obesity: importance of early life nutrition  
There is a growing body of evidence, from epidemiological studies in humans and animal 
models, showing that early life environmental factors, especially early nutrition during prenatal 
and neonatal periods, have profound effects on genome regulation modifying, in turn, the 
susceptibility of an individual to develop a wide spectrum of metabolic diseases later in life 
(Guilloteau, et al. 2009; Martin-Gronert and Ozanne 2013). In this sense, it has been estimated 
that 62% of the variation in human birth weight results from the intrauterine environment, 
including maternal gestational nutrition, compared with 20% and 18% resulting from maternal 
and paternal genetic heredity, respectively (Holt 2002).  
The idea that nutritional and environmental factors during early life have lasting consequences 
on the future metabolic health of an individual was firstly developed in 1990, by Barker, with 
the hypothesis of the “foetal origin of adult diseases” (Barker 1990). For most organs and 
systems, the critical period of plasticity is during intrauterine development (Barker 2007). 
Based on the observation that environmental changes during a critical period of life can 
readjust the developmental path, the concepts of plasticity and programming appear. 
Developmental plasticity is defined as the ability of an organism to change his phenotype in 
response to changes in the environment (Cota and Allen 2010). If this change or adaptation is 
permanent, it is considered a “programming”. Programming is defined as the induction, 
silencing or restriction of development of a permanent somatic structure or physiological 
system―caused by stimuli, nutritional or disturbing factors acting during a sensitive time 
period―with long term effects on foetal growth quality and on the metabolic responses of the 
offspring (McMillen and Robinson 2005). Interestingly, although developmental programming 
is induced by processes of developmental plasticity, once induced, the organism has a reduced 
capacity to reverse the developmental trajectory chosen, making developmental programming 
irreversible in a particular nutritional range (Bateson, et al. 2004).  
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Pregnancy and lactation are revealed as these critical periods where maternal energy status, 
diet, body composition and health have long-term effects on metabolic mechanism in the 
offspring (Sullivan and Grove 2010). Barker and collaborators observed that maternal 
undernutrition during pregnancy leads to metabolic adaptations in the foetus to increase its 
survival by producing an individual who can maximize the storage of calories during times of 
plenty and minimize loss of energy stores during times of famine. Thus, Hales and Barker 
proposed that poor foetal and early postnatal nutrition imposes mechanisms of nutritional thrift 
upon the growing individual; it is their hypothesis of the “Thrifty phenotype” (Hales and 
Barker 2001). In the past, such evolutionary changes were beneficial. However, nowadays and 
in developed countries, where there is an overabundance of highly palatable food, which can be 
obtained easily, with minimal energy expenditure, such individuals show a rapid growth 
throughout childhood, adolescence and adulthood, a great increase in adiposity and hence, a 
great risk of becoming obese and developing the metabolic disorders associated to obesity, such 
as insulin resistance, in adulthood (Martin-Gronert and Ozanne 2013). 
Therefore, bearing in mind that nutrition during early life can program body composition and 
the metabolic health of an individual in adult life, Martorell et al. (Martorell, et al. 2001) 
proposed the effects of nutrition in early life throughout three distinct hypotheses: 1) 
overnutrition increases the risk of later fatness; 2) the opposite, i.e. undernutrition, is also 
associated with increased risk of fatness; and 3) optimal nutrition during infancy, represented 
by breastfeeding, is protective against future obesity.  
 
3.1. Programming effects of maternal calorie restriction during gestation 
Initial programming studies have mainly focused on the effects of intrauterine malnutrition. 
Epidemiological studies in humans suggest that poor early nutrition has different effects on the 
metabolic health of the offspring depending on when in gestation occurs (Ravelli, et al. 1976). 
Poor nutrition of the mother during maximal placenta growth has been reported to influence 
foetal growth and body weight in human babies. Concretely, food restriction during early 
gestation influences the cardiovascular system, reflected as an increased risk of coronary heart 
disease in humans. Whereas, nutrient restriction during late gestation, coincident with the 
period of maximal foetal growth, affects intermediary metabolism, particularly, glucose and 
insulin homeostasis, leading to an increased risk of type 2 diabetes [reviewed by (Guilloteau, et 
al. 2009)].  
The association between intrauterine malnutrition and subsequent development of obesity has 
been supported by the emblematic example of the Dutch famine that devastated the West part 
of Holland during the last 6 months of World War II (Ravelli, et al. 1976). In October 1944, the 
German authorities blocked all food supplies to the occupied west of The Netherlands. These 
were restored immediately after liberation on May 1945. Therefore, children exposed to famine 
in utero during the known as the “hunger winter” were well nourished in childhood and, in 
consequence, had accelerated weight gain (Lumey, et al. 2007). The hunger winter cohort was 
used to examine how maternal undernutrition during specific gestational time windows affects 
the subsequent life course of offspring who experienced the famine in utero. The results of 
these studies showed that 19-year-old men, exposed to the acute famine in utero during the first 
half of gestation, displayed increased obesity rates. However, exposure to famine during the 
last trimester of gestation and in early postnatal life was associated with reduced obesity 
(Ravelli, et al. 1976). In addition to the studies of the Dutch hunger winter, many other 
epidemiological studies have indicated that obesity and impaired glucose tolerance are highly 
prevalent in subjects born from dams that were exposed to famine during gestation. Another 
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example is the Great Chinese famine that affected the Chongqing population during 1959-1961, 
which was more devastating in rural areas and caused millions of deaths. Individuals exposed 
in utero to the Chinese famine were at increased risk of overweight and hyperglycemia in adult 
life (Li, et al. 2010). 
From human studies it is virtually impossible to identify the underlying mechanisms involved 
in developmental programming. For this reason, animal models have become a mainstay of 
research and have supported the observations made in epidemiological studies. Most of the 
studies associating foetal malnutrition and adult obesity are from rat models. Indeed, different 
outcomes have been described regarding subsequent offspring body weight depending on the 
type, severity and timing of the restriction, and also on the gender of the progeny (Picó, et al. 
2012; Symonds, et al. 2004). In these sense, 50% maternal calorie restriction during the first 
two weeks of gestation led to obesity development in male, but not in female, offspring shortly 
after weaning (Jones and Friedman 1982). In addition, Desai and colleges observed that the 
offspring of rat dams exposed to 50% calorie restriction from day 10 of gestation until delivery 
displayed a significant intrauterine-growth restriction; however, these pups experienced a 
markedly increased weigh gain after birth, even bigger than body weight of control pups, under 
ad libitum feeding conditions. Interestingly, male offspring also had significantly higher body 
weights than females from the age of 4 weeks, and this difference became perceptibly 
accentuated with advancing age (Desai, et al. 2005). Other studies consisting in less severe 
maternal calorie restriction were also performed. In this regard, Vickers and colleges performed 
a moderate 30% maternal calorie restriction throughout pregnancy, which resulted in male 
offspring developing hyperphagia and greater accumulation of adipose tissue without any 
change in body weight (Vickers, et al. 2000).    
Many animal studies coupled with new experimental tools have showed that the mechanisms, 
by which nutrition during foetal development lead to influence the propensity to develop 
obesity and other related metabolic alterations later in life, are very complex and may include 
epigenetic modifications and also changes on key structures, such as the hypothalamus and the 
peripheral nervous system [reviewed by (Picó, et al. 2012)]. In this regard, nutrition during 
critical windows of foetal development, especially the availability of dietary methyl donors and 
cofactors in food, may induce DNA methylation patterns (epigenetic modification generally 
associated with transcriptional repression) across a number of tissues and organs, leading to 
premature changes and conferring an enhanced susceptibility to adult diseases in later life 
(Vickers and Sloboda 2012). Interestingly, in rodents, the hypothalamic Pomc gene promoter 
region is a key target of epigenetic changes, following perinatal nutritional manipulation. 
Concretely, the Pomc promoter was found to be less methylated in weanling rat offspring from 
low-protein isocaloric fed dams (Coupe, et al. 2010), whereas hypermethylation of the 
hypothalamic Pomc gene promoter and also of insulin receptor promoter were reported in 
weanling pups raised in small litters, which in turn could contribute to hypothalamic 
leptin/insulin resistance and obese phenotype observed in this animal model (Plagemann, et al. 
2009). 
Furthermore, early nutrition, including maternal nutrient restriction or maternal HF-diet feeding 
during perinatal period, has been shown to modify the structure and physiology of the 
hypothalamus (Remmers and Delemarre-van de Waal 2011). In particular, 50% calorie 
restriction during pregnancy and lactation results in an increase in cell proliferation in PVN, 
VMN and ARC hypothalamic areas of pups (Coupe, et al. 2009), a reduction of nerve fibres 
projection from the ARC neurons to the PVN, and a diminished expression of Pomc in neonate 
rats (Delahaye, et al. 2008). García et al. also showed that a less severe maternal calorie 
restriction (20%) during the first 12 days of pregnancy also altered hypothalamic structure in 
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weaned rats, by decreasing the presence of total number of cells, particularly NPY-neurons 
(García, et al. 2010). Interestingly, these changes occurring in hypothalamic structures are also 
accompanied, in most cases, by alterations in the expression of neuropeptides. In these regard, 
García et al. also showed that the offspring of calorie restricted dams during pregnancy showed 
reduced hypothalamic mRNA expression levels of Pomc and Npy (only female pups) and of 
Obrb and Insr (both male and female pups) at weaning (García, et al. 2010). 
The identification of such mechanisms has made possible the development of strategies 
addressed to revert or prevent at early ages the metabolic programming for obesity and its 
related metabolic disorders. In this sense, Konieczna and coworkers (Konieczna, et al. 2013) 
showed that oral supplementation with physiological doses of leptin during lactation is able to 
revert, at least in part, most of the detrimental effects in the offspring on hypothalamic structure 
and function caused by maternal calorie restriction during gestation. Therefore, developmental 
malprogramming during foetal life can be reversed by nutritional interventions during the 
neonatal period, such as the intake of appropriate doses of leptin through lactation, which in 
turn, could be considered a strategy to revert or prevent programmed obesity and its metabolic-
related alterations (Konieczna, et al. 2013). Identification of other strategies able to revert or 
ameliorate detrimental programmed effects due to adverse conditions during gestation is of 
great interest. 
 
3.2. Programming effects of maternal calorie restriction during lactation 
The early postnatal period is also critical for determination of long-term body weight. Unlike 
the known negative effects of calorie restriction during foetal life, increasing the risk of 
developing obesity, the lasting consequences of maternal undernutrition during the suckling 
period are uncertain. In fact, studies in humans are scarce mainly due to ethical aspects; 
however, some interventional studies in humans have been performed. McCrory and coworkers 
evaluated whether maternal weight loss by 35% calorie restriction, with or without aerobic 
exercise, had adverse effects on lactation. They showed that short-term weight loss of 1 Kg per 
week, by a combination of dieting and aerobic exercise for 11 days, appears safe for 
breastfeeding mothers and no significant changes were detected neither in the amount and 
energy output of milk nor in frequency of nursing and weight gain of infants (McCrory, et al. 
1999). In another study, overweight lactating women, who were exclusively breastfeeding, 
were subjected to calorie restriction of 500 Kcal less than control mothers, and also to moderate 
exercise between 4 and 14 weeks postpartum. These lactating women also showed a moderate 
weight loss of 0.5 Kg per week and no alterations on normal weight gain of infants were 
observed (Lovelady, et al. 2000). Further studies in humans are needed to assess whether this 
maternal nutritional condition during lactation has long-term effects on their offspring, because 
all the studies performed until date have been only focused on the short-term effects.  
Several rodent models have also been used to study the effects of nutrition during the suckling 
period. It is known that the quantity of food available during suckling is also a determinant 
issue for the development of obesity in pups (Levin 2006). In these sense, one approach to alter 
the intake of neonates consists in the reduction or the increase in litter size. Small litter size 
leads to a relative excess of milk for each pup and changes the composition of maternal milk, 
leading to increased fat content. It results in hyperphagia and increased growth rates leading to 
permanent overweight and increased fat deposition (Plagemann, et al. 1999b). However, an 
increased litter size from 10 to 20 pups during lactation resulted in lower body weight and food 
intake of both male and female restricted pups in adulthood. These animals displayed reduced 
body dimensions at weaning and also showed incomplete catch-up growth size afterwards 
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(Remmers, et al. 2008a). Velkoska and collaborators also demonstrated that pups raised in large 
litters (18 pups per litter) were lighter than their controls and remained significantly lighter 
throughout the study, however no evidence of incomplete catch-up growth was observed 
(Velkoska, et al. 2008). Other approaches involve maternal calorie restriction through the 
lactating period. This condition also leads to lower body weight of pups at weaning; however a 
severe nutritional deprivation (67%) of lactating dams caused a considerable retardation of the 
rate of growth in pups, probably because dams were unable to deliver sufficient amount of milk 
to sustain the normal growth (Boxwell, et al. 1995). Vicente and coworkers also showed that 
65% maternal protein restriction or maternal energy restriction (to the same amount of calories 
eaten by the protein restricted group) during lactation in rat dams resulted in lower body weight 
of offspring at weaning. In adulthood, animals whose mothers were fed the protein restricted 
diet weighed significantly less than the controls. However, the animals whose dams were fed 
the energy restricted diet weighed more than the controls (Vicente, et al. 2004). Another study 
showed that female offspring of 50% calorie-restricted dams during the suckling period, 
although presenting a lower body weight than their controls, displayed increased food intake 
(Šefčíková  and Mozeš 2002). 
Therefore, animal studies show that maternal dietary restriction during lactation (total calorie or 
protein content) or by increase in the litter size during lactation results in a different 
programming of body weight and food intake control in the offspring, which may affect the 
propensity to develop obesity. It is shown that severe maternal deprivation during the suckling 
period leads to detrimental outcomes in the offspring (Boxwell, et al. 1995; Remmers, et al. 
2008a); however, the effects on their offspring of a less severe maternal dietary restriction have 
not been directly explored. 
 
Breast milk 
Bearing in mind that nutrition during early life has a considerable influence on long-term body 
weight and future metabolic health, and considering that in animals and fully breastfed infants 
maternal milk is the only source of food during this period, it has been suggested that 
composition of maternal milk may have an important role in developmental programming (von 
Kries, et al. 1999). Besides the basal nutritive function of maternal milk, to promote the 
properly postnatal growth and provide all the nutritional needs of infants (Ip, et al. 2007), the 
mother is able to communicate metabolic information or even social cues to the infant directly 
through her milk, helping the infant to adapt to the variable nutritional and environmental 
conditions (Newburg, et al. 2010).  
Breastfeeding has been reported to bring more advantages for the metabolic health of the 
infants than formula feeding. Concretely, breastfeeding has been associated with reduction of 
incidences and severity of infections in infants, prevention of allergies, prevention of some 
gastrointestinal pathologies and sudden infant death syndrome, as well as enhancement of 
cognitive development (Leung and Sauve 2005). Moreover, there is a growing body of 
evidence, from epidemiological studies, suggesting that breastfeeding allows appropriate 
metabolic programming by lowering postnatal growth rate and fat deposition during the first 
year of life, and hence, reducing the risk of obesity and its related metabolic disorders in 
childhood and adolescence (Gunderson 2008; Ip, et al. 2007; von Kries, et al. 1999). 
Despite the beneficial effects of breastfeeding for the future health of the individual, changes in 
the composition of breast milk may have profound effects on its role in developmental 
programming. In this sense, maternal behavioural, maternal lifestyle or maternal nutrition 
during lactation may affect specific components contained in milk, either by changing the 
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composition of maternal milk or changing the integrity of milk components. These changes in 
breast milk composition may affect the metabolic programming of their offspring, modifying 
their propensity to develop obesity and other related metabolic alterations (Pico, et al. 2011).  
Therefore, identification of these changes in breast milk composition―changes that underlie 
the better or worse metabolic health programming due to a particular nutritional environment of 
their dams during lactation―becomes of special interest nowadays.  
In this sense, in order to identify changes in maternal milk composition, the  identification of 
free amino acids and free glycation, oxidation or nitration adducts, which have been formed as 
a result of the degradation of misfolded proteins and are considered to be potential biomarkers 
of protein damage (Karachalias, et al. 2010; Thornalley 2008; Thornalley, et al. 2003) is of 
particular interest. Therefore, identification of these biomarkers of protein damage in breast 
milk samples from mothers exposed to a particular nutritional environment during lactation 
could help us to explain the way by which changes in the nutritional environments of lactating 
dams can affect the future metabolic health of their offspring.  
 
4. Biomarkers of metabolic health 
Searching for new biomarkers in the field of human health is an interesting way to obtain 
biological tools which can help us to improve health outcomes and reduce total health care 
costs in the long term. In particular, application of novel health biomarkers may improve the 
understanding of the mechanisms of disease, may provide new knowledge for the identification 
of processes to improve health management through the earlier diagnosis of disease and may 
help the delivery of more efficacious and safer therapies to modulate disease progression 
(OECD 2011).  
Biomarkers in the field of human health are considered as measurable indicators of biological 
states, which can provide us information on the presence of disease, or susceptibility to disease, 
or predict patient response to therapeutic interventions (OECD 2011). From a clinical 
standpoint, the most useful biomarkers provide a definitive link to a very specific disease risk 
or condition. Additionally, nowadays, a huge effort is directed towards the identification of 
markers that provide the earliest possible indication of disease (Elliott, et al. 2007). 
Nevertheless, all these biomarkers allow identifying and quantifying disease or damage. This 
has led to major problems in demonstrating health benefits of food and establishing health 
claims. For this reason, the BIOCLAIMS project― “BIOmarkers of Robustness of Metabolic 
Homeostasis for Nutrigenomics-derived Health CLAIMS Made on Food” (BIOCLAMS, Grant 
agreement no. 244995) ― attempts to identify new early healthy biomarkers through 
quantification of the robustness of the homeostatic mechanisms involved in maintaining 
optimal health, based on the assumption that the ability to maintain homeostasis in a 
continuously challenged environment is crucial for healthy ageing. This flags the way for the 
development of a new generation of robust biomarkers and their potentially related health 
claims made on foods.  
A biomarker of health, to be optimal, must be analytically robust, sensitive, quantitative, 
practical and mechanism-linked so that implications of changes can be understood. Moreover, 
an optimal health biomarker should be based around measurements performed on accessible 
substrates, such as biological fluids (Elliott, et al. 2007). The major bottleneck in identification 
of biomarkers of health in humans, for predicting later metabolic alterations or for assessing 
their metabolic status, is the limited accessibility of tissues of healthy volunteers. In ill subjects 
that need to undergo surgery biopsies, both pathological and more normal surrounding tissue 
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samples can be easily obtained, whereas in patients without necessity of surgery and especially 
in healthy volunteers, collection of samples from internal organs such as liver, pancreas and 
visceral adipose tissue are not assessable for invasive investigations because of ethical reasons 
(Afman and Muller 2012). Therefore, less invasive sources for biomarkers identification are 
needed. Some of these new sources are PBMCs, a subset of white blood cells, which have 
emerged as a convenient surrogate tissue for biomarker identification in toxicological, 
nutritional and clinical studies (Rockett, et al. 2004). 
Another important fact to take into account is that individual markers, used in isolation, are not 
able to measure health reliably. Therefore, in spite of individual markers, integrated multi-
component biomarkers are required, because they would examine a far broader concept of 
health than simply individual parameters. According to this, the BIOCLAIMS project, in order 
to identify and validate multi-component markers of health, makes use of advanced analytical 
methodologies, including OMIC technologies―that enable to analyse the expression of large 
number of mRNA (transcriptomics), metabolites (metabolomics) or proteins (proteomics) ― 
and other tools, such as the analysis of protein damage. 
Particularly, transcriptomics techniques, such as whole genome microarray analysis, enable the 
unbiased measurement of total genome-wide effects on the cellular level and generate a 
comprehensive overview on molecular changes at gene expression level, to specifically 
interventions, such as nutritional interventions, in a given tissue at a given time; it is suitable 
for a first screening in regulatory networks (Kussmann, et al. 2006). Concerning metabolomics, 
it is a diagnostic tool that study the changes in metabolites (from body fluids, such as urine, 
blood and saliva) and whose goal is to isolate and characterize these metabolites in order to 
allow knowing the arrangements caused by a particular diet and how these changes may affect 
the metabolic health of an individual (Sales, et al. 2014). Proteomics is the science that studies 
the complete set of proteins involved in the biological processes and is suitable for discovering 
bioactive food proteins and peptides (Kussmann, et al. 2006; Sales, et al. 2014).  Regarding 
protein damage, in physiological systems proteins undergo modifications (spontaneously, 
during aging or due to particular diseases) leading to change their structures and functions. As 
consequence, damaged proteins undergo proteolysis and free amino acids and free adducts are 
released and can be considered as robust biomarkers of protein damage (Karachalias, et al. 
2010; Thornalley 2008; Thornalley, et al. 2003). 
In this Thesis, two different tools have been used to identify biomarkers of metabolic health: 1) 
gene expression analysis using transcriptomic techniques; 2) analysis of protein damage using 
the technique of liquid chromatography with tandem mass spectrometry detection (LC-
MS/MS).    
 
4.1. Gene expression analysis in PBMCs 
PBMCs are a subset of white blood cells from innate and adaptive immune systems, including 
lymphocytes and monocytes/macrophages, which travel through the entire body and respond to 
various internal and external signals.  
Researches have focused on PBMCs as a potential source of biomarkers, because, contrary to 
adipose tissue, liver and muscle (tissues in which sample collection requires invasive biopsies), 
PBMCs are easily obtainable from healthy human volunteers. PBMCs can be easily isolated 
from blood, through venipuncture and can also be repeatedly collected in sufficient quantities 
in contrast to other tissues (de Mello, et al. 2012). PBMCs circulate throughout the body and 
can infiltrate the endothelium; hence, PBMCs are exposed to both exogenous and endogenous 
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stimuli from the adipose tissue and other metabolic tissues, as well as to all physiological 
changes, including changes in nutrient levels, and metabolism-related hormones (O'Grada, et 
al. 2014). Therefore, PBMCs may reflect systematic health (Afman, et al. 2014).  
PBMCs have been shown to express about 80% of the genes encoded by the human genome 
(Liew, et al. 2006). Recent studies have proven that gene expression profile of PBMCs is a 
highly robust tool to distinguish a disease state from the healthy state and also to differentiate 
several phases/diagnostics of disease (Afman and Muller 2012; Bouwens, et al. 2008; 
Burczynski and Dorner 2006). In particular, gene expression profile of PBMCs could reflect 
the presence and the extent of different physio-pathological conditions of a person, such as 
coronary artery stenosis, chronic heart failure, hypertension, atherosclerosis, and inflammatory 
autoimmune diseases such as systemic lupus erythematosus [reviewed by (Afman, et al. 2014)]. 
Moreover, gene expression levels of PBMCs can reflect global gene expression profile of 
skeletal muscle (Rudkowska, et al. 2011) and can also reflect metabolic and immune responses 
of adipocytes or hepatocytes (Fuchs, et al. 2007). Furthermore, PBMCs can also reflect the 
responses to dietary interventions (Caimari, et al. 2010b; Radler, et al. 2011), fasting (Caimari, 
et al. 2010a; Oliver, et al. 2013) and to weight reduction strategies (de Mello, et al. 2008).  
All in all, considering that PBMC gene expression profile may reflect the gene expression 
profile of liver, adipose tissue and muscle, and taking advantage of their easy accessibility and 
their exposure to such a variety of organ systems, PBMCs provide and attractive target tissue 
and an interesting source of biomarkers of health in the field of human nutrigenomics.  
 
4.2. Quantitative screening of protein damage biomarkers  
The term of protein damage biomarkers includes glycation, oxidation and nitration adducts. 
The accumulation of these adducts in biological systems represents a new type of metabolic 
imbalance that is providing improved understanding of disease and health decline in ageing. 
Among adducts of protein damage, advanced glycation endproducts (AGEs) are of special 
interest. AGEs are yellow-brown fluorescent and insoluble adducts that are formed 
endogenously in body tissues by protein glycation reactions. Interestingly, their formation 
progressively increases with normal ageing; however, their formation can be even significantly 
increased by several pathological conditions, such as diabetes. Diabetic patients, as 
consequence of the high glucose and other saccharide derivatives levels in plasma, display a 
raised AGE formation and hence an increased level of glycation of various structural and 
functional proteins including plasma proteins and collagen (Ahmed and Thornalley 2007; 
Singh, et al. 2014). AGEs are accumulated intracellularly on long-lived proteins playing 
important roles as stimuli for activating intracellular signalling pathways, as well as modifying 
the function of intracellular proteins and even modifying the functions of the whole cell. On the 
one hand, AGEs impair the physiological functions of proteins, which undergo accelerated 
degradation to free AGEs adducts. AGEs-modified proteins lose their specific functions by 
disrupting molecular conformation, altering enzymatic activity, reproducing degradation 
capacity, and interfering with receptor recognition. On the other hand, glycation of proteins can 
also alter the cell functions. The mechanisms by which AGEs modify the cell functions include 
denaturation and functional decline of the target protein or lipid, organopathy due to 
accumulation of AGEs in the tissue, activation of receptor mediated signal pathway in cells, 
and generation of oxidative stress and carbonyl stress [reviewed by (Singh, et al. 2014)]. 
Physiologically, there is a ubiquitous enzymatic defence against glycation which consists of 
enzymes that repair early glycated proteins and prevent glycation by metabolizing dicarbonyl 
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glycating agents. The imbalance between glycating agents and enzymatic defence against 
glycation in favour of glycating agents has been termed carbonyl stress and is thought to 
contribute to ageing and disease (Xue, et al. 2009). In the clinical setting, increased formation 
and steady-state accumulation of glycated proteins have been linked to disease development 
and progression, particularly diabetes and its vascular complications. Furthermore, formation 
and accumulation of AGEs have also been linked with renal failure (Agalou, et al. 2005) and 
with cardiovascular and Alzheimer´s diseases (Ahmed, et al. 2005; Thornalley, et al. 2003). In 
addition, there is substantial evidence linking glycation damage protein to obesity and pro-
oxidative and pro-inflammatory events (Klenovics, et al. 2013; Thornalley, et al. 2003). 
Involvement of AGEs in arthritis and cirrhosis (Ahmed, et al. 2004), anxiety and Schizophrenia 
(Arai, et al. 2010), and other diseases is emerging.  
Concerning AGEs formation (Figure 4), protein glycation reactions occurs by complex series 
of sequential and parallel non-enzymatic reactions called collectively the Maillard reaction  
(Rabbani and Thornalley 2012). This reaction is subdivided into three stages. In the early stage, 
carbonyl groups of glucose or other reducing sugars react with free amino groups of proteins, 
leading to the formation of glycosylamine which dehydrates to form an unstable compound, the 
Schiff base. The Schiff’s base undergoes an Amadori rearrangement to form N-(1-deoxy-D-
fructos-1-yl)amino acids or fructosamine. Glycosylamine, Schiff´s base and fructosamines are 
considered to be early stage glycation adducts [reviewed by (Rabbani and Thornalley 2012)]. In 
an intermediary stage, the amadori products degrade to a variety of reactive dicarbonyl 
compounds or α-oxoaldehydes such as glyoxal, methyl-glyoxal and deoxyglucosones via 
dehydration, oxidation and other chemical reactions. In the late stage, the reactive dicarbonyls 
react irreversibly with amino groups of amino compounds to form AGEs through oxidation, 
dehydration and cyclization reactions [reviewed by (Singh, et al. 2014)]. Moreover, the reactive 
dicarbonyls formed during the intermediary stage of Maillard reaction can also react with 
proteins to directly form AGEs. The Schiff´s base adducts can also degrade via non-Amadori 
rearrangement reaction pathways to α-oxoaldehydes which also leads to the formation of 
AGEs. The latter are also formed by the direct modification of proteins by α-oxoaldehydes 
produced by the degradation of glycolytic intermediates and lipid peroxidation.  
 
Figure 4. Early glycation and sources of advanced glycation endproducts (AGEs) (Rabbani and Thornalley 2012) 
 
Long-lived proteins contain numerous lysine, hydroxylysine and arginine residues that are 
prone to age-related accumulation of glycation damage. In this regard, some free glycation 
adducts derived from arginine residues are: Nω-carboxymethylarginine (CMA), Nδ-(5-hydro-
4-imidazolon-2-yl)ornithine (G-H1), Glucosepane,  Nδ-(5-hydro-5-methyl-4-imidazolon-2-
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yl)ornithine (MG-H1), 3-deoxyglucosone (3DG-H)  and Ornithine (Ahmed and Thornalley 
2007). The glycation adducts derived from lysine residues are: Nε-carboxyethyl-lysine (CEL), 
Nε-carboxymethyl-lysine (CML), Fructosyl-lysine (FL), bis(lysyl) crosslink derived from 
methylglyoxal (MOLD) and Pyrraline. Further classification of AGEs has been made to relate 
to the mechanisms of AGE formation (Figure 5). Major glycation adducts in physiological 
systems are formed by non-oxidative processes. They include hydroimidazolones (G-H1, MG-
H1 and 3DG-H), Monolysine adducts (CEL and Pyrraline), Imidazolium and non-fluorescent 
crosslinks (MOLD and Glucosepane) and other structures such as CMA. Some AGEs are 
formed by oxidative processes and are called “glycoxidation products”. Examples of 
glycoxidation products are pentosidine and CML (Rabbani and Thornalley 2012). 
 
 
Figure 5. Molecular structures of protein glycation adduct residues. a) Early glycation adducts formed by 
glycation with glucose. b-f Advanced glycation endproducts (AGEs). b Hydroimidazolones. c Monolysine 
adducts. d Imidazolium and other non-fluorescent crosslinks. e Glycoxidation products, and f Other structures. For 
the corresponding free adducts at physiological pH, the N-terminal amino group is protonated –NH3
+
 and the C-
terminal carbonyl is a carboxylate –CO2
-
 moiety. Adapted from (Thornalley and Rabbani 2014). 
 
Despite AGEs are formed endogenously in physiological systems, protein glycation reactions 
also occurs in culinary processing, particularly during heat treatment of saccharide-rich food 
and alkaline treated bakery products (Singh, et al. 2014). The content of glycation protein 
adducts in food, their bioavailability, clearance and residence time in the body, as well as their 
functional effects, still remain controversial. Therefore, the contribution of glycation adducts 
from food to total physiological exposure to glycation adducts remains a critical issue for 
further investigation [(reviewed by (Rabbani and Thornalley 2012)]. 
It has been demonstrated in rats that AGEs from food are absorbed by the intestines into 
circulation and are eliminated from the organism, as reflected by the increase in their kidney 
content and urinary excretion  (Somoza, et al. 2006). In fact, in healthy humans, urinary 
excretion of AGEs is considered to be strictly dependent on daily diet (Forster, et al. 2005). 
Several lines of evidence favour the concept that exaggerated intake of thermally processed 
food might induce pathogenic pathways or aggravate a pre-existing pathology. In this sense, 
human studies have revealed that there are significant correlations between ingested AGEs, 
circulating AGEs, and several markers of inflammation (Vlassara 2005). Strikingly, at least in 
experimental animals, high consumption of heat treated foods may promote the manifestation 
of diabetes, and substantially contribute to the acceleration of the development of diabetic 
complications (Sebekova and Somoza 2007). In addition, animal studies suggest that feeding an 
AGE-rich diet may accelerate chronic kidney disease progression and renal fibrosis via a 
redox-sensitive inflammatory pathway (Sebekova and Somoza 2007). Therefore, highly 
thermally modified food may exert, in rodents and humans, various metabolic and nephrotoxic 
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effects, aggravating inflammation and oxidative stress. Thus, the recommendation of avoiding 
high intakes of severely thermally treated foods may be of clinical relevance and can possibly 
result in an extended healthy life span (Vlassara 2005).  
Concerning protein oxidation and nitration, are also implicated in some diseases (Finkel and 
Holbrook 2000; Greenacre and Ischiropoulos 2001). Concretely, oxidative protein adducts are 
formed by the reaction of peroxides, hypochlorite, oxidizing free radicals and heme iron 
species with susceptible amino acids, particularly methionine and tyrosine, and cysteine thiols, 
tryptophan and histidine. These reactions may be increased by oxidative stress arising from 
mitochondrial dysfunction, activation of NADPH oxidase, uncoupling of nitric oxide synthase, 
metabolism of environmental chemicals and drugs, and many other processes (Chance, et al. 
1979; Horiuchi 1996). Concerning protein nitration, it is increased in cellular-mediated 
immunity, vascular disorders, endotoxaemia and other diseases, particularly when there is high 
expression of inducible nitric oxide synthase (Greenacre and Ischiropoulos 2001). The major 
protein nitrosation biomarker is 3-nitrotyrosine (3-NT), formed by the reaction of tyrosine with 
peroxynitrite and chlorylnitrite (Greenacre and Ischiropoulos 2001). Other important protein 
oxidation biomarkers are: Glutamyl semialdehide (GSA), Methionine sulfoxide (MetSO) and 
N-formylkynurenine (NFK) (Rabbani and Thornalley 2009) (Figure 6). 
 
 
Figure 6. Molecular structures of protein oxidation (a) and nitration (b) adduct residues. For the corresponding 
free adducts at physiological pH, the N-terminal amino group is protonated –NH3
+
 and the C-terminal carbonyl is a 
carboxylate –CO2
-
 moiety. Figure adapted from (Thornalley and Rabbani 2014).  
 
In summary, biological proteins can be damaged, endogenously, by glycation, oxidation and 
nitration reactions throughout life (Karachalias, et al. 2010). Moreover, these reactions can be 
even significantly increased by several pathological conditions, such as diabetes and other 
metabolic diseases. Due to the fact that glycation, oxidation and nitration reactions are 
implicated in protein misfolding, the modified proteins lost their normal functions and are 
finally degraded by the proteasome (Thornalley 2008). As a result, free amino acids and free 
glycation, oxidation or nitration adducts, are released into the bloodstream (Thornalley 2005) 
and are considered to be potential biomarkers of protein damage (Thornalley, et al. 2003). 
Therefore, identification of free amino acids, and free glycation, oxidation and nitration adducts 
in biological samples from individual exposed to specific nutritional environments during 
critical periods of their development could throw light upon which factors, due to this 
nutritional condition, could affect the future metabolic health of an individual.   
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Aim and Experimental design 
Obesity has become a worldwide health problem, particularly in developed countries where its 
prevalence has increased substantially over the last decades. Moreover, obesity also increases the 
risk of insulin resistance, type 2 diabetes, hypertension and cardiovascular disease. As 
consequence, obesity has received considerable attention from the media and from the scientific 
community, who is trying to develop and implement therapeutic or preventive strategies to combat 
the global burden of obesity and its related metabolic alterations.  
The rising rate of obesity has been long attributed to a direct consequence of modern life’s access 
to large amounts of palatable, high calorie food and limited physical activity, together with the 
genetic background. However, many studies in human and animal models suggests that obesity 
prevalence and its raise in last decades may also be associated to complex environmental, 
behavioural and genetic influences during prenatal and postnatal stages of life, which ultimately 
may lead to a chronic energy imbalance that favours energy accumulation and excessive weight 
gain (Guilloteau, et al. 2009; Martin-Gronert and Ozanne 2013; Martorell, et al. 2001). In this 
regard, maternal nutritional environment, such as food restriction, during perinatal stages may 
program the risk in their offspring to develop obesity and related metabolic pathologies in adult 
life. Therefore, considering that obesity and its related metabolic alterations can be programmed 
already at early stages of life, understanding the molecular mechanisms underlying this 
developmental programming becomes crucial. Identification of these mechanisms could make 
possible the development of new strategies for reverting or preventing the programmed obesity 
and related metabolic alterations; they may also help in the identification of early biomarkers 
which could predict the propensity to develop obesity at very early stages of life, before the 
phenotypic features become evident. Identification of such biomarkers, particularly those related 
with improved metabolic health, becomes very interesting because they may also be used as tools 
to determine the effectiveness of nutritional intervention strategies during critical periods of 
development directed to program a greater protection against obesity and its related metabolic 
disorders in adult life.  
Therefore, the main aim of the present PhD Thesis was:  
To characterize in rats the programming effects of moderate maternal energy restriction during 
pregnancy or lactation on the metabolic health of their offspring in terms of obesity and related 
metabolic alterations, as well as to identify new preventing strategies against programmed 
obesity and early biomarkers of metabolic health. 
The experimental work has been performed at the Laboratory of Molecular Biology, Nutrition and 
Biotechnology (LBNB) ―directed by Professor Andreu Palou― of the University of the Balearic 
Islands (UIB) and Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y 
Nutrición (CIBERobn). The PhD project has been possible thanks to a pre-doctoral research 
fellowship from the Spanish Government, (FPU, “Formación de Profesorado Universitario”). The 
research has been funded mainly by the European Union project “BIOCLAIMS” (FP7-244995) 
and also by the national projects: “BIOBESMARKERS” (AGL2009-11277) and “EPIMILK” 
(AGL2012-33692). 
In addition, to advance in the development of this research project and to broaden the PhD 
candidate formation, I performed two research periods of 3 months each one (from the 21
st
 of 
September, 2012 until the 21
st
 of December, 2012; and from the 19
th
 of August, 2013 until 18
th
 of 
November, 2013) in the laboratory of Professor Paul Thornalley of the Division of Metabolic and 
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Vascular Health, Warwick Medical School at University of Warwick (Coventry, United 
Kingdom). These training periods abroad were performed within the framework of the 
BIOCLAIMS and EPIMILK projects, and were partially funded by the CIBERObn. The purpose 
of these stages was to learn the technique of liquid chromatography with tandem mass 
spectrometry detection (LC-MS/MS) and to apply it for the analysis of free amino acids and 
protein damage markers in milk and plasma samples.  
In order to achieve the principal aim of this PhD Thesis four specific objectives have been 
established, and for each of them several specific tasks have been undertaken.  
 
1. To determine the mechanisms underlying the higher susceptibility to obesity and related 
metabolic alterations of the offspring of rat dams exposed to food intake restriction during 
pregnancy, and to test whether an experimentally induced increase of hepatic fatty-acid 
oxidation (FAO) in these animals could be considered as a strategy to reverse the metabolic 
disturbances related to developmental programming.   
Previous studies in our laboratory showed that maternal calorie restriction of 20% during the first 
12 days of gestation has negative outcomes in the adult offspring. In particular, males and females 
showed higher food intake than their controls and this resulted in higher body weight in adulthood, 
but only in male animals. These results suggested that maternal calorie restriction during gestation 
has different lasting outcomes on offspring´s body weight depending on the gender (Palou, et al. 
2010a). Hence, the specific objective was to identify potential mechanisms involved in these 
programming effects and to test one concrete strategy to reverse, at least in part, these adverse 
effects. Two tasks were set out in order to achieve the first specific objective: 
Task 1.1. To study the effects of moderate maternal calorie restriction during pregnancy on 
determinants of later leptin and insulin resistance, and the different programming effects between 
male and female animals. To perform this, two groups of male and female rats were studied: the 
offspring of control dams and the offspring of dams subjected to moderate calorie restriction 
(20%) during the first 12 days of pregnancy (CRG animals).  
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Body weight and food intake of control and CRG animals were measured from delivery until the 
age of 6 months. All animals were fed with standard diet until the age of 4 months, and then, all of 
them were exposed to a HF-diet (4.7 kcal/g, with 45% calories from fat) until the age of 6 months. 
The expression of energy balance-related genes (including insulin, leptin and their respective 
receptors) in hypothalamus, retroperitoneal white adipose tissue (rWAT) and liver were analysed 
both at juvenile age (25 days old; to determine whether this dietary stressor during gestation was 
able to step up early programmed disorders) and in adulthood (6 months old). Moreover, 
considering the important role of leptin during perinatal development, we also investigated 
whether the effects of maternal calorie restriction during gestation on later leptin and insulin 
homeostasis could be related with alterations in leptin levels during the suckling period. To 
achieve this, blood samples from pups were collected at different stages of lactation (days 6, 9 and 
15 of lactation) under ad libitum feeding conditions to obtain plasma for leptin determination. 
Furthermore, insulin and leptin levels were measured in plasma samples from 25-day- and 6-
month-old animals. HOMA-IR was also determined at the age of 6 months. Results from this 
study are included in the manuscript 1. 
Task 1.2. To study whether increased hepatic FAO through AAV-mediated gene transference of 
Cpt1am at juvenile ages may prevent or revers the metabolic negative outcomes observed in the 
offspring of 20% maternal calorie restriction during gestation due to developmental programming. 
There is evidence in the literature showing that, in obese mice, a permanent increase of hepatic 
FAO by injection of AAV vectors containing the key gene for mitochondrial β-oxidation, the 
Cpt1a or Cpt1am (which encodes for a permanently active form of CPT1A insensitive to its 
physiological inhibitor malonyl-CoA), leads to a reduction of obesity-induced hepatic steatosis, 
weight gain, inflammation, diabetes and insulin resistance in obese mice consuming HF-diet. 
Therefore, considering this and to accomplish the task 1.2, we used a new cohort of control and 
CRG male animals. AAV vectors were administered by tail vein injection in 18-day-old control 
and CRG male pups. Half of the male control and CRG pups were injected with control AAV 
vectors (Control-C and CRG-C animals, respectively); the other half of pups were injected with 
AAV vectors carrying the cDNA for Cpt1am (Control-CPT and CRG-CPT animals, respectively).  
 
Body weight and food intake of control and CRG animals were recorded from delivery until the 
age of 6 months. All animals were fed with standard diet until the age of 4 months, and then, all of 
them were exposed to a HF-diet until the age of 6 months. Locomotive activity and energy 
expenditure were measured at the age of 3 months by indirect calorimetry. Blood pressure was 
Juana María Torrens García – Doctoral Thesis 
 
- 38 - 
 
also measured at the age of 5 months. Finally, at the age of 6 months, animals were killed to 
collect liver, rWAT and blood samples. Gene expression analysis of liver, as well as 
morphological, histological and biochemical analysis of liver and rWAT were performed. Results 
from this study are included in the manuscript 2. 
 
2. To characterize the effects of food intake restriction of rat dams during lactation on the 
offspring predisposition to obesity and related metabolic disorders, as well as to identify 
potential mechanisms involved in the early postnatal nutrition programming. 
Maternal calorie restriction during gestation is already known to have long lasting negative effects 
on their offspring, which become programmed for a higher propensity the develop obesity and 
related metabolic alterations in a gender depended manner. However, the lasting effects of early 
postnatal nutrition, particularly moderate maternal calorie restriction during lactation, are still 
uncertain. Several animal studies have been previously performed focusing on severe maternal 
energy restriction and/or protein restriction during lactation, or by increasing the litter size during 
the suckling period. In general, these conditions showed protective effects against overweight in 
the offspring, however, some detrimental effects could also be observed on the normal 
development of these animals. Therefore, in order to fulfil the second specific objective, two 
groups of male and female animals were studied: the offspring of control dams and the offspring 
of dams exposed to moderate calorie restriction (30%) throughout the whole lactating period (CRL 
animals). 
 
All animals were fed with standard diet until the age of 4 months; then, half of them continued 
with standard diet (normal fat – NF – animals), and the other half was fed with HF-diet (HF 
animals) until the age of 6 months.  
Hence, two tasks were performed: 
Task 2.1. To study the effects of 30% moderate maternal calorie restriction during lactation on 
later body weight, insulin sensitivity and other energy homeostasis-related parameters of their 
adult male and female offspring. To achieve this, body weight and food intake of control and CRL 
animals were recorded from delivery until the age of 6 months. Circulating parameters were also 
measured in plasma of 5-month-old offspring. Additionally, we determined whether leptin content 
in maternal milk or leptin production by the mammary gland could be affected by maternal calorie 
restriction during lactation. To accomplish this, milk samples were collected from control and 
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CRL dams at day 18 of lactation, and milk leptin levels were measured. mRNA expression levels 
of leptin were also determined in mammary gland of dams. Results from this study are included in 
the manuscript 3. 
Task 2.2. To gain further insight into the mechanisms that could underlie the beneficial outcomes 
observed in the adult offspring of dams subjected to 30% moderate calorie restriction during 
lactation. To achieve this, mRNA expression levels of selected genes involved in the regulation of 
food intake (in the hypothalamus) and fat accumulation (in rWAT) were analysed. In addition, 
circulating parameters of 6-month-old control and CRL animals, under NF and HF-diet, were 
analysed under feeding conditions (and also under fasting conditions for HF-diet exposed 
animals). The relationship between mRNA expression levels of those genes analysed and energy 
homeostasis-related parameters under HF-diet feeding conditions in adulthood was also examined. 
Results from this study are included in the manuscript 4. 
 
3. To use the offspring of dams exposed to food intake restriction during lactation, as an 
animal model programmed for a lower propensity to develop obesity and related metabolic 
alterations, for identifying early transcriptome-based biomarkers of metabolic health. 
In previous tasks (2.1 and 2.2), we studied the effects of 30% maternal calorie restriction during 
lactation on the offspring metabolic health in adult life. Here we analysed whether a less severe 
maternal calorie restriction (20%) during lactation, which could be a typical situation of dieting 
representative or applicable in humans, also causes beneficial effects in offspring against obesity 
development and other metabolic alterations in adult life. If so, we planned to use this model as a 
tool to identify early biomarkers of metabolic health.  
In order to accomplish this specific objective, two groups of male and female animals were 
studied: the offspring of control dams and the offspring of dams subjected to 20% moderate 
calorie restriction throughout the whole lactating period (CRL animals).   
All animals were fed with standard diet until the age of 4 months; then, half of them continued 
with standard diet (NF animals), and the other half was fed with HF-diet (HF animals) until the 
age of 6 months.  
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Two tasks were developed: 
Task 3.1. To characterise the effects of 20% maternal calorie restriction during lactation in the 
offspring, in terms of body weight and metabolic health. To achieve this, body weight and food 
intake of control and CRL animals were recorded from delivery until the age of 6 months. 
Circulating parameters were also measured at weaning (postnatal day 21) and at the age of 6 
months. In addition, we investigated early adaptations at the transcriptional level in key tissues 
involved in energy homeostasis, such as rWAT and liver, and whether these changes are 
maintained in adulthood (6 months old) under HF-diet exposure. Results from this study are 
included in the manuscript 5. 
Task 3.2. To use the animal model consisting in the offspring of 20% calorie restricted dams 
during lactation to identify early predictive biomarkers of metabolic health by transcriptome 
profiling of PBMCs samples. We also studied whether the potential biomarkers identified at 
juvenile age continue to serve as potential biomarkers in adulthood, and whether the changes 
occurring in blood cells reflect the metabolic environment in key tissues. To achieve this task, 
whole-genome microarray analysis of PBMCs samples from 21-day-old control and CRL pups 
were performed. To validate microarray analysis, expression patterns of selected genes related to 
lipid metabolism were fully confirmed by Real-Time quantitative Polymerase Chain Reaction 
(RT-qPCR). Transcript levels of these genes were also assessed by RT-qPCR in PBMCs from 6-
month-old adult rats and in relevant metabolic tissue samples, such as liver and WAT, of 21-day- 
and 6-month-old animals. Results from this study are included in the manuscript 6. 
 
4. To determine whether the beneficial effects observed in the offspring of moderate calorie 
restricted lactating rat dams might be related with changes in free amino acid levels and 
protein damage markers in maternal plasma and breast milk.  
Maternal nutritional environment during the lactating period may result in changes in milk 
composition. Such changes could be modifications in the integrity of specific components 
contained in breast milk, throughout reactions of glycation, oxidation or nitration reactions. These 
reactions generate, in turn, misfolded proteins that are degraded into free amino acids and free 
protein damage adducts, including glycation, oxidation or nitration free adducts. Thus, the analysis 
of free protein damage adducts and of free amino acids, in breast milk and plasma samples of 
mothers exposed to moderate food restriction during lactation, could throw light upon the 
mechanisms that can affect the future metabolic health of an individual, as consequence of 
changes in its nutritional environment during lactation. To accomplish this, the following task was 
performed: 
Task 4.1. Quantitative screening of free amino acids and of a comprehensive range of free 
glycation, oxidation and nitration adducts in breast milk and plasma samples from control and 
20% calorie restricted dams during lactation. To achieve this, two groups of lactating rat dams 
were studied: control dams and dams subjected to moderate calorie restriction (20%) throughout 
the lactating period (CRL dams).  
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Breast milk samples ―collected at days 5, 10 and 15 of lactation― as well as, maternal plasma 
―collected at day 21 of lactation― from control and CRL dams were analysed by liquid 
chromatography with tandem mass spectrometry detection (LC-MS/MS). Results from this study 
are included in the manuscript 7. 
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Materials and methods 
1. Experimental animals 
All the studies were conducted on male and female Wistar rats purchased from Charles River 
Laboratories (Barcelona, Spain). During experiments, animals were housed under standard 
conditions in the animal house at University of the Balearic Islands (UIB): controlled 
temperature (22ºC), 12 h light-dark cycle and, free access to tap water and standard laboratory 
rodent chow diet (3 Kcal/g, with 8% calories from fat; Panlab, Barcelona, Spain), unless 
specify.  
Body weight and food intake of animals were recorded. Body length was measured from the tip 
of the nose to the anus. Body composition was determined by using an EchoMRI-700TM 
(Echo Medical Systems). All these measures were performed without anesthesia.   
In some studies it was necessary to collect tissue samples from juvenile animals. Hence, in 
these experiments a set of animals were killed at juvenile ages, either at weaning (21 days old) 
or at the age of 25 days, while the other set of animals was killed in adulthood (at the age of 6 
months). Animals were killed by decapitation during the first 2 h at the beginning of the light 
cycle, under ad libitum feeding conditions or after 12 h fasting, depending on the experimental 
design. Selected tissues, such as hypothalamus, liver, mammary gland and white adipose tissue 
depots (gonadal, inguinal, mesenteric and retroperitoneal; gWAT, iWAT, mWAT and rWAT, 
respectively) were rapidly removed, weighed, washed with 0.1% diethyl pyrocarbonate 
(DEPC) saline solution (to avoid biochemical and molecular tissue degradation), frozen in 
liquid nitrogen and stored at -80ºC until posterior analysis. 
Blood samples were collected from all animals at different time-points (at 2, 4 and 6 months of 
life) and under ad libitum feeding conditions and/or under 12 h fasting conditions. At 2 and 4 
months, blood samples were collected in heparinized containers from the saphenous vein, 
without anesthesia and during the first 2 h at the beginning of the light cycle. When animals 
were killed, trunk blood samples were collected in heparinized containers, after animal 
decapitation, for plasma and peripheral blood mononuclear cells (PBMCs) isolation. Plasma 
was obtained by centrifugation of heparinized blood at 1000 x g for 10 min at 4ºC. Plasma was 
saved in new sterile containers and stored at -20ºC until posterior analysis.   
The animal protocol followed in all studies was reviewed and approved by the Bioethical 
Committee of the University of the Balearic Islands, and guidelines for the use and care of 
laboratory animals of the university were followed.    
Reagents: 
- Standard chow diet (Panlab).  
- 0.1% DEPC-saline solution: 1 mL of DEPC (Sigma) in 1 L of saline solution.  
 
2. PBMCs isolation  
PBMCs, a subset of white blood cells including lymphocytes and monocytes, were isolated 
from the samples of trunk blood by density gradient separation using the medium Ficoll-
Paque™ PLUS (GE Healthcare). 
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Density gradient centrifugation is a technique that allows the separation of cells, organelles and 
macromolecules, depending on their size, shape and density. A density gradient is created in a 
centrifuge tube by layering solutions of varying densities with the dense end at the bottom of 
the tube. Differential migration during centrifugation results in the formation of layers 
containing different cell types. When isolating PBMCs, the bottom layer contains erythrocytes 
which have been aggregated by the medium. The layer above the erythrocytes contains mostly 
granulocytes and PBMCs are found at the interface (buffy coat) between the plasma and the 
medium with other slowly sedimenting particles, such as platelets. 
The medium Ficoll-Paque™ PLUS (GE Healthcare) is a shallow density gradient of Ficoll 
sodium diatrizoate solution with a proper density of 1.077 g/mL. In addition to its viscosity, 
and osmotic pressure, this medium allows lymphocyte isolation in a simple and rapid 
procedure, following the instructions of the manufacturer.  
Blood samples were collected using heparin in 0.9% sodium chloride (NaCl) solution as 
anticoagulant (200 µl of heparin in 0.9% NaCl for 500-600 µl of blood), and then diluted with 
an equal volume of balanced salt solution (BSS) (200 µl of heparin in NaCl 0.9% + 500 µl of 
blood + 700 µl of BSS). Blood treated with anticoagulant was then layered on the Ficoll-Paque 
PLUS solution (1.5 ml of Ficoll for 2 mL of blood mixed with BSS and heparin in NaCl) and 
centrifuged at 900 x g for 40 min at 20ºC (with minimum acceleration and deceleration). After 
centrifugation and layers formation, the cell ring fraction (buffy coat) containing PBMCs were 
harvested. This material was then washed by centrifugation in 3 volumes of  BSS at 900 x g for 
10 min at 20ºC to remove any platelets, Ficoll-Paque PLUS and plasma, and finally frozen at -
80°C until RNA extraction. 
Reagents: 
- 0.2% Heparin in 0.9% NaCl: 0.2 g of heparin (Sigma) in 100 mL of 0.9%NaCl (Panreac) 
- Balanced Salt Solution (BSS): mixture 1:9 of solution A and solution B. Solution A: 5.5 
mM anhydrous D-glucose (Merck), 5 mM CaCl2 x 2H20 (Pancreac), 0.98 mM MgCl2 x 
6H20 (Pancreac), 5.4 mM KCl (Pancreac), 145 mM Trizma base (Sigma), pH adjusted to 
7.6. Solution B: 140 mM NaCl (Pancreac). 
- Ficoll-Paque™ PLUS (GE Healthcare) 
 
3. RNA isolation and quantification 
Total RNA was isolated from hypothalamus, liver, mammary gland, iWAT and rWAT by 
commercial Tripure Reagent Method (Roche Applied Science) or by E.Z.N.A. Total RNA kit I 
(Omega Bio-Tek), depending on the type of tissue and its size. In general, when the entire 
tissue needed to be homogenized for gene expression analysis, such as hypothalamus, or the 
size of tissue was too small (especially tissue samples collected from young animals), the 
extraction was performed following the Tripure Reagent Method, according to the 
manufacturer´s instructions. For tissue samples collected from adult animals (relatively larger 
size of tissue) or when the intended use of extracted yield required its high quality and purity 
(for example to use RNA from PBMCs for microarray analysis), total RNA was extracted using 
E.Z.N.A. Total RNA kit I, according to the manufacturer´s instructions. 
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3.1.Tripure reagent method for RNA isolation 
The whole hypothalamus or approximately 100 mg of WAT, liver or mammary gland were 
homogenized in ice, in 1 mL of Tripure Reagent using a tissue homogenizer. Tripure Reagent, 
is a mono-phasic solution of phenol and guanidine isothiocyanate that allows the maintenance 
of the RNA integrity and denatures endogenous nucleases, while disrupting cells and dissolving 
cell components. 
In case of WAT, liver and mammary gland, to remove the fat fraction, homogenates were 
centrifuged at 12000 x g for 10 min at 4ºC, and the upper fat layer was discarded. To separate 
RNA, 200 µl of chloroform were added and samples were vigorously shaken for 15 s. 
Straightaway, a centrifugation at 12000 x g for 15 min at 4ºC was performed to generate three 
phases: a colorless aqueous upper phase which contains RNA, a white interphase with DNA 
and an organic pink phenol-chloroform lower phase which contains proteins (which was stored 
at -20ºC). For RNA precipitation, the aqueous phase was transferred into a separate fresh tube 
and 500 µl of isopropanol were added. Samples were mixed by inversion and incubated 
overnight at -20ºC. Afterwards, samples were centrifuged at 12000 x g for 10 min at 4ºC to 
precipitate RNA. Isopropanol was removed and the precipitated RNA was washed with 1 mL 
of 75% ethanol, vigorously shaken and centrifuged at 7600 x g for 5 min at 4ºC to remove 
ethanol completely. To increase the efficiency and have a major purity of RNA, the ethanol 
wash step was performed twice. Finally, ethanol was completely removed and the precipitated 
RNA was dried (air-dry) for 5-10 min to evaporate any rests of ethanol. Finally, RNA pellet 
was resuspended in a volume of RNAase-free water and stored at -80ºC.   
 
3.2. E.Z.N.A. total RNA kit I for RNA isolation 
E.Z.N.A. Total RNA Kit I provides a simple and rapid method to obtain purified RNA from 
relatively low amount of tissue. This system uses the reversible binding properties of the 
HiBind Matrix in combination with the speed of mini-column spin technology, thereby 
permitting single or multiple simultaneous processing of samples. Samples are applied to the 
HiBind RNA spin column to which total RNA binds. Cellular debris and other contaminants 
are effectively washed away after a few quick wash steps. 
PBMCS or, 10 mg of WAT or liver, were homogenized in 350 µl of TRK Lysis Buffer (700 µl 
for WAT) using a tissue homogenizer. Optionally, before homogenizing, 10 µl of β-
mercaptoethanol per 1 mL of TRK Lysis Buffer, were added to achieve a working solution. β-
mercaptoethanol reduces RNA degradation. To remove the fat fraction, homogenates were 
centrifuged at 13000 x g for 5 min at 4ºC. Cleared supernatant was transferred carefully into a 
fresh sterile tube and 350 µl (or 700 µl) of 70% ethanol were added.  Samples were vigorously 
shaken and the entire volume was transferred to a HiBind RNA spin column pre-inserted into a 
2 mL collection tube, and then centrifuged at 10000 x g for 2 minutes at room temperature. The 
flow-through was discarded. Then, samples were washed with 350 µl of RNA Wash Buffer I, 
centrifuged at 10000 x g for 1 min and the flow-through was discarded. To avoid DNA 
contamination, 35 µl of DNAase I digestion reaction mix were added directly onto the surface 
of membrane’s column. After incubating for 15 min at room temperature, 400 µl of RNA Wash 
Buffer I were added and columns were centrifuged at 10000 x g for 1 min at room temperature. 
The flow-through was discarded. All columns were washed again with 500 µl of RNA Wash 
Buffer II and centrifuged at 10000 x g for 1 min at room temperature. The flow-through was 
discarded. The final washing was performed with 350 µl of RNA Wash Buffer II, centrifuged 
at 10000 x g for 1 min at room temperature and discarded the flow-through. Then, to 
completely dry the HiBind membrane, columns were centrifuged, with the collection tube 
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empty, at maximum speed (20000 x g) for 2 min. Finally, columns were transferred into a clean 
1.5 mL microfuge tube and RNA was eluted with 50-100 µl of DEPC-treated water (added 
directly onto the center of the membrane’s column) by centrifuging at 12000 x g for 4 min at 
room temperature.   
 
3.3. RNA quantification and assessment of its integrity  
Isolated RNA was quantified using the NanoDrop ND-1000 spectrophotometer (NanoDrop 
Technologies). This spectrophotometer is used for quantification of nucleic acids by using UV 
absorption. The concentration of the nucleic acid can be determined using the Beer-Lambert 
law, which predicts a linear change in absorbance with concentration. RNA has its maximum 
absorption at 260 nm, therefore, absorption at 260 nm of 1.0 is equivalent to about 40 µg/ml of 
RNA and hence, the optical density at 260 nm is used to determine the RNA concentration in a 
solution. NanoDrop ND-1000 spectrophotometer also determines the ratio of absorbance at 260 
nm and 280 nm to assess the purity of RNA. A ratio of ~ 1.8 is generally accepted as “pure” for 
DNA; a ratio of ~ 2.0 is generally accepted as “pure” for RNA. If the ratio is appreciably lower 
in either case, it may indicate the presence of proteins that absorb strongly at or near 280 nm. If 
the ratio for RNA is appreciably upper than 2, it determines contamination with DNA. Indeed, 
this spectrophotometer also determines a secondary ratio of absorbance at 260 nm and 230 nm, 
which indicates the contamination degree with organic dissolvent. Expected 260/230 values for 
“pure” nucleic acid are commonly in the range of 2.0-2.2. If the ratio is appreciably lower than 
expected, it may indicate the presence of contaminants, which absorb at 230 nm, such as 
organic solvents. For spectrophotometric quantification of isolated total RNA, 2 µl of sample 
were used.  
Verification of integrity of isolated RNA was confirmed using 1% agarose gel electrophoresis. 
Electrophoresis technique relies on the negative charge of nucleic acids for size separation in a 
sieved matrix. Visualization of 28S and 18S ribosomic RNA (rRNA) bands is an indicator of 
sample integrity. Intact total RNA is characterized by sharp bands, from which the 28S rRNA 
band should be approximately twice as intense as the 18S rRNA band. Completely degraded 
RNA appears as a very low molecular weight smear. 
Agarose gels were made in 0.5x electrophoresis running buffer and stained with SYBR Safe 
DNA Gel Staining (1 µl of SYBR Safe DNA Gel Staining for each 10 mL of 0.5x 
electrophoresis running buffer). RNA samples (250 ng) were mixed with 3 µl of sample 
loading buffer. Electrophoresis was performed by running the gel at 90 V for 30 min. SYBR 
Safe DNA Gel Staining has fluorescence maximum excitation at 280 and 502 nm, and a 
maximun emission at 530 nm. Thus, RNA bands stained with SYBR Safe DNA gel staining 
were visualized using a UV transilluminator imaging system (ChemiGeninus Bio, Syngene). 
After irradiating the gel with UV light, the emitted fluorescence was photographed using the 
GeneSnap Software and sharpness of 28S and 18S rRNA bands was evaluated.  
Reagents: 
- Agarose (Pronadisa) 
- β-mercaptoethanol (Sigma) 
- Chloroform (Sigma) 
- DNAase I digestion reaction mix: 0.75 µl of RNAase-free DNAase I (20 Kunitz/ µl) per 
each 36.75 µl of E.Z.N.A
TM
 DNase I Digestion Buffer; (Omega Bio-Tek) 
- Ethanol absolute (Panreac) 
- Glycerol (Sigma) 
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- Isopropanol (Sigma) 
- RNAase-free water (Sigma) 
- SYBR Safe DNA Gel Staining (Invitrogene) 
- Tripure Reagent (Roche Applied Science) 
- E.Z.N.A. Total RNA kit I (Omega Bio-Tek): TRK Lysis Buffer, DEPC-treated water, 
RNA Wash Buffer I (Omega Bio-Tek) and RNA Wash Buffer II (Omega Bio-Tek). 
- 0.5x electrophoresis running buffer: Tris-borate-EDTA buffer (TBE) containing: 44.5 mM 
Tris base, 44.5 mM Boric acid and 1 mM EDTA 
- Sample loading buffer: 50% glycerol (Sigma), 50% water and 2.5 mg/mL bromophenol 
blue (Panreac) 
 
 
4. Gene expression analysis by Real-Time quantitative polymerase chain reaction (RT-
qPCR) 
To measure mRNA expression levels of selected genes, firstly, total isolated RNA was reverse 
trasncribed into complementary DNA (cDNA) and then, the resulting cDNA was amplifiyed 
and quantified by RT-qPCR. 
 
4.1. Reverse transcription 
Isolated total RNA (0.25 µg, in a final volume of 5 µl with RNAase-free water) was denatured 
for 10 min at 65ºC in an Applied Biosystems 2720 Thermal Cycler (Applied Biosystem). Then, 
denatured RNA was reverse transcribed to cDNA after adding 7.5 µl of a reaction mix into in 
each sample. The reaction mix contained per sample: 1.25 µl of 10x Buffer, 1.25 µl of 25 mM 
MgCl2, 2 µl of 2.5 mM dNTPs, 0.5 µl of random hexamers, 0.5 µl of RNAase inhibitor, 0.5 µl 
of murine leukemia virus reverse transcriptase and 1.5 µl of RNAase free water. The reverse 
transcription process was performed in an Applied Biosystems 2720 Thermal Cycler (Applied 
Biosystem) following this program: 15 min at 20ºC, 30 min at 42ºC, 5 min at 95ºC and a final 
step of 4ºC indefinitely.  
 
4.2. Real Time quantitative Polymerase Chain Reaction (RT-qPCR) 
cDNA obtained by reverse transcription was used to quantify mRNA levels of selected genes 
by RT-qPCR. The principle of this method is that there is an increase in fluorescence from 
SYBR Green dye meanwhile the PCR amplification process progresses. As the SYBR Green 
dye binds to double-stranded amplicons, it undergoes a conformational change and emits 
fluorescence at exponential intensity. 
To achieve this, 2 µl of diluted (1/5 or 1/10) cDNA template were mixed with 9 µl of a reaction 
mix. Per each sample, the reaction mix contained: 3.1 µl of RNAase free water, 0.45 µl of each 
forward and reverse primers (5 µM or 10 µM) and 5 µl Power SYBER Green PCR Master Mix. 
RT-qPCR was performed using the Applied Biosystems Step OnePlusTM Real-Time PCR 
Systems (Applied Biosystems) with the following program: 10 min at 95ºC, followed by a total 
of 40 two-temperature cycles (15 s at 95ºC and 1 min at 60ºC). To verify the purity of the 
products, a melting curve was produced after each run according to the manufacturer’s 
instructions. The threshold cycle was calculated by the instrument’s software (StepOne 
Software version 2.2). Relative gene expression numbers were calculated as a percentage of 
control animals, using the 2-∆∆Ct method (Livak and Schmittgen 2001). Different 
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housekeeping genes were used as internal controls for gene expression normalization, 
depending on the tissue, the age and sex of animals, according to their better suitability. 
Reagents: 
- 50 U/µl murine leukemia virus reverse transcriptase (Applied Biosystem) 
- RNAase free water (Sigma) 
- 1x Buffer (Promega) 
- 2.5 mM MgCl2 (Promega) 
- 100 mM dATP solution (Invitrogen) 
- 100 mM dGTP solution (Invitrogen) 
- 100 mM dCTP solution (Invitrogen) 
- 100 mM dTTP solution (Invitrogen) 
- Power SYBER Green PCR Master Mix (Applied Biosystem) 
- 50 U/µl random hexamers (Applied Biosystem) 
- 20 U/µl RNAase inhibitor (Applied Biosystem) 
- Forwards and reverse primers (provided by Sigma) 
 
 
5. Determination of circulating parameters 
5.1. Insulin  
Insulin levels were measured in plasma samples using a quantitative two-site sandwich 
Enzyme-linked Immunosorbent Assay technique (ELISA) applied on the commercial “Rat 
Insulin ELISA kit” from Mercodia. Insulin levels in plasma samples from young rats (until the 
age of 1 month) were quantified by using the “Ultrasensitive Rat Insulin ELISA Kit” from 
Mercodia.  
The assay is based on the direct sandwich technique in which two monoclonal antibodies are 
directed against separate antigenic determinants on the insulin molecule. 10 µl of plasma 
sample or calibrators (25 µl in case of ultrasensitive insulin kit) were added into their respective 
wells and then 100 µl of enzyme conjugated 1x solution were also added into each well. The 
enzyme conjugated 1x solution was previously prepared according to the manufacturer´s 
instructions: dilution of Enzyme Conjugate 11x in Enzyme Conjugate buffer 1+10.  During 
incubation (2 h at room temperature on a plate shaker, 700-900 rpm), insulin in the sample 
reacted with peroxidase-conjugated anti-insulin antibodies and anti-insulin antibodies, bounded 
to micro-titer well. After 5 washing steps (by aspiration and washing with Wash Buffer), every 
unbound molecule and unbound enzyme labeled antibody was removed. Subsequently, the 
bound conjugate was detected by adding 200 µl of substrate 3,3’,5,5’-tetramethylbenzidine 
(TMB) and by incubating the microplate for 15 min at room temperature. The reaction was 
stopped by adding the Stop Solution to give a colorimetric endpoint that was read 
spectrophotometrically at 450 nm using a spectrophotometer for microplates (Tecan Sunrise 
Absorbance Reader). 
Reagents: 
- Rat Insulin ELISA (Mercodia) 
- Ultrasensitive Rat Insulin ELISA (Mercodia) 
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5.2. Glucose 
Glucose levels were measured in fresh blood using an ACCU-CHEK Aviva system glucometer 
and test strips from Roche Diagnostics. To achieve this, a fresh blood drop, obtained during 
blood sample collection from saphenous vein or after killing the animals by decapitation from 
trunk blood, was applied to the test strip. After waiting some seconds, glucose concentration 
(mg/dL) appeared on the glucometer screen.   
The ACCU-CHEK Aviva system uses patented electrochemical methods for glucose 
determination. Test strips contain a capillary that sucks up 0.6 μl of blood. The glucose in the 
blood reacts with an enzyme electrode containing glucose dehydrogenase. Firstly glucose is 
oxidized to gluconic acid and the enzyme is temporally reduced by two electrons transferred 
from glucose to the enzyme. The reduced enzyme next reacts with an oxidized mediator, 
ferricyanide, transferring a single electron to each of two mediator ions. The enzyme is returned 
to its original state, and the two oxidized mediators are reduced to ferrocyanide. Ferricyanide 
and ferrocyanide are capable of rapidly transferring electrons with an electrode. Then, the 
glucometer applies a potential difference between the working and counter electrodes. The 
counter electrode potential is defined by the ratio of ferricyanide and ferrocyanide at the 
electrode surface. Since the amount of ferrocyanide is small relative to the amount of 
ferricyanide, the concentration ratio (and hence the counter electrode potential) is effectively 
constant. This applied potential difference is sufficient to provide a diffusion-limited current at 
the working electrode, so the ferrocyanide concentration may be determined by biamperometry. 
The meter measures working electrode current, which is linked to ferrocyanide concentration. 
Because the ferrocyanide concentration is coupled to glucose concentration, the current 
measurement permits calculation of blood glucose. Finally, current data are analyzed, and the 
result is recorded and displayed.  
Due to ACCU-CHEK Aviva system uses glucose dehydrogenase chemistry, glucose 
determination is not affected by varying degrees of sample oxygenation (capillary, venous, 
alternate site).  
 
5.3. Homeostatic model assessment for insulin resistance (HOMA-IR) 
Homeostatic model assessment for insulin resistance (HOMA-IR) is a method used to quantify 
insulin resistance through plasmatic insulin and glucose levels, both under fasting conditions. 
HOMA-IR was calculated using the formula of Matthews et al. previously described 
(Matthews, et al. 1985)  
HOMA-IR = fasting glucose (mmol/L) x fasting insulin (mU/L) / 22.5 
 
5.4. Leptin 
Leptin levels were measured in plasma and milk samples using a quantitative sandwich enzyme 
immunoassay technique applied on kit “Quantikine Mouse/Rat Leptin Immunoassay” from 
R&D Systems.  
The microplate provided in this kit is pre-coated with a polyclonal antibody specific for 
mouse/rat Leptin. The assay was performed according to the manufacturer´s instructions.  
Firstly, 50 µl of Assay Diluent RD1W were added into each well and 50 µl of standard or 
sample were added into their respective wells. Microplate was incubated for 2 h at room 
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temperature. During incubation process, mouse/rat leptin that is present in the sample bound 
the immobilized antibody. After removing any unbound substances, by 5 washing steps (by 
aspiration and washing with Wash Buffer), 100 µl of an enzyme-linked polyclonal antibody 
specific for mouse Leptin was added into each well. Microplate was incubated for 2 h at room 
temperature. After 5 washing steps, to remove any unbound antibody-enzyme reagent, 100 µl 
of substrate solution were added into each well, and microplate was incubated for 30 min at 
room temperature. During incubation process, the enzyme reaction yielded a blue product that 
turned yellow when 100 µl of the Stop Solution were added. The intensity of the color was 
measured at 450 nm (with wavelength correction at 540 nm) and was in proportion to the 
amount of Leptin bounded in the initial step. The sample values were then read off the standard 
curve. To measure the intensity of the color of each well a spectrophotometer for microplates 
(Tecan Sunrise Absorbance Reader) was used. 
Reagents: 
- Quantikine® ELISA Mouse/Rat Leptin Immunoassay (R&D Systems).  
 
5.5. Triglycerides (TGs) 
Plasma triglyceride levels were determined using an enzymatic colorimetric method applied on 
“Serum Triglyceride Determination Kit” from Sigma. The procedure of this kit involves 
enzymatic hydrolysis by lipase of TG to glycerol and free fatty acids. The glycerol produced is 
then measured by coupled enzyme reactions: firstly, glycerol is phosphorylated by adenosine-
5´-triphosphate (ATP) forming glycerol-1-phosphate (G-1-P) and adenosine-5´-diphosphate 
(ADP) in the reaction catalyzed by glycerol kinase (GK); G-1-P is then oxidized by glycerol 
phosphate oxidase (GPO) to dihydroxyacetone phosphate (DAP) and hydrogen peroxide 
(H2O2) 
Subsequently, peroxidase catalyzes the coupling of H2O2 with 4-aminoantipyrine (4-AAP) and 
sodium N-ethyl-N-(3-sulfopropyl) m-anisidine (ESPA) to produce a quinoneimine dye that 
shows an absorbance maximum at 540 nm. The increase in absorbance at 540 nm is directly 
proportional to TG concentration of the sample. Free endogenous glycerol can be measured 
using the same coupled enzyme reactions without the initial lipase hydrolysis. The reaction 
sequence would be the same except for the lipolytic reaction. The increase in absorbance at 540 
nm is then directly proportional to glycerol concentration of the sample. 
This assay was performed according to the manufacturer´s instructions with some 
modifications in order to use the kit in a microplate format. Firstly, 240 µl of Free Glycerol 
Reagent were added into each well. Then, 3 µl of water, Glycerol Standard or plasma sample 
were added into their respective wells. The microplate was incubated for 5 min at 37ºC and 
afterwards, the absorbance was read at 540 nm (initial absorbance). After determination of 
glycerol concentrations, 60 µl of the Triglyceride Reagent were added into each well and the 
microplate was again incubated for 5 min at 37ºC. Finally, the absorbance was read at 540 nm 
(final absorbance) to determine total TG concentration. Initial and final Absorbance was 
measured using a spectrophotometer for microplates (Tecan Sunrise Absorbance Reader). To 
calculate the concentration of TG in the sample, the content of glycerol was subtracted from the 
concentration of total TG.    
Reagents: 
- Serum Triglyceride Determination Kit (Sigma) 
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5.6. Non-esterified fatty acids (NEFAs) 
Plasma NEFA levels were measured using a enzymatic colorimetric method applied on kit 
“NEFA-HR(2) assay” from Wako Chemicals. The procedure involves the enzymatic activity of 
Acyl-CoA synthetase (ACS), which catalyzes the acylation of coenzyme A (CoA) by the fatty 
acids. The acyl-CoA thus produced is oxidized by added acyl-CoA oxidase (ACOX) with 
generation of hydrogen peroxide, that in the presence of peroxidase (POD) permits the 
oxidative condensation of 3-methy-N-ethyl-N(β-hydroxyethyl)-aniline (MEFA) with 4-
aminoantipyrine to form a purple colored, 3-Methyl-N-Ethyl-N-(β-Hydroxyethyl)-Aniline 
(MEHA), which can be measured colorimetrically at 550 nm. The intensity of this pigment is 
proportional to the concentration of free fatty acids in the sample. Ascorbic acid is removed by 
ascorbate oxidase from the sample. 
This assay was performed according to the manufacturer´s instructions with slight 
modifications. Firstly, 7 µl of plasma sample or NEFA standard were loaded into their 
respective wells. Then, 150 µl of the Reagent 1, which contains the ACS, were added into each 
well. After incubating the microplate for 5 min at 37ºC, 75 µl of Reagent 2 were loaded into 
each well. After incubating the microplate for 5 min at room temperature, the absorbance was 
measured at 550 nm using a spectrophotometer for microplates (Tecan Sunrise Absorbance 
Reader).  
 Reagents: 
- NEFA-HR(2) assay (Wako). 
 
5.7. β-hydroxybutyrate (BHB) 
BHB circulating levels were measured using the “β-hydroxybutyrate determination kit” from 
Materlab. The principle of this assays focuses on the enzymatic activity of BHB dehydrogenase 
which catalyzes the oxidation of BHB to acetoacetate with simultaneous reduction of NAD to 
NADH. The increase of absorbance of NADH is directly proportional to the BHB in the 
sample. Then, to measure BHB levels in plasma samples, 10 µl of plasma sample or standard 
were added into their respective wells and 180 µl of Working Reagent were also added into 
each well. After incubating for 10 min at 37ºC, samples were excited at 355 nm and the 
emission of fluorescence was read at 460 nm by using a spectrofluorimeter for microplates 
(Mithras LB 940). Finally, 30 µl of Reagent 3 were added into each well and after mixing for 
10 min, fluorescence was read again with the spectral properties from above (355 nm excitation 
and emission at 460 nm).  
Reagents: 
- β-hydroxybutyrate determination kit (MATERLAB). 
 
5.8. Adiponectin 
Plasma adiponectin levels were measured using a quantitative sandwich enzyme immunoassay 
technique applied on “Rat total Adiponectin/Acrp30 Inmmunoassay” from R&D Systems. In 
this assay, a monoclonal antibody specific for rat Adiponectin has been pre-coated onto a 
microplate. To determine adiponectin levels in plasma, the assay was performed according to 
the manufacturer´s instructions. Firstly, 50 µl of Assay Diluent RD1W were added into each 
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well and 50 µl of standard or sample were added into their respective wells. The microplate 
was incubated for 1 h at room temperature on a horizontal orbital shaker; during incubation 
process, the immobilized antibody bound any rat adiponectin present in the sample. After 5 
washing steps (by aspiration and washing with Wash Buffer), to remove any unbound 
substances, 100 µl of Rat adiponectin conjugated (an enzyme-linked polyclonal antibody 
specific for rat Adiponectin) was added to the wells. After 1 h incubation at room temperature 
on the shaker, 5 washing steps were performed to remove any unbound antibody-enzyme 
reagent. Then, 100 µl of Substrate Solution were added to the wells and microplate was 
incubated for 30 min at room temperature on the benchtop protected from light. During the 
incubation process, the enzyme reaction yielded a blue product that turned yellow when 100 µl 
of the stop solution were added. The intensity of the color measured is in proportion to the 
amount of rat adiponectin bound in the initial step. Optical density of each well was determined 
using a spectrophotometer for microplates (Tecan Sunrise Absorbance Reader) set a 450 nm 
(with wavelength correction at 540 nm). The sample values were then read off the standard 
curve.  
Reagents: 
- Quantikine® ELISA Rat Total Adiponectin/Acrp30 Immunoassay (R&D System). 
 
5.9 Tumor Necrosis Factor alpha (TNFα) 
Levels of TNFα in plasma samples were measured using a quantitative sandwich enzyme 
immunoassay technique applied on the “Rat TNFα Immunoassay” from R&D Systems. In this 
assay, a monoclonal antibody specific for rat TNFα has been previously coated onto a 
microplate. To quantify TNFα in plasma, the manufacturer´s instructions were followed. 
Firstly, 50 µl of Assay Diluent RD1-41 were added into each well and 50 µl of standard or 
sample were added into their respective wells. The microplate was incubated for 2 h at room 
temperature; during incubation process, any rat TNFα present in the sample was bound by the 
immobilized antibody. After 5 washing steps (by aspiration and washing with Wash Buffer), to 
remove any unbound substances, 100 µl of Rat TNFα Conjugated (an enzyme-linked 
polyclonal antibody specific for rat TNFα) was added to the wells. After 2 h incubation at room 
temperature, 5 washing steps were performed to remove any unbound antibody-enzyme 
reagent. Then, 100 µl of Substrate Solution were added to the wells and microplate was 
incubated for 30 min at room temperature protected from light. During the incubation process, 
the enzyme reaction yielded a blue product that turned yellow when 100 µl of the stop solution 
were added. The intensity of the color measured is in proportion to the amount of rat TNFα 
bound in the initial step. Optical density of each well was determined using a 
spectrophotometer for microplates (Tecan Sunrise Absorbance Reader) set a 450 nm (with 
wavelength correction at 540 nm). The sample values were then read off the standard curve. 
Reagents: 
- Quantikine® ELISA Rat TNFα Immunoassay (R&D System). 
 
6. Measurement of hepatic glycogen content 
Determination of glycogen was performed following the method of the Anthrone reagent with 
some modifications. Particularly, for hepatic glycogen isolation, 0.3-0.8 g of liver were 
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digested and boiled, in test tubes, in 1 mL of 30% KOH at 100ºC for 10 min. Then, 2 mL of 
100% ethanol were added into each tube and glycogen and proteins were precipitated overnight 
at -20ºC. To remove proteins and collect glycogen, samples were centrifugated at 3000 rpm for 
30 min at 4ºC. The precipitate was redissolved in 1 mL of 8% trichloroacetic acid (TCA) and 
then centrifuged at 3000 rpm for 15 min at 4ºC. Supernatant was stored at 4ºC, whereas the 
pellet was again redissolved in 1 mL of 8% TCA and centrifuged at 3000 rpm for 15min at 4ºC; 
the resulting supernatant was added to the stored one. Finally, glycogen was obtained from the 
supernatant by precipitation with 4 mL of 96% cold ethanol followed by centrifugation at 3000 
rpm for 15 min at 4ºC. The pellet, containing purified hepatic glycogen, was then redissolved in 
1 mL of water and was ready to be quantified by using the Anthrone reagent. 1 mM Glucose 
solution was used as standard. At this point, 3 mL of Anthrone reagent were delivered into each 
tube and then boiled at 100ºC until the sample color changed from yellow to green-blue 
(approximately 5 min). Absorbance was read at 590 nm using a colorimeter for test tubes.  
Reagents: 
- KOH (Panreac) 
- Trichloroacetic acid (TCA) (sigma) 
- 96% ethanol (Panreac) 
- Absolute ethanol (Panreac) 
- Anthrone reagent: 0.1% anthrone (Merck) in 84% v/v H2SO4 (Panreac) 
- Glucose (Merck) 
 
7. Total hepatic lipid content measurement 
The extraction of total lipids from liver samples was performed with Folch et al. extraction 
procedure (Folch, et al. 1957).  
The liver tissue weighed precisely (0.3 g) was homogenized with 5 mL of chloroform-methanol 
reagent (2:1 v/v). The exact weight of tissue was recorded for the following calculations. The 
tissue was disrupted using Potter-Elvehjem homogenizer with a motorized PTFE pestle, and the 
homogenate was filtrated (funnel with a folded filter paper) to recover the liquid phase. Then, 
the total volume of the mixture was filled up to 10 mL with chloroform-methanol reagent (2:1 
v/v) and the mixture was washed with 2 mL of 0.45% NaCl solution. After dispersion, the 
whole mixture was agitated vigorously 2 min in an orbital shaker and centrifuged at low speed 
(3000 rpm) for 10 min at room temperature to separate the two phases. The upper phase 
(methanol and impurities) was removed, the lower phase (chloroform with lipids) was filled up 
to 10 mL with pure methanol, and washed with 2 mL of 0.9% NaCl solution. Subsequently, the 
whole mixture was agitated vigorously 2 min in an orbital shaker and centrifuged at low speed 
(3000 rpm) for 10 min at room temperature. After centrifugation and siphoning of the upper 
phase, the lower phase (chloroform with lipids) was filled up to 10 mL with chloroform-
methanol reagent (2:1 by volume). 5 mL of the extract was then leaved in a pre-weighted glass 
vial at 60ºC for 24 h to evaporate chloroform. The dry and empty glass vials and vials with 
lipid extracts were weighed, and the total lipid content was calculated using the following 
formula: 
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Lipid content [mg/g liver]=[(extract weight[mg]/ extract weight [mL]) x 10]/sample weight [g] 
Where: 
 extract weight [mg] = (weight of the empty glass vial [g] - weight of the glass vial with the 
extract after evaporation [g] ) x 1000 
 extract weight [mL] = 5 mL 
 sample weight [g] = weight of liver sample taken for homogenization (the recommended 
amount of sample is ~0.3 g, although the exactly amount taken was noted). 
Knowing the weight of the liver of each animal, the content of lipid in the whole liver was 
calculated. 
Reagents: 
- Chloroform/methanol (2/1): 2 parts of chloroform (Sigma) diluted with 1 part of methanol 
absolute (Pancreac)  
- 0.45% NaCl: 2.25 g NaCl (Pancreac) dissolved in 500 mL of distilled water  
- 0.90% NaCl: 4.5 g NaCl (Pancreac) dissolved in 500 ml of distilled water 
 
8. Measurement of hepatic triglyceride content 
To determine TG levels in liver, an extraction of the lipid fraction was firstly needed. Hepatic 
lipid extraction was conducted by mixing 50-100 mg of liver with 1 mL of hexane/isopropanol 
(3:2, v/v). To minimize lipid oxidation, tubes were gassed with nitrogen before being closed. 
Tubes were then left overnight under orbital agitation at room temperature and protected 
against direct light. Then, 300 µl of 0.47 M Na2SO4 were added into each tube, mixed for 5 
min, left for 15 min in orbital agitation and finally, centrifuged at 1000 x g for 10 min at 4ºC. 
The bottom phase (containing isopropanol and other polar components) was discarded, while 
the upper phase of each tube, which contained lipids dissolved in hexane, was transferred to a 
clean glass tube. Hexane extract was dried with nitrogen gas.  
Dry hepatic lipid extracts were resuspended in 1.2 mL of LPL buffer with 0.1% sodium 
dodecyl sulfate (SDS). Then, samples were sonicated for 30 s, and tubes were left overnight in 
an orbital shaker at room temperature, protected from light. On the following day, tubes were 
cold sonicated with three pulses of 30 s each one, and their TG levels were measured 
immediately using the commercial enzymatic colorimetric kit “Serum Triglyceride 
Determination Kit” from Sigma, and following the protocol described in section 5.5.  
Reagents: 
- Hexane (Panreac) 
- Isopropanol (Sigma) 
- Nitrogen gas (“Carburos Metálicos”) 
- 0.47 M Na2SO4: 33.4 g of Na2SO4 (Panreac) in 500 mL distilled water.  
- Sodium dodecyl sulfate (SDS) (Panreac)  
- LPL buffer: 28.75 mM Pipes (Sigma), 57.4 mM MgCl2·6H2O (Panreac) and 0.569 mg/mL 
bovine serum albumin-fatty acid free (Sigma) 
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9. Histological analysis 
Pieces of fresh tissues, such as liver and retroperitoneal white adipose tissue (rWAT) were 
collected during dissection after animal killing for histological analysis. To avoid cell damage 
and to preserve the integrity of their membranes, tissue samples were immediately fixed by 
immersion in 4% paraformaldehyde in 0.1 M phosphate buffer (pH= 7.4) at 4ºC for 24 h. Then, 
fixed samples were washed and stored in 0.1 M phosphate buffer (pH= 7.4) until posterior 
analysis. 
 Before sectioning, fixed samples needed to be embedded in paraffin blocks to provide 
sufficient external support during sectioning. To perform this, the fixative and water from the 
tissue were removed by dehydration in graded series of ethanol (50% ethanol for 30 min, 75% 
ethanol for 30 min, 96% ethanol for 45 min, 96% ethanol for 45 min at room temperature and 
then overnight at 4ºC; finally, three-times with absolute ethanol for 60 min). The following day, 
tissue samples were cleared in xylene (two times for 45 min) and finally embedded in paraffin 
into plastic bottles. Different tissues embedded in paraffin can be stored in the same bottle until 
sectioning. To obtain tissue sections, paraffin was firstly melt in the oven, at 60ºC overnight, to 
pick up from the bottle the specific tissue we wanted to cut off. The selected tissue was laid on 
a cassette base and embedded with paraffin to obtain a paraffin block. Then, 5 μm thick 
sections of tissues were cut using a microtome and mounted on Super-Frost/Plus slides.  
Previously to the staining step, the slides were deparaffinised with xylene and re-hydrated with 
a series of decreasing concentration of ethanol and finally with distilled water. Then, slides 
were stained with hematoxylin for 2 min and eosin for 5 min, and finally dehydrated with a 
series of increasing concentration of ethanol. Stained and dehydrated slides were then cleared 
with xylene and finally mounted with Eukit.  
Liver and rWAT sections were digitalized using a light microscope (Zeiss Acioskop) connected 
with a digital camera (AxioCam Icc3, Carl Zeiss).  
To study the presence of fatty vesicles in liver slides or for measuring the diameter of the 
adipocytes from rWAT slides, software AxioVision 40V 4.6.3.0 (Carl Zeiss, Imaging 
Solutions) was used.  
Reagents: 
- 4% Paraformaldehyde: 40 mL Paraformaldehyde (Sigma) up to 1 L in 0.1 M phosphate 
buffer pH= 7.4 
- 0.1 M phosphate buffer pH= 7.4: 0.2 M phosphate buffer diluted 1:1 in distillate water 
- 0.2 M phosphate buffer pH= 7.4: 3.25 g NaH2PO4·2H2O (Panreac), 11.24 g Na2HPO4 
(Panreac) in 1L  
- 50% Ethanol: 92 mL of distillate water for each 100 mL of 96% ethanol (Panreac) 
- 75% Ethanol: 28 mL of distillate water for each 100 mL of 96% ethanol (Panreac) 
- 96% Ethanol (Panreac) 
- Absolute Ethanol (Panreac) 
- Xylene (Panreac) 
- Paraffin wax (Sigma) 
- Hematoxilyn (Panreac) 
- Eosin (Panreac) 
- Eukit (Panreac).  
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10. Confocal Microscopy for Green Fluorescent Protein Detection in liver samples 
Due to the autofluorescence of paraffin, confocal microscopy requires a different way to 
prepare slide tissues than light microscopy. Hence, instead to use paraffin, tissue samples were 
frozen and embedded in O.C.T
TM
 compound, which provides a convenient specimen matrix for 
cryostat sectioning at temperatures below zero using the cryomicrotome HM 505E (Microm 
International). 
To prepare samples, pieces of frozen liver were firstly fixed by immersion in 4% 
paraformaldehyde in 0.1 M phosphate buffer (pH= 7.4) at 4ºC for 24 h, and washed in 0.1 M 
phosphate buffer (pH= 7.4) for 24 h. For cryoprotection, samples were immersed in 30% 
sucrose in PBS buffer 1x for 72 h at 4ºC, embedded in O.C.T
TM
 compound on the specimen 
stage and put into the fast freezing station, for 24 h, in the microtome chamber of the cryostat 
settled at -25ºC (the optimal cutting temperature for liver samples). Fifteen micrometer-thick 
sections of tissues were cut and mounted on slides. For fluorescent staining, sections were 
firstly washed in PBS buffer 1x and then, hepatocyte nuclei were stained with blue-
fluorescence DAPI dilactate 300 nM in PBS buffer for 5 min and protected from light. Slides 
were washed several times with PBS buffer 1x and dryed.  Finally, slides were mounted with 
Dako Fluorescence Mounting Medium, cover-slipped and protected from light. 
Microscopic examinations were conducted with an automated inverted microscope DMI 4000B 
coupled with Leica TCS SPE Confocal Laser System (Leica Microsystems). The fluorescence 
spectral properties selected were: for DAPI, 405 nm excitation maximum and emission spectral 
range from 418 to 468 nm; for GFP, 488 nm excitation maximum and emission spectral range 
from 500 to 550 nm. Digital images were acquired by scanning with the fluorescence spectral 
properties described above and the projections of the individual channels were merged in Leica 
Application Suite Software 2.3.6 to facilitate visualization. 
Reagents: 
- O.C.TTM compound (Sakura Finetek) 
- Blue-fluorescence DAPI dilactate 300 nM (Life Technologies) 
- Dako Fluorescence Mounting Medium (Dako Diagnostics) 
- 4% paraformaldehyde (Sigma) 
- 0.1 M phosphate buffer pH= 7.4: 0.2 M phosphate buffer diluted 1:1 in distillate water 
- 0.2 M phosphate buffer pH= 7.4: 3.25 g NaH2PO4·2H2O (Panreac), 11.24 g Na2HPO4 (Panreac) 
in 1L 
- 30% sucrose (Panreac) 
- PBS buffer 1x pH=7.4: 137 mM NaCl (Panreac), 2.7 mm KCl (Panreac), and 10 mM phosphate 
buffer 
 
11. Isolation of mitochondria from liver 
Hepatic mitochondria were isolated from 2 g of fresh liver that was immediately homogenized 
in 20 mL of a buffer solution using a glass homogenizer Potter-Elvehjem. Homogenate was 
then centrifuged at 600 x g for 15 min at 4ºC and the supernatant was centrifuged again at 
12000 x g for 20 min at 4ºC. The pellet was resuspended in 2 mL of buffer solution and 
centrifuged at 7000 x g for 10 min at 4ºC. Finally, the mitochondrial-enriched pellet was 
resuspended in 1 mL of buffer solution and stored at -80ºC until used for Western blot analysis. 
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Reagents: 
- Buffer solution pH= 7.4: 70 mM sucrose (Panreac), 220 mM D-mannitol (Sigma), 2 mM 
EDTA (Merck), 5 mM HEPES (Sigma) 
- Protease inhibitor cocktail (Roche) 
 
12. Western blot analysis 
Western blotting is a method used to detect a target protein from a mixture of proteins. It uses 
gel electrophoresis to separate denatured proteins by the length of the polypeptide. The proteins 
are then transferred to a membrane, where they are detected using antibodies specific to the 
target protein. The membrane is then scanned and the bands are quantified. 
Western blot was performed to determine CPT1A, total AKT (serine/threonine protein kinase) 
and phosphorylated AKT on Serine 473 (pAKT) in homogenates of whole liver. Moreover, 
Western blot was also performed to determine CPT1A in homogenates of the hepatic 
mitochondrial fraction.  
 
12.1. Sample preparation 
Total protein isolation and quantification from whole liver 
An accurately weighed piece of liver was homogenized at 4ºC in 1:10 (w:v) of RIPA Lysis 
buffer 1x supplemented with protease and phosphatase inhibitor cocktail 1x. Completely 
homogenized liver was centrifuged at 7500 x g for 2 min at 4ºC, and the supernatant, 
containing proteins, was used for protein analysis. Total hepatic protein content was measured 
with the Pierce BCA protein assay kit, using 2 Albumin Standard Ampules as a standard. 
Briefly, 25 µl of sample or standard were loaded into their respective wells of standard ELISA 
plate, and then 200 µl of Working Reagent were added into all wells. Plate was covered and 
incubated for 30 min at 37ºC. Then, absorbance was read at 562 nm using a spectrophotometer 
for microplates (Tecan Sunrise Absorbance Reader).  
Samples were prepared by solubilizing 60 µg of total protein (for CPT1A quantification) or 50 
µg of total protein (for total AKT and pAKT quantification) in Laemmli sample buffer (1 µl of 
sample buffer per each 10 µg of total protein). Samples were heated in a boiling water bath for 
3 min to denature proteins.  
Total protein isolation and quantification from the hepatic mitochondrial fraction 
Mitochondria from liver samples were isolated as described in section 11. Mitochondria were 
precipitated from the mitochondrial-enriched pellet in buffer solution by centrifuging at 7000 x 
g for 10 min at 4ºC. The pellet was sonicated at 4ºC in 150 µl of cellular PBS buffer 
supplemented with protease and phosphatase inhibitor cocktail 1x. The homogenate was 
centrifuged at 7500 x g for 2 min at 4ºC, and the supernatant was used for protein analysis. 
Total mitochondrial protein content was measured by the method of Bradford (Bradford 1976), 
using 0.1% bovine serum albumin (BSA) as a standard (standard curve: 0-10 µg).  
The Bradford method, a colorimetric protein assay, is based on the binding of the dye 
Coomassie Blue G250 to protein. Upon binding of the dye to protein, the blue form of dye is 
generated with maximun absorption at 595 nm. Thus, the quantity of protein can be estimated 
by determining the amount of dye in the blue ionic form. This is usually achieved by measuring 
the absorbance of the solution at 595 nm. Therefore, to perform the Bradford assay and 
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quantify total amount of proteins in the hepatic mitochondrial fraction, 5 µl of sample or 
standard were loaded into their respective wells of standard ELISA plate and then 250 µl of 
Bradford reagent were added into each well. After 2 min incubation at room temperature, the 
absorbance was read at 595 nm using a spectrophotometer for microplates (Tecan Sunrise 
Absorbance Reader).  
Samples were prepared by solubilizing 40 µg of total protein (for CPT1A quantification in 
hepatic mitochondrial fraction) in Laemmli sample buffer (1 µl of sample buffer per each 10 µg 
of total protein). Samples were heated in a boiling water bath for 3 min to denature proteins.  
Reagents: 
- HaltTM Protease & Phosphatase Inhibitor Cocktail 100x (Thermo Fisher Scientific). 
- RIPA Lysis buffer 1x: 50 mM Tris-HCl (Sigma) buffer pH=7.4, 150 mM NaCl (Panreac), 
0.25% deoxycholic acid (Panreac), 1% NP40 (Sigma) and 1 mM  EDTA (Merck) 
- Pierce BCA protein assay kit (Thermo Scientific) 
- Laemmli sample buffer: 0.5 M Tris-HCl (Sigma) pH=6.8, 5% SDS (Sigma), 10% Glycerol 
(Sigma), 5% β-mercaptoethanol (Sigma) and 1% Bromophenol blue (Panreac).  
- Cellular PBS buffer pH 7,4: 137 mM  NaCl (Panreac), 2.7 mM  KCl (Panreac), 10 mM 
Na2HPO4 (Panreac), 1.5 mM KH2PO4 (Panreac)  
- Bradford reagent: 100 g Coomassie brilliant blue G-250 (Merck), 100 mL 85% 
orthophosphoric acid (Panreac), 50 mL absolute ethanol (Panreac) up to 1L of distillate 
water.  
- 0.1% Bovine Serum Albumine (Sigma) in Cellular PBS buffer pH 7,4. 
- Working reagent: 50:1 (v/v) BCA Reagent A: BCA Reagent B (Thermo Scientific) 
- Albumine Standard Ampule, 2 mg/mL (Thermo Scientfic).  
 
12.2. Electrophoresis  
Total protein was fractionated by using a 4–15% precast polyacrylamide gel with a standard 
Tris-glycine running buffer system. A molecular weight marker Dual color was used.  
Electrophoresis was performed at 120 V for 90 min. 
Reagents: 
- 4–15% precast polyacrylamide gel (CriterionTMTGXTM, Bio-Rad Laboratories) 
- Tris-glycine running buffer 0.5x pH=8.3: 0.025 M Tris-Base (Sigma), 0.195 M glycine 
(Sigma) and 0.02% SDS (Sigma). 
- Dual Color, Plus Protein Standards (Bio-Rad) 
 
12.3.Electroblotting 
When electrophoresis finished, fractioned proteins were electrotransferred from the gel onto a 
0.2 µm nitrocellulose membrane using a Trans-blot Turbo Transfer System (Bio-Rad). To 
achieve this, 7 transfer papers were wetted in Trans-blot Turbo Transfer buffer solution and 
placed on bottom of cassette electrode (anode). Then, the nitrocellulose membrane, wetted also 
in Trans-blot Turbo Transfer buffer solution, was placed on top of wetted stack in the cassette, 
and subsequently, the gel was placed on membrane. Finally, 7 transfer papers were wetted in 
Trans-blot Turbo Transfer buffer solution and placed on top of gel. The system was closed with 
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the cassette electrode (catode) and inserted in the instrument. Electrotransference conditions 
were: 7 min at 2.5 A constant, up to 25 V.  
Reagents: 
- 0.2 µm nitrocellulose membrane (Bio-Rad).  
- Trans-Blot® Turbo™ Transfer buffer solution (Bio-Rad).  
- Trans-Blot® Turbo™ RTA Midi Nitrocellulose Transfer Kit (Bio-Rad). 
 
12.4. Labeling and detection 
After electroblotting, the membrane was blocked by incubation with Odyssey Blocking Buffer 
Solution in TBS 1x (1:1) overnight at 4ºC. After blocking, the membrane was washed with 
0.1% Tween 20 in TBS 1x for 60 s and then incubated with the primary antibody specific for 
CPT1A, total AKT or pAKT, for 60 min at room temperature on a rocking shaker. After 
incubation, the membrane was washed 4 times for 5 min each one with 0.1% Tween 20 in TBS 
1x at room temperature and on a rocking shaker. Then, the membrane was incubated with 
secondary antibody infrared (IR)-dyed-800 or secondary antibody infrared (IR)-dyed 680, 
depending on the primary antibody used previously. Secondary antibody was prepared in the 
same host species that the first antibody. Incubation with the secondary antibody was 
performed for 30 min at room temperature, protected from light and on a rocking shaker.  
For IR detection, membranes were washed 4 times for 5 min each one with 0.1% Tween 20 in 
TBS 1x at room temperature and on a rocking shaker. Finally, the membrane was washed again 
with TBS 1x for 5 min and then was scanned in Odyssey Infrared Imaging System (LI-COR 
Biociences). Bands were quantified using the analysis software provided (Odyssey Software 
V.3.0). β-Actin was used as a housekeeping protein. 
Reagents: 
- Odyssey Blocking Buffer Solution (LI-COR Biociences) 
- TBS 10x wash buffer, pH 7.4: 500 mL of 1M Tris-Cl (Sigma), pH 7.4 and 300 mL of 5M 
NaCl (Panreac), filled up to 1 L with distilled water. 
- 0.1% Tween-20 TBS 1x wash buffer: TBS 10x buffer diluted 1:10 with distilled water, 1 g 
Tween-20 (Sigma)  
- primary rabbit polyclonal anti-CPT1A antibody (Santa Cruz Biotechnology) diluted 
1:1000 in TBS 1x with 0.1% BSA (Sigma), 0.1% sodium azide (Sigma) and 0.1% Tween-
20 (Sigma). 
- anti-total AKT antibody (Cell Signalling Technology) diluted 1:2000 in TBS 1x with 0.1% 
BSA (Sigma), 0.1% sodium azide (Sigma) and 0.1% Tween-20 (Sigma). 
- primary mouse polyclonal anti-pAKT (Cell Signalling Technology) diluted 1:2000 in TBS 
1x with 0.1% BSA (Sigma), 0.1% sodium azide (Sigma) and 0.1% Tween-20 (Sigma). 
- secondary goat anti-rabbit antibody infrared (IR)-dyed-800 (LI-COR Biociences) diluted 
1:25000 in Odyssey Blocking Buffer and TBS 1x mixed 1:1, with 0.1% BSA (Sigma), 
0.1% sodium azide (Sigma) and 0.1% Tween-20 (Sigma). 
- secondary goat anti-mouse antibody infrared (IR)-dyed-680 (LI-COR Biociences) diluted 
1:25000 in Odyssey Blocking Buffer and TBS 1x mixed 1:1, with 0.1% BSA (Sigma), 
0.1% sodium azide (Sigma) and 0.1% Tween-20 (Sigma). 
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12.5. Scanning and quantification 
The membrane was scanned on Odyssey Scanner with Infrared Imaging System (LI-COR 
Biosciences) in the appropriate channels IR-dyed (700 nm green channel when anti-mouse 
secondary antibody was used or 800 nm red channel when anti-rabbit secondary antibody was 
used). The quantification of all sample bands was performed using the Odyssey software V3.0 
(LI-COR Biosciences). Individual features (squares) that surrounded all the fluorescent bands 
in the image were drawn. Then, the image data (including raw intensity, average intensity and 
integrated intensity) within the feature were quantiﬁed automatically. For more reliable results 
in the quantification the option for Integrated Intensity [the sum of the intensity values for all 
pixels enclosed by a feature, multiplied by the area of the feature (mm
2
)] was chosen. Since 
background pixels should not be part of this calculation, background was calculated (Lane 
Background method) and subtracted. 
 
12.6. Loading control 
For the evidence of correct loading and blotting of proteins, incubation with β-actin antibody or 
staining with amido-black was performed.  
In order to stain with β-actin antibody, the membrane was incubated with mouse monoclonal 
anti-β-actin antibody, diluted 1:4000 (Cell Signaling). Staining with β-actin was performed 
according to the protocol described above in the section 12.4 for labelling and detection. The 
membrane was scanned, β-actin bands were quantified (according to the section 12.5 Scanning 
and quantification), and then, the band intensity for the specific protein was normalized to that 
of β-actin. 
In order to stain with amido-black, Amido Black Staining Solution (Sigma) was prepared by 
diluting Amido Black 1X Staining Solution with distilled water 1:1, according to 
manufacturer’s instruction. After transferring proteins onto nitrocellulose membrane, the 
membrane was immersed in sufficient Amido Black 1X Staining Solution to cover, stained for 
about 1 min, and rinsed with deionized water until the lighter color of background was 
obtained. Stains were visualized using ChemiGenius connected with a program GeneSnap.  
Reagents: 
- Amido black staining solution (Sigma) 
 
13. Indirect gas calorimetry and locomotive activity measurements  
Energy expenditure and locomotive activity of our experimental rat animals was measured by 
using the LabMaster module for indirect gas calorimetry (CaloSys) from TSE Systems. 
CaloSys is a fully automated high-throughput system for short- and long-term metabolic 
experiments that uses measurements of the animal’s oxygen consumption (VO2) and carbon 
dioxide production (VCO2) to estimate energy expenditure. Moreover CaloSys displays a TSE 
InfraMot system that is designed to register total activity of one animal under any lighting 
condition by reliably sensing the heat radiating from the animal’s body and its displacement 
over time. 
To assess energy expenditure and to quantify locomotive activity, rat animals were monitored 
for 24 h using the CaloSys. In order to reduce potential stress of the animals, they were 
individually housed and acclimated to the respiratory cages for 24 h before starting 
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measurements. After acclimation, data on gas exchanges (VO2, ml kg
−1
 h
−1
 and VCO2, ml kg
−1
 
h
−1
) were measured via an open-circuit indirect calorimetry system for 24 h. To calculate 
energy expenditure (kcal/h), rates of oxygen consumption and carbon dioxide production were 
monitored for 5 min every 45 min for each animal or reference cage (our system can handle 8 
animal cages and 1 reference cage, simultaneously). Locomotive activity (counts/h) was 
measured continuously by the infrared beam system of the TSE InfraMot system for 24 h.  
 
14. Blood pressure measurement 
Systolic blood pressure (SBP) was determined without anaesthesia using the tail-cuff method, a 
non-invasive blood pressure methodology. It consists in inflatable rubber tail-cuff 
sphygmomanometer with a photoelectric sensor (Niprem 546, Cibertec) placed on the animal’s 
tail to occlude the blood flow. With this method, the arterial pulsations, which are used as 
endpoints for indirect determination of SBP, can be detected in the rat tail only after 
vasodilatation. Heart rate was also registered. 
Before starting the measurements, rats were placed in a rat holder and the tail-cuff 
sphygmomanometer and the photoelectric sensor were placed on the base of the tail for at least 
30 min, to acclimate the animals and prevent hypertension by stress. During this acclimation 
time, vasodilatation was induced by preheating the rat with a red light bulb. Signals from the 
tail-cuff pressure transducer and the photoelectric sensor were recorder continuously. Niprem 
software V1.8 was used to determine the SBP value and heart rate value. For each rat, SBP and 
heart rate values were calculated as the mean of a minimum of five measurements. 
 
15. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) 
LC-MS/MS is now a routine technique with the development of electrospray ionisation (ESI), 
which provides a simple and robust interface. It can be applied to a wide range of biological 
molecules and the use of tandem mass spectrometry and stable isotope internal standards 
allows highly sensitive and accurate assays. Fast scanning speeds allow a high degree of 
multiplexing and many compounds can be measured in a single analytical run.  
LC-MS/MS consists, firstly, on separating analytes and isotopic standards by ultrahigh 
performance liquid chromatography (UPLC) and then, the use of tandem mass spectrometry 
allows ionization and finally detection of the resolved analytes and isotopic standards. Mass 
spectrometers operate by converting the analyte molecules to a charged (ionized) state, with 
subsequent analysis of the ions and any fragment ions that are produced during the ionization 
process, on the basis of their mass to charge ratio (m/z). Several different technologies are 
available for both ionization and ion analysis.  
During my stay in the laboratory of Professor Paul Thornalley and Dr Naila Rabani, of the 
Division of Metabolic and Vascular Health, Warwick Medical School (University of Warwick, 
Coventry, United Kingdom), I performed a quantitative screening of all the amino acids and a 
comprehensive range of protein damage biomarkers, in the ultrafiltrate of maternal plasma and 
milk samples, by using LC-MS/MS. Particularly, UPLC was performed to separate analytes 
and isotopic standards and then, through the mass spectrometer, the resolved analytes were 
detected and quantified, by using ESI as source of ionization and Quadrupole Analysers for ion 
analysis.  
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15.1. Sample preparation 
Ultrafiltrates from plasma samples were prepared by microspin ultrafiltration, using a 10 KDa 
cut-off filter, of 60 µl of plasma at 14000 x g for 30 min at 4ºC. Ultrafiltrates from milk 
samples were prepared by microspin ultrafiltration, using a 3 KDa cut-off filter, of 50 µl of 
milk at 14000 x g for 2 h at 4ºC. UPLC vials were prepared by adding 5 µl of plasma 
ultrafiltrate or 5 µl of milk ultrafiltrate with 20 µl of 0.1% Trifluoroacetic acid (TFA) in water 
and 25 µl of a cocktail of stable isotope substituted internal standards.  
 
15.2. Ultrahigh Performance Liquid Chromatography (UPLC) 
Chromatography was performed on a graphitic stationary phase, using two 5 µm particle size 
Hypercarb
TM
 columns: first column, 2.1 x 50 mm and second column, 2.1 x 250 mm (Thermo 
Hypersil Ltd). The chromatographic procedure was customized to complete data collection of 
all analytes in a 35-minute run. The mobile phase was solvent A (0.1% TFA in water) and 
solvent B [0.1% TFA in 50% acetonitrile (ACN)]. The two columns were initially used in 
series with a flow rate of 0.2 mL/min and later (at 20 min) the second column was then 
switched out of the flow to facilitate elution of strongly hydrophobic analytes. The post-run 
method for washing used solvent A1 (0.1% TFA in water) and solvent B2 [0.1% TFA in 50% 
tetrahydrofuran (THF)] for 30 minutes. Optimized custom gradients were used for analysis and 
post-run column wash/re-equilibration runs.  Flow from the column in the interval 4-35 min 
was directed to the mass spectrometry (MS/MS) detector. 
 
15.3. MS/MS detection 
Each analyte was detected by electrospray positive ionization mass spectrometric multiple 
reaction monitoring (MRM). The ionization source of temperature was 150ºC and the 
desolvation gas temperature 500ºC. The cone gas and desolvation gas flow were 150 L/h and 
1000 L/h, respectively. The capillary voltage and source offset were 0.50 kV and 50°C, 
respectively. Each analyte was detected by selective ion monitoring of its molecular ion in the 
first mass analyser after fragmentation with argon atoms in the collision cell. Each analyte, 
therefore, was detected by characteristic chromatographic retention time, molecular ion 
mass/charge ratio m/z and fragmentation ion m/z. Programmed molecular ion and fragment ion 
masses and collision energies were optimized to ± 0.1 Da and ± 1 eV, respectively, for MRM 
detection of analytes. Detector response was normalized to the added stable isotopic standard 
response, which has the same retention time as the normal anlyte and a different molecular ion 
or molecular ion and fragment ion m/z value. Data were collected sequentially and rapidly for 
many mass transitions (up to 32) such that multiple mass chromatograms may be recorded for 
each analyte and isotopic standard.  
 
15.4. Calculation 
Analyte content was determined from the anlyte/internal standard peak response peak area ratio 
by reference to calibration curves recorded under the same conditions with the same content of 
internal standard as the samples and known amounts of normal reference standard analyte. The 
Software MassLynx V4.1 from Waters was used to integrate analyte/internal standard peaks.  
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Reagents: 
- Trifluoroacetic acid (TFA) (Panreac) 
- Acetonitrile (ACN) (Panreac) 
- Tetrahydrofuran (THF) (Panreac) 
 
16. Statistical analysis  
The methods used for statistical analyses were chosen based on the experimental questions 
involved. To study individual differences between experimental groups, multiple comparisons 
were assessed by repeated measures, one- and two-way analysis of variance (ANOVA). In 
some cases, Bonferroni correction was applied to prevent data from incorrectly appearing to be 
statistically significant by lowering the alpha value. The relationship between random variables 
was estimated with use of Person´s correlation coefficient. In some cases, Bonferroni post hoc 
test was performed. Single comparisons between groups were assessed by Student’s t test and 
Paired t test. Threshold of significance was set at p<0.05. When Bonferroni correction was 
applied, alpha value was dived by the number of tests (p-value = α/n). All the analyses were 
performed with SPSS for Windows (SPSS version 19.0, Chicago, IL). 
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Abstract 
We aimed to assess the mechanisms responsible for hyperphagia and metabolic alterations 
caused by maternal moderate caloric restriction during gestation. Male and female offspring of 
control and 20% caloric-restricted rats (CRG) were studied. They were fed a normal-fat diet 
until 4-months of age, and then moved to a high-fat diet until 6-months of age. Blood 
parameters and expression of selected genes in hypothalamus, retroperitoneal white adipose 
tissue (rWAT) and liver were analyzed at 25-days and 6-months of age. Plasma leptin was 
measured during suckling. Levels of proteins involved in insulin and leptin signaling were 
determined at 6-months of age. CRG ate more calories than controls, but only males gained 
more weight. A peak in plasma leptin was found in 9-day-old controls, but was absent in CRG. 
25-day-old CRG showed lower Insr mRNA levels in hypothalamus, rWAT and liver, and of 
ObRb in hypothalamus. At the age of 6-months, HOMA-IR index was higher in CRG than 
controls, and CRG males also displayed hyperleptinemia. Adult CRG also showed lower ObRb 
mRNA levels in the hypothalamus (only females, but both showed altered Npy/Pomc mRNA 
ratio), rWAT, and liver (males), and a decrease in PKCδ levels, in rWAT (females) and liver 
(males), and of pSTAT3 in liver(females). These results suggest CRG animals are programmed 
for insulin and central leptin resistance, which may explain the dysregulation of appetite and 
other metabolic alterations, favoring obesity development, although only manifested in males. 
These early programming effects could be associated with the absence of leptin surge during 
lactation.  
 
Key words: insulin and leptin sensitivity, caloric restriction, gestation, early programming, 
leptin surge 
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Introduction 
It is becoming increasingly clear that environmental conditions during critical periods of 
development may lead to differential programming of the mechanisms involved in the control 
of energy balance (McMillen, et al. 2008). Gestation and lactation are considered critical 
periods for development, and food restriction during these periods has been described to induce 
permanent adaptive changes that may have lasting effects on the metabolic regulatory 
mechanisms of the offspring, leading to different outcomes in the propensity to suffer obesity 
in adult life (Martin-Gronert and Ozanne 2006; McMillen, et al. 2005). While moderate caloric 
restriction during lactation has been associated with certain protection against later obesity in 
rats (Palou, et al. 2010b; Palou, et al. 2011), caloric restriction during pregnancy has been 
reported to be a risk factor increasing the vulnerability to later obesogenic environmental 
stimuli (McMillen, et al. 2008; Palou, et al. 2010a; Thompson, et al. 2007), in both cases with 
different outputs depending on the severity or type of restriction and also on the gender of 
animals (Palou, et al. 2010a; Palou, et al. 2010b; Palou, et al. 2011). In this sense, we have 
previously described that 20% caloric restriction in rats during the first half of gestation results 
in higher food intake in their offspring in adulthood and this concludes in higher body weight in 
males but not in females (Palou, et al. 2010a). 
Central resistance to insulin and/or leptin has been proposed as important mechanisms 
responsible for the dysregulation of energy homeostasis, which may lead to obesity (Levin and 
Dunn-Meynell 2002; Lustig, et al. 2004; Palou, et al. 2010a). In fact, the offspring of 20% 
caloric restricted animals during gestation, both males and females, display hyperinsulinemia, 
which is already present at a juvenile age, and previous to any apparent effect on body weight 
(Palou, et al. 2010a). In addition, these animals, but only males, also display hyperleptinemia in 
adulthood, when exposed to a HF diet (Palou, et al. 2010a). These results suggest that 
mechanisms involved in insulin and/or leptin sensibility could have been affected as a 
consequence of this prenatal condition, with these later consequences on body weight control 
capacity. However, the concrete mechanisms involved and why programming mechanisms had 
different outcomes in male and female were not determined. 
The hypothalamus is the main organ responsible for the central control of energy balance and 
appetite behavior, by the production of many neuropeptides and the establishment of 
sympathetic connections, responding to different stimuli, such as the circulating hormones 
insulin and leptin (Schwartz and Porte 2005; Schwartz, et al. 2000); the brain is particularly 
sensitive during the perinatal period and it has been described to undergo alterations in 
response to particular nutritional conditions during fetal development and neonatal life 
(McMillen, et al. 2005). Leptin has been shown to play an important role during the perinatal 
period (Palou and Pico 2009). In fact, supplementation to neonate rats with physiological doses 
of leptin during lactation has been described to improve body weight control and leptin and 
insulin sensitivity in adult life (Pico, et al. 2007; Sánchez, et al. 2008), while a lack of leptin 
during this period occurring in leptin-deficient mice disrupts the normal postnatal 
developmental pattern of neural projection in the hypothalamus (Bouret, et al. 2004). Previous 
studies have shown that maternal 20% caloric restriction during the first half of pregnancy 
resulted in lower cellularity and neuropeptide Y (NPY) - and α-melanocyte-stimulating 
hormone (αMSH)-neurons in the arcuate nucleus (ACR) in the offspring (Garcia, et al. 2010). 
Delahaye et al. (Delahaye, et al. 2008) also described that maternal severe (50%) caloric 
restriction during both gestation and lactation reduced fiber projections from ARC neurons to 
other hypothalamic structures and decreased proopiomelanocortin (Pomc) and αMsh mRNA 
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expression levels in neonate rats. In addition, adult offspring from 30% caloric restricted 
pregnant dams have been shown to have the hypothalamic gene expression of Pomc, Npy, 
Agouti-related protein (AgRP) and leptin receptor (ObRb) altered (Ikenasio-Thorpe, et al. 
2007). In addition, without neglecting the important role of the hypothalamus in regulating 
energy homeostasis, both white adipose tissue (WAT) and liver are also key organs in the 
regulation of energy balance and substrate metabolism and targets of the peripheral actions of 
insulin and leptin (Palou, et al. 2008). In fact, the response of these tissues to feeding conditions 
may be another major factor determining the higher susceptibility to developing obesity and 
related metabolic alterations (Palou, et al. 2008; Priego, et al. 2008).  
Thus the aim of the present study was to determine the effects of moderate (20%) maternal 
caloric restriction during the first 12 days of gestation on determinants of later leptin and 
insulin resistance, by exploring the expression of selected genes involved in insulin and leptin 
signaling in key tissues such as the hypothalamus, rWAT and the liver, both at a juvenile age 
(25 days) and in adulthood (6 months, after a 2-month-period of HF diet exposure), to analyze 
whether this dietary stressor is able to step up early programmed disorders. Ultimately, 
considering the important role of leptin during a critical window of development, it was also 
the aim of this study to ascertain whether the effects of caloric restriction during gestation on 
later leptin and insulin homeostasis could be related, in part, with an alteration or a deficiency 
in leptin during the suckling period. 
 
Materials and methods 
Animals and experimental design 
The study was performed in male and female rats from 32 different litters, following the 
protocol below. All rats were housed under controlled temperature (22 ºC) and a 12 h light–
dark cycle (light on from 0800 to 2000), and had unlimited access to tap water and standard 
chow diet (3 kcal/g, with 2.9% calories from fat; Panlab, Barcelona, Spain) unless mentioned 
otherwise. Briefly, virgin female Wistar rats weighing between 200 g and 225 g were mated 
with male rats (Charles River Laboratories, Barcelona, Spain). Day of conception (day 0 of 
pregnancy) was determined by examination of vaginal smears for the presence of sperm, and 
then female rats were single caged. Pregnant rats were divided into two groups: one with free 
access to standard chow diet, and the other one underwent 20% restriction of caloric intake 
from day 1 to day 12 of pregnancy. Caloric restriction was performed by offering each dam a 
daily amount of food corresponding to 80% of the calories that should be eaten according to 
body weight. This amount was calculated considering the calories daily consumed by their 
control animals under ad libitum feeding conditions. After the caloric restriction period, rats 
were allowed to eat ad libitum, and food intake was measured. At day 1 after delivery, excess 
pups of each sex in each litter were removed to keep 10 pups per dam (five males and five 
females, when possible). Weaning was conducted at 21 days of life.   
One set of animals from 10 control dams and from 9 caloric restricted dams was used to obtain 
blood samples at different stages of lactation (days 5, 9 and 15 of lactation), under ad libitum 
feeding conditions (n= 5-10 animals/group). Blood was collected in heparinized containers to 
obtain plasma for leptin determination. 
On day 25 of life, another set of control and CRG animals (n= 5-7 animals/group) (from 6 and 
8 dams, respectively) were killed by decapitation under fed conditions, during the first 2 h at 
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the beginning of the light cycle. Blood samples were collected in heparinized containers, then 
centrifuged at 700 g for 10 min to obtain the plasma, and stored at -20ºC until analysis. The 
hypothalamus, the retroperitoneal WAT (rWAT) depot and the liver were rapidly removed, 
weighed, frozen in liquid nitrogen and stored at -80ºC until ulterior studies. 
At weaning, a third set of animals from the same dams as those killed on day 25 of life, 
including 24 controls (12 males and 12 females) and 28 CRG animals (12 males and 16 
females), was kept alive.. They were placed two per cage, paired with another animal of the 
same group, and fed with standard diet until the age of 4 months; then they were exposed to a 
high fat (HF) diet (4.7 kcal/g, with 45% calories from fat, Research Diets, Inc., NJ, USA) until 
the age of 6 months. HF diet contained 5.5% calories from soybean oil and 39.5% from lard. 
Body weight and food intake of the offspring were followed. 
At the age of 6 months, both control and CRG rats were killed under two feeding conditions: ad 
libitum feeding conditions (fed group, n=6-8/group), and 12-h fasting conditions (fasted group, 
n=6-8/group). All animals were sacrificed by decapitation during the first 2 h of the beginning 
at the light cycle and on different consecutive days (including animals from each group every 
day). Blood samples were collected in heparinized containers, then centrifuged at 700 g for 10 
min to obtain the plasma, and stored at -20ºC until analysis. The hypothalamus, WAT depots 
(retroperitoneal, mesenteric, gonadal and inguinal) and liver were rapidly removed, weighed, 
frozen in liquid nitrogen and stored at -80ºC until ulterior studies.  
Although different WAT depots were sampled to be weighed, the retroperitoneal depot was 
selected as representative to be analyzed for gene expression, based in literature showing that 
this depot seems to be more sensitive to nutritional status, compared with other depots (Palou, 
et al. 2010a). 
The animal protocol followed in this study was reviewed and approved by the Bioethical 
Committee of our University and guidelines for the use and care of laboratory animals of the 
University were followed. 
 
Measurement of circulating parameters under fed/fasting conditions, and calculation of the 
homeostatic model assessment for insulin resistance (under fasting conditions) 
Blood glucose concentration was measured using Accu-Chek Glucometer (Roche Diagnostics, 
Barcelona, Spain). Plasma insulin concentration was determined using a rat insulin
 
enzyme-
linked immunosorbent assay (ELISA) kit (Mercodia AB, Uppsala, Sweden) following standard 
procedures. Plasma leptin concentration was measured using a mouse leptin ELISA kit (R&D 
Systems, Minneapolis, MN). Circulating triglycerides (TG) were measured by commercial 
enzymatic colorimetric kit (Triglyceride (INT), Sigma Diagnostics, St Louis, MO, USA). 
The homeostatic model assessment for insulin resistance (HOMA-IR) was used to assess 
insulin resistance. It was calculated from fasting insulin and glucose concentration using the 
formula of Matthews et al. (Matthews, et al. 1985): HOMA-IR = fasting glucose (mmol/liter) x 
fasting insulin (mU/liter)/22.5. 
 
RNA extraction 
Total RNA was extracted from the hypothalamus, rWAT and the liver by Tripure Reagent 
(Roche Diagnostic Gmbh, Mannheim, Germany) according to the manufacturer's instructions. 
Isolated RNA was quantified using the NanoDrop ND-1000 spectrophotometer (NadroDrop 
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Technologies Inc., Wilmington, Delaware, USA) and its integrity confirmed using agarose gel 
electrophoresis.  
 
Real-time quantitative PCR (RT-qPCR) analysis  
Real-time polymerase chain reaction (PCR) was used to measure mRNA expression levels of 
long form leptin receptor (Obrb) and insulin receptor (Insr) in hypothalamus, rWAT and liver 
of 25-day and 6 month-old rats; neuropeptide Y (Npy) and proopiomelanocortin (Pomc) in 
hypothalamus, tumor necrosis factor alpha (Tnf), adipose triglyceride lipase (Atgl) and 
carnitine palmitoyltransferase 1 (Cpt1) in rWAT, and sterol response element binding protein 
1c (Srebp1c), acetyl-coenzyme A carboxylase alpha (Acc1) and glycerol-3-phosphate 
acyltransferase (Gpat) in liver, in rats of 6 months of age. 0.25 µg of total RNA (in a final 
volume of 5 µl) was denatured at 65 ºC for 10 min and then reverse transcribed to cDNA using 
MuLV reverse transcriptase (Applied Biosystem, Madrid, Spain) at 20ºC for 15 min, 42ºC for 
30 min, with a final step of 5 min at 95ºC in an Applied Biosystems 2720 Thermal Cycler 
(Applied Biosystem, Madrid, Spain). Each PCR was performed from diluted cDNA template, 
forward and reverse primers (1 M each), and Power SYBER Green PCR Master Mix (Applied 
Biosystems, CA, USA). Primers were obtained from Sigma (Madrid, Spain) and sequences are 
described in Table 1. Real time PCR was performed using the Applied Biosystems 
StepOnePlusTM Real-Time PCR Systems (Applied Biosystems) with the following profile: 10 
min at 95ºC, followed by a total of 40 two- temperature cycles (15 s at 95ºC and 1 min at 
60ºC). In order to verify the purity of the products, a melting curve was produced after each run 
according to the manufacturer's instructions. The threshold cycle (Ct) was calculated by the 
instrument's software (StepOne Software v2.0) and the relative expression of each mRNA was 
calculated as a percentage of NF control rats under ad libitum feeding conditions, using the 2
-
ΔΔCt
 method (Pfaffl 2001). Beta-actin and Gdi1 were used as reference genes depending on the 
tissue, age and sex of the animals, according to their better suitability.  
Table 1. Nucleotide sequences of primers used for PCR amplification 
Gene Fordward Primer (5’ to 3’) Reverse Primer (5’ to 3’) 
Amplicon size 
(pb) 
β-actin GAAGCTGTGCTATGTTGCCC GGATTCCATACCCAGGAAGG 184 
Gdi1 CCGCACAAGGCAAATACATC GACTCTCTGAACCGTCATCAA 210 
Insr GTCCGGCGTTCATCAGAG CTCCTGGGATTCATGCTGTT 242 
Obrb AGCCAAACAAAAGCACCATT TCCTGAGCCATCCAGTCTCT 174 
Leptin TTCACACACGCAGTCGGTAT AGGTCTCGCAGGTTCTCCAG 186 
Npy TGGACTGACCCTCGCTCTAT GTGTCTCAGGGCTGGATCTC 188 
Pomc CCTGTGAAGGTGTACCCCAATGTC CACGTTCTTGATGATGGCGTTC 266 
Tnf CCGATTTGCCATTTCATACC TCGCTTCACAGAGCAATGAC 230 
Atgl TGTGGCCTCATTCCTCCTAC AGCCCTGTTTGCACATCTCT 271 
Cpt1 GCAAACTGGACCGAGAAGAG CCTTGAAGAAGCGACCTTTG 180 
Srebp1c AGCCATGGATTGCACATTTG GGTACATCTTTACAGCAGTG  260 
Acc1 TGCAGGTATCCCCACTCTTC TTCTGATTCCCTTCCCTCCT 212 
Gpat CAGCGTGATTGCTACCTGAA CTCTCCGTCCTGGTGAGAAG 194 
Abbreviations: Gdi1, guanosine diphosphate dissociation inhibitor 1; Insr, insulin receptor; Obrb, long-form leptin 
receptor; Npy, neuropeptide Y; Pomc, proopiomelanocortin; Tnf, tumor necrosis factor alpha; Atgl, adipose 
triglyceride lipase; Cpt1, carnitine palmitoyltransferase 1; Srebp1c, sterol response element binding protein 1c; 
Acc1, acetyl-coenzyme A carboxylase alpha; Gpat, glycerol-3-phosphate acyltransferase. 
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Western blot analysis  
The amount of total insulin receptor substrate 1 (IRS1), phosphorilated IRS1 on Try612 
(pIRS1), protein kinase C zeta (PKC), signal transducer and activator of transcription 3 
(STAT3) and tyrosine 705 phosphorylated STAT3 (pSTAT3) in rWAT and liver of control and 
CRG rats at the age of 6 months were determined by Western blot. Tissue was homogenized at 
4 ºC in 1:3 (w:v) or 1:20 (w:v), for rWAT and liver respectively, of lysis buffer as previously 
described in (Mercader, et al. 2006). The homogenate was centrifuged at 500 g for 10 min at 4 
ºC and the supernatant was used for protein analysis. Total protein content was measured by the 
method of Bradford (Bradford 1976). For analysis, 300 g (for rWAT analysis) or 30g (for 
liver analysis) of total protein was solubilized and boiled for 3 min in Laemmli sample buffer 
containing 5% 2-beta-mercaptoethanol. Then, total protein was fractionated by SDS–
polyacrylamide gel electrophoresis (SDS–PAGE; 7.5 % polyacrylamide) and electrotransferred 
onto a nitrocellulose membrane (Bio-Rad, Madrid, Spain). Black amide B10 staining provided 
visual evidence for correct loading and blotting of proteins. After blocking, the membrane was 
incubated with the primary rabbit polyclonal anti-IRS1, anti-pIRS1(Tyr632), anti-PKC, anti-
STAT3 or anti-pSTAT3(Tyr705) antibody (Santa Cruz Biotechnology, Inc., CA, USA), and 
then with the infrared (IR)-dyed secondary anti-IgG antibody (LI-COR Biociences, Nebraska, 
USA) diluted 1:10000. For IR detection membranes were scanned in Odyssed Infrared Imaging 
System (LI-COR Biociences, Nebraska, USA), and the bands were quantified using the 
analysis software provided. 
 
Statistical analysis 
Data were expressed as mean  S.E.M. Multiple comparisons were assessed by one-, two- and 
three-way ANOVA to determine the effects of different factors (sex, caloric restriction during 
pregnancy, feeding conditions and/or the day of lactation). Single comparisons between groups 
were assessed by Student’s t test. The analyses were performed with SPSS for Windows (SPSS, 
Chicago, IL). P<0.05 was the threshold of significance. 
 
Results 
Body weight gain and cumulative food intake of control and CRG animals until the age of 6 
months 
Moderate caloric restriction during the first 12 days of gestation resulted in higher body weight 
in the male offspring from day 74 of life onwards (Student’s t test) compared with their 
controls (Figure 1A). When animals were 4 months old (just before changing to HF diet), CRG 
male animals weighed 6.9% more than their controls, and the difference was even higher 
(12.5%) when animals were 6 months old and were under HF diet. Unlike males, no significant 
changes concerning body weight were found between control and CRG female animals, either 
under NF diet or HF diet.  
As shown in Figure 1B, cumulative food intake from weaning until the age of 6 months was 
significantly higher in both male and female CRG compared with their controls. These 
differences were found during the feeding period with the NF diet, as well as, and even higher, 
when they were under HF diet. 
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Figure 1. (A) Body weight over time until the age of 6 months of male and female offspring of controls and 
caloric restricted dams during gestation (CRG). Animals were fed with standard normal fat (NF) diet until the age 
of 4 months and then exposed to a high fat (HF) diet (the dotted line indicates the time point of change from NF to 
HF diet). (B) Cumulative caloric intake from weaning at the age of 21 days until 6 months of age (TOTAL), as 
well as during NF diet feeding (from 21 days to 4 months old) (NF) and when animals were exposed to HF diet 
(from 4 to 6 months old) (HF) of male and female control and CRG rats. The percentage increase in food intake of 
CRG compared with controls is indicated in brackets. Data are expressed as the mean  SEM of 12-16 animals per 
group. Statistics: A, effect of age; RxA, interaction between caloric restriction during gestation and age (p<0.05, 
ANOVA repeated measures). *, different from their respective control group (p<0.05, Student’s t test). The arrow 
indicates the starting point of significant effects on body weight in male animals. 
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Circulating leptin levels in control and CRG pups during lactation 
No significant differences were found in body weight between control and CRG animals at 
birth, or during lactation (data not shown).  
Circulating leptin levels were studied at different stages of lactation (5, 9 and 15 days of life) 
(Figure 2). No significant differences were found between control and CRG animals 
concerning leptin levels on days 5, 9 and 15 of lactation. However, interestingly, male and 
female control animals showed a surge of circulating leptin concentration at the age of 9 days 
(one-way ANOVA), in contrast with CRG rats which maintained similar levels in the 3 days of 
lactation analyzed (interaction between the effect of caloric restriction and the day of lactation, 
three-way ANOVA). 
 
Figure 2. Plasma leptin levels (g/l) of male and female offspring of controls and caloric restricted dams during 
gestation (CRG) at different stages of lactation: 6 days (d6), 9 days (d9) and 15 days (d15) of life. Data are means 
 SEM (n = 5 to 10). Statistics: RxA, interaction between caloric restriction (R) and the day of lactation (A) in 
male and female pups (p<0.05, three-way ANOVA). Within each graph, bars not sharing a common letter (a, b) 
are significantly different (p<0.05, one-way ANOVA and Bonferroni post-hoc test).  
 
Results in 25-day-old control and CRG rats 
Body weight, tissue weights, and blood parameters 
As previously described in the same cohort of animals, no significant differences were found in 
body weight between control and CRG animals at the age of 25 days (two-way ANOVA) 
(Garcia, et al. 2010) (Table 2). No significant differences were found in the weight of the 
retroperitoneal WAT and liver either (Table 2).  
Concerning blood parameters, blood glucose and plasma insulin levels were not significantly 
different in CRG animals compared with their controls (two-way ANOVA). Circulating leptin 
concentration was lower in CRG male rats, but not in females, with respect to their controls 
(Student’s t test) (Table 2). 
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Table 2. Weight-related parameter and blood parameters at the age of 25 days 
 Males  Females 
 Control CRG   Control CRG  
Body weight (g) 61.4 ± 2.8  59.3 ± 2.0   58.6 ± 2.3  55.7 ± 2.8  
Liver weight (mg) 2.86 ± 0.11  2.60 ± 0.11  2.79 ± 0.07  2.69 ± 0.12 
rWAT weight (mg) 113 ± 11 95.7 ± 7.8  95.4 ± 16.5 92.2 ± 18.4  
Glucose (mg/dl) 130 ± 6  137 ± 3  124±4  131± 6  
Insulin (ng/L) 170 ± 38  122 ± 36   154 ± 41 167 ± 35 
Leptin (ng/L) 959 ± 119 608 ± 51*  984 ±164  841 ± 40  
Body weight, liver and retroperitoneal WAT (rWAT) weight, and circulating glucose, insulin, and leptin levels at 
25 days of life (n=6-8) of male and female offspring from controls and caloric restricted dams during gestation 
(CRG), under ad libitum  feeding conditions. Data are mean±S.E.M. Statistics: No significant differences were 
found by two-way ANOVA; * different from their respective Control group (p<0.05; Student’s t test). 
 
Gene expression levels in hypothalamus, retroperitoneal WAT and liver  
Figure 3 shows mRNA expression levels of Insr and Obrb in the hypothalamus, rWAT and 
liver of control and CRG animals at the age of 25 days. Interestingly, both male and female 
CRG animals displayed lower Insr and Obrb mRNA expression levels in the hypothalamus 
compared with their controls (two-way ANOVA). In rWAT and liver, Insr mRNA levels were 
also significantly lower in CRG animals compared with their controls (two-way ANOVA), but 
no significant differences were found concerning Obrb mRNA levels. 
 
Results in 6-month-old control and CRG rats  
Body weight, tissue weights and blood parameters under fed and fasting conditions 
As described above, moderate maternal caloric restriction during gestation resulted in higher 
body weight in adulthood of male offspring but not of females (two-way ANOVA). 12-h 
fasting induced a significant decrease of body weight in all animals (ANOVA repeated 
measures) (Table 3).  
The differences in body weight between control and CRG male rats can be attributed to the size 
of fat depots (Table 3). The adiposity index was higher in CRG males with respect to their 
controls (two-way ANOVA). In fact, CRG male animals showed greater fat pad weights in the 
4 depots weighed, in comparison to controls (two-way ANOVA). Although no significant 
differences were found between control and CRG female animals, a tendency to higher 
adiposity was found in the latter (p=0.066, two-way ANOVA) especially due to the 
significantly greater gonadal fat depot (two-way ANOVA). In both males and females, no 
significant differences were observed by the effect of 12-h fasting in the weights of the fat 
depots studied, and even an increase in the size of rWAT was observed in the group of female 
control animals after 12 h fasting. This difference does not seem to be a direct effect of fasting, 
but may probably be attributed to differences in the initial weight of fat depots between 
animals, which could also be masking other significant effects due to the fasting state. On the 
other hand, gestational caloric restriction resulted in higher liver weight in CRG male animals 
but not in females (two-way ANOVA), especially under fasting conditions (Student’s t test). As 
expected, fasted rats from the different groups showed lower liver weight than fed rats (two-
way ANOVA). 
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Figure 3. Insr and Obrb mRNA expression levels in hypothalamus (A), rWAT (B) and liver (C) of 25-day-old 
male and female offspring of controls and caloric restricted dams during gestation (CRG). mRNA levels were 
measured by Real-time PCR and expressed as a percentage of the value of control male rats. Data are mean ± 
S.E.M. (n=6-8). Statistics: R, effect of caloric restriction, and S, effect of sex, (p<0.05, two-way ANOVA). *, 
different from their respective control group (p<0.05; Student’s t test). 
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Table 3. Weight-related parameters at the age of 6 months 
 Control  CRG  
 ad libitum 12-h fasting  ad libitum 12-h fasting ANOVA 
Males       
Body weight before fasting (g)  495  20   546  15  
Body weight at sacrifice (g) 487  9 486  20  548  20 * 536  15 R 
Liver (g) 14.2  0.4 10.2  0.6 # 
 
15.4  0.4 11.9  0.5 * # R,F 
rWAT (g) 15.4  1.1 13.6  1.7  19.0  1.7 * 17.6  1.7 R 
mWAT(g) 6.53  0.73 5.79  0.99  9.56  1.06 * 8.04  1.04 R 
iWAT (g) 11.7  1.1 11.3  2.0  16.3  1.6 * 15.1  0.8 R 
gWAT (g) 16.0  1.3 15.1  1.7  22.9  1.7 * 20.8  1.5 * R 
Adiposity index (%) 10.1  0.6 9.32  0.81  12.3  0.6 11.4  0.6 R 
Females       
Body weight before fasting (g)  269  7   269  4  
Body weight at sacrifice (g) 263  14 261  7  274  5 262  5  
Liver (g) 7.5  0.4 6.1  0.3 #  7.8  0.3 6.1  0.2 # F 
rWAT (g) 2.96  0.34 4.13  0.39 # 
 
4.43  0.61 3.89  0.42  
mWAT(g) 2.45  0.34 2.10  0.17  2.83  0.27 2.53  0.39  
iWAT (g) 3.54  0.49 3.10  0.29  3.83  0.38 3.84  0.35  
gWAT (g) 7.64  1.21 8.62  0.73  9.79  1.01 10.8  1.0 R 
Adiposity index (%) 6.18  0.59 6.88  0.81  7.59  0.52 7.94  0.64  
Weight-related parameters at the age of 6 months from male and female offspring of controls and caloric restricted 
dams during gestation (CRG), under ad libitum feeding conditions and after 12 h fasting conditions. Data are 
mean±S.E.M. (n=6-8). Statistics: R, effect of caloric restriction, and F effect of fasting (two-way ANOVA); *, 
different from their respective control group, and #, different from fed conditions (Student’s t test). 12-h fasting 
induced a significant decrease of body weight in all animals (p<0.05, effect of fasting and sex, ANOVA repeated 
measures). 
Table 4 shows circulating glucose, insulin, leptin, and TG levels of male and female control 
and CRG animals under feeding conditions and after 12-h fasting. No significant differences 
were found in glucose levels between control and CRG rats (two-way ANOVA). Fasted rats 
presented lower glucose levels than fed animals (two-way ANOVA). Insulin levels also 
decreased after fasting in male and female control and CRG animals (two-way ANOVA), 
although a little non-significant response by Student’s t test was found in CRG male animals 
after food deprivation. In fact, CRG male rats showed higher insulin concentration under 
fasting conditions in comparison to their controls (Student’s t test). In females, no significant 
differences were observed between control and CRG rats concerning circulating insulin levels 
(Student’s t test). 
HOMA-IR was calculated to estimate insulin resistance (Figure 4). Notably, both male and 
female CRG animals showed a higher HOMA-IR index compared with their controls (two-way 
ANOVA), although the increase was more pronounced and only significant by Student’s t test 
in CRG male rats, which showed 177% increase vs controls, in contrast with the 31% increase 
found in CRG females. It should also be mentioned that HOMA-IR value was significantly 
lower in females compared with males (two-way ANOVA). 
Regarding leptin (Table 4), CRG male animals displayed higher circulating leptin levels than 
controls (two-way ANOVA), especially under fasting conditions (Student’s t test). In contrast, 
no differences were found between control and CRG females (two-way ANOVA). As 
expected, circulating leptin levels decreased after 12-h fasting in male and female control and 
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CRG rats (two-way ANOVA). 
Concerning TG, no differences were observed as a consequence of the caloric restriction or 
fasting conditions in both male and female animals (two-way ANOVA). However, it is 
interesting to highlight that control male rats showed a significant decrease in circulating TG 
levels after fasting (Student’s t test) which was not present in CRG males.  
Table 4.  Circulating parameters at the age of 6 months 
 Control  CRG  
 ad libitum 12-h fasting  ad libitum 12-h fasting ANOVA 
Males       
Glucose (mg/dl) 110  2 89.3  5.9 #  113  5 95.8  2.3 # F 
Insulin (g/l) 2.52  0.42 0.510  0.069 # 
 
2.11  0.35 1.43  0.33 *  F 
Leptin (g/l) 11.6  1.7 3.48  0.48 #  14.8  2.3 7.05  0.89 * # R,F 
Triglycerides (g/l) 3.93  0.18 2.44 0.29 #  4.38  0.85 5.32  1.89  
NEFA (mmol/l) 0.959  0.053 0.727 0.042 #  1.08  0.12 0.751  0.060 # F 
Females       
Glucose (mg/dl) 117  7 90.1  3.0 #  111  3 88.3  3.6 # F 
Insulin (g/l) 0.871  0.087 0.321  0.023 #  0.840  0.101 0.396  0.061 # F 
Leptin (g/l) 4.05  0.63 1.71  0.23 # 
 
4.27  0.60 1.72  0.26 # F 
Triglycerides (g/l) 1.83  0.24 1.85  0.05  1.91  0.22 1.67  0.32  
NEFA (mmol/l) 0.694  0.089 0.888  0.114  0.751  0.097 0.957  0.049 F 
Circulating glucose, insulin, leptin, triglycerides and non-esterified fatty acid (NEFA) in male and female 
offspring of controls and caloric restricted dams during gestation (CRG) at the age of 6 months, under ad libitum 
feeding conditions and after 12 h fasting conditions. Data are mean±S.E.M. (n=6-8). Statistics: R, effect of caloric 
restriction; F effect of fasting (two-way ANOVA). *, different from their respective control group (Student’s t 
test); #, different from fed conditions (Student’s t test). 
 
 
Figure 4. HOMA-IR index at the age of 6 months of male and female offspring of controls and caloric restricted 
dams during gestation (CRG). Results are expressed as the mean  SEM of 6-8 animals per group. The percentage 
increase in HOMA-IR index of CRG compared with controls is indicated in brackets. Statistics: R, effect of 
caloric restriction, and S, effect of sex, (p<0.05, two-way ANOVA). *, different from their respective control 
group (p<0.05; Student’s t test). 
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Gene expression levels in hypothalamus, retroperitoneal WAT and liver under fed and fasting 
conditions 
Hypothalamic mRNA levels of selected genes involved in energy balance in control and CRG 
male and female rats under fed and fasting conditions is shown in Figure 5. In male animals 
(Figure 5A), no significant differences were found concerning mRNA expression levels of Insr, 
Obrb, Npy, or Pomc as an effect of caloric restriction or fasting conditions (two-way ANOVA). 
However, it should be highlighted that the resulting Npy/Pomc mRNA ratio increased in control 
animals after fasting conditions (Student’s t test), but was unchanged in CRG male animals. 
With regard to females (Figure 5B), CRG animals showed altered gene expression of 
hypothalamic key genes; in concrete, these animals showed lower Obrb and Pomc mRNA 
levels than their controls, with no changes in Insr and Npy (two-way ANOVA). In addition, 
CRG females showed increased Pomc mRNA levels under fasting conditions (Student’s t test), 
while no significant changes were found in control animals. Moreover, as occurring in males, 
the resulting Npy/Pomc mRNA ratio increased in control animals after fasting conditions 
(Student’s t test), but was unchanged in CRG female animals.  
 
Figure 5. mRNA expression levels of insulin receptor (Insr), long form leptin receptor (Obrb), neuropeptide Y 
(Npy) and proopiomelanocortin (Pomc), and the Npy/Pomc ratio in the hypothalamus of male (A) and female (B) 
offspring of controls and caloric restricted dams during gestation (CRG), at the age of 6 months, under ad libitum  
feeding (AL) and fasting (F) conditions. mRNA levels were measured by Real-time PCR and expressed as a 
percentage of the mean value of the control group under ad libitum  feeding conditions. Data are mean  SEM (n = 
6-8). Statistics: R, effect of caloric restriction (p<0.05, two-way ANOVA). *, Control vs. CRG; and 
#
, ad libitum 
vs. Fasting (p<0.05, Student’s t test). 
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Figure 6 shows mRNA expression levels of selected genes related with energy balance in 
rWAT of control and CRG male and female rats. Although different adipose tissue depots were 
harvested, gene expression analyses were performed in the retroperitoneal depot, based on the 
literature showing that this depot seems to be more sensitive to nutritional status, compared 
with other depots (Palou, et al. 2010c). CRG male animals showed lower Insr and Obrb mRNA 
levels than their controls (two-way ANOVA) (Figure 6A). In addition, concerning Insr, their 
mRNA levels increased in control animals under fasting conditions, but did not change in CRG 
animals as an effect of food deprivation. CRG animals also showed higher Tnf mRNA 
expression levels under fasting conditions in comparison to fasted control rats (Student’s t test). 
Moreover CRG male animals showed a different response to fasting conditions concerning 
Cpt1 expression levels: they increased in control animals under fasting conditions, but not in 
CRG animals. In addition, CRG male animals showed lower Cpt1 mRNA levels under fasting 
conditions than their controls (Student’s t test). Figure 6B shows gene expression in rWAT of 
female animals. Interestingly, CRG female animals, under fed conditions, showed lower Obrb 
mRNA levels than their controls. CRG animals also showed higher Tnf expression levels 
compared to controls (two-way ANOVA). In addition there was a different response to fasting 
conditions between control and CRG animals concerning Atgl mRNA expression (interaction 
between caloric restriction and fasting, two-way ANOVA), since mRNA levels increased in 
control animals under fasting conditions, but levels did not change in CRG animals. In fact, 
CRG female animals under fasting conditions showed lower Atgl mRNA levels than their 
controls (Student’s t test). No significant differences were found between control and CRG 
female animals concerning Insr mRNA levels.  
Liver mRNA levels of selected genes related with energy balance in control and CRG male and 
female rats are shown in Figure 7. Interestingly, CRG male animals showed lower Obrb mRNA 
expression levels under ad libitum fed conditions than their controls (Figure 7A). Fasting 
induced an increase in Obrb mRNA levels in both groups, although this was more pronounced 
and only significant by Student t test in CRG rats (interactive effect between caloric restriction 
during pregnancy and food deprivation, two-way ANOVA). Both Srebp1c and Acc1 mRNA 
expression levels decreased under fasting conditions in control and CRG male animals, but in 
both cases the response to starvation was of a greater magnitude in control animals. Concerning 
Gpat, a significant decrease was found in control animals as an effect of fasting, but no changes 
were found in CRG animals.  
The results of hepatic gene expression in females are shown in Figure 7B. Both control and 
CRG females displayed higher Insr mRNA levels after fasting conditions (two-way ANOVA), 
but the increase was higher and significant (by Student’s t test) in controls. Obrb mRNA 
expression levels also increased after fasting conditions in both groups (two-way ANOVA), but 
the response was higher in CRG animals; therefore female CRG rats showed higher Obrb 
mRNA levels under fasting conditions compared to controls (two-way ANOVA). Srebp1c, 
Acc1 and Gpat mRNA levels decreased in both control and CRG female animals as an effect of 
fasting, while no significant differences were found between control and CRG female animals 
concerning the expression of these genes.  
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Figure 6. mRNA expression levels of insulin receptor (Insr), long form leptin receptor (Obrb), tumor necrosis 
factor alpha (Tnf), adipose triglyceride lipase (Atgl) and carnitine palmitoyltransferase 1 (Cpt1) in rWAT of male 
(A) and female (B) offspring of controls and caloric restricted dams during gestation (CRG), at the age of 6 
months, under ad libitum  feeding (AL) and 12-h fasting (F) conditions. mRNA levels were measured by Real-
time PCR and expressed as a percentage of the mean value of the control group under ad libitum  feeding 
conditions. Data are mean  SEM (n = 6-8). Statistics: R, effect of caloric restriction; F, effect of fasting; and RxF, 
interaction between caloric restriction and feeding conditions (p<0.05, two-way ANOVA). *, Control vs. CRG; 
and 
#
, ad libitum vs. Fasting (p<0.05, Student’s t test). 
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Figure 7. mRNA expression levels of insulin receptor (Insr), long form leptin receptor (Obrb), sterol response 
element binding protein 1c (Srebp1c), acetyl-coenzyme A carboxylase alpha (Acc1) and glycerol-3-phosphate 
acyltransferase (Gpat) in liver of male (A) and female (B) offspring of controls and caloric restricted dams during 
gestation (CRG), at the age of 6 months, under ad libitum feeding (AL) and 12-h fasting (F) conditions. mRNA 
levels were measured by Real-time PCR and expressed as a percentage of the mean value of the control group 
under ad libitum  feeding conditions. Data are mean  SEM (n = 6-8). Statistics: F, effect of fasting; and RxF, 
interaction between caloric restriction and feeding conditions (p<0.05, two-way ANOVA). *, Control vs. CRG; 
and 
#
, ad libitum vs. Fasting (p<0.05, Student’s t test). 
 
Protein levels of insulin and leptin signaling molecules in rWAT and liver of control and CRG 
male and female rats 
Table 5 shows protein levels of IRS1, pIRS1, PKC, STAT3 and pSTAT3 in rWAT and liver 
of control and CRG animals, under fed and fasting conditions. Compared to controls, CRG 
male animals showed higher levels of total STAT3 in rWAT and lower PKC in liver. CRG 
female animals showed lower levels of PKC in rWAT, and lower STAT3 (only under fed 
conditions) and pSTAT3 in liver. No changes were found concerning IRS1 and pIRS1 between 
controls and CRG animals either in rWAT or liver. Fasting reduced PKC and total STAT3 
protein levels in rWAT of both controls and CRG male rats (two-way ANOVA), while no 
changes were found in female animals as an effect of fasting, with the exception of a decrease 
in PKC levels in CRG rats (Student’s t test). In liver, fasting conditions resulted in lower 
pIRS1 (which was higher and significant by Student’s t test in controls), PKC, STAT3 and 
pSTAT3 in males but, notably, it resulted in increased levels of IRS1, pIRS1 and of STAT3 in 
females (two-way ANOVA).  
Juana María Torrens García – Doctoral Thesis 
 
- 88 - 
 
 
 
 
 
Table 5. Protein levels of insulin and leptin signalling molecules in the retroperitoneal WAT and liver 
 rWAT  Liver  
 Control  CR  Control  CR  
 Ad Libitum 12-h fasting  ad libitum 12-h fasting ANOVA Ad Libitum 12-h fasting  ad libitum 12-h fasting ANOVA 
Males             
IRS1 100  18 112  22  154  33 133  32  100  8 94.7  6.1  89.1  4.9 110  11  
pIRS1 (Tyr632) 100  18 116  4 
 
246  95 217  76  100  10 56.1  6.4 # 
 
98.4  11.1 70.6  6.3  F 
PKC 100  7 87.1  14.7  96.2  4.0 67.9  11.7  F 100  6 82.4  6.1  84.6  4.7 72.0  1.8 # R,F 
STAT3 100  20 83.9  11.1   141 12 110  17 R,F 100  13 57.2  14.3  102  26 56.4  13.2 F 
pSTAT3 (Tyr705) 100  29 88.5  10.2   161 43 145  42  100  14 58.1  11.5 #  75.2  11.8 56.1  9.7 F 
Females             
IRS1 100  22 108  16  81.3  22,5 94.6  19.5  100  5 119  15  113  9 151  13 # F 
pIRS1 (Tyr632) 100  24 101  17  106  11 93.0  14.1  100  5 157  13 #  106  17 157  7 # F 
PKC 100  9 123  16 
 
93.0  10.7 58.4  10.0 *# R 100  10 90.3  10.4 
 
90.9  8.5 89.1  7.3  
STAT3 100  13 87.5  25.8   163 33 128  28  100  11 144  14 #  61.1  10.6 * 215  61 F 
pSTAT3 (Tyr705) 100  18 98.1  35.3   71.6  8.9 111  23  100  25 118  9  59.4  16.2 76.2  12.1 *  R 
 
Protein levels in the retroperitoneal WAT (rWAT) and the liver of male and female offspring of controls and caloric restricted dams during gestation (CRG) at the age of 6 
months, under ad libitum feeding conditions and after 12 h fasting conditions. Data are mean±S.E.M. (n=4-6). Statistics: R, effect of caloric restriction; F effect of fasting (two-
way ANOVA). *, different from their respective control group (Student’s t test); #, different from fed conditions (Student’s t test). 
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Discussion 
In agreement with our previous results in the same cohort of animals when younger (Palou, et 
al. 2010a), we show here that moderate maternal caloric restriction of 20% during the first half 
of pregnancy programs the offspring for higher food intake, which results in higher body 
weight and higher body fat content in males but not in females. We further show here that the 
hyperphagia displayed by these animals may be related with early programming of central and 
peripheral insulin resistance, and of central leptin resistance, and it is associated with gender-
dependent changes in the expression profile of key genes involved in the control of energy 
homeostasis in adult rats. In addition, it is suggested that the lack of a circulating leptin surge 
during the suckling period in the offspring of caloric restricted animals during gestation may be 
one of the mechanisms that contribute to the metabolic malprogramming effects on target 
organs. 
Fetal programming of insulin and leptin resistance by nutritional conditions has been proposed 
as a major mechanism responsible for later energy homeostasis dysregulation (Esteghamati, et 
al. 2009; Lustig, et al. 2004). In agreement with this, the results obtained here in adult rats 
exposed to HF diet concerning plasma leptin levels in males, and the HOMA-IR index in both 
males and females, but particularly in males, also suggest an impairment of insulin and leptin 
sensitivity in CRG rats, which may explain their hyperphagia. It should be mentioned that 
although changes in leptin levels are found here in male animals under the stressor of HF diet, 
an increase in HOMA-IR in both males and females was already found in the same cohort of 
animals when younger and exposed to a NF diet (Palou, et al. 2010a).  
The effects of caloric restriction during gestation in male animals resulted in higher body 
weight and adiposity in adulthood compared to their controls. In addition, CRG male adult 
animals also displayed an altered circulating TG response to feeding conditions, since these 
animals did not exhibit a decrease in their circulating TG levels after 12-h fasting, while it 
occurred in control animals. Repeated exposure of the liver to elevated insulin levels has been 
described to induce hepatic TG production (Zammit 2002). In contrast, a better blood TG 
profile has been related with an improvement of insulin and leptin sensitivity (Palou, et al. 
2011). Hence, the dysregulation of circulating metabolic parameters in CRG male rats is in 
agreement with the development of insulin and leptin resistance.  
Unlike males, adult CRG females did not display significant changes in circulating insulin and 
leptin levels compared to their controls. However, these animals presented other alterations 
related with insulin and leptin signaling at the central and peripheral level (see below), but they 
seem to be partially protected against the excess of fat accumulation associated with HF-diet 
feeding. CRG female animals only showed greater size of the gonadal fat pad weight compared 
with their controls, but no significant changes were found in the other fat depots studied. In 
addition, they seem to be able to maintain normal levels of circulating parameters, such as TG 
levels. These results suggest that female animals are moderately protected against the 
detrimental effects of maternal caloric restriction during gestation. Jones and Friedman (Jones 
and Friedman 1982) also observed sex-differences in the offspring of 50% caloric-restricted 
dams during the first 2 weeks of pregnancy, where male rats gained more weight after 5 weeks 
of age and became obese, but female offspring did not develop obesity. The reasons for the 
sex-dependent different outcomes in adult body weight and adiposity of fetal undernutrition are 
not clearly elucidated yet. However the decrease in adipose tissue sympathetic innervation 
described in male offspring of caloric restricted dams during gestation, but not in females, 
could account for the different outcomes on later adiposity (Garcia, et al. 2011). 
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To ascertain whether the manifestation of insulin and leptin resistance seen in the adult 
offspring of caloric restricted animals during gestation was secondary to age and/or the 
obesogenic diet challenge or was the result of metabolic programmed effects, the expression of 
insulin and leptin receptors in selected tissues and circulating hormone levels were also studied 
in 25-day old animals. At this age, these animals did not display significant changes in body 
weight, and no changes were found concerning insulin levels between control and CRG 
animals either. However circulating leptin levels were lower in CRG animals compared with 
controls, and these changes do not seem to be attributed to lower body weight or adiposity. 
However, interestingly, at the age of 25 days, CRG animals showed altered expression levels 
of insulin and leptin receptors in key target organs. Specifically, CRG animals displayed lower 
mRNA expression levels of insulin receptor in the three tissues studied, the hypothalamus, 
rWAT and the liver, and lower mRNA levels of leptin receptor in the hypothalamus, with no 
significant changes in rWAT or liver.  
The hormones insulin and leptin are able to exert their function at the central level, directly to 
the hypothalamus, through the regulation of the expression of different neuropeptides and key 
factors involved in energy homeostasis maintenance (Schwartz, et al. 2000). Hypothalamic 
alterations affecting the expression levels of insulin and leptin receptors already seen in CRG 
animals at the age of 25 days suggest a malprogramming of the central control of appetite 
behavior. In agreement with these findings, we have previously described that both male and 
female offspring of caloric restricted rats during gestation had, at the early age of 25 days of 
life, lower NPY and MSH-producing neurons and lower total cells in the arcuate nucleus, 
which were accompanied by altered mRNA expression levels of these neuropeptides, as well as 
increased expression levels of SOCS-3, which could be indicative of lower central sensitivity 
to leptin and insulin (Garcia, et al. 2010).  
We show here that adult CRG animals exposed to HF diet for a 2 month period did not exhibit 
apparent differences in Insr mRNA levels in the hypothalamus compared with their controls. 
The lack of significant differences in Insr mRNA levels between control and CRG animals 
when adult, while seen at early stages of life, could be tentatively attributed to the detrimental 
effects of HF feeding that may mask the effects of the early exposure to caloric restriction. In 
fact, HF diet has been described to contribute to central insulin resistance (De Souza, et al. 
2005). Concerning Obrb mRNA levels, the early differences between control and CRG animals 
observed at the age of 25 days were maintained at the age of 6 months but only in females. 
Again, the lack of differences in male animals could be attributed to the overlapping effects of 
HF diet in these animals, whereas females could be more protected against the detrimental 
effects of this dietary challenge, according to the literature (Priego, et al. 2009b; Priego, et al. 
2008). 
In addition, CRG adult animals showed an altered response to fed/fasting conditions, 
concerning mRNA expression levels of Npy and Pomc. The Npy/Pomc ratio rose in both male 
and female control animals under fasting conditions, but such changes were not observed in 
CRG rats, suggesting a decreased capacity of the CNS to sense and respond to changes in 
nutrient availability. This may contribute to explain the higher food intake of CRG rats. 
Previous studies have also shown that obesity is characterized by an impaired response to 
feeding conditions, which has been observed both when studying the mRNA expression and 
protein levels of a number of genes involved in energy metabolism (Caimari, et al. 2007; Pico, 
et al. 2002) as well as for hundreds of genes measured by transcriptomics in peripheral tissues 
(Caimari, et al. 2010a; Caimari, et al. 2010b). Moreover, it is interesting to highlight that CRG 
females, which also exhibited lower Obrb mRNA expression, also showed lower Pomc mRNA 
levels than their controls, which would be closely involved in their dysregulated food intake. A 
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decrease in the expression of Obrb has been described to be involved in the development of 
leptin resistance (Baskin, et al. 1998). Therefore, central insulin and leptin resistance appear to 
be early malprogramming effects of moderate caloric restriction during gestation, which may 
be responsible for impaired food intake control and hence hyperphagia in both male and female 
CRG animals.  
Although the hypothalamus is the central controller of appetite behavior and energy balance, 
the peripheral response to both circulating insulin and leptin hormones may also determine the 
susceptibility to develop obesity and other related metabolic alterations. In this sense, WAT is 
a key tissue involved in both fat accumulation and mobilization, and these processes are 
regulated, among others hormones, by insulin and leptin; alterations in the action of these 
hormones due to malprogramming effects on early life (Ikenasio-Thorpe, et al. 2007; Vickers, 
et al. 2000) or in their adaptability under obesogenic environments such as HF diet feeding 
may affect the propensity to develop overweight (Priego, et al. 2008). At the age of 25 days of 
life, CRG rats already presented lower WAT Insr mRNA levels, with no changes in Obrb 
expression levels, but a tendency to lower levels. When adult and under HF diet, CRG males, 
but not females, also displayed lower Insr mRNA levels and both male and female CRG 
animals presented lower Obrb mRNA levels than their controls. 
Levels of proteins involved in insulin and leptin signaling in adult animals have been measured 
as they may provide evidence of the presumed altered sensitivity to these hormones. Results 
obtained for PKC are supportive as CRG female animals showed lower levels of PKCδ 
compared with their controls. This decrease was more marked under fasting conditions. PKCδ 
is a downstream effector in the insulin signaling pathway and plays an important role in 
activating the glucose transport response; in fact, overexpression of PKCδ or constitutively 
active PKCδ has an insulin-like effect on glucose transport during in vitro incubation of 
different kinds of cell lines (rev.(Liu, et al. 2006)). Thus, the decrease in PKCδ protein levels in 
rWAT of CRG females suggests a decrease in insulin signaling and glucose uptake by the 
adipose tissue. Decreased PKCδ levels in insulin target organs, such as muscle, have also been 
found in different experimental models of undernutrition during gestation and related with 
major propensity to insulin resistance development in adulthood (Chen, et al. 2009).  
However, despite changes in PKCδ in female CRG animals, the protein levels of total IRS1 or 
in pIRS1 were not significantly different between control and CRG animals. In the same way, 
STAT3 and pSTAT3 levels did not decrease in CRG animals either; conversely, CRG male 
animals showed higher protein concentration of total STAT3 in this tissue, but no differences 
in the pSTAT3/STAT3 ratio. The higher protein levels of STAT3 in CRG males could be the 
result of their hyperleptinemia, which allows certain leptin signaling in these animals. IRS1 
plays a critical role in insulin signaling being the initial step, while STAT3 mediates leptin 
signaling (Morris and Rui 2009). Leptin is also able to induce an insulin-like signaling pathway 
involving IRS/PI3K and making this a relevant point of cross-talk between the insulin and 
leptin signaling pathways (rev.(Fruhbeck 2006)). Protein levels of pIRS1 have been found 
altered in other models of maternal malnutrition during gestation. In particular, the offspring of 
60% protein restricted mice during gestation showed, at the age of 21 days, lower levels of 
pIRS1 and of other insulin signaling proteins in muscle, suggesting a predisposition of these 
animals to insulin resistance (Chen, et al. 2009). Here, although no effect of maternal caloric 
restriction during gestation was observed in IRS1 protein levels in adult animals, we cannot 
rule out that other key molecules of the insulin signaling cascade could be affected. In addition, 
as previously discussed, we cannot rule out either that the negative effects of HF diet on insulin 
resistance could be masking the effect of these maternal conditions during gestation.  
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Even though changes in proteins involved in insulin and leptin signaling in adult CRG animals 
under HF diet did not prove a decreased adipose tissue sensitivity to these hormones, compared 
with controls, it is interesting to highlight that both male and female CRG rats showed higher 
expression levels of the proinflammatory cytokine Tnf. Tnf is overexpressed in adipose 
tissue in many rodent models of obesity and affects insulin sensitivity (Hotamisligil, et al. 
1993). In fact a link between obesity, insulin resistance and inflammation has been proposed 
(Gual, et al. 2005). TNF has been involved in the JNK mediated serine phosphorilation of 
IRS1, which inhibits the normal tyrosine phosphorilation of IRS1 in response to insulin (Gual, 
et al. 2005). In adult CRG males, obesity was clearly manifested, but CRG females did not 
present overweight at that moment of life, but these results, in accordance with other alterations 
in the expression of other key genes in WAT, such as the Obrb gene, suggest a dysregulation 
of energy homeostasis in these animals. Since females have been described to be more 
protected against the detrimental effects associated to obesity compared to males (Priego, et al. 
2008) and CRG females presented severe alterations in other factors involved in the control of 
energy balance and appetite behavior at the central and peripheral level, it could be thought that 
CRG females might be in a previous stage of the disease and could develop excessive fat 
accumulation, together with other endocrine alterations, later on in life. In favor of the 
detrimental programming effects of maternal caloric restriction during gestation in the female 
offspring is the lack of increase in Atgl mRNA expression levels in rWAT under fasting 
conditions, which occurs in control animals, in agreement with the literature (Palou, et al. 
2008); this could be indicative of an impaired capacity to mobilize TG from this tissue under a 
negative energy balance situation. On the other hand, and in accordance with their higher fat 
accumulation in the adipose tissue, CRG male animals did not exhibit an increase in Cpt1 
mRNA levels under fasting conditions, while this increase was found in control animals.  
Regarding the liver, at the age of 25 days, CRG rats presented lower Insr mRNA levels and no 
significant changes in Obrb mRNA levels compared to controls. Interestingly, when adult, and 
under HF diet, CRG males showed lower Obrb mRNA levels than controls, but only under fed 
conditions, with no changes in Insr mRNA levels. Nevertheless, CRG males also showed lower 
PKCδ protein levels than their controls. In addition, although hepatic levels of IRS1 and 
STAT3 did not change between control and CRG animals, it must be noted that their 
phosphorilated levels (Tyr 632 and Tyr 705, respectively) showed a diminished response to 
fasting conditions compared with their controls. All in all, these results agree with impaired 
leptin and insulin signaling in liver, which could be associated with the impaired response to 
changes in fed/fasting conditions concerning lipogenesis. In fact, CRG males displayed a lower 
or even a lack of response to fasting conditions concerning the expression levels of Srebp1c 
and Gpat, respectively. Unlike males, no changes were found in females between control and 
CRG animals concerning the expression of insulin and leptin receptors, or of other genes 
related with lipid metabolism. CRG females even showed higher Obrb mRNA levels than their 
controls under fasting conditions. This does not seem to be indicative of higher leptin signaling 
in these animals, since they displayed lower protein levels of total STAT3 (only under fed 
conditions) and of their phosphorylated (Tyr705) form, which suggests lower leptin signaling. 
The function of leptin in liver is not clearly established, but it has been shown to have 
antisteatotic effects by lowering the expression of SREBP1. In fact, mice with ablated hepatic 
leptin signaling have increased lipid accumulation in the liver (Kakuma, et al. 2000). Thus, 
leptin appears to act as a negative regulator of insulin action in liver (Huynh, et al. 2010), and 
therefore impaired leptin action in liver may affect whole energy homeostasis.  
Thus, these results concerning the expression levels of insulin and leptin receptors in peripheral 
tissues such as WAT and liver at early stages of life, together with the apparent impaired action 
of these hormones found in adult life, suggests that early programming of peripheral insulin 
Results and discussion – Manuscript 1 
 
- 93 - 
 
resistance may be a direct consequence of fetal caloric restriction, while peripheral leptin 
resistance, which appears in adulthood and under HF diet, might be secondary to insulin 
resistance or to central leptin resistance. In fact it is recognized that elevated insulin levels 
promote both insulin resistance and increased leptin biosynthesis and secretion from adipose 
tissue, which may further desensitize leptin signaling and increase leptin resistance (Seufert 
2004). However, although the leptin-obesity-insulin resistance link is established, which 
alterations are causes or consequences in this particular situation and why the phenotypic 
outcomes are different between males and females needs further clarification.  
All in all, we show here that maternal caloric restriction during gestation results in early effects 
on the expression of leptin and insulin receptors in key tissues involved in energy homeostasis, 
particularly hypothalamus, which may compromise the proper functioning of the leptin and 
insulin systems. Moderate caloric restriction has also been associated with malprogramming of 
central hypothalamic structures involved in energy balance (Garcia, et al. 2010) and with a 
reduction in adipose tissue symphatetic innervation (Garcia, et al. 2011). However, the 
mechanisms or factors responsible for the detrimental effects of these perinatal conditions are 
not clearly established. Leptin, which is naturally present in maternal milk, is known to play a 
key role during the suckling period (Palou and Pico 2009). Leptin supplementation 
(physiological doses) in rats during the suckling period has later effects in the offspring 
preventing overweight in adulthood (Pico, et al. 2007) as well as other alterations related with 
the metabolic syndrome (Priego, et al. 2010), and also improves later insulin and leptin 
sensitivity (Sánchez, et al. 2008). These beneficial effects of leptin during lactation seem to be 
related, at least in part, with a better control of food intake, associated with epigenetic changes 
in the promoter methylation of Pomc (Palou, et al. 2011). Moreover, in rodents, it is known 
that plasma leptin levels rise transiently during neonatal period, peaking around day 10 of 
lactation, a process that has been termed as “neonatal leptin surge” (Ahima, et al. 1998; Pico, et 
al. 2011 May 4; Rayner, et al. 1997). This surge in leptin levels seems to be important for 
programming the structural and functional development of hypothalamic orexigenic and 
anorexigenic centers (Grove and Smith 2003) and its potential alteration by maternal caloric 
restriction has been checked here.  In control animals we observed the expected peak in 
circulating leptin levels at this period (9 days of life), but it is suggestive that this was absent in 
CRG animals. A premature or delay in leptin peak, as occurring in mice with severe fetal 
undernutrition (Yura, et al. 2005) or in protein restricted rats during gestation and during both 
gestation and lactation (Zambrano, et al. 2006), has also been associated with obesity in 
adulthood. Nevertheless, whether the malprogramming effects observed by caloric restriction 
could be simply attributed to the lack of the leptin surge needs to be specifically addressed. In 
any case, these results underscore the importance of leptin during lactation and the critical 
consequences that leptin deficiency may have during a critical period in postnatal life, being 
responsible for the common, detrimental outcomes of different adverse perinatal conditions.  
In conclusion, results show that 20% maternal caloric restriction during the first 12 days of 
gestation programs the offspring for a lower capacity to respond to insulin and to central leptin 
action, which is already present at early ages, and this leads to hyperphagia in both genders and 
higher body weight in males but not in females. Males show higher and earlier harmful effects 
by caloric restriction during fetal life than females, while females appear more resistant to the 
detrimental effects of gestational caloric restriction, in terms of maintenance of body weight, in 
spite of the altered profile of gene expression in key tissues involved in energy homeostasis. 
The lack of leptin surge during a critical window of developmental plasticity, such as the 
suckling period, appears closely associated with the adverse health effects observed in the 
offspring of caloric restricted dams.  
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Abstract 
Background/Aims: Moderate maternal calorie-restriction during gestation programmes 
offspring for a major propensity to develop metabolic alterations in adulthood. We aimed to 
assess whether increased hepatic fatty-acid oxidation (FAO), at early ages, by gene transfer of 
Cpt1am (active mutant of carnitine palmitoyltransferase-1a), may be a strategy for reversing 
metabolic disturbances associated to maternal calorie-restriction during gestation in rats. 
Methods: AAV-Gfp (control) and AAV-Cpt1am vectors were administered by tail vein 
injection in 18-day-old control-pups and the offspring of 20% calorie-restricted rats during 
gestation (CRG). After weaning, animals were fed with normal-fat diet. At the age of 4 months, 
they were moved to HF-diet and sacrificed at the age of 6 months to collect tissues. 
Locomotive activity, energy expenditure and blood pressure were measured.  
Results: Under HF-diet, CRG-animals showed higher HOMA-IR, adipocyte diameter and 
hepatic triglyceride accumulation than controls; these alterations were reverted in Cpt1am-
injected animals. In liver, this treatment ameliorated inflammatory state, decreased expression 
of lipogenesis-related genes and partially restored the decreased expression of leptin-receptor 
occurring in CRG-animals. Treatment also reverted the decreased energy expenditure and the 
increased blood pressure of CRG-animals.  
Conclusion: Increasing hepatic FAO through AAV-Cpt1am injection at juvenile ages prevents 
some metabolic disorders associated to gestational maternal calorie-restriction.  
 
Keywords: Cpt1a, calorie restriction, gestation, gene transference, liver 
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Introduction 
Obesity prevalence is increasing worldwide and hence the risk for related chronic diseases such 
as insulin resistance, type 2 diabetes, dyslipidemia, cardiovascular diseases, hypertension and 
nonalcoholic fatty liver disease (NAFLD) (Malik, et al. 2013). Besides the contribution of 
genetic and environmental factors, growing evidence links nutritional and other environmental 
conditions during early life to the subsequent development of obesity and other features of the 
metabolic syndrome (Cottrell and Ozanne 2008; Taylor and Poston 2007). Development of new 
strategies to prevent or treat obesity and its related metabolic disorders by reverting metabolic 
programming may be of interest. 
Gestation is a critical period of development, and food restriction during this stage has been 
described to induce permanent metabolic changes in the offspring increasing the propensity to 
obesity and related risk parameters in adult life (McMillen, et al. 2008). In this regard, we have 
previously shown that moderate (20%) calorie restriction in rats during the first half of 
gestation programmes the offspring for a lower capacity to respond to insulin and to central 
leptin action and results in higher food intake in adulthood (Palou, et al. 2012; Palou, et al. 
2010a). Male offspring show higher and earlier harmful effects than females, while females 
appear more resistant to the detrimental effects of gestational calorie restriction, in terms of 
maintenance of body weight (Palou, et al. 2012a).  
Bearing in mind that the ultimate cause of obesity is an imbalance between energy intake and 
expenditure, strategies enabling the energy balance to be inclined towards fatty-acid oxidation 
(FAO) could improve obesity-related disorders. In fact, chronic increased hepatic FAO through 
adeno-associated virus (AAV)-mediated gene transfer of the key gene for mitochondrial β-
oxidation, carnitine palmitoyltransferase 1a (Cpt1a), or to a better extent Cpt1am, a 
permanently active form of CPT1A insensitive to its physiological inhibitor malonyl-CoA, 
have been shown to reduce high-fat (HF) diet-induced hepatic steatosis, weight gain, 
inflammation, diabetes and insulin resistance in mice (Orellana-Gavaldà, et al. 2011). 
Genetically obese db/db mice expressing Cpt1am also show lower glucose and insulin levels 
and reduced liver steatosis (Orellana-Gavaldà, et al. 2011). Short-term studies that increase 
FAO in liver by genetic transfer of Cpt1a also show a decrease in hepatic triglyceride (TG) 
content in obese rats (Stefanovic-Racic, et al. 2008). Therefore, increased hepatic FAO in adult 
animals by overexpression of Cpt1a has been proposed as a new potential therapeutic target 
against obesity-induced disorders (Orellana-Gavaldà, et al. 2011; Stefanovic-Racic, et al. 
2008).  
Considering that offspring of 20% calorie restricted dams is an animal model with a major 
propensity to suffer obesity, hyperinsulinemia and leptin resistance (Palou, et al. 2012; Palou, 
et al. 2010a), here we aimed to assess whether increased hepatic FAO at early ages of life 
through AAV-mediated gene transfer of Cpt1am may be a strategy to trigger a persistent 
reversion of metabolic disturbances related to developmental malprogramming. 
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Methods and Materials 
Adeno-associated vectors 
AAV vectors serotype 1, AAV1-AAT-Gfp and AAV1-AAT-Cpt1am, driving mouse liver 
expression of green fluorescence protein (Gfp) and Cpt1am, respectively, were used. Details of 
these constructs are described in (Orellana-Gavaldà, et al. 2011). Briefly, vector plasmids 
carried human albumin enhancer element, human 1-antitrypsin (EalbAATp) liver-specific 
promoter, the cDNA sequence of Gfp and Cpt1am, woodchuck posttranscriptional regulatory 
element (WPRE, Access. No.AY468-486) and bovine growth hormone polyadenosine 
transcription termination signal [bGHpoly(A)] (bases 2326-2533 GenBank Access. 
No.M57764). The expression cassette was flanked by two inverted terminal repeats (ITRs) 
derived from AAV2. AAV1 vectors were produced in insect cells using baculovirus. The 
vector preparations used had titers of 1x10
12
 and 7.5x10
11 
genome copies (gc)/ml for AAV1-
AAT-Gfp and AAV1-AAT-Cpt1am, respectively. 
 
Animals and Experimental Design 
The animal protocol followed in this study was reviewed and approved by the Bioethical 
Committee of the University of the Balearic Islands and guidelines for the use and care of 
laboratory animals of the University were followed. 
The study was conducted on male Wistar rats from 16 different litters following the protocol as 
is described below. The study was performed with male animals because they have been shown 
to be more sensitive to the effects of maternal undernutrition during gestation compared to 
females, concerning features of the metabolic syndrome (Palou, et al. 2012; Palou, et al. 
2010a). 
Animals were housed under standard conditions, that is, controlled temperature (22ºC), a 12h 
light-dark cycle and free access to tap water. 16 virgin female Wistar rats weighing between 
220g and 250g were mated with male rats (Charles River Laboratories, Barcelona, Spain). Day 
of conception (day 0 of pregnancy) was determined by examination of vaginal smears for the 
presence of sperm, and then female rats were single caged. Pregnant rats were divided into 
either control (n= 7 dams) or calorie restricted (n= 9 dams) groups. Control dams had free 
access to standard chow diet (3kcal/g, with 8% calories from fat; Panlab, Barcelona, Spain), 
while calorie restricted (CRG) dams underwent 20% restriction of calorie intake from day 1 to 
day 12 of pregnancy. Calorie restriction was performed by offering each dam a daily amount of 
food corresponding to 80% of the calories they should be eaten according to body weight. This 
amount was calculated by considering the calories consumed daily by their control animals 
under ad libitum feeding conditions. After the calorie restriction period, rats were allowed to 
eat ad libitum. At day 1 after delivery, pups were weighed and the size of all litters was 
adjusted to 10 neonates per dam (five males and five females, when possible). During the 
lactating period, control and CRG dams had unlimited access to standard chow diet. Body 
weight and food intake of both control and CRG dams were measured throughout the whole 
periods of gestation and lactation.  
At the age of 18 days, AAV1 vectors were administered by tail vein injection in control (n= 21) 
and CRG (n= 19) male pups in a single dose of 7.5x10
12
 genome copies/kg of body weight, as 
described (Orellana-Gavaldà, et al. 2011). Before treatment, pups were anesthetized with 
isofluorane. Half of the male control and CRG pups were injected with the control construct 
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(AAV-Gfp), and referred to as Control-C and CRG-C, respectively. The other half of pups were 
injected with AAV1 vectors carrying the cDNA for Cpt1am (AAV-Cpt1am), and referred to as 
Control-CPT and CRG-CPT, respectively. After injections, pups were returned to their 
respective dams.  
All pups were weaned at 21 days of life, and then housed one per cage and fed on a normal-fat 
(NF) standard chow diet (3.8kcal/g, with 10% calories from fat; Research Diets, NJ, 
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901 USA) until the age of 4 months. 
Then, all animals were exposed to HF diet (4.7kcal/g, with 45% calories from fat; Research 
Diets, Inc., NJ, USA) until the age of 6 months. HF diet contained 5.5% calories from soybean 
oil and 39.5% from lard. Body weight and food intake of the offspring were recorded from 
weaning until the age of 6 months, when animals were killed. Locomotive activity and energy 
expenditure were measured at the age of 3 months by indirect calorimetry. Blood pressure was 
also measured at the age of 5 months. Two weeks before sacrifice, blood samples of all animals 
were collected after 12h fasting from the saphenous vein. Plasma was obtained as described 
above to analyze circulating parameters. Finally, at the age of 6 months, the four groups of 
animals were killed under ad libitum feeding conditions by decapitation during the first 2h at 
the beginning of the light cycle and on different consecutive days. At killing, the liver and 
retroperitoneal white adipose tissue (rWAT) were rapidly removed and weighed. A part of the 
two tissues was immediately frozen in liquid nitrogen and stored at -80ºC until analysis. 
Another part of the liver was immediately homogenised to isolate mitochondria. Finally, pieces 
of liver and rWAT were collected for histological analysis. To avoid adipocyte and hepatocyte 
damage, and to preserve the integrity of their respective membranes, liver and rWAT samples 
were immediately fixed by immersion in 4% paraformaldehyde in 0.1M phosphate buffer (pH= 
7.4) at 4ºC for 24h. Then, fixed samples were washed and stored in 0.1M phosphate buffer 
(pH= 7.4) until subsequent analysis. Trunk blood samples were also collected in heparinized 
containers. Plasma was obtained by centrifugation of heparinized blood at 1000 x g for 10min 
and stored at -20ºC until analysis of circulating parameters. 
 
GFP detection in hepatocytes 
The presence of GFP was examined in hepatocytes of animals injected with the AAV-Gfp 
vector by using a confocal laser scanning microscope. To prepare samples, pieces of frozen 
liver were fixed by immersion in 4% paraformaldehyde in 0.1M phosphate buffer (pH= 7.4) at 
4ºC for 24h, and washed in 0.1M phosphate buffer (pH= 7.4) for 24h. Then, samples were 
immersed in 30% sucrose in PBS buffer 1x for 72h at 4ºC. Before sectioning, the microtome 
chamber of the cryostat (Microtome cryostat HM 505 E, Microm International GmbH, 
Walldorf, Germany) was set at -25ºC (optimal cutting temperature for liver) for 24h. Finally, 
tissues were embedded in O.C.T
TM
 compound (Sakura Finetek, The Netherlands) on the 
specimen stage and put into the fast freezing station for 24h. Fifteen micrometer-thick sections 
of tissues were cut and mounted on slides. Liver sections were washed in PBS buffer 1x and 
hepatocyte nuclei were stained with blue-fluorescence DAPI dilactate 300nM in PBS buffer 
(Life Technologies S.A., Madrid, Spain) according to the manufacturer’s instructions. Finally, 
slides were mounted with Dako Fluorescence Mounting Medium (Dako Diagnostics, S.A. 
Barcelona, Spain), cover-slipped and protected from light. Microscopic examinations were 
conducted with an automated inverted microscope DMI 4000B coupled with Leica TCS SPE 
Confocal Laser System (Leica Microsystems S.L.U., Barcelona, Spain). The fluorescence 
spectral properties selected were: for DAPI, 405nm excitation maximum and emission spectral 
range from 418 to 468nm; for GFP, 488nm excitation maximum and emission spectral range 
from 500 to 550nm. Digital images were acquired by scanning with the fluorescence spectral 
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properties described above and the projections of the individual channels were merged in Leica 
Application Suite Software 2.3.6 to facilitate visualization.  
 
Isolation of mitochondria from liver 
Mitochondria from liver samples were isolated as previously described (Orellana-Gavaldà, et 
al. 2011) with minor modifications. Briefly, 2g of liver obtained from 6-month-old animals at 
sacrifice were immediately homogenized in 20mL of a buffer solution (70mM sucrose, 220mM 
mannitol, 2mM EDTA, 5mM HEPES and protease inhibitor cocktail from Roche, pH= 7.4) by 
using a glass homogenizer Potter-Elvehjem, and centrifuged at 600 x g for 15min at 4ºC. The 
supernatant was centrifuged again at 12000 x g for 20min at 4ºC. The pellet was resuspended in 
2mL of buffer solution and centrifuged at 7000 x g for 10min at 4ºC. Finally, the 
mitochondrial-enriched pellet was resuspended in 1mL of buffer solution and stored at -80ºC 
until used for Western blot analysis.  
 
Western blot analysis 
Western blot was performed to determine CPT1A, total AKT (serine/threonine protein kinase) 
and phosphorylated AKT on Serine 473 (pAKT) in homogenates of the whole liver and of 
CPT1A in homogenates of the hepatic mitochondrial fraction of the animals at the age of 6 
months.  
Liver was homogenized at 4ºC in 1:10 (w:v) of RIPA lysis buffer 1x (1M Tris HCl buffer 
pH=7.4, containing 1M NaCl, 10% deoxycholic acid, 10% NP40 and 0.5M EDTA) with 
protease and phosphatase inhibitor cocktail (Halt
TM
 Protease & Phosphatase Inhibitor Cocktail 
100x, Thermo Fisher Scientific Inc, Madrid, Spain). The homogenate was centrifuged at 7500 x 
g for 2min at 4ºC, and the supernatant was used for protein analysis. Total hepatic protein 
content was measured with the Pierce BCA protein assay kit (Thermo Scientific, Rockford. 
U.S.A). For analysis, 60µg (for CPT1A) or 50µg (for total AKT and pAKT) of total protein 
was solubilized and boiled for 3min in Laemmli sample buffer containing 5% 2-β-
mercaptoethanol. Then, total protein was fractionated by using a 4–15% precast 
polyacrylamide gel (Criterion
TM
TGX
TM
, Bio-Rad Laboratories, Inc, U.S.A) with a standard 
Tris-glycine running buffer system and subsequently electrotransferred onto a 0.2µm 
nitrocellulose membrane (Bio-Rad, Madrid, Spain). To electrotransfer, a Trans-blot Turbo 
Transfer System was used, following the manufacture’s instructions (Bio-Rad, Madrid, Spain). 
After blocking, the membrane was incubated with primary rabbit polyclonal anti-CPT1A 
antibody (Santa Cruz Biotechnology, Inc., CA, USA) diluted 1:1000 or anti-total AKT 
antibody (Cell Signalling Technology, Inc., Danvers, MA) diluted 1:2000, and then with 
secondary goat anti-rabbit antibody infrared (IR)-dyed-800 (LI-COR Biociences, Nebraska, 
USA) diluted 1:25000. For pAKT analysis, the membrane was incubated with primary mouse 
polyclonal anti-pAKT (Cell Signalling Technology, Inc., Danvers, MA) diluted 1:2000, and 
then with secondary goat anti-mouse antibody infrared (IR)-dyed-680 (LI-COR Biociences, 
Nebraska, USA) diluted 1:25000. For IR detection, membranes were scanned in Odyssey 
Infrared Imaging System (LI-COR Biociences, NE, USA), and the bands were quantified using 
the analysis software provided (Odyssey Software V.3.0). β-Actin was used as a housekeeping 
protein. 
CPT1A was also determined in the hepatic mitochondrial fraction. Mitochondria were 
precipitated from the mitochondrial-enriched pellet in buffer solution by centrifuging at 7000 x 
g for 10min at 4ºC. The pellet was sonicated at 4ºC in 150µl of cellular PBS buffer with 
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protease and phosphatase inhibitor cocktail (Halt
TM
 Protease & Phosphatase Inhibitor Cocktail 
100x, Thermo Fisher Scientific Inc, Madrid, Spain). The homogenate was centrifuged at 7500 x 
g for 2min at 4ºC, and the supernatant was used for protein analysis. Total mitochondrial 
protein content was measured by the method of Bradford (Bradford 1976). For analysis, 40µg 
of total mitochondrial protein was solubilized and boiled for 3min in Laemmli sample buffer 
containing 5% 2-β-mercaptoethanol. Western blot and CPT1A detection was performed as 
described above. 
 
Histological analysis  
rWAT and liver samples from all groups were processed. Firstly, fixed samples were 
dehydrated in graded series of ethanol, cleared in xylene and embedded in paraffin blocks. 
Then, five micrometre-thick sections of tissues were cut with a microtome and mounted on 
slides.  
For histological analysis, slides were stained with hematoxylin and eosin, dehydrated with 
ethanol, cleared in xylene and mounted with Eukitt (Panreac Quimica SA). For each rWAT and 
liver sample, 2-3 photos from the most preserved and representative sections of the slides were 
digitalized from light microscopy (Zeiss Axioskop 2 microscope) connected with AxioCam 
Icc3 digital camera (Carl Zeiss, S.A., Barcelona, Spain). In liver sections, the presence of fatty 
vesicles was studied by using the software AxioVision 40V 4.6.3.0. (Carl Zeiss, Imaging 
Solutions GmbH, Germany). Morphometric analyses were performed in rWAT. The diameter 
of all adipocytes from each photo of rWAT was measured by using the software AxioVision 
40V 4.6.3.0. mentioned above, and then averaged. Only adipocytes which had an intact 
membrane were measured. Image analyses from all samples and groups were examined in a 
blind fashion.  
 
Measurement of circulating parameters  
Circulating parameters were measured at the age of 6 months under fed and/or fasting 
conditions. Blood glucose concentration was measured by Accu-Chek Glucometer (Roche 
Diagnostics, Barcelona, Spain). Commercial enzyme-linked immunosorbent assay (ELISA) 
kits were used for the quantification of circulating plasma levels of hormones: insulin 
(Mercodia AB, Uppsala, Sweden), and adiponectin, leptin and TNFα (R&D Systems, 
Minneapolis, MN, USA), according to the manufacturer’s instructions. Absorbance of the 
samples was read with a spectrophotometer Tecan Sunrise Absorbance Reader. A fluorimetric 
assay was used for the quantification of β-hydroxybutyrate (BHB) plasma levels (kit from BEN 
S.r.l.-Biochemical enterprise). Fluorescense was detected by using a spectrofluorimeter Mithras 
LB 940 (Berthold Technologies GmgH & Co KG, Bad Wildbad, Germany).  
The homeostatic model assessment for insulin resistance (HOMA-IR) was used to assess 
insulin resistance. It is calculated from fasting insulin and glucose concentration using the 
formula of Matthews et al. (Matthews, et al. 1985). HOMA-IR= fasting glucose (mmol/L) x 
fasting insulin (mU/L)/22.5. 
 
Hepatic triglycerides, extraction and quantification 
Lipid extraction was performed in the liver of 6-month-old animals to evaluate hepatic TG 
content. The protocol followed was described in Caimari et al. (Caimari, et al. 2012) with some 
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modifications. Briefly, 50-100mg of liver was mixed with 1mL of hexane/isopropanol (3:2, 
vol/vol). Hepatic lipid extracts were resuspended in 1.2mL of LPL buffer (28.75mM Pipes, 
57.4 mM MgCl2·6H20, 0.569mg/mL bovine serum albumin-fatty acid free) with sodium 
dodecyl sulfate (SDS) 0.1%. Then, samples were sonicated for 30s, and tubes were left 
overnight in an orbital shaker at room temperature and protected from light. On the following 
day, tubes were cold sonicated with three pulses of 30s each, and their TG levels were 
measured immediately using a commercial enzymatic colorimetric kit (Triglyceride (INT) 20, 
Sigma Diagnostics, St Louis, MO, USA). 
 
Quantification of hepatic glycogen levels  
Hepatic glycogen was quantified in liver samples from 6-month-old animals. Glycogen 
isolation was performed by digestion of 0.3-0.8g of liver in  1 mL of 30% KOH at 100ºC for 
10min. Glycogen was precipitated overnight at -20ºC with 2mL of 100% ethanol and collected 
by centrifugation at 3000rpm for 30min at 4ºC. The precipitate was redissolved in 1mL of 8% 
tricholoracetic acid (TCA) and centrifuged at 3000rpm for 15min at 4ºC; the supernatant was 
stored at 4ºC, whereas the pellet was redissolved in 1mL of 8% TCA and centrifuged at 
3000rpm for 15min at 4ºC; the resulting supernatant was added to the stored one. Glycogen 
was again obtained from the supernatant by precipitation with 4mL of 96% cold ethanol 
followed by centrifugation at 3000rpm for 15min at 4ºC. Finally, the pellet was then 
redissolved in 1mL of water. Glycogen concentration was measured with the anthrone reagent 
as previously described (Roe and Dailey 1966). 
 
Indirect calorimetry and locomotive activity measurements 
At the age of 3 months, animals were monitored for 24h to assess energy expenditure by 
indirect calorimetry and locomotive activity by using the LabMaster-CaloSys-Calorimetry 
System (TSE Systems, Bad Homburg, Germany). Before starting measurements, and in order 
to reduce potential stress, animals were individually housed and acclimated to the respiratory 
cages for 24h. Then, data on gas exchanges (VO2; ml kg
−1
 h
−1
 and VCO2; ml kg
−1
 h
−1
) were 
measured via an open-circuit indirect calorimetry system for 24h. To calculate energy 
expenditure (kcal/h), rates of oxygen consumption and carbon dioxide production were 
monitored for 5min every 45min for each animal or reference cage (our system can handle 8 
animal cages and 1 reference cage, simultaneously). Locomotive activity (counts/h) was 
measured continuously by an infrared beam system integrated in the LabMaster System for 
24h.  
 
Blood pressure measurement 
Systolic blood pressure (SBP) was measured when animals were 5 months old. SBP was 
determined without anaesthesia using non-invasive blood pressure methodology. It consists of 
using a tail-cuff sphygmomanometer with a photoelectric sensor (Niprem 546, Cibertec S.A., 
Spain) placed on the animal’s tail to occlude the blood flow. Heart rate was also registered. 
Niprem software V1.8 was used to determine the SBP value and heart rate value. For each rat, 
SBP and heart rate values were calculated as the mean of a minimum of five measurements.  
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Gene expression analysis in liver  
Total RNA was extracted from liver by EZNA® TOTAL RNA kit I (Omega Bio-Tek Inc., 
Norcross, GA, USA) following the manufacturer’s instructions. Isolated RNA was quantified 
using the NanoDrop ND-1000 spectrophotometer (NanoDrop Techonologies, Ins., Wilmington, 
DE) and its integrity confirmed using agarose 1% gel electrophoresis.  
Real-time quantitative polymerase chain reaction (RT-qPCR) was used to measure mRNA 
expression levels in liver of Acaca (Acetyl-CoA carboxylase subunit alpha), Cd68 (cluster of 
differentiation 68), Fasn (fatty acid synthase), G6pd (glucose-6-phosphate dehydrogenase), 
ObRb (long form leptin receptor) and Tnfa (tumor necrosis factor alpha). Gdi1 (guanosine 
diphosphate (GDP) dissociation inhibitor 1) and Rn18s (18S ribosomal RNA) were used as 
housekeeping genes. All primers used for RT-qPCR amplification were obtained from Sigma 
Genosys (Sigma Aldrich Química SA, Madrid, Spain) and sequences are described in (Palou, et 
al. 2012; Palou, et al. 2009a; Ribot, et al. 2008), except for: G6pd (forward sequence: 5’-
CGAACCACATCTCCTCTCTG-3’ and reverse sequence 5’-
ATCAAAATAGCCCCCACGAC-3’) and Cd68 (forward sequence: 5’-
AATGTGTCCTTCCCACAAGC-3’ and reverse sequence 5’-
GGCAGCAAGAGAGATTGGTC -3’).  
Total RNA (0.25µg; in a final volume of 5µl) was denatured for 10min at 65ºC and then 
reverse transcribed to cDNA using murine leukemia virus reverse transcriptase (Applied 
Biosystem, Madrid Spain) for 15min at 20ºC, for 30min at 42ºC, with a final step of 5min at 
95ºC in an Applied Biosystems 2720 Thermal Cycler (Applied Biosystem). Each qPCR was 
performed from diluted (1/10) cDNA template, forward and reverse primers (5µM and 10µM), 
and Power SYBER Green PCR Master Mix (Applied Biosystems, Foster City, CA). qPCR was 
performed using the Applied Biosystems Step OnePlusTM Real-Time PCR Systems (Applied 
Biosystems) with the following profile: 10min at 95ºC, followed by a total of 40 two-
temperature cycles (15s at 95ºC and 1min at 60ºC). To verify the purity of the products, a 
melting curve was produced after each run according to the manufacturer’s instructions. The 
threshold cycle was calculated by the instrument’s software (StepOne Software version 2.2). 
Relative gene expression numbers were calculated as a percentage of male control AAV-Gfp 
(Control-C) rats, using the 2-∆∆Ct method (Livak and Schmittgen 2001). 
 
Statistical analysis 
Data are mean ± standard error of the mean (S.E.M.). Multiple comparisons were assessed by 
two-way or repeated measures analysis of variance (ANOVA) to determine the effects of 
calorie restriction during gestation, and AAV-Cpt1am injection vs AAV-Gfp. Single 
comparisons between groups were assessed by Student’s t test and the effect of fasting 
conditions by Paired t test. Threshold of significance was set at p<0.05, unless indicated. 
Analysis was performed with SPSS for Windows (SPSS version 19.0, Chicago, IL). 
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Results 
Vector insertion verification in hepatic cells  
The AAV-Gfp and AAV-Cpt1am constructs used here were the same as in a previous study 
(Orellana-Gavaldà, et al. 2011). Their capacity to insert in hepatic cells and drive 
overexpression of the target genes had been previously proven (Orellana-Gavaldà, et al. 2011).  
Since vector insertion was made at an early age of life (postnatal day 18), relative Cpt1a 
expression was expected to be decreased as the animals grew. Western Blot analysis of CPT1A 
in liver was performed in adult animals to verify whether overexpression of Cpt1a remained at 
the age of 6 months. Fig. 1 shows protein levels of hepatic CPT1A in the whole protein extract 
in liver (Fig. 1a) and levels of hepatic CPT1A in the mitochondrial protein fraction in liver 
(Fig. 1b). When analysing the whole protein extract, we did not observe significant changes in 
CPT1A protein levels due to the injection of AAV-Cpt1am vectors (no significant differences 
by two-way ANOVA). Control-CPT and CRG-CPT animals tended toward slightly higher but 
not significantly different levels of CPT1A than those animals injected with control-vectors. 
When analysing the mitochondrial protein extract, Control-CPT animals showed greater 
CPT1A levels than Control-C rats (p<0.05, Student’s t test). No changes were observed in 
CPT1A protein content by effect of maternal calorie restriction during gestation (no significant 
differences by two-way ANOVA).  
The presence of GFP in hepatocytes of animals injected with control (AAV-Gfp) vectors was 
used to demonstrate the achievement of injection and vector insertion. AAV-Cpt1am injected 
animals were used as a negative control. Relative Gfp expression was also expected to decrease 
as the animals grew, but was still detected in adult animals. Fig. 2 shows digital images of 
representative liver slides of Control-C, Control-CPT, CRG-C and CRG-CPT animals acquired 
by using confocal laser scanning microscopy. Fluorescent signals from GFP were found as 
spots distributed in the cytoplasm of hepatocytes of Control-C and CRG-C animals (GFP 
images), while no green fluorescence emission was observed in hepatocytes of Control-CPT 
and CRG-CPT. Nuclear DAPI staining is also shown in blue (DAPI images). Merge images 
show the superposition of DAPI and GFP images, evidencing the cell localisation of green 
fluorescence. 
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Figure 1. Protein levels of CPT1A measured in whole-protein extracts of liver (a), or in the mitochondrial 
protein fraction (b) from 6-month-old offspring of control dams injected on postnatal day 18 with Gfp and 
Cpt1am vectors (Control-C and Control-CPT, respectively) and offspring of calorie restricted dams during 
gestation injected with Gfp and Cpt1am vectors (CRG-C and CRG-CPT, respectively). Data are mean ± 
S.E.M. (n= 9-11 animals per group). Statistics: Ω, Cpt1am vs Gfp-injection, (p<0.05, Student’s t test). 
Abbreviations: carnitine palmitoyltransferase 1A (CPT1A); no significant differences (n.s.).  
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Figure 2. GFP detection in hepatocytes from 6-month-old offspring of control dams and calorie restricted dams 
during gestation, injected on postnatal day 18 with Gfp (Control-C and CRG-C, respectively) compared to those 
AAV-Cpt1am injected ones (Control-CPT and CRG-CPT, respectively). Detection was made by confocal laser 
scanning microscopy of frozen liver sections stained with DAPI for nucleus identification. Excitation wavelength 
was set at 405nm (for DAPI) and 488nm (for GFP). Images were scanned at 64X. Abbreviations: blue-
fluorescence DAPI dilactate (DAPI) and green fluorescence protein (GFP).  
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AAV-Cpt1am treatment at early ages improved insulin sensitivity and prevented increased 
adiposity size occurring in the offspring of calorie restricted dams during gestation without 
affecting body weight 
Body weight 
As shown in Table 1, moderate maternal calorie restriction during the first 12 days of 
pregnancy did not result in different offspring body weight at birth with respect to their 
controls. Neither were significant differences found between control and CRG animals 
throughout the study period, either under NF-diet or when moved to a HF diet. Neither did 
AAV-Cpt1am injection affect body weight of animals compared to their AAV-Gfp injected 
control ones.  
The weight of WAT depots (inguinal or retroperitoneal) was not different between groups at 
the age of 6 months.  
Table 1. Body weight at different ages and weight of WAT depots and liver at sacrifice 
 Age Control CRG 
Body weight (g)    
   Birth PND-1 6.72 ± 1.16 6.72 ± 0.20 
 Control-C Control-CPT CRG-C CRG-CPT 
   AAV-Injection  PND-18 35.5 ± 0.8 35.8 ± 0.9 35.6 ± 1.6 34.9 ± 1.4 
   Weaning  PND-21 45.8 ± 1.2 46.4 ± 1.1 46.1 ± 2.4 45.0 ± 1.9 
   Before HF-diet 4 months 411 ± 9 401 ± 8 407 ± 9 399 ± 11 
   After HF-diet 6 months 479 ± 10 471± 13 478 ± 14 464 ± 14 
WAT weight (g)      
   iWAT 6 months 12.4 ± 0.8 13.2 ± 0.9 13.7 ± 1.2 11.7 ± 1.0 
   rWAT 6 months 17.8 ± 1.4 18.4 ± 1.4 18.9 ± 1.7 18.5 ± 1.2 
Liver weight (g) 6 months 13.6 ± 0.4 12.8 ± 0.6 12.5 ± 0.3 12.6 ± 0.5 
At birth, data are mean ± S.E.M (n=19-21 animals per group) of the offspring of control and calorie restricted 
dams during gestation (control and CRG, respectively). From PND-18, data are mean ± S.E.M (n=9-11 animals 
per groups) of the offspring of control dams injected in postnatal day 18 with Gfp and Cpt1am vectors (Control-C 
and Control-CPT, respectively) and the offspring of calorie restricted dams during gestation injected with Gfp and 
Cpt1am vectors (CRG-C and CRG-CPT, respectively). Abbreviations: inguinal white adipose tissue (iWAT), 
postnatal day (PND), and retroperitoneal white adipose tissue (rWAT).  
 
Circulating parameters 
Table 2 shows circulating levels of glucose, insulin, BHB, TG, leptin, adiponectin and TNFα of 
control (Control-C and Control-CPT) and CRG (CRG-C and CRG-CPT) animals at the age of 6 
months under feeding or 12h fasting conditions, as indicated. Leptin to adiponectin (L/A) ratio 
and HOMA-IR are also presented. CRG animals (both CRG-C and CRG-CPT) showed higher 
fasted insulin and HOMA-IR than controls (p<0.05 two-way ANOVA). It is worth noting that, 
AAV-Cpt1am injected animals showed lower fasted insulin levels (only control animals, 
p<0.05, Student’s t test) and lower HOMA-IR (both control and CRG animals, p<0.05 two-way 
ANOVA) than their respective AAV-Gfp controls. CRG-CPT animals also showed lower 
fasted glucose levels than CRG-C animals (p<0.05, Student’s t test). CRG-CPT animals also 
showed a response to fasting conditions, regarding glucose and insulin levels, while this 
response was not shown in CRG-C animals.  
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Table 2. Circulating parameters at the age of 6 months 
  Control-C Control-CPT CRG-C CRG-CPT ANOVA 
Glucose 
(mg/dL) 
Fed 
Fasting 
121 ± 3 
104 ± 3# 
115 ± 2 
107 ± 4# p=0.06 
111 ± 4 
110 ± 4 
117 ± 4 
97.1 ± 1.0#, Ω,* 
 
RxT 
Insulin (µg/L) 
Fed 
Fasting 
2.09 ± 0.18 
0.974 ± 0.154# 
2.84 ± 0.54 
0.583 ± 0.100#, Ω 
2.54 ±  0.46 
1.62 ± 0.41 
3.54 ± 0.56 
1.19 ± 0.24#,* 
 
R 
BHB (μmol/L) 
Fed 
Fasting 
666 ± 84 
841 ± 73 
652 ± 70 
911 ± 222 
466 ± 112 
2000 ± 194#,* 
596 ± 79 
1433 ± 205#, Ω 
 
R 
TG (mg/mL) 
Fed 
Fasting 
2.23 ± 0.31 
0.408 ± 0.042# 
1.67 ± 0.28 
0.446 ± 0.095# 
1.57 ± 0.22 
0.457 ± 0.078# 
1.54 ± 0.22 
0.380 ± 0.096# 
 
Leptin (µg/L) 
Fed 
Fasting 
12.2 ± 1.2 
4.93 ± 0.58# 
12.4 ± 1.4 
5.97 ± 0.77# 
12.4 ± 1.4 
7.25 ± 1.0#,* p=0.062 
11.2 ± 1.1 
6.76 ± 0.67# 
 
Adiponectin 
(mg/L) 
Fed 
Fasting 
9.36 ± 0.82 
8.76 ± 0.62 
10.4 ± 0.9 
8.85 ± 0.55 
8.89 ± 0.37 
8.05 ± 0.59 
9.05 ± 1.20 
9.02 ± 0.50 
 
L/A ratio 
(µg/mg) 
Fed 
Fasting 
1.31 ± 0.14 
0.58 ± 0.08# 
1.31 ± 0.20 
0.68 ± 0.08# 
1.41 ± 0.15 
0.92 ± 0.15#,* 
1.42 ± 0.21 
0.70 ± 0.07# 
 
HOMA-IR Fasting 6.25 ± 1.06 3.77 ± 0.67 
Ω p=0.07 10.7 ± 2.8 6.97 ± 1.14* R, T 
TNFα (pg/mL) Fed 4.40 ± 0.80 4.66 ± 0.80 6.62 ± 0.77
* p=0.066 5.50 ± 1.15  
Circulating parameters under fed and fasting conditions from 6-month-old offspring of control dams injected in 
postnatal day 18 with Gfp and Cpt1am vectors (Control-C and Control-CPT, respectively) and offspring of calorie 
restricted dams during gestation injected with Gfp and Cpt1am vectors (CRG-C and CRG-CPT, respectively). 
Data are mean ± S.E.M (n=9-11 animals per group) Statistics: RxT, interaction between maternal calorie restriction 
during gestation and Cpt1am-injection; R, effect of maternal calorie restriction during gestation; T, effect of 
Cpt1am-injection (p<0.05, two-way ANOVA). #, fasting vs feeding conditions (p<0.05, Paired t test); *, CRG vs 
Control animals; 
Ω
, Cpt1am vs Gfp-injection (p<0.05, Student’s t test). Abbreviations: BHB, (β-hydroxybutyrate), 
HOMA-IR (insulin resistance HOMA index), L/A ratio (leptin-to-adiponectin ratio), TG (triglycerides) and TNFα 
(tumor necrosis factor alpha). 
Concerning leptin, CRG-C animals revealed a trend to higher leptin levels under fasting 
conditions than controls (p=0.062, Student’s t test). In addition, although adiponectin levels 
were not significantly different between groups, L/A ratio of fasted CRG-C animals was 
significantly higher compared to Control-C animals (p<0.05 Student’s t test). Differences were 
not observed between CRG-CPT and Control-CPT animals.  
Regarding BHB, under fasting conditions, CRG animals showed higher levels than their 
controls (p<0.05 two-way ANOVA); CRG-CPT animals displayed lower levels than CRG-C 
animals (p<0.05, Student’s t test). No differences between groups were observed concerning 
TG levels. Finally, plasma levels of TNFα tended toward being higher in CRG-C animals 
compared to Control-C rats (p=0.066, Student’s t test). No changes were observed between the 
other groups of animals.  
 
Protein levels of total AKT and pAKT in liver 
The potential effect of increased hepatic Cpt1a expression at early ages on insulin signalling 
was evaluated by studying total AKT and pAKT in liver at the age of 6 months (Fig. 3). CRG 
animals injected with AAV-Cpt1am vectors showed a lower pAKT/total AKT ratio compared 
to CRG-C and Control-C animals (p<0.05, Student’s t test). Thus, an interaction between 
calorie restriction and Cpt1am-injection was observed for total AKT and pAKT/total AKT ratio 
(p=0.057 and 0.056, respectively, two-way ANOVA). 
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Figure 3. Protein levels of total AKT and pAKT/total AKT ratio in liver from 6-month-old offspring of control 
dams injected on postnatal day 18 with Gfp and Cpt1am vectors (Control-C and Control-CPT, respectively) and 
offspring of calorie restricted dams during gestation injected with Gfp and Cpt1am vectors (CRG-C and CRG-
CPT, respectively). Data are mean ± S.E.M. (n= 9-11 animals per group). β-Actin was used a housekeeping 
protein. Statistics: RxT, interaction between maternal calorie restriction during gestation and Cpt1am-injection, 
(two-way ANOVA). Ω, Cpt1am vs Gfp-injection); *, CRG vs Control animals (p<0.05, Student’s t test). 
Abbreviations: total protein kinase B (total AKT) and phosphorylated AKT on Serine 473 (pAKT).  
 
Composition and histological analyses of liver and rWAT 
Fig. 4a shows the hepatic content of TG of animals at the age of 6 months. CRG-C animals 
tended toward displaying higher hepatic TG levels than their controls (p=0.081, Student’s t 
test) while no differences were observed between the other groups. Fig. 4b shows 
representative images of hematoxylin/eosin stained liver slides of animals from the different 
groups. All the animals presented fatty vesicles in their hepatocytes but CRG animals showed a 
greater amount of fat vesicles than control animals, especially CRG-C animals. Interestingly, 
fewer fatty vesicles were observed in CRG-CPT animals compared to those injected with 
control-vectors. 
Regarding hepatic glycogen content (Fig. 4c), AAV-Cpt1am injected animals revealed a trend 
to higher levels, although differences did not reach statistical significance (p=0.087, two-way 
ANOVA). 
Fig. 5a shows the diameter of adipocytes measured in sections of rWAT from animals at the 
age of 6 months. Representative rWAT sections stained with hematoxylin/eosin of the different 
groups of animals are also given (Fig. 5b). Although no significant differences were observed 
concerning the weight of WAT depots, adipocytes of CRG-C animals had a larger diameter 
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than Control-C animals; interestingly, this effect was not seen in AAV-Cpt1am injected CRG 
animals. CRG-CPT animals presented adipocytes with a significantly lower diameter than 
CRG-C rats (p<0.05 two-way ANOVA). 
 
Figure 4. Triglyceride content in liver (a); representative liver slides stained with hematoxylin/eosin (x20); (b) and hepatic 
glycogen content (c) from 6-month-old offspring of control dams injected on postnatal day 18 with Gfp and Cpt1am vectors 
(Control-C and Control-CPT, respectively) and offspring of calorie restricted dams during gestation injected with Gfp and 
Cpt1am vectors (CRG-C and CRG-CPT, respectively). Data are mean ± S.E.M. (n= 9-11 animals per group). Statistics: R, 
effects of maternal calorie restriction during gestation (p=0.087, two-way ANOVA); T, effects of Cpt1am-injection (p=0.087, 
two-way ANOVA). *, CRG vs Control animals, (p<0.05, Student’s t test). Abbreviations: triglycerides (TG). Symbol images: 
V, indicate a central vein; the arrows indicate some lipid droplets. 
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Figure 5. Adipocyte size in rWAT (a) and images (20x) of rWAT sections with hematoxylin/eosing staining (b) 
from 6-month-old offspring of control dams injected on postnatal day 18 with Gfp and Cpt1am vectors (Control-C 
and Control-CPT, respectively) and offspring of calorie restricted dams during gestation injected with Gfp and 
Cpt1am vectors (CRG-C and CRG-CPT, respectively). Data are mean ± S.E.M. (n= 9-11 animals per group). 
Statistics: RxT, interaction between maternal calorie restriction during gestation and Cpt1am-injection (p<0.05, 
two-way ANOVA). *, CRG vs Control animals; Ω, Cpt1am vs Gfp-injection (p<0.05, Student’s t test). 
Abbreviations: rWAT (retroperitoneal white adipose tissue).  
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AAV-Cpt1am treatment at early ages restored changes in energy metabolism, locomotive 
activity and systolic blood pressure programmed by calorie restriction during gestation 
Energy expenditure 
Energy expenditure was measured by indirect calorimetry at the age of 3 months. As shown in 
Fig. 6a, CRG animals, both CRG-C and CRG-CPT, showed lower energy expenditure than 
their controls (p<0.05, repeated measures ANOVA) and especially during the nocturnal period 
(p<0.05, Student’s t test). Despite the lower energy expenditure observed in CRG animals, 
CRG-CPT rats displayed higher energy expenditure during the nocturnal period than CRG-C 
animals (p<0.05, Student’s t test). Energy expenditure was significantly higher during the 
nocturnal period in all groups of animals than during the diurnal period (p<0.05, repeated 
measures ANOVA).  
 
Locomotive activity 
Locomotive activity of animals at the age of 3 months is shown in Fig. 6b. CRG-C animals 
showed a trend to lower locomotive activity compared to their controls; this tendency was not 
shown in CRG-CPT animals, which exhibited similar levels to control animals. In fact, CRG-
CPT animals displayed higher activity than CRG-C animals during the diurnal period (p<0.05, 
Student’s t test), but a trend toward higher activity was also observed during the nocturnal 
phase (p=0.073, Student’s t test). Interactive effects were found between light (diurnal or 
nocturnal period), calorie restriction during gestation and Cpt1am-injection (p<0.05, repeated 
measures ANOVA). When diurnal and nocturnal period were analysed separately, an 
interaction between calorie restriction and Cpt1am-injection was found during the nocturnal 
period (p<0.05, two-way ANOVA). Considering all animals as a whole, locomotive activity 
during the nocturnal phase showed a positive correlation with energy expenditure (r= 0.414; p= 
0.010, Pearson’s correlation).   
 
Systolic blood pressure 
SBP was measured when animals were 5 months old (Fig. 6c). CRG-C animals displayed a 
significantly higher SBP than their Control-C animals (p<0.05, Student’s t test). Interestingly, 
CRG-CPT animals did not show significant differences in SBP in comparison to Control-CPT 
animals. Heart rate was also measured but, no differences between groups were observed (data 
not shown).  
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Fig. 6 Energy expenditure (a), locomotive activity (b) and systolic blood pressure (c) of offspring of control dams 
injected on postnatal day 18 with Gfp and Cpt1am vectors (Control-C and Control-CPT, respectively) and 
offspring of calorie restricted dams during gestation injected with Gfp and Cpt1am vectors (CRG-C and CRG-
CPT, respectively), at the age of 3 months (for a and b) and at the age of 5 months (for c). Data are mean ± S.E.M. 
(n= 9-11 animals per group). Statistics: LxRxT, interaction between light, maternal calorie restriction during 
gestation and Cpt1am-injection; LxR, interaction between light and maternal calorie restriction during gestation; L, 
effect of light; R, effect of maternal calorie restriction during gestation, (p<0.05, repeated measures ANOVA). λ, 
nocturnal vs diurnal phase (p<0.05, Paired t test). *, CRG vs Control animals; Ω, Cpt1am vs Gfp-injection, 
(p<0.05, Student’s t test). Abbreviations: systolic blood pressure (SBP). 
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Effects of calorie restriction during gestation and AAV-Cpt1am treatment at an early age on 
the hepatic expression of leptin receptor and genes related to lipogenesis and inflammation  
Fig. 7 shows mRNA expression levels of selected genes in liver of 6-month-old animals. 
Calorie restriction during gestation resulted in lower hepatic mRNA expression levels of leptin 
receptor. This effect was partially reverted by AAV-Cpt1am treatment at early stages of life. 
Therefore, ObRb expression levels in CRG-CPT animals were not different compared to their 
controls (Control-CPT animals). Concerning the expression of lipogenesis related genes, AAV-
Cpt1am treatment resulted in lower expression levels of G6pd (p<0.05, two-way ANOVA), 
particularly in CRG animals (p<0.05, Student’s t test), and of Acaca, but only in CRG animals 
(p<0.05, Student’s t test, and interactive effect between calorie restriction during gestation and 
AAV-Cpt1am injection, p<0.05, two-way ANOVA). No significant differences were found 
concerning Fasn expression. AAV-Cpt1am injection resulted in lower expression levels of the 
inflammation-related genes, Tnfa and Cd68 (p<0.05, two-way ANOVA). In the case of Tnfa, 
the effect was more marked and significant by Student’s t test in CRG animals (p<0.05). No 
significant differences between groups were found concerning mRNA expression levels of Il6 
(interleukin 6) and Il1b (interleukin 1 beta) (data not shown).  
 
Figure 7. mRNA levels of selected genes in liver from 6-month-old offspring of control dams injected on 
postnatal day 18 with Gfp and Cpt1am vectors (Control-C and Control-CPT, respectively) and offspring of calorie 
restricted dams during gestation injected with Gfp and Cpt1am vectors (CRG-C and CRG-CPT, respectively). 
Data are mean ± S.E.M. (n= 9-11 animals per group). Statistics: RxT, interaction between maternal calorie 
restriction during gestation and Cpt1am-injection; T, effects of Cpt1am-injection; R, effects of maternal calorie 
restriction during gestation (p<0.05, two-way ANOVA). *, CRG vs Controls; Ω, Cpt1am vs Gfp-injection animals, 
(p<0.05, Student’s t test). Abbreviations: Acetyl-CoA carboxylase subunit alpha (Acaca), cluster of differentiation 
68 (Cd68), fatty acid synthase (Fasn), glucose-6-phosphate dehydrogenase (G6pd), long form leptin receptor 
(Obrb) and tumor necrosis factor alpha (Tnfa).  
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Discussion 
We have previously described that 20% calorie restriction in rats during the first half of 
gestation results in metabolic disturbances in the offspring related to the metabolic syndrome 
(Palou, et al. 2012; Palou, et al. 2010a). These animals, particularly males, show in adulthood 
altered circulating parameters, impaired insulin and leptin sensitivity and a distorted profile of 
gene expression in key tissues involved in energy homeostasis (Palou, et al. 2012; Palou, et al. 
2010a). Besides, it is accepted that pharmacological or genetic strategies enabling FAO to be 
enhanced may be beneficial for the treatment of the metabolic disorders related to obesity 
(Orellana-Gavaldà, et al. 2011; Stefanovic-Racic, et al. 2008). Orellana-Gavaldà et al. 
(Orellana-Gavaldà, et al. 2011) described that AAV-mediated expression of Cpt1am, a 
permanently active mutant form of CPT1A insensitive to malonyl-CoA, protected mice against 
HF diet-induced obesity, hepatic steatosis and insulin resistance. Interestingly, the use of AAV 
for gene therapy in humans has become attractive because AAV vectors show wide tissue 
tropism, efficient transduction, and lack of human pathology (Jazwa A. 2007). Due to the above 
characteristics and the need for strategies to prevent or treat obesity and its related metabolic 
disorders, here we aimed to assess whether an AAV-mediated increased expression of Cpt1am, 
and hence enhanced hepatic FAO, at early ages of life is able to revert adverse metabolic 
malprogramming due to maternal moderate calorie restriction during gestation. 
The effectiveness of the AAV-Cpt1am vector used here to mediate long-term expression of 
Cpt1a in liver has been previously described (Orellana-Gavaldà, et al. 2011). In our case, 
injection of AAV was made at early stages of life, postnatal day 18; hence the relative 
contribution of exogenous Cpt1a expression to the total expression was expected to decrease 
with the animals’ growth, particularly with the increase in liver size. In fact, at the age of 6 
months, AAV-Cpt1am injected animals only showed a small trend to display higher protein 
levels of CPT1A than animals injected with control-vectors. Higher CPT1A protein levels were 
only detected in Control-CPT animals compared to Control-C animals in the isolated 
mitochondrial protein fraction. This is attributable to the fact that AAV can infect both dividing 
and quiescent cells but persists in an extrachromosomal state without integrating into the 
genome of the host cell. Therefore, due to the lack of the elements in AAV required for their 
replication and encapsidation, the number of hepatocytes carrying the Cpt1am-vector is 
expected to become relatively lower compared to the total amount of hepatocytes as animals 
grew. The presence of green fluorescence in some hepatocytes of adult animals that were 
injected with AAV-Gfp, used as a control, proved the correct insertion of vectors in hepatic 
cells.   
Concerning the lasting effects of maternal undernutrition during gestation, we show here that 
adult male offspring fed on a HF diet displayed higher fasting levels of insulin, a trend toward 
higher leptin levels, as well as greater HOMA-IR and L/A ratio compared to controls. In 
addition to HOMA-IR, L/A ratio has been proposed as a useful, reliable measure of insulin 
resistance and vascular risk (Finucane, et al. 2009; Satoh, et al. 2004). These results suggest 
that the offspring of undernourished dams during the first part of gestation presents features of 
impaired insulin and leptin sensitivity in adulthood, in accordance with our previous results 
using the same animal model (Palou, et al. 2012; Palou, et al. 2010a). Notably, AAV-mediated 
Cpt1am expression reverted the alterations in plasma insulin levels, HOMA-IR and L/A ratio 
found in CRG animals. Fasting insulin levels and HOMA-IR were also decreased in control 
animals injected with AAV-Cpt1am. Moreover, CRG-CPT animals also recovered the capacity 
to respond to feeding/fasting conditions as far as glucose and insulin levels were concerned, 
which was impaired in CRG animals.  
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For further study, the potential effects of Cpt1am-injection on insulin signalling, hepatic levels 
of total AKT and its phosphorylated form were determined. It is known that interaction of 
insulin with its receptor leads to phosphorylation of insulin receptor substrate and initiates a 
signalling cascade that culminates in the phosphorylation of the serine/threonine-specific 
protein kinases AKT (Choi and Kim 2010). Once activated, AKT kinases use distinct 
downstream pathways to modulate metabolism, resulting in enhanced protein synthesis and cell 
growth, glucose uptake, glycogen synthesis, and lipogenesis (Choi and Kim 2010). Insulin 
resistance is associated with defective AKT activation (Farese, et al. 2005). However basal 
levels of pAKT have been found to be increased in HF diet fed mice, and have been related 
with insulin resistance (Liu, et al. 2009). Here, samples were not obtained under basal 
conditions, but under feeding conditions at the beginning of the light phase. However, at this 
time, plasma insulin levels are decreased compared to levels found during the dark phase, when 
animals consume most of their daily food intake (Sánchez, et al. 2004). Thus, although CRG-C 
animals showed no changes in hepatic protein levels of total AKT or of the pAKT/total AKT 
ratio compared to their controls, CRG-CPT rats showed a trend toward increased total protein 
levels of AKT compared to CRG-C animals, and they displayed a decreased pAKT/total AKT 
ratio. Hence, the blockade of the continuously elevated AKT-dependent insulin signalling that 
CRG-CPT animals revealed compared to CRG-C could be tentatively related with an 
improvement in insulin sensitivity of animals, according to (Liu, et al. 2009); however 
additional analysis would need to be performed to verify the functioning of this signalling 
pathway in these animals.  
Repeated exposure of the liver to elevated insulin levels has been described to induce increased 
hepatic TG production (Zammit 2002). In agreement with this, CRG-C animals, which 
displayed higher fasted insulin levels compared to their controls, also presented a trend to 
greater amount of lipid vesicles and higher TG content in liver. Notably, CRG-CPT animals, 
which showed lower fasting insulin levels than CRG-C animals, did not show the mentioned 
trend, and TG content was similar to that of control animals. Moreover, CRG-CPT animals also 
showed fewer lipid vesicles than CRG-C animals. The occurrence of higher fasting levels of 
ketone bodies in CRG compared to their controls may also be related to increased TG 
accumulation in these animals. In fact, increased levels of plasma ketone bodies have been 
reported in patients with NAFLD (Sanyal, et al. 2001). Notably, CRG-CPT animals shower 
lower ketone bodies than CRG-C animals. Changes in liver TG content between control and 
AAV-Cpt1am animals may be related to lower expression levels of lipogenesis-related genes, 
such as G6pd and Acaca. G6PD catalyses the first, rate-limiting, step of the pentose phosphate 
pathway. NADPH is the important product of the reaction and is used for the reductive 
biosynthesis of fatty acids and cholesterol (Singh 2012). NADPH also plays an important 
function in the protection of the cell against oxidative agents by transferring its reductive power 
to glutathione disulphide via glutathione disulphide reductase (Singh 2012). Regarding the 
lipogenic activity of this enzyme, hepatic G6PD has been demonstrated to be regulated by 
nutritional and hormonal factors, particularly insulin, in function of the demand for NADPH 
needed for cholesterol and/fatty acid metabolism (Gupte 2010). G6pd expression and activity 
are upregulated in rat and mouse models of obesity, hyperglycemia and hyperinsulinemia, and 
a role for G6pd in the development of insulin resistance in type 2 diabetes has been proposed 
(Gupte 2010). AAV-Cpt1am injected animals, particularly CRG animals, showed lower 
expression levels of G6pd compared to their respective controls. This could be related to lower 
hepatic lipogenesis activity and the relative protection of these animals to developing insulin 
resistance. Consistent with these results, CRG-CPT animals also revealed lower mRNA 
expression levels of Acaca compared to their controls. This enzyme is highly expressed in liver 
and catalyses malonyl-CoA formation, the first step for fatty acid synthesis (Savage, et al. 
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2006). Moreover, malonyl-CoA also suppresses fatty acid oxidation by inhibiting CPT1A; 
therefore reduction of Acaca may also increase fat oxidation (Savage, et al. 2006).  
Differences between groups concerning hepatic glycogen content may also be reflecting 
differences in insulin sensitivity between groups. Glycogen storage and release of glucose are 
major functions of the liver, and insulin also plays a main role in the regulation of these 
processes. Although we did not directly measure glycogen synthesis, the trend to higher hepatic 
glycogen content in AAV-Cpt1am injected animals compared to those injected with the 
control-vector may suggest increased glycogen synthesis capacity. This could be tentatively 
related to improved insulin sensitivity in AAV-Cpt1am injected animals. Defective hepatic 
glycogen synthesis would be expected to exacerbate postprandial hyperglycemia, and hence 
have clinical implications. In this regard, human studies have shown that poorly controlled 
insulin dependent diabetes mellitus subjects had impaired glycogen synthesis and augmented 
hepatic gluconeogenesis compared to control subjects (Hwang, et al. 1995). 
In addition to insulin, impairment in leptin sensitivity, both central and peripheral, may play a 
role in the metabolic disturbances associated to undernutrition during gestation (Palou, et al. 
2012; Palou, et al. 2010a). Here, even despite the absence of differences concerning body 
weight between the groups of animals, fasted CRG-C animals showed a trend toward higher 
leptin levels than controls, suggesting some impairment in leptin sensitivity. In accordance with 
this, CRG-C animals also displayed lower ObRb mRNA levels in liver compared to their 
controls. Notably, AAV-Cpt1am injection at an early age was able to revert, at least partially, 
the negative lasting effects of maternal calorie restriction on leptin sensitivity, as evidenced by 
circulating leptin levels and hepatic ObRb mRNA levels.  
Later undesirable effects associated to severe maternal undernutrition during gestation (both 
calorie restriction and protein restriction) have also been related to impaired renal function and 
hypertension (Almeida and Mandarim-de-Lacerda 2005; Vickers, et al. 2000). 
Hyperinsulinemia may contribute to this alteration but it seems to be particularly caused by 
alterations in the development of kidneys, leading to a decrease in the number of glomeruli 
(Almeida and Mandarim-de-Lacerda 2005). In accordance with this, we show here that 
moderate maternal calorie restriction during gestation also leads to increased blood pressure in 
adult animals. Interestingly this increase was not seen in AAV-Cpt1am injected CRG animals, 
which showed similar values to those of controls. 
The results obtained here regarding the effects of moderate maternal calorie restriction during 
gestation are generally in agreement with our previous studies using the same conditions 
(Palou, et al. 2012; Palou, et al. 2010a), as well as with results from other authors using a 
greater degree of maternal calorie restriction (30%) throughout gestation (Vickers, et al. 2000). 
However, unlike our previous studies, here we did not observe significant effects of this 
prenatal moderate restriction on later food intake (data not shown) as animals were able to 
maintain similar body weight to that of controls, at least during the period studied. Neither did 
we observe significant differences between control and CRG animals concerning fat 
accumulation. Nevertheless, CRG-C animals showed a significant increase in the size of 
adipocytes in rWAT. It is widely known that adipose tissue can respond rapidly and 
dynamically to alterations in nutrient supply through changes in the number and size of 
adipocytes, thereby fulfilling its major role in whole body energy homeostasis. It is recognized 
that adipocyte hypertrophy (an increase in adipocyte volume) prevails in obesity (Sun, et al. 
2011), and exposure to a HF diet for a few days has been shown to result in a significant 
increase in adipocyte size (Sun, et al. 2011). Adipocyte hypertrophy has been previously 
described in rWAT of adult CRG animals, while hyperplasia is characteristic of the 
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subcutaneous inguinal depot and associated to the lower sympathetic innervation occurring in 
these animals (Garcia, et al. 2011). Here, the increased size of adipocytes in CRG animals 
compared to controls may indicate that these animals have impaired capacity to burn excess 
energy under HF diet conditions. Interestingly, CRG-CPT animals showed a significant 
reduction in adipocyte size to levels similar, or even slightly lower, than controls.  
Energy expenditure and locomotive activity measures are also in favour of an imbalance of 
energy homeostasis toward lower energy expenditure in the offspring of calorie restricted dams 
during gestation. These animals revealed lower energy expenditure during the nocturnal period, 
which can be associated to a trend to lower locomotive activity. AAV-Cpt1am injection in 
CRG animals reverted the decreased locomotive activity, and this resulted in a partial recovery 
of energy expenditure levels.  
Therefore, increased FAO at early stages of life prevents or ameliorates increased propensity of 
animals to develop features of the metabolic syndrome associated to maternal undernutrition 
during gestation. However, increased FAO may be associated with enhanced reactive oxygen 
species (ROS) production and a consequent inflammatory state (Orellana-Gavaldà, et al. 2011). 
Thus, to rule out this possibility, inflammation markers were determined.  
TNFα is a cytokine involved in systemic inflammation and appears to participate in the 
induction and maintenance of the subacute inflammatory state associated with obesity. TNFα is 
overproduced in fatty liver and participates in the development of insulin resistance (Shoelson, 
et al. 2006). Here we show that CRG-C animals tended toward displaying higher plasma levels 
of TNFα than their respective controls. These relatively high levels of TNFα could be due to 
the greater hepatic TG content of these animals and could explain, in part, their insulin 
resistance. AAV-Cpt1am injection in CRG rats led to maintaining TNFα in adulthood at levels 
similar to their control group. Expression of Tnfa in liver was also decreased in AAV-Cpt1am 
injected animals in comparison to animals injected with the AAV-Gfp, the decrease being more 
marked in CRG animals. mRNA expression levels of tissue macrophage marker Cd68 (Tomita, 
et al. 1994) were also decreased in AAV-Cpt1am injected animals, both control and CRG 
animals. We did not observe changes in mRNA expression levels of the cytokines Il6 and Il1b 
in liver (data not shown), which have been described to be overproduced in fatty liver 
(Shoelson, et al. 2006). This could be due to the fact that here all groups of animals were under 
HF diet, which could be masking the potential effects of maternal undernutrition on the 
expression of these genes.  
In summary, AAV-Cpt1am mediated increased hepatic FAO at a juvenile age is able to revert 
or prevent some of the metabolic alterations associated to gestational maternal calorie 
restriction seen in adult animals when exposed to obesogenic conditions, including impaired 
insulin and leptin sensitivity, and increased systolic blood pressure. This treatment is also able 
to improve inflammatory markers and prevent the decreased energy expenditure characteristic 
of these animals. Therefore, enhancement of hepatic FAO at early ages could be considered as 
a strategy for reverting metabolic disturbances related to developmental malprogramming. 
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Abstract 
We aimed to assess the lasting effects of caloric restriction in lactating rats on body weight and 
insulin sensitivity of their offspring. Dams were fed with either ad libitum standard diet or a 
30% caloric restricted diet throughout lactation. After weaning, the offspring were fed with a 
normal-fat (NF) diet until the age of 15 weeks, and then with a NF or a high-fat (HF) diet until 
the age of 26 weeks. Blood parameters were measured during ad libitum feeding conditions 
and after 14-h fasting. Food preferences were also measured. In dams, milk leptin 
concentration and leptin mRNA and protein levels in mammary gland were also determined. 
Caloric restricted dams showed higher mRNA and protein levels of leptin in mammary gland 
than controls, without significant changes in milk leptin concentration. The offspring of caloric 
restricted dams (CRL) ate fewer calories and showed lower body weight gain and fat 
accumulation under the HF diet than their controls. CRL also maintained unchanged 
circulating leptin levels under HF diet, while levels increased in controls. In addition, male 
CRL were resistant to the increase of circulating triglycerides and of the HOMA-IR produced 
in male controls under HF diet feeding; CRL were also protected against the increased 
preference for fat-food occurring in females upon HF diet. These results suggest moderate 
caloric restriction during lactation protects from obesity development in offspring in adult life 
and from the related metabolic alterations, particularly dyslipidemia, insulin resistance and 
hyperleptinemia, associated with HF diet feeding. 
 
Keywords: caloric restriction, lactation, obesity, insulin resistance 
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Introduction 
Obesity is a key risk factor in the development of insulin resistance and cardiovascular disease. 
Both epidemiological and in vivo animal studies agree that the origins of obesity and its related 
metabolic alterations in adulthood lie not only in genetic heritability and environmental risk 
factors in adult life, but are also linked to perinatal factors (Taylor and Poston 2007). In this 
sense, several studies have shown that maternal food restriction during pregnancy may 
program the risks for adverse health outcomes in the adult offspring (Plagemann 2008; 
Rasmussen 1998; Wells 2007; Zambrano, et al. 2006; Zubieta and Lonnerdal 2006). This can 
be explained by the “thrifty phenotype” hypothesis, which postulates that poor fetal nutrition 
triggers adaptations that improve offspring survival or prepare the fetus to optimize survival in 
similar nutritional postnatal environments (Fowden, et al. 2005; Gluckman and Hanson 2004; 
Hales and Barker 2001); however, this may also program subjects to develop obesity and 
insulin resistance under obesogenic environments in adulthood (Gluckman and Hanson 2004; 
Wells 2007).  
The lasting effects of early postnatal nutrition, particularly during the lactation period have 
received less attention. In particular, undernutrition during lactation has been studied using 
several animal models, focusing on caloric and/or protein restriction in the dams (de Moura 
and Passos 2005; Levin 2006; Rasmussen 1998). In rats, malnutrition produced by protein 
restriction in the dams during lactation has been associated in the adult offspring with reduced 
body weight, despite no changes in food intake (de Moura, et al. 2007; de Souza Caldeira Filho 
and Moura 2000; Fagundes, et al. 2007). Other energy restriction models obtained by severe 
maternal food restriction during the suckling period (Boxwell, et al. 1995) or by increasing the 
litter size (Remmers, et al. 2008a; Remmers, et al. 2008b), were also associated with lower 
body weight and length and also with lower energy intake in adulthood. On the other hand, 
overnutrition during lactation, induced by reducing litter size, has been associated with higher 
body weight at weaning and in adulthood and with higher food intake in adulthood (Bassett 
and Craig 1988; Boullu-Ciocca, et al. 2005; Plagemann, et al. 1999a).  
However, most of the studies dealing with the effects of nutrition restriction during lactation 
have been performed with highly restrictive diets of the dams, such as protein free diets or 
severe restrictions of food intake (Boxwell, et al. 1995; de Moura, et al. 2007; de Souza 
Caldeira Filho and Moura 2000; Fagundes, et al. 2007; Moura, et al. 2002; Teixeira, et al. 
2002), or by increasing the litter size (Remmers, et al. 2008a; Remmers, et al. 2008b). We 
hypothesized that 30% caloric restriction during lactation could exert beneficial effects later in 
life concerning obesity prevention, particularly under obesogenic environments. Thus, here we 
aimed to assess the effects of moderate caloric restriction (30%) in lactating rats on later body 
weight, insulin sensitivity, and other energy homeostasis related parameters of their male and 
female offspring, when exposed to high fat (HF) diet feeding conditions in adulthood. In 
addition, considering the presence of leptin in maternal milk (Casabiell, et al. 1997; 
Houseknecht, et al. 1997), its absorption by the stomach of neonate rats (Oliver, et al. 2002; 
Sanchez, et al. 2005) and the reported protective effects of leptin supply during lactation 
against obesity and related metabolic alterations in later life (Pico, et al. 2007; Sánchez, et al. 
2008), we also aimed to investigate whether changes in the leptin content of milk could be 
related with the lasting effects of this maternal condition on their offspring.  
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Materials and Methods 
Experimental animals 
The study was performed in male and female rats from 12 different litters, following the 
protocol below. All rats were housed under controlled temperature (22 ºC) and a 12 h light–
dark cycle (light on from 0800 to 2000), and had unlimited access to tap water and standard 
chow diet (Panlab, Barcelona, Spain) unless mentioned otherwise. Briefly, twelve virgin 
female Wistar rats weighing between 200 g and 225 g were mated with male rats (Charles 
River Laboratories, Barcelona, Spain). After mating, each female was placed in an individual 
cage. At day 1 after delivery, excess pups in each litter were removed in order to keep 10 pups 
per dam (five males and five females, when possible) and dams were assigned to either control 
or caloric restricted group (n=6 in each group). From postnatal day 1 to postnatal day 21, dams 
were fed either with ad libitum standard normal-fat (NF) diet (3 kcal/g; Panlab, Barcelona, 
Spain) or a 30% caloric restricted diet. Caloric restriction was performed by offering to each 
dam a daily amount of food corresponding to 70% of the calories that should eat according to 
its body weight. This amount was calculated considering the calories daily consumed by their 
control animals under ad libitum feeding conditions. Body weight of dams was periodically 
recorded throughout lactation. Offspring were weaned to solid food at day 21. After weaning, 
36 animals from control dams (controls) (18 males and 18 females) and 36 from caloric 
restricted dams (CRL) (18 males and 18 females) were placed two per cage, paired with 
another animal of the same group, and fed with standard diet until the age of 15 weeks; then 
they were distributed into two groups; normal fat (NF) group – animals continued with 
standard diet (2.9% calories from fat) - and high-fat (HF) group – fed with a chow diet (4.7 
kcal/g) with 45% calories from fat (Research Diets, Inc., NJ, USA). HF diet contained 5.5% 
calories from soybean oil and 39.5% from lard.  
In offspring, blood samples were collected under ad libitum feeding conditions and after 14-h 
fasting at the age of 20 weeks (5 weeks after the exposure to half of the animals to HF diet) to 
analyze circulating parameters. A food preference test was also performed at the age of 12 and 
24 weeks to determine dietary preferences. Body weight and food intake was followed until the 
age of 26 weeks; in addition, body length (from the tip of the nose to the anus) and body fat 
content (by EchoMRI-700
TM
, Echo Medical Systems, LLC., TX, USA) were measured without 
anesthesia (11 weeks after the exposure to half of the animals to HF diet). 
The animal protocol followed in this study was reviewed and approved by the Bioethical 
Committee of our University, and guidelines for the use and care of laboratory animals of the 
University were followed. 
 
Measurements in dams 
Sampling 
At day 18 after delivery, blood samples (from the saphenous vein, without anesthesia) and milk 
samples (as previously described (Sanchez, et al. 2005)) were obtained, in both control and 
caloric restricted dams, under feeding conditions. Plasma was obtained by centrifugation of 
heparinized blood at 700 g for 10 min. Leptin in plasma and milk was determined using a 
mouse leptin ELISA kit (R&D Systems, Minneapolis, MN). Total protein levels in milk were 
measured by the method of Bradford (Bradford 1976). 
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At weaning, day 21 after delivery, dams were sacrificed by decapitation during the first 2 h 
after the beginning of the light cycle under feeding conditions. After killing the animals, the 
mammary gland and the retroperitoneal white adipose tissue (WAT) were rapidly removed, 
weighed, and frozen in liquid nitrogen and stored at –70 °C until RNA and/or protein analysis. 
Leptin mRNA expression in mammary gland and in WAT, and leptin protein concentration in 
mammary gland of control and caloric restricted dams were measured. 
 
RNA extraction 
Total RNA was extracted from mammary gland and WAT by Tripure Reagent (Roche 
Diagnostic Gmbh, Mannheim, Germany) according to the manufacturer's instructions. Isolated 
RNA was quantified using the NanoDrop ND-1000 spectrophotometer (NadroDrop 
Technologies Inc., Wilmington, Delaware, USA) and its integrity confirmed using agarose gel 
electrophoresis.  
 
Real-time quantitative PCR (RT-qPCR) analysis  
Real-time polymerase chain reaction (PCR) was used to measure mRNA expression levels of 
leptin in mammary gland and WAT of control and caloric restricted dams. 
0.25 µg of total RNA (in a final volume of 12.5µl) was denatured at 65 ºC for 10 min and then 
reverse transcribed to cDNA using MuLV reverse transcriptase (Applied Biosystem, Madrid, 
Spain) at 20 ºC for 15 min, 42 °C for 30 min, with a final step of 5 min at 95 °C a Applied 
Biosystems 2720 Thermal Cycler (Applied Biosystem, Madrid, Spain). Each PCR was 
performed from diluted (1/5) cDNA template, forward and reverse primers (1 M each), and 
Power SYBER Green PCR Master Mix (Applied Biosystems, CA, USA). The leptin primers 
were: forward 5’-TTCACACACGCAGTCGGTAT-3’ and reverse 5’-
AGGTCTCGCAGGTTCTCCAG-3’, with a final product of 186 pb. Real time PCR was 
performed using the Applied Biosystems StepOnePlusTM Real-Time PCR Systems (Applied 
Biosystems) with the following profile: 10 min at 95ºC, followed by a total of 40 two- 
temperature cycles (15 s at 95ºC and 1 min at 60ºC). In order to verify the purity of the 
products, a melting curve was produced after each run according to the manufacturer's 
instructions. The threshold cycle (Ct) was calculated by the instrument's software (StepOne 
Software v2.0). Relative gene expression numbers were calculated as a percentage of control 
rats, using the 2
-Ct
 method with the beta-actin as reference gene (Pfaffl 2001). The primers 
used for the beta-actin gene were: forward 5’-TACAGCTTCACCACCACAGC-3’ and reverse 
5’-TCTCCAGGGAGGAAGAGGAT-3’, with a final product of 164 pb. All primers were 
obtained from Sigma Genosys (Sigma Aldrich Química SA, Madrid, Spain). 
 
Western blot analysis  
The amount of leptin in mammary gland of control and caloric restricted dams was determined 
by Western blot. Tissue was homogenized at 4 ºC in 1:2 (w:v) of phosphate buffered saline 
(PBS) in a Teflon glass homogenizer. The homogenate was centrifuged at 500 g for 10 min at 
4 ºC and the supernatant was used for total protein and leptin analysis. Total protein content 
was measured by the method of Bradford (Bradford 1976). For leptin analysis, 350 g of total 
protein was solubilized and boiled for 3 min in Laemmli sample buffer containing 5% 2-
mercaptoethanol. Then, total protein was fractionated by SDS–polyacrylamide gel 
electrophoresis (SDS–PAGE; 15% polyacrylamide) and electrotransferred onto a 
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nitrocellulose membrane (Bio-Rad, Madrid, Spain). Black amide B10 staining provided visual 
evidence for correct loading and blotting of proteins. After blocking, the membrane was 
incubated with the primary rabbit polyclonal anti-leptin antibody (Santa Cruz Biotechnology, 
Inc., CA, USA), diluted 1:1000, and then with the secondary biotinylated anti-rabbit IgG 
antibody conjugated to a streptavidin-biotinylated horseradish peroxidase complex (Amersham 
Biosciences, Barcelona, Spain) diluted 1:5000. The immunocomplexes were revealed using an 
ECLplus (Amersham Biosciences, Barcelona, Spain). Membranes were exposed to Hyperfilm 
ECL (Amersham Biosciences, Barcelona, Spain). The films were scanned in a Chemigenius 
BioImaging System (Syngene, UK), and the bands were quantified using the GeneTools 
Software (Syngene, UK). 
 
Measurements in offspring 
Measurement of circulating parameters under fed/fasting conditions, and calculation of the 
homeostatic model assessment for insulin resistance 
At the age of 20 weeks (5 weeks after submitting half of the animals to HF diet), blood samples 
(n = 6-8 animals/group) were collected (in heparinized containers) from the saphenous vein of 
control and CRL animals, under different feeding conditions: ad libitum – animals provided 
with free access to chow diet – and fasting – animals deprived of food for 14 h. In both 
conditions, samples were obtained without anesthesia and during the first 2 h of the beginning 
of the light cycle. Plasma was obtained by centrifugation of heparinized blood at 700 g for 10 
min. 
Blood glucose concentration was measured by Accu-Chek Glucometer (Roche Diagnostics, 
Barcelona, Spain). Plasma insulin concentration was determined using a rat insulin
 
enzyme-
linked immunosorbent assay (ELISA) kit (DRG Instruments
 
GmbH, Marburg, Germany) 
following standard procedures. Plasma leptin concentration was measured using a mouse leptin 
ELISA kit (R&D Systems, Minneapolis, MN). Commercial enzymatic colorimetric kits were 
used for the determination of plasma non-esterified fatty acid (NEFA) (Wako Chemicals 
GmbH, Neuss, Germany) and triglyceride (TG) levels (Triglyceride (INT) 20, Sigma 
Diagnostics, St Louis, MO, USA). 
The homeostatic model assessment for insulin resistance (HOMA-IR) was used to assess 
insulin resistance. It was calculated from fasting insulin and glucose concentration using the 
formula of Matthews et al. (Matthews, et al. 1985): HOMA-IR = fasting glucose (mmol/liter) x 
fasting insulin (mU/liter)/22.5. 
 
Two-bottle preference test 
Food preferences were assessed by a two-bottle preference test as previously described 
(Sánchez, et al. 2008). Briefly, the rats had to choose between two bottles containing either a 
carbohydrate (CHO)-rich liquid diet or a fat-rich liquid diet. The two diets had identical caloric 
density (2.31 kcal/g) and the following ingredients: for the CHO-rich diet, 10 g/100 ml 
skimmed milk, 40 g/100 ml sucrose, 4 g/100 ml olive oil, and 0.35 g/100 ml xanthan gum 
(Sigma, Madrid, Spain); and for the fat-rich diet, 10 g/100 ml skimmed milk, 10 g/100 ml 
sucrose, 17.3 g/100 ml olive oil, and 0.35 g/100 ml xanthan gum. Before the test started, and 
during a period of 8 d, the rats were habituated to each bottle given individually on alternate 
days for 1 h, without withdrawing the standard chow diet. The test was started 2 d after the 
adaptation period. Solid food was withdrawn at the beginning of the light phase. Two bottles 
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containing pre-weighed quantities of either the CHO- or fat-rich diet were placed side-by-side 
4 h after the beginning of the light cycle for 1 h. The bottles were then reweighed, and the 
intake of each diet was determined and corrected for spillage. Spillage was estimated by 
weighing small collection plates placed underneath the spout of the bottles. The test was 
performed at two stages of life, when rats were 12 weeks old (all of them under NF diet) and 
24 weeks old (10 weeks after HF diet exposure to half of the animals). 
 
Statistical analysis 
Given that the animals studied were from six different litters in each treatment group, the effect 
of litter was simultaneously factored with all data by repeated measures ANOVA. No 
interactions between the litter and treatment were found across all the data, thus, data were 
expressed as mean  sem of animals from the six different litters (n = 6-8 animals per group). 
Multiple comparisons were assessed by repeated measures ANOVA and two-way ANOVA to 
determine the effects of different factors (age, caloric restriction during lactation, type of diet 
and feeding conditions). One-way ANOVA followed by Tukey HSD test was used for 
individual differences between groups to study body weight changes over time. Single 
comparisons between groups were assessed by Student’s t test or Paired t test. P < 0.05 was the 
threshold of significance. 
 
Results 
Results in dams 
Body weights of control and caloric restricted dams after delivery and at weaning are shown in 
Table 1. As expected, caloric restricted dams had at the end of the suckling period lower body 
weight than their controls. These animals also showed a significant reduction in the weight of 
mammary gland compared with their controls. No statistical differences were found in leptin 
concentration in plasma and milk and in total protein concentration in milk at day 18 after 
delivery between both groups of dams (Table 1).  
Interestingly, at day 21 after delivery, caloric restricted dams showed significantly higher leptin 
mRNA expression levels in mammary gland with respect to their controls (Fig. 1), while no 
statistical differences were found in the mRNA expression of leptin in WAT. Higher leptin 
mRNA levels in mammary gland of caloric restricted dams were accompanied by higher leptin 
abundance, both considering specific levels of leptin (the relative abundance of this protein in 
the mixture) and total leptin levels (referred to the whole mammary gland). These results 
concerning to the mammary gland correspond to the whole homogenate tissue, hence, the 
relative contribution of epithelial and adipose cells to leptin production cannot be specified. 
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Figure 1. Leptin mRNA expression levels in retroperitoneal WAT (A) and in mammary gland (m.gland) (B), and 
leptin abundance in mammary gland expressed per mg protein (C) or referred to the whole mammary gland (D) of 
controls (C-dams) and caloric restricted dams (CRL-dams), under feeding conditions, at day 21 after delivery. A 
representative western blot of leptin in mammary gland from 2 different dams of each group is also included. Data 
are expressed as a percentage of the mean value of control dams. Data are mean  SEM of 5-6 dams per group. 
STATISTICS: #, effect of caloric restriction during lactation (Student’s t test).  
Table 1. Parameters in control and caloric restricted dams. 
 Control-dams CRL-dams 
Body weight after delivery (g) 270 ± 10 260 ± 12 
Body weight at weaning (g) 298 ± 7 ( 10%) 244 ± 11 ( 6%) # 
Weight of mammary gland (g) 17.1 ± 0.8 10.9 ± 0.7 
#
 
Plasma leptin concentration (pg/ml) 683 ± 96 457 ± 115 
Milk leptin concentration (pg/ml) 169 ± 22 173 ± 39 
Milk protein concentration (mg/ml) 118 ± 12 93 ± 4 
Milk leptin/total protein ratio 1.49 ± 0.24 1.92 ± 0.42 
Body weight after delivery (at day 1 of lactation) and at weaning (at day 21 of lactation), weight of the mammary gland 
at weaning, leptin concentration in plasma and milk, total protein concentration in milk and the milk leptin/total protein 
ratio (multiplied by 10
9
) at day 18 of lactation, in control (C-dams) and caloric restricted dams (CRL-dams) during 
lactation under feeding conditions. Data are means  SEM (n = 6). STATISTICS: # C-dams vs CRL-dams (Student’s t 
test). The percentages in brackets represent the increase or decrease of body weight between day 1 and day 21 of 
lactation. 
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Results in the offspring 
Body weight and food intake 
Moderate caloric restriction in dams during lactation resulted in lower body weight of their 
offspring, both males and females. This lower body weight was already significant at the age of 
6 days and was persistent when animals were growing, with significant differences among the 
four groups of animals since week 7 of age (one-way ANOVA followed by Tukey HSD test) 
(Fig. 2). However, differences practically disappeared (no differences by Student’s t test) at the 
age of 26 weeks in those animals maintained under NF diet (Fig. 3A). Nevertheless, CRL 
animals were more protected against body weight gain when exposed to the HF diet in 
adulthood (Fig.3A). In fact, after an 11-week period of HF diet feeding, both CRL male and 
females rats displayed lower body weight than their controls under HF diet (Student’s t test).  
To ascertain whether lower body weight in CRL animals could be due to lower body length, 
body length was measured at the end of the follow up, when animals were 26 weeks old. No 
significant differences were found between body length in CRL animals compared with their 
controls, either in male or female animals, or under NF or HF diet conditions (data not shown). 
Differences in body weight between control and CRL animals can be mainly explained by 
differences in body fat content (Fig 3B). Body fat content of both control and CRL male 
animals was higher under HF diet than under NF diet (two-way ANOVA), although the 
increase by HF diet in CRL rats was not as great as in controls (25% vs 36% respectively). In 
addition, body fat content was also significantly lower in CRL animals compared with control 
animals (two-way ANOVA), although differences were only significant under HF-diet 
(Student’s t test). Concerning females, control and CRL rats showed a different response to HF 
diet feeding (interaction between caloric restriction and diet, two-way ANOVA), since CRL 
animals were protected against the increase in body fat under HF diet feeding (9% increase in 
CRL animals versus 31% increase in controls). Notably, CRL female rats had a lower 
percentage of body fat than their HF diet fed controls, while differences between controls and 
CRL animals were not observed under NF diet. 
 
Figure 2. Body weight over time of male and female offspring of control and caloric restricted dams during 
lactation (CRL) from day 6 until day 105 of age. The inset details body weight during the lactation period and 
throughout the experiment. Data are expressed as the mean  SEM of 18 animals per group. STATISTICS: arrows 
indicate the age since significant differences were found: #, differences between control and CRL, both in male 
and female rats; , differences among the four groups of animals (one-way ANOVA followed by Tukey HSD test)   
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Cumulative food intake from week 15 to week 26 of age (corresponding to the HF diet feeding 
period) was also measured to determine whether differences in body weight gain under HF diet 
between control and CRL animals could be explained by differences in food intake (Fig 3C). 
As expected, male and female animals exposed to the HF diet ate more calories than when 
exposed to the NF diet; in males, the increase in total calories was lower in CRL animals than 
in controls (21% vs 15% respectively), while in females the increase was similar in both groups 
of animals. Both male and female CRL animals ate fewer calories than their controls, both 
under NF and HF diet (two-way ANOVA).  
 
Figure 3. Body weight (A), body fat content (B) and cumulative food intake from day 105 until day 182 (C) of 
male and female offspring of controls and caloric restricted dams during lactation (CRL) that were fed after day 
105 with a NF or a HF diet until the age of 6 months. Results are expressed as the mean  SEM of 6 to 12 animals 
per group. STATISTICS: D, effect of the type of diet; R, effect of caloric restriction during lactation; and RxD, 
interaction between caloric restriction and diet (two-way ANOVA). *, effect of HF diet (Student’s t test). #, effect 
of caloric restriction (Student’s t test). The percentages in brackets represent the increase as a consequence of the 
HF diet. 
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Circulating parameters under fed and fasting conditions 
Table 2 shows circulating levels of glucose, insulin, leptin, NEFA and TG of male and female 
control and CRL animals, under feeding and 14-h fasting conditions at the age of 20 weeks (5 
weeks after the exposure of half of the animals to a HF diet).  
No significant differences were found in glucose levels as an effect of maternal caloric 
restriction during lactation. Glucose levels did not significantly decrease in male animals under 
fasting conditions, with the exception of controls under NF diet (Paired t test). Unlike males, 
glucose levels in females were significantly lower under fasting conditions compared with fed 
conditions (ANOVA repeated measures), but the decrease was not significant in controls under 
NF diet (Paired t test). Insulin levels decreased under fasting conditions in both male and 
female animals (ANOVA repeated measures). In addition, in male rats, insulin levels were 
significantly lower in CRL animals than in their respective controls (ANOVA repeated 
measures), without significant changes in females. No significant differences were found in 
glucose and insulin levels as an effect of HF diet feeding, either in control or in CRL animals, 
except control fasted males that showed higher glucose and insulin levels under HF-diet 
feeding conditions (Student’s t test). The HOMA-IR index was calculated to estimate insulin 
sensitivity (Table 2). This value increased in control male animals under HF diet conditions, 
while this increase was not found in CRL animals (interaction between caloric restriction and 
diet, two-way ANOVA). In females, no significant differences were found in the HOMA-IR 
value as an effect of either HF diet feeding or maternal caloric restriction during lactation.  
HF diet feeding resulted in higher circulating leptin levels in both male and female control rats 
(Student’s t test). This increase was also found in CRL male animals under ad libitum feeding 
conditions but not when they were under fasting conditions (Student’s t test). However, female 
CRL animals did not exhibit higher leptin levels when exposed to HF diet, either under feeding 
or fasting conditions.   
Concerning the lipid profile, NEFA levels increased in NF fed control male animals under 
fasting conditions; however this increase was not found when they were exposed to HF diet. 
This impairment in the response to fasting conditions was not found in CRL animals exposed 
to HF diet feeding (Paired t test). Unlike males, both control and CRL female rats increased 
their NEFA levels under fasting conditions (ANOVA repeated measures), although the highest 
response (and significant by Student’s t test) was found in control animals under NF diet. 
Regarding TG, CRL male rats displayed lower plasma TG concentration than their controls 
(ANOVA repeated measures), and, moreover, they were prevented from the HF-induced 
increase of TG levels shown in control male animals (Student’s t test). Unlike males, no 
significant differences were found in TG levels among the different female groups (ANOVA 
repeated measures). 
 
Food preferences 
Food preferences were measured at the ages of 12 and 24 weeks with the two-bottle preference 
test (Fig. 4). When rats were 12 weeks old (Fig. 4A), both control and CRL rats showed a 
significant preference for CHO-rich food versus fat-rich food (ANOVA repeated measures), 
which was more evident in males than in females.  Moreover, analyzing preferences separately 
in control and CRL female rats, control rats ate 19% more CHO-rich food than fat-rich (Paired 
t test) while CRL females only ate 8% more CHO-rich than fat-rich food. When animals were 
24 weeks old (Fig. 4B), food preferences were not significantly altered in males under HF-diet 
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feeding, since both control and CRL animals continued preferring CHO-rich food versus fat-
rich food (ANOVA repeated measures). However, female rats under HF diet increased their 
preference for fat-rich food compared with CHO-rich food (diet interaction with dietary 
preference, ANOVA repeated measures), but when analyzing control and CRL animals 
separately, this effect was only significant in control animals (Student’s t test). Therefore, 
significant differences were found between food preferences of control and CRL female rats 
when were under HF diet feeding (Student’s t test). 
 
 
 
Figure 4.  Dietary preferences measured by the two-bottle preference test of the offspring male and female 
offspring of controls and caloric restricted dams during lactation (CRL) at the age of 12- (A) and 24- (B) week-
old. Bars represent the percentage of the amount of carbohydrate (CHO) rich food and fat rich food with respect to 
the total food ingested in the choice test. STATISTICS: FP, effect of food preference (two way ANOVA); DxFP, 
interaction between the type of diet and the food preference (ANOVA repeated measures); +, CHO vs Fat diet 
(Paired t test); *, effect of HF (Student’s t test); #, effect of caloric restriction (Student’s t test). 
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Table 2. Circulating parameters of offspring of controls and caloric restricted dams during lactation 
 
 
Blood glucose and plasma insulin, leptin, non-esterified fatty acid (NEFA) and triglycerides concentration under ad libitum feeding or 14 h fasting conditions, and HOMA-IR 
index at the age of 20 weeks of male and female offspring of controls and caloric restricted dams during lactation (CR), that where fed with a NF or a HF diet. Results are 
expressed as the mean   SEM of 6 to 8 animals per group. STATISTICS: R, effect of caloric restriction during lactation; F, effect of feeding conditions; D, effect of the type 
of diet; and RxD,  interaction between caloric restriction and diet; FxR, interaction between feeding conditions and caloric restriction; and RxD, interaction between caloric 
restriction and diet (ANOVA repeated measures). 
+
, ad libitum vs. Fasting (Paired t test). *, NF vs. HF diet; 
#
, Control vs. CR (Student’s t test). 
 
 
 
  MALES FEMALES 
  NF Control HF Control NF CRL HF CRL ANOVA NF Control HF Control NF CRL HF CRL ANOVA 
Glucose  Ad libitum 71.3  1.7 66.6  4.6  73.0  2.0 73.6  5.0 
 
66.0  5.2 75.1  2.4 72.4  5.8 76.4  1.8 
F 
(mg/dl) 14-h fasting 60.3  3.5 + 72.0  2 .1 * 66.8  4.3 68.0  3.0 65.5  4.1  61.8  2.7 + 62.0  3.6 + 59.3  3.8 + 
Insulin  Ad libitum 4.26  1.52 5.35  0.94 2.78  0.63 2.47  0.43 # F 
R 
1.82  0.36 2.01  0.14 1.39  0.48 1.77  0.38 
F 
(g/l) 14-h fasting 0.81  0.32 + 1.88  0.30 + * 0.93  0.25 0.96  0.16 + # 0.37  0.09 + 0.32  0.04 + 0.20  0.01 0.48  0.16 + 
HOMA-IR 14-h fasting 3.09  1.44 7.89  1.17 * 3.91  1.22 3.83  0.62 # RxD 1.54  0.49 1.22  0.21 0.73  0.05 1.72  0.53  
Leptin  Ad libitum 5.92  1.38 11.2  1.0 * 3.77  0.68 6.22  0.59 * # FxR  
FxD     
2.40  0.32 6.53  1.08 * 2.63  0.62 3.64  0.58 # RxD 
FxD (g/l) 14-h fasting 2.03  0.59 + 4.98  0.37 + * 1.59  0.22 + 2.23  0.24 + # 0.63  0.07 + 1.60  0.19 + * 0.63  0.11 + 0.72  0.09 + # 
NEFAs Ad libitum 1.14  0.15 1.44  0.11 1.26  0.19 1.46  0.13 
FxD 
0.79  0.18 0.87  0.13 1.34  0.29 1.06  0.19 
F 
(g/l) 14-h fasting 1.89  0.16 + 1.58  0.19 2.85  0.60 + 2.16  0.28 + 1.34  0.12 + 1.16  0.13 1.45  0.23 1.16  0.15 
Triglycerides Ad libitum 1.24  0.11 2.19  0.27 * 1.17  0.27 1.05  0.12 # F 
R 
0.53  0.10 0.56  0.08 0.56  0.09 0.53  0.04 
 
(mg/ml) 14-h fasting 1.53  0.43 1.10  0.27 + 0.49  0.14 + 0.62  0.13 + 0.50  0.04 0.41  0.04 0.54  0.08 0.45  0.04 
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Discussion 
Epidemiological and animal model studies have shown a link between the perinatal nutritional 
environment and the susceptibility to suffer obesity and metabolic alterations in adult life 
(Cripps, et al. 2005; Gluckman and Hanson 2004; Plagemann 2008). In particular, conditions 
such as undernourishment during gestation and overfeeding during early postnatal life have 
been described to have a strong negative impact in adulthood (Martorell, et al. 2001). The 
present study was conducted to determine the effects of moderate maternal caloric restriction 
(30%) during lactation on offspring body weight, insulin sensitivity, and other physiological 
parameters related with energy homeostasis, including energy intake and food preferences, 
after HF-diet feeding in adulthood and to find out whether there is a sex-associated response.  
Our results show that moderate caloric restriction (30%) during lactation resulted in lower 
body weight of male and female offspring which was already manifest as of the first days of 
life; this could be attributed to lower maternal milk supply as previously described in other 
models of food restriction during lactation (Bautista, et al. 2008; Grigor, et al. 1987). This 
lower body weight was maintained while the animals were growing, but was gradually 
attenuated with aging. The effect of maternal caloric restriction was more evident when rats 
were exposed to the HF diet, although in a sex-dependent manner. CRL male and female 
animals under HF diet gained less body weight and accumulated lower body fat than their 
controls, but interestingly, CRL females were almost resistant to body weight and body fat 
accumulation under HF diet. The effect in male animals can be explained, at least in part, by 
lower food intake. In fact, the increased intake of calories under HF diet was lower in CRL 
animals versus their controls. However, in CRL female rats under HF diet exposure, the 
difference cannot be explained by lower induction of food intake. In fact, energy intake in CRL 
female animals was lower than that of control animals, but the increase under HF diet was not 
different to that of control animals under this diet.  
Despite changes in body weight, maternal caloric restriction did not affect body length of the 
animals. Thus, the results of this study suggest that moderate maternal caloric restriction during 
lactation protects against diet-induced obesity in rats but does not impede catching up the 
normal body length and weight under standard, NF diet conditions. These results contrast with 
those obtained by increasing the litter size (Remmers, et al. 2008a; Remmers, et al. 2008b), 
since these animals maintained lower body weight and length than their controls. Other models 
of nutrient restriction during lactation obtained by a 50% or a 65% maternal protein restriction 
(Fagundes, et al. 2007; Zambrano, et al. 2006) also showed more severe results with also lower 
body weight and fat content of restricted offspring. This finding underscores the importance of 
the type and degree of restriction on the resulting effects.  
Leptin, a hormone primarily produced by the adipose tissue, and the pancreatic hormone 
insulin have elicited great attention as important modulators of feeding patterns and energy 
expenditure at the hypothalamic level (Schwartz, et al. 2000). Both proteins are closely related 
with the regulation of energy balance at different levels (Cripps, et al. 2005; Moura, et al. 
2002), and their circulating levels, together with their adaptations under fed/fasting conditions, 
may be considered as markers of metabolic health and of appropriate body weight and food 
intake control. Programming of the leptin and insulin systems by early life nutrition may 
contribute to the long-term maintenance of energy homeostasis. Sex-dependent differences 
have been described concerning the response of these systems to dietary stressors (Priego, et al. 
2009b; Priego, et al. 2008; Woods, et al. 2003). Regarding insulin, diet-induced obesity has 
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been associated with an impairment of insulin sensitivity and the development of Type II 
diabetes (Woods, et al. 2004). Interestingly, male rats have been found to exhibit a higher 
tendency for hyperinsulinemia induced by hyperlipidic diets than females (Priego, et al. 2008). 
In this sense, we also found an increase in the HOMA-IR value occurring in male control rats 
under HF diet but not in female rats. Nevertheless, the male offspring of caloric restricted dams 
during lactation appeared to be protected against HF diet-induced insulin resistance. No 
differences were found in the HOMA-IR value between control and CRL female animals, 
although females did not show increased HOMA-IR index under HF diet but maintained 
similar values to those of NF diet fed animals. Thus, these results concerning HOMA-IR 
suggest that moderate maternal energy restriction throughout lactation may confer protection 
against diet-induced insulin resistance in male offspring in later life, which are more prone to 
suffer this metabolic alteration under HF diet conditions, as previously described (Priego, et al. 
2008). Maternal isocaloric protein restriction during lactation has also been shown to result in 
higher insulin sensitivity in their offspring: in concrete, 21-day-old pups from 60% protein 
restricted dams during lactation displayed lower fasted insulin levels and an up-regulation of 
the insulin receptor beta (Martin-Gronert, et al. 2008); moreover, offspring from 50% protein 
restricted dams showed lower area under the curve for glucose and insulin in a glucose tolerant 
test in adulthood (Zambrano, et al. 2006). 
Concerning the leptin system, moderate maternal caloric restriction during lactation did not 
seem to have lasting effects on circulating leptin levels in the offspring; when animals were 
under NF diet, a tendency to lower levels was only found in male animals. The effect of caloric 
restriction was more evident under dietary stressors, such as HF diet exposure, particularly in 
female rats. These animals maintained the leptin levels of NF fed animals when exposed to HF 
diet, in accordance with the maintenance of the amount of fat. This is of interest because the 
presence of low leptin levels has been associated with an improvement of leptin sensitivity 
(Sánchez, et al. 2008), whereas an increase of circulating leptin levels may contribute to the 
dysregulation of energy balance that occurs associated to HF diet feeding and with age and 
involves impairment of the fasting-induced suppression of leptin production (Iossa, et al. 1999; 
Pico, et al. 2007; Sánchez, et al. 2008). Thus, moderate caloric restriction to lactating dams 
may help maintain lower leptin levels in the offspring on later life under HF diet feeding 
conditions, and could help these animals be more responsive to adaptive changes in leptin 
levels. Nevertheless, plasma leptin concentration decreased in both control and CRL animals 
under fasting conditions, although, under these conditions, CRL animals also maintained lower 
plasma leptin levels than their controls. More restrictive maternal caloric restriction during 
lactation (67%) also resulted in lower circulating leptin levels in offspring at the age of 21 days 
(Boxwell, et al. 1995); in addition, another energy restriction model during lactation obtained 
by increasing litter size also resulted in lower circulating leptin levels in their offspring, already 
since the age of 10 days (Remmers, et al. 2008a). On the other hand, a 65% maternal isocaloric 
protein restriction during lactation resulted in lower leptin levels of their offspring at the age of 
12 days compared with controls, but levels became higher at the age of 21 days (Teixeira, et al. 
2002).   
Together with circulating insulin and leptin levels, blood lipid profile can be considered as 
indicators of metabolic health. Male rats have been described to be more prone to suffer a 
higher increase in circulating lipids under HF diet, and this has been linked to the detrimental 
effects of the overweight in this gender in comparison with females (Priego, et al. 2008; 
Regitz-Zagrosek, et al. 2006). Our results also showed an impairment of the NEFA response to 
fasting and also higher TG levels under feeding conditions in control male rats under HF diet 
feeding, while these effects were not found in CRL male rats under HF diet. Thus, plasma lipid 
profile of CRL male rats, with higher NEFA response to fasting under HF diet and with lower 
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circulating TG levels, may contribute to explain their increased insulin sensitivity. 
Programming food preferences, as a part of the feeding behavior, may contribute to body 
weight control and to the development of obesity. This is particularly relevant in humans where 
obesity development is generally associated with increased appetite and preference for highly 
caloric food, together with a sedentary life, among other factors (Rissanen, et al. 2002). Here, 
we show that caloric restriction to lactating dams affected food preferences of adult female 
offspring when exposed to a HF diet. Female animals, compared with males had higher 
preference for fat-rich food, as previously described (Bellinger, et al. 2004; Eckel and Moore 
2004; Roca, et al. 1999). Moreover, these animals, when exposed to HF diet, increased their 
preference for fat-rich food compared with CHO-rich food. However, this preference for fat-
rich food was not observed in CRL female animals; these animals even had a slightly lower 
preference for fat-rich food than for CHO-rich food. Less preference for fat-rich food could 
entail better feeding behavior, considering that these animals are exposed to a HF diet. Even 
though CRL female animals showed a lower preference for fat-rich food when were able to 
chose between CHO and fat food, this did not prevent that these animals experienced a similar 
increase in the intake of calories to that of control animals when exposed to HF diet. Other 
studies related with modifications of perinatal nutrition have described changes in food 
preferences in later life. For example, oral supplementation with leptin during lactation protects 
animals against diet induced obesity and enhances preferences for CHO-rich foods than for fat-
rich foods (Sánchez, et al. 2008). On the other hand, maternal protein restriction during fetal 
stage is associated with an obesogenic phenotype in adulthood and causes an increase of fat 
food preferences (Bellinger, et al. 2004). Thus, nutritional changes during critical stages of 
development, such as fetal life or lactation, may program the control mechanisms of appetite 
and food preferences, which are important in the susceptibility to suffering obesity later on; 
therefore, the study of this perinatal programming may provide effective tools to curb obesity 
and related metabolic diseases.  
Mechanisms involved in the developmental programming by maternal caloric restriction during 
lactation, as well as specific changes occurring in milk composition under these conditions are 
currently unknown. Leptin is a hormone naturally present in breast milk (Casabiell, et al. 1997; 
Houseknecht, et al. 1997) and previous studies have shown that supplementation of neonate 
rats with physiological doses of leptin during lactation protects against the development of 
overweight in adulthood (Pico, et al. 2007) and improves insulin and leptin sensitivity 
(Sánchez, et al. 2008); in addition, a negative correlation has been found in humans between 
maternal milk leptin levels and body weight gain of infants (Miralles, et al. 2006). Thus, 
considering the importance of leptin supply during lactation, we postulated that changes in 
leptin concentration in milk as an effect of caloric restriction could account, at least in part, for 
these metabolic programming effects. Leptin levels in maternal milk have been shown to be 
positively correlated with maternal adiposity and body mass index (Miralles, et al. 2006), 
however, little is known about the regulation of milk leptin concentration by maternal 
nutritional factors. Of interest, some authors have described an increase in leptin content in 
milk as a consequence of maternal protein restriction in lactating dams (Bautista, et al. 2008). It 
must be pointed out that leptin in milk comes from both the maternal blood source and its 
production in the mammary gland (Casabiell, et al. 1997). Blood leptin seems to be 
differentially regulated during lactation. Ferreira et al. (Ferreira, et al. 2007) have shown that 
isocaloric protein restricted dams during the first 14 days of lactation display higher serum 
leptin levels than their controls, despite having lower body weight. Our results, showed no 
statistical differences in plasma leptin levels between control and caloric restricted dams, 
suggesting maintenance of the adequate circulating leptin levels in these rats. On the other 
hand, concerning leptin production by the mammary gland, we found that caloric restricted 
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dams had, at weaning, higher mRNA and protein levels of leptin in mammary gland compared 
with their controls. Moreover, although caloric restricted dams exhibited a reduction in the 
weight of mammary gland compared with controls, total leptin abundance estimated in the 
whole mammary gland was still higher than in their controls. The increased expression of 
leptin was tissue-specific, since no changes were observed in the retroperitoneal WAT of these 
dams. However, milk leptin concentration in caloric restricted dams measured before weaning 
(at day 18 after delivery) was similar to that of control animals. At present, the postulated 
contribution of milk leptin to the lasting effects of moderate caloric restriction during lactation 
in the offspring must be considered as speculative, but this is an interesting subject to be 
considered for future investigations. 
All in all, these results showing the potential benefits of moderate maternal caloric restriction 
during lactation fit with the relatively recent idea that promoting catch-up growth in low birth 
weight infants may not be beneficial for their long-term outcome (Fagerberg, et al. 2004). 
However, it must be stressed that we should be cautious in extrapolating these results to 
humans due to differences between species, particularly in the different timing of birth relative 
to development. 
In conclusion, here we show that moderate maternal caloric restriction during the lactation 
period has lasting gender-specific effects in the offspring in adult life. Regardless of these 
gender-specific particularities, the offspring from caloric restricted dams become less prone to 
diet-induced obesity and related metabolic alterations in adult life, particularly dyslipidemia, 
insulin resistance and hyperleptinemia.  
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Abstract 
We aimed to assess the lasting effects of moderate caloric restriction in lactating rats on the 
expression of key genes involved in energy balance of their adult offspring, and their 
adaptations under high-fat (HF) diet. Dams were fed with either ad libitum standard diet or a 
30% caloric restricted diet throughout lactation. After weaning, the offspring were fed with a 
normal-fat (NF) diet until the age of 15 weeks, and then with a NF- or a HF-diet until the age 
of 28 weeks, when they were sacrificed. Body weight and food intake were followed. Blood 
parameters and the expression of selected genes involved in food intake and fat accumulation 
in hypothalamus and white adipose tissue (WAT), respectively, were analysed. The offspring 
of caloric restricted dams (CRL) ate fewer calories and showed lower body weight gain under 
HF-diet than their controls. CRL males were also resistant to the increase of insulin and leptin 
occurring in their controls under HF-diet conditions, and HF-diet exposed CRL females 
showed lower circulating fasting TG levels than their controls. In the hypothalamus, CRL 
males had higher Obrb mRNA levels than controls, and CRL females displayed greater Insr 
mRNA levels than controls and decreased Npy mRNA levels when exposed to HF diet 
(contrary to controls). CRL males maintained WAT capacity of fat uptake and storage and of 
fatty acid oxidation under HF-diet, whereas these capacities were impaired in controls; female 
CRL showed higher WAT Obrb mRNA levels than controls. These results suggest that 30% 
caloric restriction in lactating dams ameliorates diet-induced obesity in their offspring by 
enhancing their sensitivity to insulin and leptin signaling, but in a gender-dependent manner. 
 
Key words: caloric restriction, lactation, obesity, insulin and leptin sensitivity, hypothalamus, 
adipose tissue 
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Introduction 
Epidemiological and experimental studies have described that the programming of energy 
balance already begins in very early development. Indeed, particular conditions in the 
nutritional environment during the perinatal period may lead to adjustments in the physiology 
of humans and animals, with lasting effects in adulthood (Bertram and Hanson 2001; Cripps, et 
al. 2005; Gluckman and Hanson 2004; McMillen, et al. 2005).  
The hypothalamus plays a major role in the regulation of energy balance, producing many 
orexigenic and anorexigenic peptides that stimulate or inhibit food intake in response to 
different factors, such as circulating hormones like leptin and insulin (Wilding 2002). The 
brain is particularly sensitive to external factors during the early period of life (McMillen, et al. 
2005); in this sense, many studies have shown the importance of nutricional factors during this 
period in the programming of appetite behavior in the adult life (García, et al. 2010; Pico, et al. 
2007; Sánchez, et al. 2008). Perinatal nutrition leading to changes in the control of body weight 
and food intake has been associated with developmental programming of structural and 
functional changes in hypothalamus affecting the expression of key genes involved in food 
intake and energy balance (García, et al. 2010; Pico, et al. 2007) 
On the other hand, the adipose tissue is recognized to have different functions that are 
important in the regulation of energy balance and substrate metabolism (Palou, et al. 2008). 
Both fat storage and fat mobilization processes normally occur in the white adipose tissue 
(WAT) under the habitual food intake/fasting patterns of feeding, and allow the maintenance of 
energy homeostasis (Goodman, et al. 1980; Palou, et al. 1981; Palou, et al. 2009). Alterations 
of these processes by different stressor factors such as high fat (HF) diet feeding or food 
deprivation promote dysregulation in the overall control of fat deposition affecting energy 
balance (Palou, et al. 2008; Priego, et al. 2008). It is clear that the maintenance of nutrient 
homeostasis under different feeding conditions and the metabolic response to these situations 
involve hormonal and metabolic adaptations which are accompanied by changes in gene 
expression (Palou, et al. 2009; Palou, et al. 2009c; Priego, et al. 2008).  
In mammals, maternal nourishment establishes the first nutritional environment of their 
offspring; thus, changes in maternal nutrition may program alterations in the metabolism of 
offspring later on in life (Armitage, et al. 2005; Dewey 1998a; Levin 2006). In this sense, 
strong evidence has linked low birth weight with the susceptibility to suffer obesity in adult 
life. This has allowed to establish the thrifty phenotype hypothesis (Cripps, et al. 2005; 
Gluckman and Hanson 2004; Wells 2007), which relates malnutrition during the fetal stage and 
the adaptations for survival experienced by the offspring. On the other hand, early postnatal 
nutrition may also cause differential programming of energy homeostasis. In particular, 
malnutrition produced by protein restriction in lactating dams has been associated with reduced 
body weight in the adult offspring, despite no changes in food intake (de Moura, et al. 2007; de 
Souza Caldeira Filho and Moura 2000; Fagundes, et al. 2007). Other models of energy 
restriction obtained by severe food restriction in lactating dams (Boxwell, et al. 1995)or by 
increasing the litter size (Remmers, et al. 2008a; Remmers, et al. 2008b) have also been 
associated with lower body weight and lower food intake in their adult offspring. In this sense, 
we have also recently described in rats that moderate caloric restriction (30%) in lactating dams 
protects their offspring against obesity as well as against insulin resistance in adulthood (Palou, 
et al. 2010b). Most of these studies analyzing the lasting effects of maternal caloric restriction 
in offspring have mainly focused on the changes in body weight, food intake and/or circulating 
hormone levels (Moura, et al. 2002; Remmers, et al. 2008a; Šefčíková 2002; Teixeira, et al. 
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2002). However little is known about the changes occurring at gene expression level in key 
tissues involved in energy balance as a consequence of maternal food restriction during 
suckling period that may be determinant of the lower propensity to obesity. We hypothesized 
that early postnatal food restriction may induce developmental programming of hypothalamic 
and WAT gene expression of key factors involved in the regulation of energy balance. Thus, 
we aimed to gain further insight into the mechanisms that could underlie the substantial 
outcome in the male and female offspring of moderate caloric restricted (30%) lactating dams 
by analyzing the mRNA expression levels of selected genes involved in the regulation of food 
intake and fat accumulation in the hypothalamus and WAT, respectively, and establishing their 
relationship with energy homeostasis-related parameters when these animals were exposed in 
adulthood to HF diet conditions. In addition, considering that the adaptation to fed/fasting 
conditions may be impaired in obese animals, HF diet exposed animals were studied under 
both feeding and fasting conditions.  
 
Materials and methods 
Experimental animals 
The study was performed in male and female rats from 12 different litters, following the 
protocol below. All rats were housed under controlled temperature (22ºC) and a 12 h light–dark 
cycle (light on from 08:00 to 20:00), and had unlimited access to tap water and standard chow 
diet (Panlab, Barcelona, Spain) unless mentioned otherwise. Briefly, twelve virgin female 
Wistar rats weighing between 200 g and 225 g were mated with male rats (Charles River 
Laboratories, Barcelona, Spain). After matching, each female was placed in an individual cage. 
At day 1 after delivery, excess pups in each litter were removed in order to keep 10 pups per 
dam (five males and five females, when possible) and dams were assigned to either control or 
caloric restricted group (n=6 in each group). The control group was fed ad libitum with 
standard diet, while the caloric restricted group was provided daily with a 30% caloric 
restricted diet throughout lactation, starting on day 1 after delivery and ending at weaning (day 
21) as previously described (Palou, et al. 2010b). After weaning, 36 animals from control dams 
(controls) (18 males and 18 females) and 36 from caloric restricted dams (CRL) (18 males and 
18 females) were placed two per cage, paired with another animal of the same group, and fed 
with standard diet until the age of 15 weeks; then they were distributed into two groups; normal 
fat (NF) group – animals (n=6/group) continued with standard diet (2.9% calories from fat) - 
and high-fat (HF) group – animals (n=12/group) fed with a chow diet (4.7 kcal/g) with 45% 
calories from fat (Research Diets, Inc., NJ, USA). HF diet contained 5.5% calories from 
soybean oil and 39.5% from lard. Body weight and food intake were followed.  
At the age of 28 weeks, NF diet and a half of the HF diet fed rats (n=6/group) were killed 
under ad libitum feeding conditions, while the second half of HF diet group (n=6/group) was 
killed after 12-h fasting. All animals were sacrificed by decapitation during the first 2 h of the 
beginning of the light cycle and on different consecutive days (including animals from each 
group every day). Blood samples were collected in heparinized containers, then centrifuged at 
700 g for 10 min to obtain the plasma, and stored at -20ºC until analysis. The hypothalamus 
and the main WAT depots (retroperitoneal, mesenteric, gonadal and inguinal) were rapidly 
removed, weighed, frozen in liquid nitrogen and stored at -70ºC until ulterior studies. The 
hypothalamus was harvested by using the following landmarks, i.e., frontal edge of the optical 
chiasm, lateral sulci, caudal edge of the mammary bodies, and a depth of 2 mm. Although 
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different WAT depots were sampled to be weighed, the retroperitoneal depot was selected as 
representative to be analyzed for gene expression. 
The animal protocol followed in this study was reviewed and approved by the Bioethical 
Committee of our University, and guidelines for the use and care of laboratory animals of the 
University were followed. 
 
Measurement of circulating parameters under fed/fasting conditions, and calculation of the 
homeostatic model assessment for insulin resistance 
Blood glucose concentration was measured by Accu-Chek Glucometer (Roche Diagnostics, 
Barcelona, Spain). Plasma insulin concentration was determined using a rat insulin
 
enzyme-
linked immunosorbent assay (ELISA) kit (Mercodia AB, Uppsala, Sweden) following standard 
procedures. Plasma leptin concentration was measured using a mouse leptin ELISA kit (R&D 
Systems, Minneapolis, MN). Circulating triglycerides were measured by commercial 
enzymatic colorimetric kit (Triglyceride (INT), Sigma Diagnostics, St Louis, MO, USA). 
The homeostatic model assessment for insulin resistance (HOMA-IR) was used to assess 
insulin resistance. It was calculated from fasting insulin and glucose concentration using the 
formula of Matthews et al. (Matthews, et al. 1985): HOMA-IR = fasting glucose (mmol/liter) x 
fasting insulin (mU/liter)/22.5. 
 
RNA extraction 
Total RNA was extracted from the hypothalamus and the retroperitoneal WAT depot by 
Tripure Reagent (Roche Diagnostic Gmbh, Mannheim, Germany) according to the 
manufacturer's instructions. Isolated RNA was quantified using the NanoDrop ND-1000 
spectrophotometer (NadroDrop Technologies Inc., Wilmington, Delaware, USA) and its 
integrity confirmed using agarose gel electrophoresis.  
 
Real-time quantitative PCR (RT-qPCR) analysis  
Real-time polymerase chain reaction (PCR) was used to measure mRNA expression levels of 
neuropeptide Y (Npy), proopiomelanocortin (Pomc), long form leptin receptor (Obrb), insulin 
receptor (Insr), and suppressor of cytokine signaling 3 (Socs3) in hypothalamus, peroxisome 
proliferator activated receptor gamma 2 (Pparγ2), acetyl-coenzyme A carboxylase alpha 
(Acc1), glycerol-3-phosphate acyltransferase (Gpat), glucose transporter 4 (Glut4), lipoprotein 
lipase (Lpl), the free fatty acid transporter Cd36, muscle carnitine palmitoyltransferase 1a 
(Cpt1m), Obrb and Insr in rWAT. 0.25 µg of total RNA (in a final volume of 5 µl) was 
denatured at 65C for 10 min and then reverse transcribed to cDNA using MuLV reverse 
transcriptase (Applied Biosystem, Madrid, Spain) at 20ºC for 15 min, 42C for 30 min, with a 
final step of 5 min at 95C in an Applied Biosystems 2720 Thermal Cycler (Applied 
Biosystem, Madrid, Spain). Each PCR was performed from diluted cDNA template, forward 
and reverse primers (1 M each), and Power SYBER Green PCR Master Mix (Applied 
Biosystems, CA, USA). Primers were obtained from Sigma (Madrid, Spain) and sequences are 
described (García, et al. 2010; Palou, et al. 2009; Priego, et al. 2008), except for the Socs3 
sequences that were: forward 5’-ACTGAGCCGACCTCTCTCCT-3’ and reverse 5’-
CCCCTCTGACCCTTTCTTTG-3’.  Real time PCR was performed using the Applied 
Biosystems StepOnePlusTM Real-Time PCR Systems (Applied Biosystems) with the 
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following profile: 10 min at 95ºC, followed by a total of 40 two- temperature cycles (15 s at 
95ºC and 1 min at 60ºC). In order to verify the purity of the products, a melting curve was 
produced after each run according to the manufacturer's instructions. The threshold cycle (Ct) 
was calculated by the instrument's software (StepOne Software v2.0) and the relative 
expression of each mRNA was calculated as a percentage of NF control rats under ad libitum 
feeding conditions, using the 2
-Ct
 method with the beta-actin and 18S as reference genes 
(Pfaffl 2001). All primers were obtained from Sigma Genosys (Sigma Aldrich Química SA, 
Madrid, Spain). 
 
Statistical analysis 
Given that the animals studied were from six different litters in each treatment group, the effect 
of litter was simultaneously factored with all data by repeated measures ANOVA. No 
interactions between the litter and treatment were found across all the data, thus, data were 
expressed as mean  sem of animals from the six different litters. Multiple comparisons were 
assessed by repeated measures ANOVA and two-way ANOVA. Single comparisons between 
groups were assessed by Student’s t test or Paired t test. P < 0.05 was the threshold of 
significance. 
 
Results 
Weight-related parameters and food intake 
As shown in Figure 1A, moderate caloric restriction in dams during lactation resulted in lower 
body weight of their offspring in adulthood, both males and females (two-way ANOVA). This 
effect was more pronounced under HF diet feeding; in fact, by individual comparison, there 
were no statistical differences between control and CRL rats under NF diet (Student’s t test). 
This lower body weight can be explained, at least in part, by lower food intake. Both male and 
female CRL animals ate fewer calories than their controls, both under NF and HF diet (Figure 
1B). 
Differences in body weight between control and CRL animals can be attributed to the size of 
fat depots (Table 1). The inguinal and mesenteric adipose tissue weights in both CRL male and 
female animals and the weight of the gonadal depot in CRL females were lower than in control 
animals (two-way ANOVA). Differences were generally found both under NF and HF diet 
conditions, but were more marked under HF diet. Moreover, CRL males presented lower 
adiposity index than their controls boht under NF and HF diet (two-way ANOVA), and this 
effect was also more pronounced under HF (Student’s t test).  
 
Circulating parameters under fed and fasting conditions 
Table 2 shows circulating glucose, insulin, leptin, and TG levels of male and female control 
and CRL animals exposed to NF and HF diet, under feeding conditions, as well as after 12-h 
fasting conditions in HF-diet exposed animals. No significant differences were found in 
glucose levels between control and CRL rats as an effect of the caloric restriction or HF diet 
feeding (two-way ANOVA). Fasted rats presented lower glucose levels than fed animals (two-
way ANOVA). Control male animals, but not CRL males, showed increased insulin 
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concentration under feeding conditions when exposed to HF diet (two-way ANOVA); in fact, 
under HF diet conditions, CRL males had lower insulin levels than their controls both under 
feeding and fasting conditions (two-way ANOVA). In females, no changes were found as an 
effect of caloric restriction or HF diet feeding (two-way ANOVA). Both males and females 
showed a decrease in insulin levels after 12-h fasting (Student’s t test). Interestingly, under HF 
diet, control males showed a tendency to higher insulin resistance index (HOMA-IR) versus 
CRL rats (p=0.062, Student’s t test) (Figure 2). 
 
Figure 1. Body weight (A), and cumulative food intake from day 105 until day 200 (B) of male and female 
offspring of controls and caloric restricted dams during lactation (CRL) that were fed after day 105 with a NF or a 
HF diet until the age of 28 weeks. Results are expressed as the mean ± SEM of 6 to 12 animals per group. 
STATISTICS: D, effect of the type of diet; R, effect of caloric restriction during lactation; and DxR, interaction 
between caloric restriction and diet (two-way ANOVA). *, effect of HF diet (Student’s t test). #, effect of maternal 
caloric restriction (Student’s t test). The percentages in brackets represent the increase as a consequence of the HF 
diet. 
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Table 1. Weights of inguinal, retroperitoneal, mesenteric and gonadal white adipose tissue of 
male and female offspring of control and caloric restricted dams during lactation (CRL), at the 
age of 28 weeks, under NF- and HF-diet feeding and under ad libitum feeding conditions.  
  MALES FEMALES 
  NF diet HF diet NF diet HF diet 
iWAT (g) Control 11.5 ± 1.4 19.9 ± 2.6
 
* 3.12 ± 0.19 5.28 ± 0.50
 
* 
 CRL 8.34 ± 0.94 
# 
12.7 ± 0.9 
# 
* 2.87 ± 0.39 3.76 ± 0.31 
# 
 ANOVA D, R D, R 
rWAT (g) Control 14.5 ± 2.5 26.6 ± 3.9
 
* 2.78 ± 0.28 4.90 ± 0.81
 
* 
 CRL 10.9 ± 1.5 18.5 ± 3.0 * 2.90 ± 0.32 4.42 ± 0.61 
 
* 
 ANOVA D D 
mWAT (g) Control 6.63 ± 1.09 11.4 ± 2.4
 
* 2.82 ± 0.36 4.36 ± 0.78 
 CRL 4.64 ± 0.76 6.06 ± 0.52 
# 
2.03 ± 0.18 
# 
2.78 ± 0.30 
# 
* 
 ANOVA D, R D, R 
gWAT (g) Control 15.1 ± 2.4 22.9 ± 4.9 8.77 ± 0.95 14.4 ± 2.2
 
* 
 CRL 12.2 ± 1.7 14.4 ± 2.1 7.09 ± 0.93 9.48 ± 1.27 
# 
 ANOVA 
 
D, R 
Adiposity Control 9.08 ± 1.07 13.5 ± 1.2 * 6.27 ± 0.39 9.62 ± 1.09
 
* 
Index (AI) CRL 7.52 ± 0.84 10.3 ± 1.2  
# 
* 5.73 ± 0.48 7.57 ± 0.65
 
* 
 ANOVA D, R D 
Weights are expressed in grams. Data are means ± SEM of 6 animals per group. STATISTICS: D, effect of the 
type of diet; and R, effect of caloric restriction during lactation (two-way ANOVA). *, NF vs. HF diet; #, Control 
vs. CRL (Student’s t test). Abbreviations: inguinal white adipose tissue (iWAT), retroperitoneal white adipose 
tissue (rWAT), mesenteric white adipose tissue (mWAT), gonadal white adipose tissue (gWAT) and adiposity 
index (AI).  
 
 
 
Figure 2. HOMA-IR index at the age of 28 weeks of male and female offspring of controls and maternal caloric 
restricted dams during lactation (CRL), which were fed with HF diet. Results are expressed as the mean ± SEM of 
6 animals per group. 
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Table 2. Plasma glucose, insulin, leptin and triglyceride concentration under NF and HF diet under feeding conditions, and also for the latter 
under fasting conditions of male and female offspring of controls and caloric restricted dams during lactation (CRL) at the age of 28 weeks.  
  MALES FEMALES 
  Feeding Fasting Feeding Fasting 
  NF diet HF diet HF diet NF diet HF diet HF diet 
Glucose (mg/dl) Control 104 ± 6 111 ± 2 94 ± 5 
+
 106 ± 3 104 ± 5 89 ± 4 
+
 
 CRL 108 ± 5 104 ± 3 95 ± 4 
+ 
113 ± 2 114 ± 7 90 ± 5 
+ 
 ANOVA     
Insulin (μg/l) Control 2.87 ± 0.72 6.01 ± 0.32 * 1.71 ± 0.27 
+
 1.52 ± 0.29 1.34 ± 0.310 0.55 ± 0.04 
+ 
 CRL 2.15 ± 0.36 1.71 ± 0.24 
# 
0.97 ± 0.20 
+ 
1.14 ± 0.23 1.11 ± 0.21 0.55 ± 0.10 
+ 
 ANOVA DxR    
Leptin (μg/l) Control 7.68 ± 1.38 17.9 ± 1.4
 
* 8.98 ± 1.70 
+ 
2.33 ± 0.21 4.03 ± 0.65 * 2.80 ± 0.64 
 CRL 6.21 ± 1.39 9.48 ± 1.46 
# 
5.31 ± 1.17 
+ 
2.13 ± 0.44 2.23 ± 0.38
 # 
1.00 ± 0.16 
+ # 
 ANOVA DxR  R  
Triglycerides Control 2.81 ± 0.54 2.76 ± 0.40 2.47 ± 0.51 
+ 
2.87 ± 0.66 1.91 ± 0.39 1.18 ± 0.16 
(mg/ml) CRL 2.76 ± 0.50 1.46 ± 0.35 0.902 ± 0.207 
+ 
2.77 ± 0.50 1.00 ± 0.16 * 0.500 ± 0.115 
+ # 
 ANOVA 
 
 D  
Results are expressed as the mean  SEM of 6 animals per group. STATISTICS: D, effect of the type of diet; R, effect of caloric restriction during lactation; DxR, interaction 
between caloric restriction and diet (two-way ANOVA). *, NF vs. HF diet; 
#
, Control vs. CRL 
+
; ad libitum vs. Fasting (Student’s t test) 
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Both male and female control rats, but not CRL rats, increased their plasma leptin levels as an 
effect of HF diet (two-way ANOVA). In addition, CRL females showed lower leptin 
concentration under both NF- and HF diet than their controls (two-way ANOVA). Male 
animals and CRL females, but not control females, decreased their circulating leptin levels 
after 12-h fasting (Student’s t test); in fact, under HF diet conditions, CRL females had lower 
leptin levels than their controls both under feeding and fasting conditions (Student’s t test). 
Regarding TG, no differences were observed between control and CRL rats or after HF diet 
feeding in males (two-way ANOVA). A decrease in TG levels was found in both control and 
CRL male rats exposed to HF diet as an effect of fasting. However, unlike males, control and 
CRL females displayed lower TG concentration under HF diet compared with NF diet 
conditions (two-way ANOVA), but differences were more marked and significant by Student’s 
t test only in CRL animals. Under HF diet conditions, TG levels decreased in CRL females, but 
not control females, as an effect of fasting, and levels in fasted CRL were lower than in fasted 
control animals (Student’s t test).  
 
Hypothalamic mRNA levels of selected genes involved in energy balance in control and CRL 
male and female rats  
Figure 3 shows mRNA expression levels of selected genes in the hypothalamus of male rats, 
under NF and HF diet under feeding conditions, and also for the latter under fasting conditions. 
No significant differences were found concerning Npy and Pomc mRNA levels as an effect of 
caloric restriction or HF diet exposure, either in the ratio Npy/Pomc (two-way ANOVA) (Fig 
3A). Neither were any differences found concerning Insr mRNA levels. However, CRL 
animals showed higher Obrb mRNA levels than their controls (two-way ANOVA) (although 
these levels were lower by Student’s t test under HF diet compared with NF diet), and a 
tendency to lower Socs3 expression levels (p=0.07, two-way ANOVA). 
HF-diet exposed male animals showed no significant changes in the expression levels of the 
analysed genes as an effect of fasting, with the exception of Npy, whose expression levels 
increased in control and CRL animals (two-way ANOVA) (Fig 3B), and of Insr, whose 
expression levels decreased only in control animals. Interestingly, the resulting Npy/Pomc 
mRNA ratio increased in CRL male rats after 12-h fasting, compared with fed conditions 
(Student’s t test). 
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Figure 3. mRNA expression levels of neuropeptide Y (NPY), proopiomelanocortin (POMC), long form leptin 
receptor (ObRb), insulin receptor (InsR), and suppressor of cytokine signalling-3 (SOCS-3) and the NPY/POMC 
ratio in the hypothalamus of male rats, under NF and HF diet under feeding conditions (A), and also for the latter 
under fasting conditions (B). mRNA levels were measured by Real-time PCR and expressed as a percentage of the 
mean value of NF diet fed control males under ad libitum  
STATISTICS: R, effect of maternal caloric restriction during lactation; F, effect of fasting (two-way ANOVA). *, 
NF vs. HF diet; 
#
, Control vs. CR 
+
; ad libitum vs. Fasting (Student’s t test). 
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Results on gene expression in the hypothalamus of females are shown in Figure 4. Control 
females increased Npy expression levels under HF diet, while CRL rats showed a decreased 
expression (interaction between caloric restriction and the type of diet, two-way ANOVA) (Fig 
4A); no significant differences appeared in the expression of Pomc as an effect of caloric 
restriction or HF diet feeding (two-way ANOVA). The resulting Npy/Pomc mRNA ratio was 
lower in CRL female animals under HF diet compared with levels under NF diet, without 
significant changes in control animals. In addition, CRL female rats showed higher expression 
levels of Insr than their controls (two-way ANOVA), and a tendency to higher Obrb mRNA 
levels (p=0.07; two-way ANOVA). SOCS-3 mRNA levels were higher in control and CRL 
animals under HF diet compared with levels under NF diet, without differences between 
control and CRL animals (two-way ANOVA).  
Interestingly, under fasting conditions, HF-diet exposed CRL female animals increased Npy 
mRNA levels and the Npy/Pomc mRNA ratio; however, the expression levels of this gene and 
the Npy/Pomc mRNA ratio did not change in control animals as an effect of fasting (Student’s t 
test) (Fig 4B). Furthermore, Socs3 mRNA levels decreased in control animals as an effect of 
fasting, but remained unaltered in CRL female animals (Student’s t test).  
 
Retroperitoneal WAT mRNA levels of selected genes involved in energy homeostasis in control 
and CRL male and female rats 
Figure 5 shows mRNA expression levels of selected genes in WAT of male rats, under NF and 
HF diet under feeding conditions, and also for the latter under fasting conditions Control male 
rats showed lower mRNA expression levels of Pparγ2, Acc1, Gpat, LDL, Cpt1m and Insr 
under HF diet, compared with those under NF diet (Student’s t test), whereas this decrease was 
not found (for Pparγ2, Cpt1m and Insr) or was not significant (for Acc1 and Gpat) in CRL 
animals (Student’s t test) (Fig 5A). Moreover, Gpat mRNA levels were also significantly lower 
in CRL animals compared with their controls (two-way ANOVA), but were significant by 
Student’s t test only under NF diet. Glut4 expression levels decreased under HF diet in both 
control and CRL male rats, although the decrease was more marked and significant by 
Student’s t test in CRL animals. Notably, when HF diet fed animals were deprived of food (Fig 
5B), Glut4 expression also decreased under fasting conditions (two-way ANOVA), but the 
decrease was significant by Student’s t test only in CRL animals. However, Gpat mRNA levels 
decreased by Student’s t test only in control rats, and remained unchanged in CRL animals. No 
response to fasting was found for the other genes studied, either in control or in CRL animals 
exposed to HF diet.  
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Figure 4. mRNA expression levels of neuropeptide Y (Npy), proopiomelanocortin (Pomc), long form leptin 
receptor (Obrb), insulin receptor (Insr), and suppressor of cytokine signaling 3 (Socs3)and the Npy/Pomc ratio in 
the hypothalamus of female rats, under NF and HF diet under feeding conditions (A), and also for the latter under 
fasting conditions (B). mRNA levels were measured by Real-time PCR and expressed as a percentage of the mean 
value of NF diet fed control males under ad libitum feeding conditions. Data are mean  SEM (n = 6). 
STATISTICS: D, effect of the type of diet; R, effect of caloric restriction during lactation; F, effect of feeding 
conditions; DxR, interaction between  maternal caloric restriction and diet; and FxR, interaction between maternal 
caloric restriction and feeding conditions (two-way ANOVA). *, NF vs. HF diet; 
#
, Control vs. CRL 
+
; ad libitum 
vs. Fasting (Student’s t test). 
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Figure 5. mRNA expression levels of selected genes in the WAT of male rats, under NF and HF diet under 
feeding conditions (A), and also for the latter under fasting conditions (B). mRNA levels were measured by Real-
time PCR and expressed as a percentage of the mean value of NF diet fed control males under ad libitum feeding 
conditions. Data are mean  SEM (n = 6). Genes determined were: peroxisome proliferator activated receptor 
gamma 2 (Pparγ2), acetyl-coenzyme A carboxylase alpha (Acc1), glycerol-3-phosphate acyltransferase (Gpat), 
glucose transporter 4 (Glut4), lipoprotein lipase (Lpl), muscle carnitine palmitoyltransferase 1a (Cpt1m), the leptin 
receptor (Obrb) and the insulin receptor (Insr). STATISTICS: D, effect of the type of diet; R, effect of caloric 
restriction during lactation; F, effect of feeding conditions; DxR, interaction between maternal caloric restriction 
and diet; and FxR, interaction between maternal caloric restriction and feeding conditions (two-way ANOVA). *, 
NF vs. HF diet; 
#
, Control vs. CRL 
+
; ad libitum vs. Fasting (Student’s t test). 
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Results on gene expression in WAT of females are shown in Figure 6.  
 
Figure 6. mRNA expression levels of selected genes in the WAT of female rats, under NF and HF diet under 
feeding conditions (A), and also for the latter under fasting conditions (B). mRNA levels were measured by Real-
time PCR and expressed as a percentage of the mean value of NF diet fed control males under ad libitum feeding 
conditions. Data are mean  SEM (n = 6). Genes determined were: peroxisome proliferator activated receptor 
gamma 2 (Pparγ2), acetyl-coenzyme A carboxylase alpha (Acc1), glycerol-3-phosphate acyltransferase (Gpat), 
glucose transporter 4 (Glut4), lipoprotein lipase (Lpl), muscle carnitine palmitoyltransferase 1a (CPT1m), the 
leptin receptor (Obrb) and the insulin receptor (Insr). STATISTICS: R, effect of caloric restriction during 
lactation; F, effect of feeding conditions; FxR, interaction between maternal caloric restriction and feeding 
conditions (two-way ANOVA). *, NF vs. HF diet; 
#
, Control vs. CRL 
+
; ad libitum vs. Fasting (Student’s t test). 
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No significant differences were found in females as an effect of HF diet or caloric restriction in 
the expression of Pparγ2, Acc1, Glut4, Lpl and Insr in WAT (two-way ANOVA) (Figure 6A). 
CRL females showed higher Obrb mRNA levels than their controls (two-way ANOVA), 
greater Cpt1m mRNA levels but only under NF diet (Student’s t test), and lower mRNA levels 
on Gpat but only under HF diet (Student’s t test).  
CRL female animals under HF diet, besides expressing greater Obrb mRNA levels than their 
controls under this diet, they showed a different response to fasting conditions compared with 
their controls (interaction between caloric restriction and fasting, two-way ANOVA): Obrb 
mRNA levels tended to decrease in CRL animals, but to increase in controls (Figure 6B). In 
turn, Gpat mRNA levels decreased after fasting in control rats without showing significant 
changes in CRL (interaction between caloric restriction and fasting, two-way ANOVA). Both 
control and CRL females exposed to HF diet decreased their Glut4 mRNA levels with fasting 
(two-way ANOVA), while mRNA levels of Acc1, Lpl, Cpt1m and Insr did not change under 
fasting conditions in either control or CRL females (two-way ANOVA).   
 
Discussion 
It is well known that maternal nutrition during perinatal periods may program the development 
of their offspring towards different consequences (Bertram and Hanson 2001; Cripps, et al. 
2005; Gluckman and Hanson 2004; McMillen, et al. 2005; Taylor and Poston 2007). We 
previously described that a moderate caloric restriction (30%) in lactating dams confers certain 
protection against obesity development and from related metabolic alterations in adult life, 
particularly insulin resistance and hyperleptinemia (Palou, et al. 2010b). However, little is 
known about the mechanisms that underlie these alterations and whether they are associated 
with changes in the expression of key genes involved in energy homeostasis. Here, we show 
that programming of gene expression related with central and peripheral leptin and insulin 
sensibility may be involved in the beneficial effects of moderate caloric restriction during 
lactation. 
In accordance with our previous results in the same cohort of animals at younger ages (Palou, 
et al. 2010b), we also show here that the offspring of caloric restricted dams during the 
suckling period display lower body weight and lower fat content in adulthood, compared with 
their controls, the difference being more patent when animals are exposed to the challenge of 
HF diet feeding. The lower body weight can be explained, at least in part, by lower food intake. 
Comparison of accumulated calories eaten in adulthood during the 13-week period of exposure 
to NF or HF diet showed that food intake was lower in CRL animals compared with their 
controls, both under NF and HF diet. The increased intake of calories associated with HF diet 
exposure was lower in CRL male animals compared with their controls (increase of 15% and 
20%, respectively), but was similar in CRL female rats compared with their controls (increase 
of 12% an 12%, respectively). Remmers et al. (Remmers, et al. 2008c) also showed reduced 
body weight, fat content and food intake in male and female caloric restricted rats during 
lactation obtained by large litter size; in contrast, malnutrition produced by protein restriction 
to the dams during lactation has been associated in the adult offspring with reduced body 
weight, despite no changes in food intake (de Moura, et al. 2007; de Souza Caldeira Filho and 
Moura 2000; Fagundes, et al. 2007). 
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Central resistance to insulin and/or leptin have been proposed as important mechanisms 
responsible for the dysregulation of energy homeostasis, which may lead to obesity 
(Esteghamati, et al. 2009; Levin and Dunn-Meynell 2002; Lustig, et al. 2004). Regarding 
insulin, male rats are known to have a higher tendency for hyperinsulinemia induced by 
hyperlipidic diets than females (Priego, et al. 2008). In this sense, we have previously 
described that male offspring of caloric restricted rats during lactation are protected against 
diet-induced hyperinsulinemia and insulin resistance when animals are exposed for 5 weeks in 
adulthood to HF diet (Palou, et al. 2010b); in agreement, here we also found lower insulin 
levels under feeding conditions and a tendency to lower HOMA-IR in CRL males exposed for 
a longer period (13 weeks) to HF diet, suggesting a better resistance of CRL male rats against 
the detrimental effects of an obesogenic environment on circulating insulin profile. Concerning 
the leptin system, CRL animals showed lower circulating leptin levels, particularly under HF 
diet feeding, compared with controls. This is in accordance with their lower body weight and 
agrees with the results obtained when these animals were younger (20 weeks old) (Palou, et al. 
2010b). Interestingly, lower leptin levels have been associated with a better sensitivity to leptin 
(Sánchez, et al. 2008) but, in contrast, higher circulating leptin levels may contribute to the 
energy imbalance induced by HF diet feeding or age and are involved with the impairment of 
the fasting-induced suppression of leptin production (Iossa, et al. 1999; Pico, et al. 2007; 
Sánchez, et al. 2008). On the other hand, gender-differences have been described concerning 
the leptin system; female rats seem to be relatively more sensitive to leptin system regulation, 
whereas male rats are more sensitive to insulin regulation (Clegg, et al. 2003; Priego, et al. 
2008; Woods, et al. 2003). Nevertheless, HF diet fed control male animals showed decreased 
plasma leptin levels under fasting conditions, whereas the decrease was not significant in 
female control animals. However, both HF diet fed male and female CRL animals responded to 
fasting conditions by lowering their plasma leptin levels. 
Leptin and insulin are thought to regulate feeding behavior through their abilities to modulate 
the transcription of several neuropeptide genes. Thus, to ascertain whether changes in food 
intake between control and CRL animals could be related with central effects of these 
hormones, the expression of hypothalamic genes related with leptin and insulin action were 
determined. NPY is considered one of the main peptides regulating food intake with orexigenic 
activity (Dryden, et al. 1994). Increased NPY protein and/or mRNA levels have been described 
in the hypothalamus of different animal models of obesity (Dryden, et al. 1994); for instance, 
higher Npy mRNA levels have been found in female rats chronically fed with HF diet (Priego, 
et al. 2009b). We also found here that Npy mRNA levels increased in control female animals 
when exposed to HF diet, but, interestingly, they decreased in CRL females exposed to this 
diet; moreover HF diet exposed CRL females, but not their controls, displayed higher Npy 
mRNA levels after fasting conditions; this suggests not only a better adaptation to this 
hyperlipidic diet, but also a better response to the feeding/fasting patterns. However, it is worth 
mentioning that, under NF diet, CRL female animals displayed higher Npy mRNA levels than 
their controls; this fact cannot explain the hypophagia or the lower body weight of these 
animals compared with their controls. This suggests that caloric restriction may also affect 
other processes that could counteract the increased expression of Npy in these animals. Unlike 
females, Npy mRNA expression levels did not change in male animals, either as an effect of 
diet or caloric restriction.  
POMC is the precursor of the anorexigenic peptide alpha-melanocyte stimulating hormone 
(αMSH) (Bell, et al. 2000), but no significant differences were found between control and CRL 
animals concerning Pomc expression. Considering that both NPY and POMC are the main 
neuropeptides stimulating and inhibiting food intake, respectively, it is interesting to highlight 
that the Npy/Pomc ratio decreased in CRL females under HF diet and increased under fasting 
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conditions in both HF diet exposed CRL male and female animals, but not in controls, although 
the difference in males did not reach statistical significance (p=0.06, Student’s t test). These 
results may also contribute to explain the better control of food intake and body weight in CRL 
rats under HF diet.  
This pattern of expression of neuropeptides involved in food intake control and regulated at the 
central level by leptin and insulin may be indicative of a better sensitivity to these hormones. 
The responsiveness of the hypothalamus to leptin and insulin action depends not only on the 
circulating levels of these hormones, but also on different factors determining the sensitivity to 
these signals, such as the leptin and insulin receptors or the cytokine inhibitory protein Socs3 
(Baskin, et al. 1998; Peiser, et al. 2000). The ObRb, the longest isoform of all leptin receptors, 
is mainly expressed in the hypothalamus and is considered to be the signaling-competent 
isoform (Baskin, et al. 1998). This form is sensitive to genetic and physiological interventions 
that change circulating leptin levels, indicating that overexpression of Obrb in the 
hypothalamus may contribute to increased leptin sensitivity (Baskin, et al. 1998). Here, we 
measured the expression of Obrb in the hypothalamus to evaluate possible differences in leptin 
responsiveness between control and CRL rats under NF or HF diet feeding. CRL male rats 
showed higher Obrb mRNA levels than controls, particularly under NF diet; a non significant 
tendency (p=0.073) was also observed in CRL females. This is likely to be, an indicator of 
better leptin sensitivity and a higher resistance to obesity development. On the other hand, 
SOCS3 is a leptin-inducible inhibitor of leptin signaling, and a potential mediator of leptin 
resistance in obesity (Bjorbaek, et al. 1998). No significant differences were found between 
control and CRL animals concerning the expression of levels of Socs3 in the hypothalamus, 
but, notably, CRL males presented a tendency (p=0.074) to lower Socs3 expression levels both 
under NF (21% reduction) and HF diet (45% reduction). This reduction could contribute to 
increase leptin action and attenuate sensitivity to diet-induced obesity. This is supported by the 
fact that mice, which at are heterozygous for an Socs3 gene deletion and hence have a 50% 
reduction of Socs3 expression, exhibit enhanced Obrb activation induced by leptin (Howard, et 
al. 2004). In addition, SOCS3 is also an inhibitor of insulin action (Emanuelli, et al. 2000). 
Thus, these changes in the expression levels of Socs3 in the hypothalamus of CRL male 
animals could also account for a better responsiveness to the central action of insulin. Insulin, 
like leptin, is secreted in proportion to fat stores, and also enters the CNS in proportion to its 
plasma levels (Plum, et al. 2006). Insulin receptors are expressed in neurons of brain areas 
involved in feeding control, and central administration of insulin can reduce food intake and 
body weight (Morton and Schwartz 2001; Plum, et al. 2006). Interestingly, CRL female 
animals showed increased Insr mRNA levels with respect to their controls which may 
determine a better response to insulin action, improving their feeding behaviour. All in all, 
these results may illustrate that a better responsiveness to the central action of leptin (in CRL 
male animals) and insulin (in CRL female animals) could be the mechanisms underlying the 
better control of food intake and body weight at the central level.  
In addition to the hypothalamus, the adipose tissue is a target of the peripheral action of leptin 
and insulin. The adaptations of this tissue to an obesogenic environment and also to feeding 
conditions are another main determinant of the propensity to suffer obesity or other metabolic 
alterations (Palou, et al. 2008; Priego, et al. 2008). In this sense, visceral fat accumulation, 
rather than subcutaneous, has been strongly linked to features of the metabolic syndrome, 
including leptin resistance, type 2 diabetes, hypertension and dyslipidemia (Despres 2001; 
Masuzaki, et al. 2001; Weiss 2007). Here, we show that CRL rats appear to be more prepared 
to resist obesity development, the protective effect being more evident in males. This can be 
associated in male animals with an improvement of adipose tissue responsiveness to insulin. In 
fact, CRL male animals were resistant to the decrease occurring in Insr mRNA levels in the 
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internal (retroperitoneal) WAT depot under HF diet feeding. In addition, CRL males had a 
better response to HF diet feeding, by maintaining fat uptake capacity and its storage by the 
adipose tissue, as well as the fatty acid oxidation capacity, whereas their controls presented an 
impairment of these processes. In fact, control male rats showed a decreased expression of 
lipogenic-related genes such as Pparγ2, Lpl, which are regulated by this transcription factor 
(Tsai and Maeda 2005), Acc1 and Gpat, and also of the catabolic-related gene Cpt1m after HF 
diet feeding, whereas expression levels were mostly maintained unaltered in CRL male animals 
(with the exception of Acc1, which showed a non significant tendency to decrease). A greater 
capacity to channel the excess of energy from the diet to the adipose tissue has been related 
with a better adaptive response to a HF diet (Priego, et al. 2008) and higher sensitivity to 
insulin (Slawik and Vidal-Puig 2006). In fact, insulin regulates Pparγ mRNA expression by the 
adipose tissue (Rieusset, et al. 1999), and this factor is involved in whole-body insulin 
sensitivity, probably through its effects on adipocyte metabolism and secretory function (Tsai 
and Maeda 2005). Thus, these results agree with an impairment of insulin sensitivity of control 
males under HF diet, at least at the gene expression level, whereas insulin sensitivity was not 
apparently impaired in CRL male animals under HF diet. This is also in accordance with the 
pattern observed in the HOMA-IR in these animals. Increased insulin sensitivity has also been 
previously described in the offspring of severe protein and caloric restricted rats during 
lactation (Martin-Gronert, et al. 2008; Palou, et al. 2010b; Sampaio de Freitas, et al. 2003; 
Zambrano, et al. 2006). Other conditions during the early neonatal period, such as the 
supplement of suckling rats with physiological doses of leptin has also been associated in male 
animals with improved insulin sensitivity (Sánchez, et al. 2008) and with better metabolic 
adaptations to HF diet feeding (Priego, et al. 2010); in concrete, changes at the gene expression 
level in the adipose tissue evidenced a better capacity of leptin-treated animals to handle and 
partition the excess of fuel under HF diet feeding, preventing other metabolic disorders related 
with HF-diet feeding, such as hepatic lipid accumulation (Priego, et al. 2010).  
Unlike males, no significant differences were found between control and CRL female animals 
concerning the expression of Insr and of metabolism-related genes in the adipose tissue, 
although it must be mentioned that female animals appear to be more protected against the 
detrimental effects of HF diet on the expression of these genes, as previously described 
(Priego, et al. 2008). These results also point out the increased capacity of the adipose tissue of 
female animals to store an excess of fat (Priego, et al. 2008), in accordance with their healthier 
response to obesogenic environments in comparison with males (Priego, et al. 2009a; Priego, et 
al. 2008; Woods, et al. 2003). These results are also in accordance with the lack of apparent 
effects of caloric restriction during lactation on insulin resistance (measured by the HOMA-IR) 
in CRL female animals under HF diet.  
It is worth noting, HF diet exposed CRL females presented lower circulating fasting TG levels 
than their controls; thus, although they did not apparently improve their insulin sensitivity, like 
CRL males, a better blood TG profile could be related to an improvement of the capacity to 
store the excess of fuel in the adipose tissue. Results of Zammit (Zammit 2002)have 
demonstrated that repeated exposure of the liver to elevated levels of insulin has a potent 
stimulatory effect on hepatic TG production. Thus, this over-stimulation of hepatic TG 
production through insulin action may outline a mechanistic basis for the development of leptin 
resistance, even independently of HF diet feeding (Krechowec, et al. 2006). Elevated fasting 
plasma TG levels have also been described in the offspring of 30% caloric restricted dams 
throughout pregnancy (Krechowec, et al. 2006), and this has been found in conjunction with 
hyperinsulinemia and leptin resistance. In this sense, female CRL rats displayed higher Obrb 
mRNA levels in the adipose tissue than their controls, and, when exposed to HF diet, their 
expression levels were sensitive to feeding/fasting conditions, which is also in accordance with 
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the circulating leptin patterns observed. Interestingly, CRL female animals also showed higher 
expression levels of CPT1 in the adipose tissue than their controls, although only under NF 
diet. This suggests that CRL female rats may have greater fatty acid oxidation capacity in 
adipose tissue, which is of great importance for the control of whole body weight and fat 
reserves, and may be related to the pattern of Obrb expression in this tissue, as previously 
described (Priego, et al. 2010). All in all, these results may indicate that CRL female animals 
are more sensitive to the peripheral action of leptin, and this agrees with the lower plasma 
leptin levels and the better response of the circulating hormone to fasting, suggesting that CRL 
females are more resistant to the development of overweight under HF diet conditions than 
their controls.  
In conclusion, we show here that moderate caloric restriction (30%) in lactating dams results in 
lower body weight, adiposity and food intake in their male and female offspring in adulthood, 
but the mechanisms underlying these adaptations are gender-dependent. Changes in blood 
hormone concentration and at the gene expression level suggest that CRL male rats seem to be 
more protected against HF-diet induced peripheral insulin resistance, and this results in an 
improved capacity of the adipose tissue to handle and store the excess of fuel from the diet. In 
addition, these animals also show improved capacity to respond to leptin at the central level. 
CRL female animals, in turn, appear to be programmed for a better sensitivity to the peripheral 
actions of leptin on the adipose tissue and to the central action of insulin. Both mechanisms 
may have similar outcomes in males and females, providing a better adaptation to the challenge 
of HF diet feeding. These results could help our understanding of the differential regulation of 
energy homeostasis in both genders, as well as the mechanisms responsible for the beneficial 
effects of moderate caloric restriction of the dams during lactation. 
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Abstract 
Moderate maternal calorie restriction during lactation in rats provides certain protection against 
obesity in adult offspring. Hence, we used this model with 20% calorie restriction to identify 
early changes at gene expression level in key tissues involved in energy homeostasis, as well as 
to assess whether they are maintained in adulthood, to consider them as potential biomarkers of 
metabolic health. Offspring of control and 20% calorie restricted dams during lactation (CRL) 
were followed. Animals were studied at weaning and at 6 months old under normal-fat (NF) 
diet and after being moved to a high-fat (HF) diet for the last 2 months. Adult CRL-animals 
showed lower body weight, decreased hepatic lipids, and improved circulating parameters 
versus controls. At weaning, CRL-pups, in retroperitoneal white adipose tissue (rWAT), 
displayed lower mRNA levels of lipogenesis-related genes and higher mRNA levels of genes 
related with lipolysis and insulin signalling versus controls. CRL-animals also showed lower 
hepatic mRNA levels of the lipogenesis-related gene Srebp1c and higher mRNA levels of 
Cpt1a, Atgl and Obrb. Some of these changes were sustained in adulthood under HF-diet, and 
mRNA levels of Irs1 (rWAT) and of Obrb and Srebp1c (liver) in adult animals correlated with 
hepatic lipids and circulating parameters. In conclusion, the protective effects of moderate 
calorie restriction during lactation on offspring metabolic health are reflected in early changes 
at gene expression level in key tissues. Among them, transcript levels of Irs1 (rWAT) and of 
Obrb and Srebp1c (liver) emerge as particularly interesting as potential transcript-based 
biomarkers of metabolic health. 
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Introduction 
Obesity is a worldwide epidemic and a key risk factor in the development of insulin resistance, 
type 2 diabetes, hypertension and cardiovascular disease (Taylor and Poston 2007). Its 
prevalence is mainly associated to unhealthy habits, such as a sedentary lifestyle and excessive 
calorie intake, together with genetic factors. However, emerging evidence in humans and 
animal models indicates that early life nutrition may also play an important role programming 
the risk of obesity and other features of the metabolic syndrome in adult life (McMillen, et al. 
2008; Picó, et al. 2012). In this regard, pregnancy and lactation are revealed as critical periods, 
where maternal diabetes, overnutrition or undernutrition may lead to permanent adaptations 
with lasting effects on metabolic mechanism in the offspring, thereby changing the propensity 
to obesity and related metabolic alterations in adult life (McMillen, et al. 2005). In this sense, 
the undernourishment produced by protein restriction or severe calorie restriction (up to 50%) 
of lactating dams, which has been related with lower body weight of offspring, affects the 
normal development of offspring (de Moura, et al. 2007; Fagundes, et al. 2007). However, we 
have previously described that moderate maternal calorie restriction (30%) during the suckling 
period results in lower body weight and fat content of the offspring, without affecting body 
length (Palou, et al. 2010b). Moreover, these animals are protected against the detrimental 
effects of a high-fat (HF) diet feeding in adulthood; they show changes at the gene expression 
level in key tissues involved in energy balance, related with higher leptin and insulin 
signalling, which could explain the improved capacity of these animals to handle and store the 
excess of fuel from the diet, thus providing a better adaptation to the challenge of HF-diet 
(Palou, et al. 2012). Therefore, the exploration of mechanisms by which early maternal diet 
could program offspring for lower susceptibility to obesity in adulthood becomes of interest. 
This model may also be helpful to develop preventive strategies and identify early biomarkers 
of improved metabolic health. 
Besides, although direct animal-to-human extrapolation is complex, regarding the beneficial 
effects of moderate calorie restriction during lactation on offspring metabolic health in rats, it 
would be of interest to consider its potential application in humans. However, studies on early 
postnatal undernutrition in lactating women are fewer due to ethical implications. 
Epidemiologic reports, and especially those related to reduction of maternal food intake during 
lactation, have described the effects on infant body weight gain or on maternal milk production 
depending on the severity of the restriction (Dewey 1998b; Dusdieker, et al. 1994). Other 
studies carried out in baboons, have shown no significant effect on milk output with a moderate 
calorie restriction of 20%, but milk output was significantly lower in those with 40% calorie 
restriction (Roberts, et al. 1985). Therefore, although 30% calorie restriction during lactation in 
rats has shown benefits in the offspring preventing later obesity (Palou, et al. 2012; Palou, et al. 
2010b), this restriction might be associated with a reduction in milk production and hence does 
not seem to be feasible to extrapolate to humans, if applicable.  
Hence, the present study was conducted to determine whether the potential benefits described 
in the offspring with 30% maternal calorie restriction during lactation in rats on body weight 
gain in adulthood could also be achieved with a less severe calorie restriction (20%), which 
could be more easily representative or applicable in humans. If so, the main objective of this 
study was to use this model to identify early adaptations occurring at the transcriptional level in 
key tissues involved in energy homeostasis, such as retroperitoneal white adipose tissue 
(rWAT) and liver, which may account for the protection against obesity development and 
improved metabolic health found in their offspring. In a second step, we also aimed to assess 
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whether these changes in gene expression levels at early stages were maintained in adulthood, 
evaluating their behavior under stressful dietary conditions, such as HF-diet feeding, and their 
potential relation with the improvement of metabolic health.  
 
Methods and Materials 
Animals and Experimental Design 
The animal protocol followed in this study was reviewed and approved by the Bioethical 
Committee of the University of the Balearic Islands and guidelines for the use and care of 
laboratory animals of the University were followed. 
The study was conducted on male and female Wistar rats from 16 different litters following the 
protocol as is described below. 
Animals were housed under standard conditions, that is, controlled temperature (22ºC), a 12h 
light-dark cycle, free access to tap water. Briefly, 16 virgin female Wistar rats weighing 
between 225g and 260g were mated with male rats (Charles River Laboratories, Barcelona, 
Spain). After matching, each female was placed in an individual cage. At day 1 after delivery, 
pups were weighed and the size of all litters was adjusted to 10 neonates per mother (five 
males and five females, when possible) to ensure adequate and standardized nutrition until 
weaning. Dams were assigned to either control (n=11 dams) or calorie restricted (n=5 dams) 
group. Throughout the lactation period, starting on day 1 after delivery until weaning (day 21), 
control dams were fed ad libitum with standard chow diet (3 kcal/g, with 8% calories from fat; 
Panlab, Barcelona, Spain), while calorie restricted dams were fed daily with 20% calorie 
restricted diet. Calorie restriction was performed by offering each dam a daily amount of food 
corresponding to 80% of the calories that they should eat according to their body weight. This 
amount was calculated considering the calories consumed daily by their control animals under 
ad libitum feeding conditions. During the lactating period, body weight of male and female 
offspring of control and calorie restricted dams (control and CRL, respectively) was followed. 
At the age of 21 days, a set of animals (n=6 per group) were killed under ad libitum feeding 
conditions by decapitation during the first 2 h at the beginning of the light cycle. WAT depots 
(gonadal, inguinal, mesenteric and retroperitoneal; gWAT, iWAT, mWAT and rWAT, 
respectively) and liver were rapidly removed, weighed, frozen in liquid nitrogen and stored at -
80ºC until RNA analysis. Trunk blood samples were also collected in heparinized containers. 
Plasma was obtained by centrifugation of heparinized blood at 1000 x g for 10 min and stored 
at -20ºC until analysis of circulating parameters. 
Another set of animals (n=11-16 per group) were weaned at 21 days of life, and were then 
housed 2 per cage (paired with another animal from the same group), and fed on a normal-fat 
(NF) standard chow diet (3.8 kcal/g, with 10% calories from fat; Research Diets, NJ, 
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901 USA) until the age of 4 months. 
Then, male and female rats from both control and CRL-groups were distributed into two 
groups: one group (n= 6-8 animals per group) that continued with NF-diet, and another group 
(n=5-8 animals per group) that was exposed to HF-diet (4.7 kcal/g, with 45% calories from fat; 
Research Diets, Inc., NJ, USA) until the age of 6 months. HF-diet contained 5.5% calories 
from soybean oil and 39.5% from lard. Body weight and food intake of the offspring were 
recorded from weaning until the age of 6 months, when animals were killed. Body length (from 
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the tip of the nose to the anus) and body composition (by EchoMRI-700TM, Echo Medical 
Systems, LLC., TX, USA) were measured without anesthesia when animals were 21 days old 
and 6 months old. 
Two weeks before sacrifice, blood samples of control and CRL-animals were collected under 
ad libitum feeding conditions and after 12 h fasting. Plasma was obtained as described above to 
analyze circulating parameters. Finally, at the age of 6 months, NF- and HF-diet fed rats were 
killed under ad libitum feeding conditions by decapitation during the first 2 h at the beginning 
of the light cycle and on different consecutive days (including animals from each group every 
day). At killing, different WAT depots (gWAT, iWAT, mWAT and rWAT) and liver were 
rapidly removed, weighed, frozen in liquid nitrogen and stored at -80ºC until RNA analysis.  
 
Measurement of circulating parameters and hepatic lipid content 
Blood glucose concentration was measured by Accu-Chek Glucometer (Roche Diagnostics, 
Barcelona, Spain). Commercial rat enzyme-linked immunosorbent assay (ELISA) kits were 
used for the quantification of circulating plasma levels of hormones: insulin (Mercodia AB, 
Uppsala, Sweden), and adiponectin and leptin (R&D Systems, Minneapolis, MN, USA), 
according to the manufacturer’s instructions. Commercial enzymatic colorimetric kits were 
used for the determination of plasma triglyceride (TG) levels (Triglyceride (INT) 20, Sigma 
Diagnostics, St Louis, MO, USA) and non-esterified fatty acid (NEFA) (Wako Chemicals 
GmbH, Neuss, Germany). Absorbance of the samples was read with a spectrophotometer 
Tecan Sunrise Absorbance Reader. 
The homeostatic model assessment for insulin resistance (HOMA-IR) was used to assess 
insulin resistance. It is calculated from fasting insulin and glucose concentration using the 
formula of Matthews et al. (Matthews, et al. 1985): HOMA-IR= fasting glucose (mmol/L) x 
fasting insulin (mU/L)/22.5. 
Total lipids in the liver were extracted and quantified by the procedure of Folch et al. (Folch, et 
al. 1957). 
 
Oral Fat Tolerance Test (OFTT) 
At the age of 4 months, an OFTT was performed on control and CRL-animals. Animals were 
deprived of food for 16 h and a load of 2.5 mL/kg body weight of virgin olive oil was orally 
given to the rats by oral gavage. Blood samples were taken from the saphenous vein, without 
anesthesia, into heparinized containers before oil load (at time zero), and at 1.5, 3, 4, 6 and 8 h 
thereafter. Plasma triglyceride levels were measured as described previously.  
 
Gene expression analysis in 21-day and 6-months old offspring 
RNA extraction  
Total RNA was extracted from liver and rWAT of control and CRL-animals by EZNA® 
TOTAL RNA kit I (Omega Bio-Tek Inc., Norcross, GA, USA) following the manufacturer’s 
instructions. Isolated RNA was quantified using the NanoDrop ND-1000 spectrophotometer 
(NanoDrop Techonologies, Ins., Wilmington, DE) and its integrity confirmed using agarose 
1% gel electrophoresis.  
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Real-time quantitative PCR-analysis  
Real-time quantitative polymerase chain reaction (RT-qPCR) was used to measure mRNA 
expression levels of Cpt1a (carnitine palmitoyltransferase 1 isoform a) and Srebp1c (sterol 
regulatory element-binding protein 1c) in liver; Cpt1b (carnitine palmitoyltransferase 1 isoform 
b), and Pparγ (peroxisome proliferator activated receptor  gamma 2) in rWAT; and Atgl 
(adipose triglyceride lipase), Fasn (fatty acid synthase), Gpat (glycerol-3-phosphate 
acyltransferase), Insr (insulin receptor), Irs1 (insulin receptor substrate 1), Pparα (peroxisome 
proliferator activated receptor alpha) and Obrb (long form leptin receptor) in liver and rWAT. 
Rho GDP dissociation inhibitor alpha (GDI) was used as a housekeeping gene. All primers 
used for RT-qPCR amplification were obtained from Sigma Genosys (Sigma Aldrich Química 
SA, Madrid, Spain) and sequences are described in (Palou, et al. 2012; Palou, et al. 2009a; 
Priego, et al. 2008) except for Irs1, whose sequences were: forward 5’-
GCAACCGCAAAGGAAATG-3’ and reverse 5’-ACCACCGCTCTCAACAGG-3’. 
Total RNA (0.25 µg; in a final volume of 5 µl) was denatured at 65ºC for 10 min and then 
reverse transcribed to cDNA using murine leukemia virus reverse transcriptase (Applied 
Biosystem, Madrid Spain) at 20ºC for 15 min, 42ºC for 30 min, with a final step of 5 min at 
95ºC in an Applied Biosystems 2720 Thermal Cycler (Applied Biosystem). Each qPCR was 
performed from diluted (1/5 or 1/10) cDNA template, forward and reverse primers (5 µM and 
10 µM), and Power SYBER Green PCR Master Mix (Applied Biosystems, Foster City, CA). 
qPCR was performed using the Applied Biosystems Step OnePlusTM Real-Time PCR Systems 
(Applied Biosystems) with the following profile: 10 min at 95ºC, followed by a total of 40 two 
temperature cycles (15 s at 95ºC and 1 min at 60ºC). To verify the purity of the products, a 
melting curve was produced after each run according to the manufacturer’s instructions. The 
threshold cycle was calculated by the instrument’s software (StepOne Software version 2.2). 
Relative gene expression numbers were calculated as a percentage of male control rats, using 
the 2-∆∆Ct method (Livak and Schmittgen 2001). 
 
Statistical analysis 
Data are mean ± standard error of the mean (S.E.M.). Multiple comparisons were assessed by 
ANOVA repeated measures and two-way ANOVA to determine the effects of different factors 
(calorie restriction during lactation, sex, and feeding conditions) separately for each diet (NF 
and HF). Single comparisons between groups were assessed by Student’s t test and Paired t 
test. A correlation analysis was performed for all the genes analyzed with hepatic lipids and 
circulating parameters considering all the animals as a whole at the age of 6 months. Only the 
genes showing significant correlations were indicated and were given their Pearson’s 
correlation index (r). To perform the correlation analysis, data of gene expression of all animals 
were referred to the expression levels of control males under NF-diet. Threshold of 
significance was set at p<0.05, unless indicated. Analysis was performed with SPSS for 
Windows (SPSS version 19.0, Chicago, IL). 
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Results 
Phenotypic traits and food intake 
20% calorie restriction during lactation resulted in lower body weight in the offspring from 
postnatal day 5 onwards, compared with their controls (Figure 1). This lower body weight was 
persistent in adulthood, under NF- and HF-diet conditions, and was more pronounced in 
females than in males. When animals were 6 months old, CRL-females weighed 11.4% and 
15.7% less than controls, under NF- and HF-diet respectively (Table 1). Notably, body weight 
of CRL-females exposed to HF-diet was even numerically lower than that of CRL-females 
under NF-diet, although differences were not significant. CRL-males weighed 7.8% and 6.4% 
less than their controls, under NF- and HF-diet, respectively. 
The lower body weight of CRL-animals could be due to shorter body length, for this reason we 
measured the length from the tip of the nose to the anus (body length) at different ages (Table 
1). At weaning (21 days), both male and female CRL-pups showed a significant shorter body 
length than their controls (p<0.05, two-way ANOVA), but no significant differences were 
found in adulthood in either sex.  
At weaning, CRL-animals showed higher body lean content and lower body fat content than 
controls; they also showed a decrease in weight of the main (gonadal, inguinal, mesenteric and 
retroperitoneal) WAT depots (p<0.05, two-way ANOVA) (Table 1). At the age of 6 months, 
differences concerning body fat content between control and CRL-animals were found under 
HF-diet (p= 0.067, two-way ANOVA), particularly in females (p<0.05, Student’s t test). A 
similar trend was found when analyzing the weight of different WAT depots. Concerning body 
lean content, HF-diet fed CRL-animals showed significantly higher lean content than controls 
(p<0.05, two-way ANOVA). Under NF-diet, only CRL-females, but not males, showed a 
higher percentage of lean mass and a tendency to lower fat content (interactive effect between 
sex and calorie restriction, p<0.05, two-way ANOVA). The same tendency was seen for the 
weight of main WAT depots, with the exception of the gonadal one, which showed a 
significant decrease in both male and female CRL-animals (p<0.05, two-way ANOVA).  
Food intake was also measured to determine whether differences in body weight gain between 
control and CRL-animals could be explained by differences in food intake (Table 1). CRL-
animals ate fewer calories than controls, both when exposed to NF- or HF-diet conditions 
(p<0.05, two-way ANOVA), with the differences being more marked and significant by 
Student’s t test in females.  
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Figure 1. Body weight over time of male and female offspring of control and calorie restricted dams during 
lactation (CRL) from day 1 until day 190 of age. From the age of 120 days, half of the animals of both control and 
CRL-group were exposed to a HF-diet, and the other half remained with NF-diet. The dashed line shows the 
beginning of the HF-diet. Data are mean ± S.E.M. (n= 11-16 animals per group until the age of 120 days; n= 5-8 
animals per group until the age of 190 days). Statistics: AxR, interaction between age and maternal calorie 
restriction during lactation (p<0.05, ANOVA repeated measures). 
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Table 1. Phenotypic traits at 21 days old and 6 months old, and cumulative food intake before 
and after exposure to HF-diet 
21 days old 
Males Females 
ANOVA 
Control CRL Control CRL 
Body weight (g) 48.1 ± 2.1 37.1 ± 0.8
*
 45.4 ± 1.1 36.9 ± 0.5
*
 R 
Body length (cm) 11.5 ± 0.2 10.8 ± 0.2
*
 11.0 ± 0.2 10.4 ± 0.1
*
 R,S 
Body fat mass (%) 10.0 ± 0.4 8.68 ± 0.26
*
 10.5 ± 0.3 8.87 ± 0.19
*
 R 
Body lean mass (%) 83.8 ± 1.0 87.2 ± 0.7
*
 83.4 ± 0.6 86.9 ± 1.0
*
 R 
gWAT (mg) 65.2 ± 8.3 47.8 ± 4.6 38.8 ± 5.2 23.2 ± 2.4
*
 R 
iWAT (mg) 294 ± 35 187 ± 19
*
 307 ± 33 186 ± 26
*
 R 
mWAT (mg) 105 ± 4 81.8 ± 2.2
*
 98.9 ± 11.2 81.2 ± 6.1 R 
rWAT (mg) 69.6 ± 9.9 40.1 ± 4.9
*
 50.5 ± 3.7 24.9 ± 3.2
*
 R,S 
6 months old – NF diet 
Males Females 
ANOVA 
Control CRL Control CRL 
Body weight (g) 498 ± 19 459 ± 17 281 ± 12 249 ± 11 R,S 
Body length (cm) 24.2 ± 0.5 24.0 ± 0.4 20.9 ± 0.4 20.3 ± 0.2 S 
Body fat mass (%) 20.7 ± 2.2 22.1 ± 1.6 22.1 ± 2.3 14.5 ± 1.2 RxS 
Body lean mass (%) 68.8 ± 2.2 67.6 ± 1.6 67.0 ± 2.1 73.9 ± 0.9
*
 RxS 
gWAT (g) 16.7 ± 2.0 12.1 ± 0.6
*
 9.96 ± 1.42 5.40 ± 0.90
*
 R,S 
iWAT (g) 9.95 ± 1.20 10.7 ± 0.7 3.93 ± 0.37 2.14 ± 0.45
*
 RxS 
mWAT (g) 7.09 ± 0.51 8.06 ± 0.79 3.60 ± 0.40 2.02 ± 0.34
*
 RxS 
rWAT (g) 12.8 ± 1.7 12.4 ± 1.0 4.53 ± 0.67 2.16 ± 0.23
*
 RxS 
6 months old – HF diet 
Males Females 
ANOVA 
Control CRL Control CRL 
Body weight (g) 517 ± 14 484 ±34 281 ± 9 237 ± 10 R,S 
Body length (cm) 24.3 ± 0.3 24.1 ± 0.4 20.6 ± 0.3 20.3 ± 0.3 S 
Body fat mass (%) 30.5 ± 1.6 27.7 ± 2.4 23.0 ± 1.1 19.3 ± 1.4
*
 R (p=0.067), S 
Body lean mass (%) 56.9 ± 2.3 63.9 ± 1.0
*
 66.3 ± 1.1 69.2 ± 1.5 R,S 
gWAT (g) 23.0 ± 1.7 18.9 ± 2.7 11.4 ± 1.1 7.18 ± 1.33
*
 R,S 
iWAT (g) 15.4 ± 1.4 13.8 ± 2.3 4.27 ± 0.53 2.93 ± 0.41 R (p=0.078), S 
mWAT (g) 10.2 ± 1.8 10.9 ± 1.6 3.10 ± 0.26 2.27 ± 0.39 S 
rWAT (g) 21.2 ± 2.0 18.9 ± 3.2 5.04 ± 0.47 3.13 ± 0.43
*
 R,S 
Cumulative food intake (Kcal) 
Males Females 
ANOVA 
Control CRL Control CRL 
From day 21 to 120 under NF-diet 6531 ± 102 6371 ± 85 4935 ± 65 4630 ± 101
*
 R,S 
From day 121 to 190 under NF-diet 4701 ± 152 4419 ± 71 3062 ± 67 2776 ± 106
*
 R,S 
From day 121 to 190 under HF-diet 5118 ± 123 4902 ± 55 3298 ± 74 2716 ± 88
*
 R,S 
Abbreviations: gonadal white adipose tissue (gWAT), inguinal white adipose tissue (iWAT), mesenteric white 
adipose tissue (mWAT), retroperitoneal white adipose tissue (rWAT), normal fat diet (NF-diet) and high fat diet 
(HF-diet). Data are mean ± S.E.M (n=5-8 animals per group) of male and female offspring of control and calorie 
restricted dams during lactation (CR). Statistics: R, effect of maternal calorie restriction during lactation; S, effect 
of sex; RxS, interaction between maternal calorie restriction during lactation and sex (p<0.05, two-way ANOVA). 
*, CRL vs. Control (p<0.05, Student’s t test).  
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Oral fat tolerance test 
At 4 months of age, we measured TG response to an OFTT in male and female offspring of 
control and calorie restricted dams (Figure 2). CRL-male animals showed a tendency to lower 
area under the curve (AUC) from 0-8h (7.9 ± 0.6 mg·h /mL) compared with their controls 
(10.4 ± 1.1 mg·h /mL) (p= 0.071, Student’s t test). These animals also showed a tendency to 
lower TG levels at the time point of 4 h (p= 0.072, Student’s t test). No significant changes 
were found between control and CRL-females.  
 
Figure 2. Triglyceride (TG) response (mg/mL) to an oral fat tolerance test (OFTT) in male (A) and female (B) 
offspring of control and calorie restricted dams during lactation (CRL) at 4 months of age. Data are mean ± 
S.E.M. (n= 6 animals per group). Statistics: *, CRL vs Control (p<0.05, Student’s t test). Abbreviations: area 
under the curve (AUC). 
 
Circulating parameters 
Circulating glucose, insulin, leptin, adiponectin, NEFA, and TG levels of control and CRL-
animals at the age of 21 days and 6 months are shown in Table 2. At weaning, compared to 
controls, male and female CRL-pups displayed lower circulating levels of glucose, insulin and 
leptin (p<0.05, two-way ANOVA) and higher adiponectin levels (only CRL-males, p<0.05 
Student’s t test). CRL-pups also showed lower leptin-to-adiponectin (L/A) ratio than controls 
Results and discussion – Manuscript 5 
- 175 - 
 
(p<0.05, Student’s t test). No differences were found concerning NEFA and TG levels between 
control and CRL-pups.  
 
Table 2. Circulating parameters under ad libitum feeding conditions and after 12h fasting 
conditions (for glucose and insulin plasma levels) at the age of 21 days under NF-diet, and 6 
months under NF- and HF-diet 
21 days old 
 Males Females 
ANOVA 
 Control CRL Control CRL 
Glucose (mg/dL) Fed 137 ± 7 120 ± 3*  141 ± 5 116 ± 4* R 
Insulin (µg/L) Fed 0.111 ± 0.042 0.044 ± 0.010 0.105 ± 0.020 0.037 ± 0.004* R 
Leptin (µg/L) Fed 0.941 ± 0.154 0.408 ± 0.045* 1.05 ± 0.11 0.585 ± 0.162* R 
Adiponectin (µg/mL) Fed 4.24 ± 0.47 9.15 ± 1.54* 9.72 ± 0.64 10.6 ± 1.3 RxS 
L/A ratio (%) Fed 100 ± 13 32.1 ± 9.7* 58.4 ± 3.9 31.3 ± 7.4* RxS 
NEFA (mM) Fed 1.46 ± 0.13 1.50 ± 0.14 1.37 ± 0.19 1.59 ± 0.13  
TG (mg/mL) Fed 1.02 ± 0.14 0.893 ± 0.130 0.938 ± 0.094 0.851 ± 0.042  
6 months old – NF diet 
 Males Females 
ANOVA 
 Control CRL Control CRL 
Glucose (mg/dL) Fed 108 ± 3 107 ± 6 105 ±4 102 ± 4 
F 
 Fasting 98 ± 8 95 ± 3
Ω 102 ± 3 90 ± 1*,Ω 
Insulin (µg/L) Fed 2.77 ± 0.94 1.44 ± 0.26 0.835 ± 0.102 0.459 ± 0.050
* 
FxR,S 
 Fasting 0.920 ± 0.379
 Ω 1.06 ± 0.24 Ω 0.558 ± 0.121 Ω 0.287 ± 0.047 Ω 
HOMA-IR Fasting 5.37 ± 2.38 5.77 ± 1.01 3.33 ± 0.75 1.67 ± 0.32 S 
Leptin (µg/L) Fed 15.8 ± 2.2 13.4 ± 1.1 6.07 ± 0.94 1.74 ± 0.19
* RxS 
Adiponectin (µg/mL) Fed 6.73 ± 0.60 6.60 ± 0.62 7.79 ± 0.63 8.05 ± 0.57 S 
L/A ratio (%) Fed 100 ± 12 90.8 ± 9.9 35.0 ± 5.6 9.39 ± 1.16
* RxS 
NEFA (mM) Fed 0.851 ± 0.152 0.910 ± 0.056 1.33 ± 0.24 0.866 ± 0.086  
TG (mg/mL) Fed 1.61 ± 0.08 1.40 ± 0.19 1.02 ± 0.12 0.920 ± 0.073 S 
6 months old – HF diet 
 Males Females 
ANOVA 
 Control CRL Control CRL 
Glucose (mg/dL) Fed 117 ± 4 108 ± 2 106 ± 4 106 ± 4 FxRxS 
 Fasting 103 ± 6 99.7 ± 4.0 106 ± 3 83 ± 1
*,Ω   
Insulin (µg/L) Fed 1.57 ± 0.33 1.79 ± 0.50 0.550 ± 0.093 0.341 ± 0.067 F,S 
 Fasting 1.05 ± 0.21 1.16 ± 0.34 0.424 ± 0.079 0.254 ± 0.047  
HOMA-IR Fasting 6.81 ± 1.05 5.41 ± 1.08 2.69 ± 0.50 1.28 ± 0.23
* R (p=0.063),S 
Leptin (µg/L) Fed 20 ± 3.6 16.5 ± 3.2 5.79 ± 0.84 2.73 ± 0.30
* R,S 
Adiponectin (µg/mL) Fed 6.86 ± 0.47 7.45 ± 0.36 7.58 ± 0.54 8.07 ± 0.53 S 
L/A ratio (%) Fed 100 ± 16 77.1 ± 15.5 25.9 ± 3.1 11.5 ± 1.7
* R,S 
NEFA (mM) Fed 0.973 ± 0.120 1.15 ± 0.13 0.917 ± 0.059 0.825 ± 0.088  
TG (mg/mL) Fed 1.35 ± 0.14  0.962 ± 0.046
* 0.662 ± 0.144 0.480 ± 0.094 R,S 
Abbreviations: insulin resistance HOMA index (HOMA-IR), leptin-to-adiponectin ratio (L/A ratio), non-esterified 
fatty acid (NEFA), triglycerides (TG). Data are mean ± S.E.M (n=5-8 animals per group) of male and female 
offspring of control and calorie restricted dams during lactation (CR). Statistics: F, effect of feeding conditions; R, 
effect of maternal calorie restriction during lactation; S, effect of sex; FxR, interaction between feeding conditions and 
maternal calorie restriction during lactation; RxS, interaction between maternal calorie restriction during lactation and 
sex; FxRxS, interaction between feeding conditions, maternal calorie restriction during lactation and sex (p<0.05, two-
way ANOVA). *, CR vs Control; 
Ω
, fasting vs feeding conditions (p<0.05, Student’s t test).  
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At the age of 6 months, under NF-diet conditions, no significant differences were found in 
glucose levels between control and CRL-rats, although fasted CRL-females showed lower 
glucose levels than controls (p<0.05, Student’s t test). Notably, only CRL-animals showed a 
significant decrease in glucose levels as an effect of fasting conditions (p<0.05, Paired t test). 
CRL-animals, and particularly females, showed lower levels of insulin than their controls 
(p<0.05, ANOVA repeated measures), and CRL-females also showed lower leptin and L/A 
ratio (p<0.05, Student’s t test; interactive effect between calorie restriction and sex, p<0.05, 
two-way ANOVA). We did not find significant differences between control and CRL-animals 
concerning HOMA index under NF-diet, but female CRL-animals showed a tendency to lower 
values than controls (p= 0.076, Student’s t test). No significant differences were found in 
adiponectin, NEFA or TG levels due to maternal calorie restriction in NF-diet fed rats. When 
exposed to HF-diet, a sex- and treatment- dependent response to feeding conditions was found 
in glucose levels (interactive effect between sex, calorie restriction and feeding conditions, 
p<0.05, ANOVA repeated measures); this is explained by the lower fasted glucose levels of 
CRL-females, but not males, with respect to their controls (p<0.05, Student’s t test) and with 
respect to the fed state (p<0.05, Paired t test). Interestingly, CRL-animals showed lower leptin, 
L/A ratio and TG levels than control rats (p<0.05, two-way ANOVA). No significant 
differences were found in insulin, adiponectin or NEFA levels as an effect of calorie restriction 
during lactation under a HF-diet. However, HF-diet exposed CRL-females, but not males, 
displayed significantly lower HOMA index than their controls (p<0.05, Student’s t test). 
 
Hepatic lipid content  
Figure 3 shows hepatic lipid content in the different groups of animals at the age of 6 months. 
CRL-animals presented lower lipid content compared to controls, both under NF- and HF-diet 
conditions (p<0.05, Student’s t test).  
 
Figure 3. Hepatic lipid content (mg) in male and female offspring control and calorie restricted dams during 
lacation (CRL) at 6 months of age under NF- and HF-diet. The number in brackets indicates the percentage of 
lipid increment in liver as effect of HF-diet vs their respective controls under NF-diet. Data are mean ± S.E.M. (n= 
6-8 animals per group under NF-diet; n= 5-8 animals per group under HF-diet). Statistics: R, effect of maternal 
calorie restriction during lactation; S, effect of sex; and RxS, interaction between maternal calorie restriction 
during lactation and sex; DxS, interaction between diet and sex (p<0.05, two-way ANOVA). *, CRL vs Controls; 
φ, HF-diet vs NF-diet (p<0.05, Student’s t test). Abbreviations: Normal-fat diet (NF-diet), high-fat diet (HF-diet). 
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Interestingly, hepatic lipid content increased in male animals when exposed to HF-diet, but this 
increase was less marked in CRL-animals (p<0.05, Student’s t test). In contrast, HF-diet 
feeding, in the conditions of this study, did not induce significant changes in hepatic lipid 
content in females, either in control or CRL-animals. 
 
mRNA levels of energy balance and lipid metabolism related-genes in rWAT and liver  
Figure 4A shows mRNA expression levels of selected genes in rWAT of 21-day-old control 
and CRL-pups. The retroperitoneal depot was selected to be analyzed for gene expression, 
based on the literature showing that this depot seems to be more sensitive to nutritional status, 
compared with other depots (Palou, et al. 2010b). CRL-pups showed lower mRNA levels of 
Fasn and greater mRNA levels of Pparα, Atgl, Insr and Irs1 than controls (p<0.05, two-way 
ANOVA). In addition, an interaction between the effects of calorie restriction during lactation 
and sex was observed in the mRNA levels of Gpat (p<0.05, two-way ANOVA), since CRL-
female animals, but not males, showed a significant decrease in their expression levels (p<0.05, 
Student’s t test). No significant differences were observed in the expression levels of the other 
genes analyzed (Pparγ, Cpt1b, and Obrb) between control and CRL-animals. Figures 4B and 
4C show mRNA levels of 6-month-old controls and CRL-animals in rWAT under NF- and HF-
diet conditions, respectively. 
Changes described in 21-day-old pups between control and CRL-animals were not maintained 
in adulthood under NF-diet conditions; adult CRL-animals showed even higher mRNA levels 
of Gpat than controls (p<0.05, two-way ANOVA), with the difference being more marked and 
significant in males (p<0.05, Student’s t test). However, under HF-diet, CRL-rats displayed 
higher mRNA levels of Atgl and Irs1 compared to their controls (p<0.05, two-way ANOVA), 
similarly to what was found at the age of 21 days. In addition, CRL-animals showed higher 
mRNA levels of Obrb and, contrary to what was found in young animals, higher Fasn mRNA 
levels than controls (p<0.05, two-way ANOVA). Moreover, CRL-females showed increased 
Cpt1b mRNA expression with respect to controls (p<0.05, Student’s t test), while no 
significant changes were found in CRL-males (interactive effect between sex and calorie 
restriction, p<0.05, two-way ANOVA).  
Results on gene expression in liver of 21-day-old control and CRL-pups are shown in Figure 
5A. CRL-animals showed lower mRNA levels of Srebp1c and higher mRNA levels of Cpt1a 
and Obrb compared to their controls (p<0.05, two-way ANOVA). CRL-animals also showed 
Atgl mRNA levels slightly higher than controls (p= 0.087, two-way ANOVA). No significant 
differences were found concerning mRNA levels of Fasn, Gpat, Pparα, Insr or Irs1 as an 
effect of calorie restriction during lactation. Figures 5B and 5C show mRNA expression levels 
in the liver of 6-month-old control and CRL-animals under NF- and under HF-diet, 
respectively. NF-diet fed CRL-animals showed lower mRNA levels of Gpat (p<0.05, two-way 
ANOVA) and Srebp1c (p=0.072, two-way ANOVA, specially CRL-males by Student’s t test, 
p<0.05) with respect to controls. No significant differences between control and CRL-animals 
were found for the rest of genes studied under NF-diet conditions, although an interaction 
between maternal calorie restriction during lactation and sex was found for mRNA levels of 
Cpt1a. When exposed to HF-diet, sex-dependent differences between control and CRL-animals 
were found. Concretely, no changes or a trend to lower mRNA levels of Srebp1c, Pparα, Insr, 
Irs1 and Obrb were found in CRL-males with respect to their controls, whereas higher mRNA 
levels (Irs1 and Obrb) or a tendency to higher levels (Srebp1c, Pparα, Insr) was found in 
females (interactive effect between calorie restriction and sex, p<0.05, two-way ANOVA). 
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Figure 4. mRNA levels of energy balance and lipid metabolism related genes in retroperitoneal white adipose 
tissue (rWAT) of male and female offspring of control and calorie restricted dams during lactation (CRL), at 21 
days old (A), 6 months old under NF-diet (B), and 6 months old under HF-diet (C). mRNA levels were measured 
by RT-qPCR and expressed as a percentage of the mean value of control males. Data are mean ± S.E.M. (n= 6-7 
animals per group at 21 days; n= 6-8 animals per group at 6 months under NF-diet; n= 5-8 animals per group at 6 
months under HF-diet). Statistics: R, effect of maternal calorie restriction during lactation; S, effect of sex; and 
RxS, interaction between maternal calorie restriction during lactation and sex (p<0.05, two-way ANOVA). *, CRL 
vs Controls (p<0.05, Student’s t test). Abbreviations: peroxisome proliferator activated receptor gamma (Pparγ), 
fatty acid synthase (Fasn), glycerol-3-phosphate acyltransferase (Gpat), peroxisome proliferator activated receptor 
alpha (Pparα), carnitine palmitoyltransferase 1 isoform b (Cpt1b), adipose triglyceride lipase (Atgl), insulin 
receptor (Insr), insulin receptor substrate 1 (Irs1) and long form leptin receptor (Obrb). 
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Figure 5. mRNA levels of energy balance and lipid metabolism related genes in liver of male and female 
offspring of control and calorie restricted dams during lactation (CRL), at 21 days old (A), 6 months old under 
NF-diet (B), and 6 months old under HF-diet (C). mRNA levels were measured by RT-qPCR and expressed as a 
percentage of the mean value of control males. Data are mean ± S.E.M. (n= 6-7 animals per group at 21 days; n= 
6-8 animals per group at 6 months under NF-diet; n= 5-8 animals per group at 6 months under HF-diet). Statistics: 
R, effect of maternal calorie restriction during lactation; S, effect of sex; and RxS, interaction between maternal 
calorie restriction during lactation and sex (p<0.05, two-way ANOVA). *, CRL vs Controls (p<0.05, Student’s t 
test). Abbreviations: sterol regulatory element-binding protein 1c (Srebp1c), fatty acid synthase (Fasn), glycerol-
3-phosphate acyltransferase (Gpat), peroxisome proliferator activated receptor alpha (Pparα), carnitine 
palmitoyltransferase 1 isoform a (Cpt1a), adipose triglyceride lipase (Atgl), insulin receptor (Insr), insulin 
receptor substrate 1 (Irs1) and long form leptin receptor (Obrb). 
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Correlation analysis of selected parameters 
We used correlation analysis to investigate putative relationships between transcript levels of 
the genes studied with hepatic lipid content and plasma circulating parameters (Table 3). 
Considering all animals as a whole at the age of 6 months, we observed a negative correlation 
between mRNA levels of Irs1 in rWAT with hepatic lipids (r= -0.436; p= 0.001, Pearson’s 
correlation) and with TG plasma levels (r= -0.386; p= 0.005, Pearson’s correlation). Obrb 
mRNA levels in liver also showed a negative correlation with hepatic lipid content (r= -0.477; 
p= 0.000, Pearson’s correlation) and with circulating levels of insulin under ad libitum feeding 
conditions (r= -0.246; p= 0.076, Pearson’s correlation). Finally, mRNA levels of hepatic 
Srebp1c showed a positive correlation with hepatic lipids (r= 0.368; p= 0.013, Pearson’s 
correlation) and with HOMA index (r= 0.276; p= 0.070, Pearson’s correlation). No significant 
correlations were found regarding transcript levels of the other genes studied in rWAT or liver 
(data not shown). 
 
Table 3. Correlation analysis of hepatic lipid content and plasma circulating parameters with 
mRNA expression levels of Irs1 in rWAT and of Obrb and Srebp1c in liver, considering all 
animals as a whole at the age of 6 months 
 
  Hepatic Lipids Plasma TG Insulin AL HOMA-IR 
Irs1 (rWAT) 
r 
p 
-0.436 
0.001** 
-0.386 
0.005** 
--- --- 
Obrb (Liver) 
r 
p 
-0.477 
0.000** 
--- 
-0.246 
0.076 
--- 
Srebp1c (Liver) 
r 
p 
0.368 
0.013* 
--- --- 
0.276 
0.070 
Correlations were performed for all genes analyzed, but only those showing significant correlations are indicated. 
r, Pearson correlation index; p, p-values for Pearson correlation coefficient. Abbreviations: ad libitum (AL), 
insulin resistance HOMA index (HOMA-IR), insulin receptor substrate 1 (Irs1), long form leptin receptor (Obrb), 
triglycerides (TG), retroperitoneal white adipose tissue (rWAT), sterol regulatory element-binding protein 1c 
(Srebp1c). Statistics: *, p-value<0.05; **, p-value<0.005. 
 
Discussion 
Here, we show that a modest maternal calorie restriction (20%) during lactation, which could 
be a typical situation of dieting representative or applicable in humans, causes beneficial 
effects in offspring against obesity development and other metabolic alterations in adult life. 
Notably, the effects of this condition during lactation improving the offspring metabolic health 
were generally more evident in females, and particularly when animals were exposed to 
obesogenic conditions. Therefore, this model can be useful to ascertain what adaptations are 
taking place at early ages that may confer protection against later development of obesity.  
Regarding the characterization of the model, in short, we found that the offspring of 20% 
calorie restricted dams during lactation showed lower body weight in adulthood, as well as 
lower adiposity when exposed to HF-diet conditions, with the differences being more evident 
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in females. These effects could be explained, in part, by their lower food intake. Cumulative 
food intake was lower in CRL-animals than their controls, both under NF- and HF-diet, with 
the differences being also more marked in females. These results are in accordance with our 
previous studies with 30% calorie restriction, where a comparison of accumulated calories 
eaten in adulthood also showed a lower value for CRL-animals, particularly females, compared 
to controls (Palou, et al. 2010b; Palou, et al. 2011).  Remmers et al. (Remmers, et al. 2008a) 
also observed a reduced body weight, fat content and food intake in calorie restricted rats 
during lactation obtained by increasing the litter size. 
At early ages, the lower body weight and body fat content of CRL-animals was associated to 
shorter body length. However, differences in body length disappeared as the animals grew and 
no differences were found in adulthood. These results contrast with those described when 
increasing litter size (Remmers, et al. 2008b) which maintained shorter body weight and length 
than their controls. Other models of nutrient restriction during lactation, such as that obtained 
by 65% maternal protein restriction also showed more severe effects on body weight in the 
offspring as well as shorter body length until the age of 6 months (de Moura, et al. 2007). 
Interestingly, the very modest calorie restricted diet used here during the suckling period (20%) 
also prevents excess weight gain in their offspring and reduces body fat accretion in females, 
without impeding catching up normal body length under standard diet conditions. 
CRL-animals also displayed a better profile of circulating parameters. Leptin and insulin are 
proteins related with energy intake and expenditure and their circulating levels may be 
considered as biomarkers of metabolic health and appropriate body weight and food intake 
control (Friedman and Halaas 1998). Adiponectin is also linked with obesity and insulin 
sensitivity (Berg, et al. 2001; Yamauchi, et al. 2001), and the leptin to adiponectin (L/A) ratio 
has been proposed as a useful, more reliable measure of insulin resistance and vascular risk 
than levels of leptin and adiponectin alone (Finucane, et al. 2009; Satoh, et al. 2004). At 
weaning, plasma levels of glucose, insulin and leptin were significantly lower in CRL-animals 
compared to their controls, remarkably in females. In turn, adiponectin levels were 
significantly higher in CRL-animals, and hence the L/A ratio was significantly lower. 
Therefore, levels of insulin, leptin and adiponectin in CRL-animals at this early age suggest 
that these animals are programmed for better body weight control. The above differences 
between control and CRL-animals were partially maintained in adulthood, but were more 
evident under HF-diet conditions. Concretely, under HF-diet, CRL-animals showed lower 
leptin levels and lower L/A ratio than controls; in both cases the improved effects were more 
marked in females. CRL-females also showed lower HOMA index than their controls. Thus, 
measures of both L/A ratio and HOMA index were indicative of improved insulin sensitivity in 
CRL-animals, particularly females.  
Circulating lipid profile could also give some clues to characterize the metabolic health of 
these animals in relation with lipid metabolism and handling. In this sense, we previously 
described that 30% moderate maternal calorie restriction in lactating rats resulted in an 
improved capacity of the adipose tissue of male adult offspring to handle and store excess fuel 
when exposed to HF-diet, as evidenced by changes at the gene expression level of key genes 
involved in lipid metabolism (Palou, et al. 2011). Thus, to further study whether a more modest 
20% calorie restriction during lactation was associated with a better capacity to handle dietary 
lipids and improved lipemia, an OFTT was performed at the age of 4 months. Impaired 
postprandial metabolism of TG in terms of a higher peak or delayed clearance has been 
associated with higher cardiovascular risk (Ansar, et al. 2011). Results showed a trend to a 
lower increase in circulating TG after the oral load of fat in CRL-male animals, compared to 
controls. It must be noted that, although differences between both groups were slight, this 
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improvement in CRL-males was already evident at the age of 4 months, and prior to apparent 
signs of an impaired function related to age. In female animals, differences between control 
and CRL were not evident, at least at this age. The protective effects of calorie restriction 
during lactation against dyslipidemia were further evident later on when animals were exposed 
to HF-diet, since CRL-animals, both males and females, showed lower TG levels than controls 
under this dietary stressor. Interestingly, CRL-animals, both under NF- and HF-diet, also 
displayed lower hepatic lipid content, the hallmark of nonalcoholic fatty liver disease 
(NAFLD), which is well recognized as being part of the metabolic syndrome (Postic and 
Girard 2008). In accordance with the literature (Priego, et al. 2008), fat overloading in the diet 
brings a different response in males and females, since males seems to be more prone to 
accumulating lipids in the liver. Here it is also shown that, in both sexes, the response to HF-
diet seem to be better in CRL-animals compared to controls.  
All in all, these results, together with our previous studies with a higher restriction (Palou, et al. 
2010b; Palou, et al. 2011), show that moderate calorie restriction during lactation may protect 
the offspring against the development of obesity and related metabolic alterations in later life, 
including insulin and leptin resistance, dyslipidemia, and hepatic steatosis. Considering the fact 
that the incidence of obesity is increasing worldwide at alarming rates, the identification of 
strategies for its prevention is of great interest, from early stages of life. This model could be 
useful to ascertain what adaptations during early life could be responsible for later benefits, and 
hence to identify potential markers of improved metabolic health and body weight control. For 
this reason we analyzed the expression of selected genes in key tissues involved in energy 
metabolism, such as rWAT and liver, at a young age (at weaning), to identify early transcript-
based markers. Besides, to ascertain the robustness of these potential biomarkers, we also 
analysed whether they were persistent in adulthood, under normal or stressful dietary 
conditions, and if a relationship exists between the levels of these transcripts and circulating 
parameters.  
Regarding rWAT, when looking at the expression of genes related with insulin and leptin 
sensitivity, results showed that CRL-pups, at weaning, displayed higher Insr and Irs1 mRNA 
expression levels. In adulthood, differences were not maintained under NF-diet; however, 
under HF-diet conditions, mRNA expression levels of Irs1 were also higher in CRL-animals in 
comparison to controls. Obesity is known to be the most common cause of insulin resistance 
and to be accompanied by a decrease in insulin receptor density and the related failure to 
activate tyrosine kinase activity (Brock and Dorman 2007). Thus, the fact that CRL-animals 
showed higher mRNA levels of proteins involved in insulin signalling in rWAT suggests that 
these animals may be programmed to better respond in this tissue to the biological actions of 
insulin. Interestingly, mRNA levels of Irs1 in adult animals were negatively correlated with 
hepatic lipid content and with TG circulating levels. Thus, although correlation does not imply 
causation, this association pinpoints the potential relevance of transcript levels of this gene as a 
marker of metabolic health, programming animals for a better body weight control. Regarding 
leptin signalling, mRNA expression levels of Obrb at weaning were not changed by the effects 
of maternal calorie restriction during lactation, nevertheless, in adulthood and under HF-diet, 
Obrb mRNA levels were increased in CRL-animals compared to controls.  
In addition, 21-day-old CRL-pups showed a better expression profile in rWAT of genes 
involved in lipid metabolism. In concrete, they showed higher expression levels of Atgl, the 
main protein involved in TG mobilization, and of PPARα, the major transcription factor 
regulating fatty acid oxidation. In adulthood and under HF-diet feeding conditions, CRL-
animals also maintained higher mRNA expression levels of Atgl than controls. Moreover, at 6 
months old, HF-diet-fed CRL-females displayed higher expression levels of Cpt1b. Curiously, 
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CRL-females but not males, showed lower Fasn and Gpat mRNA levels than controls at 
weaning, but when animals were 6 months old, CRL-rats displayed higher mRNA expression 
levels of Gpat, under NF-diet conditions, and higher mRNA levels of Fasn, under HF-diet. The 
greater expression levels of these lipogenic genes in adult CRL-animals were not associated 
with any significant increase in the size of this adipose tissue depot, but could reflect increased 
capacity of these animals to drive and store excess energy to the adipose tissue. Therefore, 
differences in the expression levels of Fasn and Gpat between controls and CRL-animals seem 
to be dependent on the age, type of diet and sex of animals. 
The liver plays an important role in energy metabolism and is also a target of the peripheral 
action of leptin and insulin. Concerning insulin signalling, HF-diet-fed female animals in the 
CRL-group, but not males, showed higher mRNA levels of Irs1 compared with their controls, 
although no significant changes were previously observed at weaning. A similar trend, but not 
significant, was also found for Insr. Interestingly, 21-day-old CRL-pups showed higher Obrb 
mRNA expression levels, and this pattern was maintained in adult CRL-females under HF-diet. 
The physiological role of peripheral leptin signalling, particularly in liver, and its relative 
contribution to whole-body energy metabolism, still remain unclear. Peripheral leptin 
signalling has been considered dispensable for whole body energy homeostasis, since mice 
lacking peripheral Obrb expression showed no significant alterations in tissue and whole-body 
energy metabolism (Guo, et al. 2007). Nevertheless, leptin action in liver has been shown to 
attenuate hepatic glucose production and insulin resistance under normal conditions of lean 
animals, hence contributing to the inhibitory effects of insulin on gluconeogenesis (Brabant, et 
al. 2005). This effect was largely lost in obese animals, which showed decreased expression of 
the leptin receptor gene in liver (Brabant, et al. 2005). Hence, maintenance of higher Obrb 
expression levels occurring in CRL-females when fed a HF-diet could be related with 
increased peripheral leptin and insulin sensitivity, as evidenced by the presence of lower 
circulating levels of leptin, as well as lower L/A ratio and HOMA index. Interestingly, hepatic 
Obrb mRNA levels in adult animals were correlated negatively with hepatic lipids and with 
circulating levels of insulin under ad libitum feeding conditions (although the latter with a p 
value of only 0.076). All in all, these results suggest that increased Obrb mRNA levels in liver 
may be considered beneficial in terms of leptin-to-insulin signalling crosstalk and concerning 
hepatic lipid storage. Thus, Obrb mRNA levels in liver could be considered as a marker of 
metabolic health.  
Other changes occurring at the gene expression level in liver are also in accordance with the 
protection of CRL-animals against hepatic TG accumulation. That is, CRL-pups showed lower 
mRNA expression levels of Srebp1c than controls. This trend was maintained in adult male 
animals, particularly under NF-diet conditions. Activation of SREBP1c has been related with 
increased lipogenesis and has been considered one of the molecular mediators of hepatic 
steatosis (Browning and Horton 2004). Interestingly, mRNA levels of Srebp1c in liver were 
positively correlated with hepatic lipid content and also with HOMA index in adult animals 
(the latter with p=0.070). In addition, adult CRL-animals under NF-diet also showed lower 
expression levels of Gpat, the rate limiting enzyme in TG synthesis (Wendel, et al. 2009). 
Moreover, at weaning, CRL-pups showed higher hepatic mRNA expression levels of genes 
related with lipid mobilization and fatty acid oxidation, Atgl and Cpt1a. ATGL is a key 
triacylglycerol lipase in the liver, and its overproduction has been associated with reduced 
steatosis and improved insulin signal transduction in this tissue (Turpin, et al. 2011). On the 
other hand, increased hepatic Cpt1a expression levels may also be a mechanism contributing to 
the protection of these animals against excessive body weight gain and related metabolic 
alterations, as evidenced in mice with adenovirus-mediated overexpression of Cpt1a in liver 
(Orellana-Gavaldà, et al. 2011). However, changes in the expression levels of the genes, Atgl 
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and Cpt1a, by the effect of calorie restriction during lactation, were no longer observed in 
adulthood.  
In conclusion, a very modest maternal calorie restriction of 20% during lactation in rats 
programs the offspring for better metabolic health in terms of body weight and lipid handling. 
This condition during lactation determines early adaptations in rWAT and liver, affecting 
lipogenic and oxidative capacity and increasing their sensitivity to the peripheral effects of 
leptin and insulin, which suggests a better control of energy metabolism. These adaptations 
occurring in early ages are partially maintained in adulthood, and are particularly evident when 
animals are exposed to an obesogenic environment. Interestingly, among the genes that exhibit 
changes at the expression level in early ages, Irs1 in rWAT and Obrb and Srebp1c in liver are 
of relevance because their transcript levels in adult animals were associated with lower hepatic 
lipid content and improved circulating parameters, thus they could be considered as potential 
biomarkers of a healthy phenotype. Validation of these biomarkers in human samples, 
particularly blood cells, which can be easily collected in sufficient quantities by a minimally 
invasive method, becomes of interest.  
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Abstract 
Moderate maternal calorie-restriction during lactation protects rat offspring against obesity 
development in adulthood, due to an improved ability to handle and store excess dietary fuel. 
We used this model to identify early transcriptome-based biomarkers of metabolic health using 
peripheral blood mononuclear cells (PBMCs), an easily accessible surrogate tissue, by focusing 
on molecular markers of lipid handling. Male and female offspring of control and 20% calorie-
restricted lactating dams (CRL) were studied. At weaning, a set of pups was killed, and 
PBMCs were isolated for whole genome microarray analysis. The remaining pups were 
sacrificed at 6 months of age. CRL gave lower body weight, food intake and fat accumulation, 
and improved levels of insulin and leptin throughout life, particularly in females. Microarray 
analysis of weaned rat PBMCs identified 278 genes significantly differentially expressed 
between control and CRL. Among lipid metabolism-related genes, expression of Cpt1a, Lipe 
and Star was increased and Fasn, Lrp1 and Rxrb decreased in CRL versus control, with 
changes fully confirmed by qPCR. Among them, Cpt1a, Fasn and Star emerged as particularly 
interesting. Transcript levels of Cpt1a in PBMCs correlated with their levels in WAT and liver 
at both ages examined; Fasn expression levels in PBMCs at an early age correlated with their 
expression levels in WAT; and early changes in Star expression levels in PBMCs correlated 
with their expression levels in liver and were sustained in adulthood. These findings reveal the 
possibility of using transcript levels of lipid metabolism-related genes in PBMCs as early 
biomarkers of metabolic health status. 
 
Keywords: early biomarkers, PBMCs, calorie-restriction, lactation, metabolic programming 
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Introduction 
The increasing prevalence of obesity has become a worldwide phenomenon, affecting both 
children and adults. Obesity and its related risks can be prevented by lifestyle changes and 
especially by changes in diet (Perk et al. 2012). Specific diets, foods and food-components can 
contribute to the development of urgently needed therapeutic and preventive strategies. The 
development of such nutrition and food based strategies is, however, severely hampered by the 
lack of predictive biomarkers, especially those that are accessible and quantify health (van 
Ommen et al. 2009). In order to identify such biomarkers a model is needed that results in 
changes that reflect the later health status. Such a model is provided by moderate calorie 
restriction during lactation. Obesity and related pathologies can be programmed by maternal 
nutrition during the perinatal period (Sullivan and Grove 2010; Pico et al. 2012). While 
maternal calorie-restriction during pregnancy has been associated with adverse health 
outcomes in adult offspring (Palou et al. 2012; Palou et al. 2010a), moderate maternal calorie-
restriction during lactation in rats has been shown to confer certain protection in the pups 
against development of obesity and related metabolic alterations associated with high-fat (HF) 
diet feeding, particularly dyslipidemia, insulin resistance, and hyperleptinemia (Palou et al. 
2010b). This provides an animal model that is suited to identify early biomarkers for metabolic 
health, in terms of a reduced tendency to develop overweight and its associated metabolic 
complications in adult life. 
Suitability of biomarkers for efficacy substantiation requires that they can readily be assessed 
in humans. Most studies that mechanistically assess effects of diet and foods on health examine 
tissues such as adipose tissues, muscle or liver which require invasive tissue biopsies (de Mello 
et al. 2012). Peripheral blood mononuclear cells (PBMCs) provide an attractive alternative that 
can be assessed in humans, because they can be easily and repeatedly collected in sufficient 
quantities (de Mello et al. 2008). Gene expression responses of PBMCs have been shown to 
reflect the liver environment (de Mello et al. 2012), as well as adipose tissue (Caimari et al. 
2010b; Caimari et al. 2010a). Therefore, whole genome transcriptome profiling of PBMCs of 
pups from calorie restricted mothers during lactation may be used to identify early biomarkers, 
reflecting current and later health of metabolic tissues.  
The aim of the current study was to identify early potentially predictive biomarkers of 
metabolic health by transcriptome profiling of PBMCs. As a model, we used the offspring of 
20% maternal calorie-restricted dams during lactation, which are less prone to obesity 
development compared to at libitum fed controls.  We also ascertained i) to what extent the 
potential markers of optimized health identified at early ages continued to serve as potential 
markers in adulthood and ii) whether the changes occurring in blood cells reflected the 
metabolic environment in key tissues. We focused on selected genes of lipid metabolism and 
assessed these in relevant metabolic tissues, liver and white adipose tissue (WAT), at different 
ages. 
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Methods and Materials 
Animals and experimental design 
The animal protocol followed in this study was reviewed and approved by the Bioethical 
Committee of the University of the Balearic Islands (Resolution Number 1798. February 18th, 
2009) and guidelines for the use and care of laboratory animals of the University were 
followed. 
The study was conducted on male and female Wistar rats from 16 different litters following the 
protocol described below. All animals were housed under standard conditions, that is, 
controlled temperature (22ºC), the normal 12 h light and 12 h dark cycle, free access to tap 
water and a standard chow diet (3 kcal/g, with 8% calories from fat; Panlab, Barcelona, Spain), 
unless specified otherwise. Briefly, 16 virgin female Wistar rats (body weight 225 - 260 g) 
were mated with male rats (Charles River Laboratories, Barcelona, Spain). After mating, each 
female was placed in an individual cage. On day 1 after delivery, excess pups in each litter 
were removed aiming for 10 pups per dam (five males and five females, when possible). Dams 
were assigned to either the control (n=11 dams) or calorie-restricted (n=5 dams) group. Control 
dams were fed ad libitum with standard chow diet (Panlab, Barcelona, Spain), while calorie-
restricted dams were fed daily with a 20% calorie-restricted diet throughout lactation, starting 
on day 1 after delivery until weaning (day 21) as previously described (Palou et al. 2010b). 
During the lactating period, body weight of male and female offspring of control and calorie-
restricted dams (control and CRL, respectively) was followed.  
At weaning, a set of animals made up of 24 pups from control (12 males and 12 females) and 
24 from CRL (12 males and 12 females) group were sacrificed by decapitation under ad 
libitum feeding conditions. One half of pups (n=6/group) were used to obtain different WAT 
depots (inguinal and retroperitoneal; iWAT and rWAT, respectively) and liver (which were 
rapidly removed, frozen in liquid nitrogen and stored at -70ºC until RNA analysis), as well as 
trunk blood samples (for peripheral blood mononuclear cells (PBMCs) isolation, as described 
in the next section). From the other half of pups (n=6/group), blood samples were collected in 
heparinized containers and plasma was obtained by centrifugation at 700 g for 10 min. 
Another set of animals, 28 control pups (12 males and 16 females) and 26 CRL pups (14 males 
and 12 females), were kept alive. They were placed two per cage, paired with another animal 
of the same group, and fed ad libitum with a normal-fat (NF) diet (3.8 kcal/g, 10% calories 
from fat, Research Diets, Inc., NJ, USA) until the age of 6 months. Body weight and food 
intake of those animals were followed. Moreover, at the age of 6 months (prior to sacrifice), 
blood samples were collected at fed state and after 12 h fasting to obtain plasma. All the 
animals were decapitated under ad libitum feeding conditions at the age of 6 months, and 
samples of trunk blood for PBMCs isolation were collected. Body length (from the tip of the 
nose to the anus) and body composition (by EchoMRI-700TM, Echo Medical Systems, LLC., 
TX, USA) were measured in control and CRL animals without anesthesia when animals were 
21 days and 6 months old. 
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Measurement of circulating parameters under fed/fasting conditions, and calculation of the 
homeostatic model assessment for insulin resistance (HOMA-IR) at different ages 
Blood samples collected at the ages of 21 days (under ad libitum feeding conditions) and 6 
months (under ad libitum and 12 h fasting conditions) were used for analysis of circulating 
parameters. Blood glucose concentration was measured by Accu-Chek Glucometer (Roche 
Diagnostics, Barcelona, Spain). Peripheral hormones were measured using commercial 
enzyme-linked immunosorbent assay (ELISA) kits: insulin concentration was determined using 
a rat insulin ELISA kit (Mercodia AB, Uppsala, Sweden) and leptin with QuantikineTM 
Mouse Leptin Inmunoassay (R&D Systems, Minneapolis, MN, USA), according to the 
manufacturer’s instructions. Plasma non-esterified fatty acid (NEFA) and triglyceride levels 
(TG) were determined with a commercial enzymatic colorimetric kits (Wako Chemicals 
GmbH, Neuss, Germany and Triglyceride (INT) 20, Sigma Diagnostics, St Louis, MO, USA, 
respectively), following standard procedures. The homeostatic model assessment for insulin 
resistance (HOMA-IR) was used to assess insulin resistance. It is calculated from fasting 
insulin and glucose concentration using the formula of Matthews et al. (Matthews et al. 1985): 
HOMA-IR=fasting glucose (mmol/liter) x fasting insulin (mU/liter)/22.5. 
 
PBMC isolation 
Trunk blood samples of control and CRL rats collected (at the age of 21 days and 6 months) 
under ad libitum feeding conditions, were used to isolate PBMCs. Peripheral blood samples  
were collected using heparin in NaCl (0.9%) as anticoagulant, and then diluted with an equal 
volume of balanced salt solution. PBMCs were immediately isolated by Ficoll density-gradient 
separation according to the instructions of the manufacturer (GE Healthcare Bio Sciences, 
Barcelona, Spain).  
 
Total RNA isolation 
Total RNA was extracted from iWAT, rWAT, liver and PBMCs of control and CRL animals 
by EZNA® TOTAL RNA kit I (Omega Bio-Tek Inc., Norcross, GA, USA) following the 
manufacturer’s instructions. Isolated RNA was quantified using the NanoDrop ND-1000 
spectrophotometer (NanoDrop Techonologies, Ins., Wilmington, DE) and its integrity 
confirmed using 1% agarose gel electrophoresis (for iWAT, rWAT and liver).  
 
Microarray processing 
For microarray analysis, RNA from PBMC samples obtained from male and female offspring 
of controls and CRL animals at the age of 21 days were used (n=6/group). RNA samples were 
analyzed on Agilent 2100 Bioanalyzer with RNA 6000 Nano chips (Agilent Technologies, 
South Queensferry, United Kingdom). To assure the high quality of RNA, all samples used for 
microarrays had a RIN number ≥ 8. Then, 0.04 µg of RNA from each sample was reverse 
transcribed to complementary DNA (cDNA) using the Agilent Low Input Quick Amp Labeling 
kit (Agilent Technologies, Inc., CA, USA), according to the manufacturer’s protocol. Then, 
half of the cDNA sample (10 µl) was used for the linear amplification of RNA and labeling 
with cyanine-3 (Cy3) or Cy5. For these reactions, half of the amounts indicated by the 
manufacturer were used (van Schothorst et al. 2007). Transcription and labeling were carried 
out at 40 °C for 2 h. Then, the labeled and amplified cRNA samples were purified using 
Qiagen Rneasy MiniSpin columns (Qiagen, Venlo, the Netherlands). The incorporation of dyes 
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and cRNA concentration was measured using the "microarray measurement mode" of the 
NanoDrop ND 1000 spectrophotometer (NanoDrop Techonologies, Ins., Wilmington, DE). 
Each sample containing 600 ng of cRNA labeled with Cy5 and 600 ng of Cy3 pool were 
hybridized on 4x44K G4131F rat whole genome Agilent microarrays (Agilent Technologies, 
Inc., Santa Clara, CA, USA) for 17 h at 65 °C in hybridization chambers in an oven rotating at 
10 rpm (Agilent Technologies). After hybridization, the arrays were washed with "GE wash 
buffer 2" for 1 min at 37 °C, followed by acetonitrile for 1 min at room temperature, and 
finally with a solution for stabilization and drying for 30 s at room temperature, according to 
the manufacturer’s protocol (Agilent Technologies). 
 
Microarray data analysis 
The arrays were scanned with an Agilent Microarray Scanner (Agilent Technologies). Scanned 
images were examined for visible defects and proper grid alignment. The intensities of the 
signals from each spot were quantified, and the raw data were extracted using Feature 
Extraction Software version 10.5.1.1 (Agilent Technologies, Inc., Santa Clara, CA, USA). 
Quality control was performed for each of the arrays using LimmaGUI package in R from 
Bioconductor Software version 2.1. Only one of the arrays did not pass quality control based 
on MA plot and signal intensity distribution (Allison et al. 2006). Thus, in total, dataset from 
23 arrays passed to the next step of analysis. Data were exported into GeneMaths XT 2.12 
(Applied Mathematics, Sint-Martens-Latem, Belgium) for background correction and 
normalization. Locally weighted linear regression (lowess) analysis was chosen as a 
normalization method, which enables intensity-dependent effects in the log2 (ratio) values to 
be removed (Yang et al. 2002). Then, the values were converted to log2 values and the target 
samples (Cy5) intensities were normalized against the intensities of reference samples (Cy3), 
as described previously (Pellis et al. 2003). Target signals with an average intensity lower than 
twofold above average background were discarded to increase accuracy of the data. Correction 
for multiple testing was not applied, as these corrections are often too strict to identify small 
effects which are usually observed in nutritional studies (Pellis et al. 2003). Validity of data 
was assured by checking biological plausibility and by independent analysis by RT-qPCR (see 
below) in PBMCs and two metabolic tissues (liver and WAT). 
To search for biomarkers of metabolic interest in both sexes, two-way analysis of variance 
(ANOVA) with factors of sex and experimental group was performed. The threshold of 
significance for this statistical test was set at p≤0.01. Moreover, fold change (FC) calculation 
between both groups of animals (CRL vs control animals) was performed; FC equals the 
expression ratio between CRL and controls in the case of increase, or equals 1/ratio in the 
case of decrease. The analyses were performed with SPSS for Windows (SPSS version 19.0, 
Chicago, IL). Subsequently, a statistically generated list of genes was manually analyzed in 
regard to their biological information, obtained with the use of available databases (Genecards, 
KEGG, NCBI, Reactome, UniProt, USCN, WikiPathways) based on key biological domains, 
such as molecular function and biological process. Some of these processes overlapped, thus 
they were collected, renamed and all the unique genes were assigned into several biological 
processes according to their function. 
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Real-time quantitative RT-polymerase chain reaction (RT-qPCR) analysis 
To validate microarray data, mRNA expression levels of apolipoprotein B48 receptor  
(Apob48r), carnitine palmitoyltransferase 1 alpha (Cpt1a), fatty acid synthase (Fasn), 
hormone-sensitive lipase (Lipe), low density lipoprotein receptor-related protein 1 (Lrp1), 
phosphate cytidylyltransferase 2, ethanolamine (Pcyt2), retinoid X receptor beta (Rxrb), 
sortilin-related receptor, LDLR class A repeats-containing (Sorl1) and steroidogenic acute 
regulatory protein (Star) were measured by RT-qPCR in PBMC RNA samples of control and 
CRL animals. Additionally, RT-qPCR was performed to analyze mRNA expression of 
aforementioned genes in PBMCs at the age of 6 months, and in iWAT, rWAT and liver, at the 
age of 21 days and 6 months. Regarding Star, its mRNA levels were only analyzed in liver, as 
its expression has not been described in WAT. We did not analyze Apob48r or Sorl1 
expression either in liver nor in WAT, as both genes are expressed mainly in blood and neural 
cells. 
For RT-qPCR analysis, 0.05 µg of PBMC total RNA was used for reverse transcription by 
using iScript
TM
 cDNA synthesis kit (Bio-Rad Laboratories, S.A., Madrid, Spain) according to 
the manufacturer’s protocol.  For iWAT, rWAT and liver, 0.25 µg of total RNA (in a final 
volume of 5 μl) was firstly denatured at 65 ⁰C for 10 min, and then reverse transcribed to 
cDNA with MuLV reverse transcriptase (Applied Biosystem, Madrid, Spain) at 20 ⁰C for 15 
min, at 42 ⁰C for 30 min, with a final step of 5 min at 95 ⁰C in an Applied Biosystems 2720 
Thermal Cycler (Applied Biosystem, Madrid, Spain).  
Real-time PCR was performed using the Applied Biosystems StepOnePlus
TM
 Real-Time PCR 
Systems (Applied Biosystems) with Power SYBER Green PCR Master Mix (Applied 
Biosystems, CA, USA). Each PCR was performed from 1/5 dilution of the cDNA product and 
forward and reverse primers (5 µM each). Primer sequences and products for the different 
genes are described in Table 1.  
Table 1. Nucleotide sequences of primers and amplicon size used for RT-qPCR analysis of 
mRNA expression levels of selected genes in PBMCs, iWAT, rWAT and liver samples 
  Gene Forward primer (5' to 3') Reverse primer (5' to 3') Amplicon (bp) 
β-actin TACAGCTTCACCACCACAGC TCTCCAGGGAGGAAGAGGAT 120 
Apob48r GGGCTACATCAGGCTTTGAG TTCCTCCCCTACAACCTTCC 150 
Cpt1a GCTCGCACATTACAAGGACAT TGGACACCACATAGAGGCAG 250 
Fasn CGGCGAGTCTATGCCACTAT ACACAGGGACCGAGTAAT 222 
Gdi-1 CCGCACAAGGCAAATACATC GACTCTCTGAACCGTCATCAA 210 
Lipe TCACGCTACATAAAGGCTGCT CCACCCGTAAAGAGGGAACT 169 
Lrp1 GAGCAGGTTGTCAGTCAGCA TAGGGTTTCCGATTTCCACA 187 
Pcyt2 CCGACAGGGATGGGTCTG TGGCTTCCTTCTTCTGATTCC 156 
Rxrb CCCTTCCCAGTCATCAGTTC GGTGGCTTCACATCTTCAGG 152 
Sorl1 CACCGTCTCATTGTCAGCAC ATCTCGTAGCCCCTGGTTTC 123 
Star GGGTGGATGGGTCAGGTC CTGCTGGCTTTCCTTCTTCC 168 
Tbp ACCCTTCACCAATGACTCCTATG ATGATGACTGCAGCAAATCGC 190 
Abbreviations: apolipoprotein B48 receptor (Apob48r); carnitine palmitoyltransferase 1alpha (Cpt1a); fatty acid 
synthase (Fasn); GDP dissociation inhibitor 1 (Gdi-1); hormone-sensitive lipase (Lipe); low density lipoprotein 
receptor-related protein 1 (Lrp1); phosphate cytidylyltransferase 2, ethanolamine (Pcyt2); retinoid X receptor beta 
(Rxrb); sortilin-related receptor, LDLR class A repeats-containing (Sorl1); steroidogenic acute regulatory protein 
(Star) and TATA-box binding protein (Tbp). 
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All primers were purchased from Sigma Genosys (Sigma Aldrich Química SA, Madrid, Spain). 
After an initial Taq activation at 95 ⁰C for 10 min, PCR was performed using 40 two-
temperature cycles with the following cycling conditions: 95 ⁰C for 15s and 60 ⁰C for 1 min. 
To verify the purity of the products, a melting curve was produced after each run according to 
the manufacturer’s instructions. The values for the threshold (Ct) were calculated by the 
instrument’s software (StepOne Software v2.2.2), and the relative expression of each mRNA 
was calculated as a percentage of male control rats, using the 2
-∆∆Ct
 method (Pfaffl 2001) with 
β-actin, GDP dissociation inhibitor 1 (Gdi-1) and TATA-Box Binding Protein (Tbp) as 
reference genes.  
 
Statistical analysis 
All data were expressed as mean  S.E.M. The statistical analysis of microarray data has been 
described in details in the section referred to microarray data analysis. Multiple comparisons 
were assessed by ANOVA repeated measures and two-way ANOVA to determine the effects 
of different factors (moderate maternal calorie-restriction during lactation and sex). Single 
comparisons between groups were assessed by Student’s t test and Paired t test. Person´s 
correlation coefficient was used to determine the association between the expression pattern of 
lipid metabolism-related genes in PBMCs and other tissues. P<0.05 was the threshold of 
significance, unless stated. The analyses were performed with SPSS for Windows (SPSS 
version 19.0, Chicago, IL). 
 
Results 
Phenotypic characteristics and blood parameters throughout life 
Maternal calorie-restriction of 20% during lactation resulted in lower body weight of both male 
and female offspring in comparison to control animals (Figure 1A). This effect was significant 
from the age of 5 days and was persistent during the whole study period (6 months) (p<0.05; 
two-way ANOVA). When animals were 6-month-old CRL male and female rats weighed 7.8% 
and 11.4% less than their controls, respectively (Table 2A).  
Notably, cumulative calorie intake of animals from weaning (day 21) until the age of 6 months 
(Figure 1B) was significantly lower in CRL animals compared with controls (3.0% and 7.5% 
less, in males and females, respectively; p<0.05; two-way ANOVA). This may explain, at least 
in part, the lower body weight occurring in CRL animals, particularly females. 
Other morphological traits of young and adult offspring are summarized in Table 2A. At 
weaning (21d), both male and female CRL pups showed lower body length than the controls 
(p<0.05; two-way ANOVA), but no significant differences were found in adult animals in 
either sex. In addition, at the age of 21 days CRL male and female animals showed lower body 
fat content (relative to their body weight) than control animals, as well as lower weight of 
inguinal and retroperitoneal WAT depots and of liver (p<0.05; two-way ANOVA). In turn, at 
the age of 6 months, female CRL animals, but not males, presented lower body fat content, as 
well as lower weight of iWAT and rWAT than controls (interactive effect between sex and 
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calorie-restriction, p<0.05; two-way ANOVA), and both CRL males and females displayed 
lower weight of liver (p<0.05; two-way ANOVA).  
 
Figure 1A. Body weight with time of male and female offspring of control and calorie-restricted dams during 
lactation (CRL) from day 1 until day 190 of age. The inset details body weight throughout the lactating period 
(from day 1 until day 21 of age). Data are mean ± S.E.M. (n=12-16 animals/group). Statistics: AxR, interaction 
between age and calorie-restriction during lactation; S, effect of sex (p<0.05; ANOVA repeated measures). B. 
Cumulative food intake (Kcal) of male and female offspring of controls and calorie-restricted dams during 
lactation (CRL) fed ad libitum with normal-fat diet from 21 days until the age of 6 months. Data are mean ± 
S.E.M. (n=12-16 animals/group until the age of 21 days; n=6-8 animals/group until the age of 190 days). 
Statistics: R, effect of maternal calorie-restriction during lactation; S, effect of sex (p<0.05; two-way ANOVA). *, 
CRL vs Controls (p<0.05; Student’s t test). 
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Table 2.  Morphological traits (A) and circulating parameters (B) in male and female offspring 
of control and calorie-restricted dams during lactation (CRL) at weaning (21-day-old) and at 
the age of 6 months  
   Males Females  
   Control CRL Control CRL ANOVA 
A) Morphological traits       
21 days Body weight (g)  48.1 ± 2.1 37.1 ± 0.8* 45.4 ± 1.1 36.9 ± 0.5* R 
 Body length (cm)  11.5 ± 0.2 10.8 ± 0.2* 11.0 ± 0.2 10.4 ± 0.1* R, S 
 Body fat (%)  10.0 ± 0.4 8.68 ± 0.26* 10.5 ± 0.3 8.87 ± 0.19* R 
 iWAT (mg)  294 ± 35 187 ± 19* 307 ± 33 186± 26* R 
 rWAT (mg)  69.6 ± 9.9 40.1 ± 4.9* 50.5 ± 3.7 24.9 ± 3.2* R 
 Liver (g)  1.68 ± 0.05 1.25 ± 0.08* 1.76 ± 0.06 1.29 ± 0.03* R 
6 months Body weight (g)  498 ± 19 459 ± 17 281 ± 12 249 ± 11 R, S 
 Body length (cm)  24.2 ± 0.5 24.0 ± 0.3 20.8 ± 0.3 20.3 ± 0.2 S 
 Body fat (%)  20.7 ± 2.2 22.1 ± 1.6 22.1 ± 2.3 14.5 ± 1.2* RxS 
 iWAT (g)  9.95 ± 1.20 10.7 ± 0.7 3.93 ± 0.37 2.14 ± 0.45* RxS 
 rWAT (g)  12.8 ± 1.7 12.4 ± 1.0 4.53 ± 0.67 2.16 ± 0.23* RxS 
 Liver (g)  16.0 ± 0.9 13.4 ± 0.6* 8.13 ± 0.47 7.35 ± 0.28 S, R 
B) Circulating parameters       
21 days Glucose (mg/dL) Fed 137 ± 7 120 ± 3* 141 ± 5 116 ± 4* R 
 Insulin (ng/L) Fed 0.111 ± 0.042 0.044 ± 0.010 0.105 ± 0.020 0.037 ± 0.004* R 
 Leptin (ng/L) Fed 0.941 ± 0.154 0.408 ± 0.045* 1.05 ± 0.11 0.585 ± 0.162* R 
 NEFA (nM) Fed 1.46 ± 0.13 1.50 ± 0.14 1.37 ± 0.19 1.59 ± 0.13  
 TG (mg/mL) Fed 1.02 ± 0.14 0.893 ± 0.130 0.938 ± 0.094 0.851 ± 0.042  
6 months Glucose (mg/dL) Fed 108 ± 3 107 ± 6 105 ± 4 102 ± 4  
  Fasting 98 ± 8 95 ± 3# 102 ± 3 90 ± 1*# R (p=0.059) 
 Insulin (ng/L) Fed 2.77 ± 0.94 1.44 ± 0.26 0.835 ± 0.102 0.459 ± 0.050* R (p=0.069), S 
  Fasting 0.920 ± 0.379# 1.06 ± 0.24# 0.558 ± 0.121# 0.287 ± 0.04#  
 HOMA-IR Fasting 5.37 ± 2.38 5.77 ± 1.01 3.33 ± 0.75 1.67 ± 0.32 S 
 Leptin (ng/L) Fed 15.8 ± 2.2 13.4 ± 1.1 6.07 ± 0.94 1.74 ± 0.19* RxS 
 NEFA (nM) Fed 0.851 ± 0.152 0.910 ± 0.056 1.33 ± 0.24 0.866 ± 0.086  
 TG (mg/mL) Fed 1.61 ± 0.08 1.40 ± 0.19 1.02 ± 0.12 0.920 ± 0.073 S 
Data are mean ± S.E.M. (n=6-8 animals/group) of male and female offspring of control and calorie-restricted 
dams during lactation (CRL), under ad libitum feeding conditions (Fed) and after 12 h fasting (Fasting). Statistics: 
R, effect of maternal calorie-restriction during lactation; F, effect of fasting conditions; S, effect of sex; FxR, 
interaction between fasting conditions and maternal calorie-restriction during lactation; RxS, interaction between 
maternal calorie-restriction during lactation and sex(p<0.05; ANOVA repeated measures).
*
, CRL vs Controls 
(p<0.05; Student’s t test); #, fasting vs fed conditions (p<0.05; Paired t test). Abbreviations: iWAT, inguinal white 
adipose tissue; rWAT, retroperitoneal white adipose tissue; NEFA, non-esterified fatty acid; TG, triglycerides. 
 
Plasma circulating parameters of control and CRL animals under ad libitum feeding conditions 
at weaning (21 days), as well as under ad libitum and 12 h fasting conditions at the age of 6 
months are shown in Table 2B. At weaning, CRL pups displayed significantly lower plasma 
levels of glucose, insulin and leptin relative to their controls (p<0.05; two-way ANOVA). No 
differences were found in NEFA and TG levels between control and CRL pups.  
At the age of 6 months, a tendency to lower glucose and insulin levels (under fasting and fed 
conditions, respectively) was found in CRL animals versus controls (p=0.059 and p=0.069, 
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respectively; two-way ANOVA). The decrease was particularly pronounced and statistically 
significant in females (p<0.05; Student’s t test). CRL females also showed lower leptin levels 
than their controls (the latter only under fed conditions) (p<0.05; Student’s t test), but no 
significant differences were found between males. Fasting conditions resulted in a significant 
decrease in glucose levels, only in CRL animals, and in insulin levels in the different groups of 
animals (p<0.05; Paired t test). No significant differences were found between control and 
CRL animals concerning HOMA-IR index, although CRL female animals showed a tendency 
to lower values than controls at 6 months (p=0.076; Student’s t test). No significant differences 
were found concerning circulating NEFA and TG levels between control and CRL adult 
animals.  
 
Lipid metabolism-related gene expression in PBMCs of pups at the age of 21 days based on 
whole-genome microarray analysis 
In our microarray analysis, 45,018 probes were tested. Of them, those having an expression 
value of twice above the background (22,920) were further taken into account and normalized. 
In total 310 probes were found to be significantly different between control and CRL animals 
(p≤0.01; two-way ANOVA). Removal of duplicates resulted in 278 unique genes. Using 
available databases (Genecards, KEGG, NCBI, Reactome, UniProt, USCN, WikiPathways), 
these genes were classified into several biological processes according to their function. 111 
genes were unknown, thus were not included in any of the processes. From the remaining 167 
known genes, 113 exhibited down-regulation and 54 up-regulation. As shown in Figure 2, the 
processes with the highest number of genes differentially expressed were related to immune 
system, signaling, cell turnover, transcription machinery and transport (28, 24, 19, 16 and 12 
genes, respectively). Other processes with a notable number of genes were related to 
metabolism of proteins, carbohydrates and lipids (11, 11 and 9, respectively). The remaining 
genes were related with the nervous system, redox metabolism, cytoskeleton, neural signaling, 
blood, cell communication, central metabolism, sensory perception, and food intake control (9 
or less genes involved in each of the processes).  
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Figure 2. Classification into biological processes of the genes differentially expressed in PBMCs samples of male 
and female offspring of control and calorie-restricted dams during lactation (CRL) at the age of 21 days. Statistical 
analysis was performed by considering males and females as a whole (p≤0.01; two-way ANOVA). The number of 
genes down- or up-regulated is indicated for each group of genes.   
 
Subsequently, genes involved in lipid metabolism were analyzed in detail (Table 3). Of the 9 
genes involved in this process (Apob48r, Cpt1a, Fasn, Lipe, Lrp1, Pcyt2, Rxrb, Sorl1, Star), 6 
showed down-regulation and 3 up-regulation. Down-regulated genes were involved in 
lipogenesis/lipolysis, glycerophospholipid biosynthesis and low density lipoprotein uptake. Up-
regulated genes were involved in β-oxidation, lipolysis and cholesterol transport. 
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Table 3. Microarray data of genes involved in lipid metabolism process and their validation by RT-qPCR in PBMCs samples of male and female 
offspring of control and calorie-restricted dams during lactation (CRL) at the age of 21 days 
p-value * of microarray data and p-value ** of RT-qPCR data for statistical analysis (two-way ANOVA). Threshold of significance was set at p≤0.01 and p<0.05 for 
microarray and RT-qPCR data. Ratios indicating fold changes in experimental group (CRL vs Controls) are presented for microarray and RT-qPCR data. +, indicates 
upregulation; -, downregulation in CRL animals of both sexes. 
Related process Gene name Gene symbol Sequence ID 
Microarray 
 
qPCR 
p-value* Fold change p-value** Fold change 
 Males Females   Males Females 
Low density lipoproteins uptake Apolipoprotein B48 receptor Apob48r NM_001109154 0.007 -1.14 -1.29  0.667 +1.00 +1.03 
β-oxidation Carnitine palmitoyltransferase 1 alpha, liver Cpt1a                                    NM_031559                   0.004                         +1.22 +1.15  0.002 +1.17 +1.13 
Lipogenesis Fatty acid synthase Fasn NM_017332                   0.002                         -1.11 -1.25  0.025 -1.19 -1.03 
Lipolysis Lipase, hormone sensitive                                Lipe NM_012859                    0.01                          +1.14 +1.10  0.004 +1.09 +1.07 
Low density lipoproteins uptake Low density lipoprotein receptor-related protein 1 Lrp1 NM_001130490 0.007 -1.15 -1.04  0.038 -1.05 -1.09 
Glycerophospholipid biosynthesis Phosphate cytidylyltransferase 2, ethanolamine Pcyt2 NM_053568 0.000 -1.07 -1.24  0.166 -1.00 -1.10 
Lipogenesis/lipolysis Retinoid X receptor beta                                   Rxrb NM_206849                   0.002                         -1.33 -1.17  0.026 -1.10 -1.05 
Low density lipoproteins uptake Sortilin-related receptor, LDLR class A repeats-containing Sorl1 NM_053519 0.002 -1.08 -1.34  0.238 -1.07 -1.03 
Cholesterol transport and uptake Steroidogenic acute regulatory protein Star NM_031558 0.006 +1.11 +1.09  0.047 +1.09 +1.10 
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Confirmation of microarray results by RT-qPCR 
To confirm gene array findings and to test whether the changes were consistent, RT-qPCR 
analysis of genes involved in the process of lipid metabolism was performed on the same RNA 
samples of 21-day-old male and female control and CRL animals. Genes chosen for 
confirmation were: Fasn (lipogenesis), Rxrb (lipogenesis/lipolysis), Cpt1a (β-oxidation), and 
Lipe (lipolysis); Apob48r, Lrp1, and Sorl1 (all involved in lipoprotein uptake); Pcyt2 
(glycerophospholipid biosynthesis); Star (cholesterol transport and uptake). 
RT-qPCR analysis confirmed most of the microarray data (Table 3), as differences in the 
expression levels of Cpt1a, Lipe, Star and Fasn, Lrp1 and Rxrb between control and CRL 
animals reached statistical significe (p<0.05; two-way ANOVA) and followed the same pattern 
of up- and down-regulation as observed in the microarray analysis. Moreover, fold changes of 
those genes were similar using both techniques. Although RT-qPCR analysis of Pcyt2 did not 
reveal significant differences between control and CRL animals, single comparison between 
groups revealed that CRL females exhibited a trend to lower Pcyt2 mRNA levels relative to 
their controls (p=0.068; Student’s t test). Differences for Apob48 and Sorl1 identified using the 
microarrays could not be confirmed by RT-qPCR analysis.  
 
Comparison of mRNA expression levels of genes involved in lipid metabolism in PBMCs with 
the expression measured in different tissues (iWAT, rWAT and liver) at the age of 21 days  
To determine whether changes in mRNA levels of genes involved in lipid metabolism due to 
moderate maternal calorie-restriction during lactation observed in PBMCs of 21-day-old pups 
reflected the changes occurring in other tissues involved in lipid metabolism, we analyzed their 
mRNA expression levels in liver and in iWAT and rWAT, representative of subcutaneous and 
internal adipose tissue depots, respectively (Figure 3). In accordance with findings in PBMCs, 
CRL animals showed higher Cpt1a mRNA levels in both WAT depots and in liver compared 
with controls (p<0.05; two-way ANOVA). Fasn expression levels in iWAT and rWAT were 
also significantly decreased in CRL animals (p<0.05; two-way ANOVA), in agreement with 
changes occurring in PBMCs. No significant changes between control and CRL animals were 
found in liver, although a trend to lower Fasn mRNA levels was observed in CRL females 
(p=0.066; Student’s t test). Differences found in PBMCs for Lipe mRNA expression levels 
were also found in iWAT, and for Star in liver (p<0.05; two-way ANOVA). Concerning Pcyt2, 
the trend to lower mRNA levels occurring in CRL female animals with respect to their controls 
was also observed in both WAT depots and in liver by Student’s t test.  
However, changes found for Rxrb in PBMCs between control and CRL animals were not 
related to changes in WAT or liver, where no changes in the expression levels of this gene 
could be shown as an effect of maternal calorie-restriction during lactation.   
Finally, changes for Lrp1 in PBMCs followed the same trend in iWAT and liver (however only 
for females), but were in the opposite direction to those found in rWAT (p<0.05; two-way 
ANOVA). 
To evaluate how closely the changes in the lipid metabolism-related gene expression levels in 
PBMCs indicate those occurring in liver, iWAT and rWAT, correlation tests on the 
corresponding genes were performed (correlation values are indicated in Figure 3). Notably, 
Cpt1 mRNA levels in PBMCs were positively correlated with their expression levels in iWAT, 
rWAT and liver; and also Fasn mRNA levels in PBMCs correlated positively with their 
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expression levels in iWAT and rWAT. Star mRNA levels in PBMCs were slightly correlated 
with Star mRNA levels in liver. On the other hand, no associations were found in relative 
mRNA expression responses of the other genes studied in PBMCs (Lipe, Lrp1, Pcyt2 and 
Rxrb) with those in WAT or liver (data not shown). 
 
mRNA expression levels of selected genes involved in lipid metabolism in PBMCs at the age of 
6 months  
We also examined how the mRNA pattern of PBMC lipid metabolism-related genes, which 
were significantly altered at the age of 21 days in CRL rats, behaved in adult animals (Table 4). 
Our results show that overexpressed levels of Star in young CRL males and females were 
maintained in adulthood, although without reaching statistical significance (p<0.077; two-way 
ANOVA). Changes found for Fasn expression levels in young animals were only preserved in 
adulthood for females (p<0.05; Student’s t test; interactive effect between moderate maternal 
calorie-restriction during lactation and sex, p<0.05; two-way ANOVA). No changes in mRNA 
levels of Apob48r, Cpt1a, Lipe, Lrp1, Pcyt2 and Sorl1 were observed between control and 
CRL animals, and, contrary to what was found in young animals, Cpt1a mRNA levels were 
down-regulated in CRL females relative to their controls (p<0.05; Student’s t test).  
 
Table 4. mRNA expression levels of genes involved in lipid metabolism in PBMCs samples of 
male and female offspring of control and calorie-restricted dams during lactation (CRL) at the 
age of 6 months 
 Males Females 
ANOVA 
 Control CRL Control CRL 
Apob48r 100 ± 12 101 ± 12 100 ± 23 110 ± 20  
Cpt1a                                    100 ± 5 102 ± 8 114 ± 12 84.4 ± 3.6 *  
Fasn 100 ± 8 109 ± 8 126 ± 4 99.7 ± 4.8 * RxS 
Lipe 100 ± 13 107 ± 12 91.9 ± 5.2 92.4 ± 12.4  
Lrp1 100 ± 25 139 ± 39 73.8 ± 13.5 110 ± 13.2  
Pcyt2 100 ± 19 121 ± 28 84.1 ± 8.8 109 ± 22  
Rxrb 100 ± 6 115 ± 6 125 ± 10 103 ± 4 RxS 
Sorl1 100 ± 21 96.5 ± 16.1 75.7 ± 2.5 103 ± 18  
Star 100 ± 15 137 ± 22 120 ± 10 167 ± 33 R (p=0.077) 
mRNA levels were measured under ad libitum feeding conditions at the age of 6 months by RT-qPCR, and 
expressed as a percentage of the mean value of males control. Data are mean ± S.E.M (n=6-8 animals/group). 
Statistics: R, effect of maternal calorie-restriction during lactation; RxS, an interaction between the effect of 
maternal calorie-restriction during lactation and the effect of sex (p<0.05; two-way ANOVA). *, CRL vs Controls 
(p<0.05; Student’s t test). 
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Figure 3.  Comparison of mRNA expression levels of lipid metabolism-related genes in PBMCs, with the 
expression determined in inguinal and retroperitoneal WAT and liver of male and female offspring of control and 
calorie-restricted dams during lactation (CRL) at the age of 21 days. mRNA levels were measured by RT-qPCR 
and expressed as a percentage of the mean value of males control. Data are mean ± S.E.M (n=6-7 animals/group). 
Statistics: R, effect of maternal calorie-restriction during lactation; S, effect of sex; RxS, interaction between the 
effect of maternal calorie-restriction during lactation and the effect of sex (p<0.05; two-way ANOVA). *, CRL vs 
Controls (p<0.05; Student’s t test); Corr, consistent positive correlations between mRNA expression levels of 
selected genes involved in lipid metabolism in PBMCs and mRNA expression levels of those genes in iWAT, 
rWAT and liver of male and female offspring of control and calorie-restricted dams during lactation (CRL) at the 
age of 21 days; r, Pearson’s correlation coefficient; p-value of the genetic correlation (p<0.05); – indicates no 
correlations. 
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Comparison of mRNA expression levels of selected genes involved in lipid metabolism in 
PBMCs with the expression measured in different tissues (iWAT, rWAT and liver) at the age of 
6 months  
We next determined if the genes showing differential expression between control and CRL 
adult animals in PBMCs, Fasn, Cpt1a and Star, also showed this in both fat depots (iWAT and 
rWAT) and in liver at an older age. We also included Rxrb, because its expression levels in 
control and CRL animals showed different patterns dependent on the sex of animals (Figure 4). 
Changes in Cpt1a mRNA levels observed in PBMCs of adult rats reflected those found in 
rWAT and liver (interactive effect between sex and calorie-restriction, p<0.05; two-way 
ANOVA), although in rWAT changes did not reach statistical significance.  
 
Figure 4. Comparison of mRNA expression levels of some lipid metabolism-related genes in PBMCs with the 
expression determined in inguinal and retroperitoneal WAT and liver of male and female offspring of control and 
at 6 months of age. Only those genes with significant differences between control and CRL animals in PBMCs of 
adult animals are shown. mRNA levels were measured by RT-qPCR, and expressed as a percentage of the mean 
value of males control. Data are mean ± S.E.M (n=6-8 animals/group). Statistics: R, effect of maternal calorie-
restriction during lactation; RxS, an interaction between the effect of maternal calorie-restriction during lactation 
and the effect of sex (p<0.05; two-way ANOVA). *, CRL vs Controls (p<0.05; Student’s t test); Corr, consistent 
positive correlations between mRNA expression levels of selected genes involved in lipid metabolism in PBMCs 
and mRNA expression levels of those genes in iWAT, rWAT and liver of male and female offspring of control 
and calorie-restricted dams during lactation (CRL) at the age of 6 months; r, Pearson’s correlation coefficient; p-
value of the genetic correlation (p<0.05); – indicates no correlations. 
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Concerning Rxrb, its mRNA levels in rWAT were differentially expressed in CRL animals 
depending on sex, the same as observed in PBMCs (interactive effect between sex and calorie-
restriction, p<0.05; two-way ANOVA). A similar trend was also found in iWAT for females 
(p<0.05; Student’s t test). Star expression profile observed in PBMCs was somewhat reflected 
in the liver, although without reaching statistical significance. Regarding Fasn, changes 
observed at mRNA levels of adult CRL animals with respect to controls in PBMCs were not 
reflected either in fat depots or in liver.  
As in young animals, we assessed the strength of association between the expression levels of 
these genes in PBMCs with those in iWAT, rWAT and liver of adult animals (Figure 4) by 
correlation analysis. Similarly to the findings in young animals, a positive significant 
correlation was observed between mRNA expression levels of Cpt1a in PBMCs and its 
expression levels in rWAT and liver at the age of 6 months. Moreover, a positive significant 
correlation was observed between expression levels of Rxrb in PBMCs and rWAT. No 
associations were found between mRNA levels of Fasn and Star in PBMCs and their 
expression levels in WAT or liver (data not shown). 
 
Discussion 
Biomarkers derived from disease processes, such as those identified in obese subjects or in 
animal models of obesity, might not serve to assess the potential benefits of bioactive 
compounds or changes in dietary habits aiming to decrease the risk of obesity and related 
metabolic alterations in healthy or at-risk individuals. Therefore, in this study we took up this 
issue and aimed at identifying early transcript-related biomarkers of improved metabolic 
health, using an animal model programmed for reduced risk for obesity development and 
related metabolic alterations in adulthood. For reasons of accessibility and minimal 
invasiveness, a blood-derived RNA source, PBMCs, was used. Findings from this study reveal 
that transcript levels of lipid metabolism-related genes in PBMCs can be used as early 
biomarkers of metabolic health and potentially reflecting metabolic processes occurring in 
other tissues. 
Early postnatal intervention based on moderate maternal calorie-restriction during lactation 
brought about improvements in some phenotypic traits in the offspring, such as body weight 
and fat content, as previously described (Palou et al. 2011). The effect of lowering body weight 
was observed in both males and females from the fifth day of life and was persistent when 
animals were adult, although it was more pronounced in females than in males. At weaning, 
both males and females also displayed lower body fat content, as well as lower weight of fat 
depots, but differences were only maintained in later life in females. Despite changes in body 
weight, body length of adult animals was not affected. The decrease of body weight of 
offspring could be partly due to lower food intake. CRL animals ate fewer calories than their 
controls, with the differences again more pronounced in females.  
Circulating hormones, such as insulin and leptin, could also contribute to characterize the 
metabolic health of these animals in relation to a better ability to maintain energy homeostasis 
throughout life. Leptin and insulin are hormones related to central control of feeding behavior 
and energy expenditure (Schwartz et al. 2000). High leptin levels are associated with insulin 
resistance and metabolic syndrome (Esteghamati et al. 2009), whereas lower leptin levels have 
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been associated with improvement of insulin sensitivity (Sanchez et al. 2008). At weaning, 
CRL animals showed lower plasma levels of insulin and leptin. This healthier profile of 
circulating hormones was sustained in adulthood, particularly in females.  
Regarding gene expression, taking both males and females into account, 278 genes were 
differentially expressed between control and CRL animals in PBMCs at the age of 21 days. As 
PBMCs are a subset of white blood cells, it is not surprising that immune system was identified 
as the most affected process in terms of gene expression. This was followed by other processes 
such as signaling, cell turnover, transcription machinery, etc. Interestingly, also the expression 
of genes involved in metabolism of proteins, carbohydrates as well as lipids, and redox and 
central metabolism were affected. In a previous study using a similar animal model of 30% 
calorie-restricted dams during lactation, the offspring showed an improved capacity to handle 
and store excess dietary fuel in adulthood (Palou et al. 2011). We therefore focused on genes 
related to lipid metabolism.   
Fatty acid synthase (FASN) catalyzes the formation of long-chain fatty acids from acetyl-CoA, 
malonyl-CoA and NADPH. Some studies have evidenced that the expression of Fasn in 
PBMCs reflects metabolic adaptations of the organism to fasting/feeding conditions. Fasn 
expression levels were found to be decreased with fasting and increased with refeeding in 
normoweight rats, however, this response was impaired in obese rats (Caimari et al. 2010a; 
Oliver et al. 2013). Here, it is shown that weaned CRL pups displayed lower Fasn mRNA 
levels than controls in PBMCs, and this decrease was also found in both WAT depots 
analyzed. This expression pattern was persistent in PBMCs at the age of 6 months, but only in 
females, in accordance with their higher protection (compared with males) against fat 
accumulation. Therefore, lower mRNA levels of this gene might be proposed as a marker for a 
higher protection against fat accumulation in adulthood, in accordance with the metabolic role 
of FASN in lipid synthesis.  
The hormone-sensitive lipase (LIPE, better known as HSL), encoded by the Lipe gene, is an 
enzyme that hydrolyzes acylglycerols, as well as several other lipids stored in adipose tissue 
(Yeaman 2004). Although transcription of Lipe was initially described as specific for 
adipocytes, subsequent studies have shown that it is expressed and has a role in lipid 
metabolism in multiple tissues, including liver and macrophages (Yeaman 2004). Its action has 
also been suggested to be linked with insulin secretion and insulin action (Kraemer and Shen 
2002). Expression of this gene has also been described in PBMCs, where its level was found to 
be reduced in “at risk” obese subjects (Telle-Hansen et al. 2013). Interestingly, in the present 
study we show that young CRL animals exhibited higher Lipe mRNA levels in PBMCs and 
similarly in iWAT. Therefore, higher mRNA levels of this gene might be proposed as an early 
marker for a better capacity to regulate lipid metabolism in adulthood, possibly in association 
with improved insulin sensitivity. However, early changes were not persistent into adulthood, 
suggesting their potential usefulness as a biomarker only at early ages. 
Cpt1a codes for carnitine palmitoyltransferase 1alpha (liver form). It mediates the transport of 
long-chain fatty-acids across the mitochondrial inner membrane and is rate limiting for their 
beta-oxidation. High expression levels of Cpt1a in PBMCs have been described in diet-induced 
obese rats (Caimari et al. 2010b). Similarly, Cpt1a mRNA levels in whole blood cells were 
higher in those overweight male children that seemed to be protected against the increase in 
plasma triglyceride levels associated with body fat accumulation (Sanchez et al. 2012). 
Conversely, lower expression of this gene in overweight male children was associated with 
higher HOMA index (Sanchez et al. 2012). In the present study, young CRL animals showed 
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higher mRNA levels of Cpt1a in PBMCs than controls. Moreover, this expression pattern was 
correlated with that occurring in liver and WAT (both inguinal and retroperitoneal depots). 
However, differences found at early ages were not sustained in adulthood, neither in PBMCs 
nor in the tissues that were investigated, although the expression profile of this gene in PBMCs 
of adult animals was also related to the expression in rWAT and liver. Altogether, these results 
suggest positive metabolic effects related with high expression levels of Cpt1a in PBMCs at 
early ages in relation to increased oxidative capacity.  
Rxrb encodes a member of the retinoid X receptor (RXR) family of nuclear receptors, which is 
involved in mediating the effects of 9-cis-retinoic acid. This protein has been linked with lipid 
metabolism, with dual effects. On the one hand, RXRb heterodimerizes with peroxisome 
proliferator-activated receptor alpha (PPARα), and in this way cooperates in the induction of 
the acyl-CoA oxidase gene, which encodes the rate-limiting enzyme of peroxisomal β-
oxidation of fatty acids (Keller et al. 1993). On the other hand, RXR may also induce FASN 
via formation of LXR/RXR heterodimers binding to their recognition sequences in the sterol 
regulatory element-binding protein (SREBP-1c) promoter (Roder et al. 2007). The correlation 
between expression levels of this gene in PBMCs and rWAT in adulthood may be associated 
with the lower degree of adipogenesis that is observed.  
The Lrp1 gene encodes the low density lipoprotein receptor-related protein 1 (LRP1), an 
endocytic receptor which is ubiquitously expressed in a variety of organs, including WAT, 
liver and brain, and is involved in several cellular processes (Hussain et al. 1999). Notably, 
Lrp1 has been described to be up-regulated in human and mouse obese adipose tissue, and 
silencing of Lrp1 expression in 3T3F442A murine preadipocytes brought about reduction of 
cellular lipid level that was associated with an inhibition of adipogenesis (Olivier et al. 2009). 
These observations suggest that changes in Lrp1 expression may have important consequences 
for fat accumulation and obesity, which agrees with the protection against fat accumulation in 
CRL animals.  
Other genes, whose expression was changed in CRL versus control animals, include Pcyt2 and 
Star, which were down-regulated and up-regulated, respectively. Pcyt2 encodes 
CPT:phosphoethanolamine cytidylyltransferase, the main regulatory enzyme in the de novo 
ethanolamine phospholipids synthesis (Pavlovic and Bakovic 2013). The meaning of 
underexpression of this gene in PBMCs at an early stage of life, as occurring in CRL animals, 
remains to be determined. Nonetheless, it must be mentioned that microarrays results of this 
gene were confirmed by RT-qPCR only in females; a similar decrease was also found in WAT 
and liver of CRL females, but not males, and these changes were not maintained in adult rats. 
Hence, its function as a potential biomarker appears more limited. The Star gene encodes for 
the steroidogenic acute regulatory protein (STAR), which is a transport protein that modulates 
cholesterol transfer within mitochondria for the production of adrenal and gonadal steroids in 
steroidogenic tissues, representing the limiting step (Lin et al. 1995). This gene has also been 
described to be expressed in monocytes, macrophages, and human aortic tissue (Taylor et al. 
2010). In macrophages, Star overexpression impacts positively on the lipid-related phenotype 
of these cells, since it represses a number of genes involved in cholesterol biosynthesis and 
LDL uptake, and markedly increases the expression of ABCA1, strongly suggesting that Star 
increases sterol efflux to apoAI (Taylor et al. 2010). This protein has also been shown to be a 
protective molecule for endothelial dysfunctions in aortic endothelium (Tian et al. 2012). 
Interestingly, presence of STAR protein has also been described in human liver cells, where it 
appears to be involved in cellular cholesterol homeostasis, representing a potential therapeutic 
target in the management of hyperlipidemia (Hall et al. 2005). Therefore, results from this 
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study suggest that increased transcript levels of Star in blood cells of young CRL animals, also 
reflecting changes occurring in liver, may be indicative of improved cholesterol metabolism 
and hence improved cardiovascular health. Notably, a trend to higher transcript levels of Star 
in PBMCs was also shown in CRL adult animals. Hence, it would be interesting to assess the 
relationship between PBMC transcript levels of Star and the ability to maintain normal blood 
cholesterol levels under appropriate dietary insults or in an animal model prone to develop 
hypercholesterolemia, since in the conditions of this study, no differences were found between 
groups concerning blood cholesterol (data not shown).  
All in all, despite the fact that nutritional-induced changes in PBMC gene expression are 
generally expected to be smaller than the effects induced by diseases (Bouwens et al. 2007), 
early programming effects occurring in CRL animals due to calorie-restriction during lactation 
were reflected in a substantial number of changes. Among genes related with lipid metabolism, 
it is noteworthy that expression levels of Cpt1a, Fasn and Star in PBMCs at early ages were 
significantly correlated with expression profiles in WAT and/or liver.  
To summarize, the findings from this study, using an animal model that confers certain 
protection in the pups against development of obesity and related metabolic alterations by 
dietary intervention in lactating dams, reveal the possibility of using transcript levels of lipid 
metabolism-related genes in PBMCs, particularly Fasn, Cpt1a and Star, as early biomarkers of 
metabolic health, potentially providing a valid biological readout for the study of metabolic 
processes in humans. 
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Abstract 
Introduction: Advanced glycation end products (AGEs) and other protein damage biomarkers 
are contributors to oxidative stress and inflammatory response. Calorie restriction slows the 
age-related processes by reduction of oxidant stress and, in lactating rats, this condition has 
been shown to protect the offspring against the development of obesity and metabolic-related 
alterations.  
Aim: To assess whether the beneficial effects of moderate maternal calorie restriction during 
lactation in rats on their offspring might be related with changes in protein damage markers in 
milk.  
Methods: A quantitative screening of glycation, oxidation and nitration free adducts and of 
individual free amino acids was performed in maternal plasma (day 21 of lactation) and milk 
samples (days 5, 10 and 15 of lactation) from control and 20% calorie restricted (CRL) 
lactating dams by using chromatographic techniques with mass spectrometric detection and 
quantification using stable isotope substituted standards.  
Results: In plasma, CRL dams showed lower levels of most amino acids and of the free 
adducts MG-H1, 3DG-H, FL, MOLD and AASA than controls. In milk, differences were 
depending on the stage of lactation. Compared to controls, milk from CRL dams contained 
higher CEL, GH1, CMA, CML, 3DG-H, Pyrraline, Dityrosine and AASA levels at day 10 of 
lactation, but it contained lower levels of free amino acids and of MG-H1, Pyrraline and NFK 
at day 15.   
Conclusion: The presence of diminished glycation and oxidation free adducts levels in milk 
from CRL dams during the second part of lactation might contribute to, and could be a marker 
of factors contributing to the health benefits of this condition in the offspring. 
 
Keywords: damage protein, LC-MS/MS, breast milk, calorie restriction 
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Introduction 
Protein damage by glycation, oxidation or nitration processes, and hence, formation of 
advanced glycation end products (AGEs), protein oxidation or nitration adducts, respectively, 
play an important role in the pathogenesis of aging-related chronic diseases, such as obesity, 
diabetes and cardiovascular and renal disorders (Singh, et al. 2014). Advanced glycation is one 
of the major pathways involved in the development and progression of different diabetic 
complications. Moreover, several studies show an association between high plasma levels of 
AGEs and a wide range of harmful health effects, such as cardiovascular disease, Alzheimer´s 
disease, cancer, uraemia, type I and II diabetes, aging and pro-oxidative and pro-inflammatory 
events (Klenovics, et al. 2013; Thornalley, et al. 2003). 
AGEs are formed during a complex series of parallel, sequential and non-enzymatic reactions 
between the free amino groups of proteins and carbonyl groups of reducing sugars or other 
carbonyl compounds; these reactions are known as the Maillard reactions or browning reactions 
(Thornalley 2008). At early stages of glycation reactions, glucose reacts with lysine residue 
side-chain amino groups to form early glycation adducts, a Schiff base adduct that slowly 
rearranges to Nε-fructoselysine (FL) (Rabbani and Thornalley 2009). In later stage reactions, 
FL adducts degrade slowly to form irreversibly AGEs through oxidation, dehydratation and 
cyclization reactions (Singh, et al. 2014). AGEs are yellow-brown insoluble adducts that 
accumulate on long-lived proteins interfering with their normal functions by disrupting 
molecular conformation, altering enzymatic activity and interfering with receptor recognition 
(Singh, et al. 2014). AGEs-modified proteins undergo accelerated degradation by the 
proteosome to form free-AGEs such as 3-deoxyglucosone (3-DG), Nδ-(5-hydro-4-imidazolon-
2-yl)ornithine (G-H1), Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl)ornithine (MG-H1), Nε-
carboxymethyl-lysine (CML), Nε-carboxyethyl-lysine (CEL) and Nω-carboxymethylarginine 
(CMA)  (Rabbani and Thornalley 2009; Thornalley 2008).  
Concerning protein oxidation adducts, they are formed mainly by exposure of amino acids 
residues in proteins to hydrogen peroxide, hypochlorite and peroxynitrite, and methionine 
sulfoxide residues (MetSO), dityrosine and N-formylkynurenine (NFK) are important markers 
of protein oxidation (Rabbani and Thornalley 2009). Protein nitration adducts, such as 3-
Nitrotyrosine (3-NT) are formed by exposure of proteins to peroxynitrite and nitryl chloride 
(Droge 2002). 
AGEs are formed endogenously in the body and their formation progressively increases with 
normal ageing and also in association with hyperglycemia, oxidative or carbonyl stress and 
decreased renal function (Sebekova and Somoza 2007). Furthermore, humans are also exposed 
to exogenous AGEs, which are ingested with food. Industrial processing of some saccharide-
rich foods requires heat-treatment; this results in the formation of substantial amounts of AGEs, 
especially CML, which is considered a stable compound and a good indicator of AGEs in food. 
It has been recently demonstrated that AGEs from saccharide-rich foods are at least partially 
absorbed from the gastrointestinal tract contributing to the circulating pool of AGEs (Sebekova, 
et al. 2008; Sebekova and Somoza 2007). Human studies have recently revealed significant 
correlations between ingested AGEs, circulating AGEs and several markers of inflammation 
(Peppa, et al. 2004; Vlassara, et al. 2002). In experimental animals, high consumption of heat 
treated foods, which are a fuel of high levels of exogenous AGEs, has been shown to promote 
the manifestation of diabetes, and to substantially contribute to the acceleration of the 
development of diabetic complications (Sebekova and Somoza 2007) and to renal and vascular 
complications (Singh, et al. 2014). According to this, a long-term AGE restriction diet, 
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although isocaloric to the standard diet, has been described to prevent age-associated weight 
gain and insulin resistance in mice, suggesting that this dietary intervention may preserve 
mechanisms related to glucose and energy utilization, which become impaired with aging (Cai 
2004).  
Likewise, reduced calorie intake has been found to delay the age-related processes and reduce 
oxidant stress in mammals [reviewed by (Vlassara 2005)]. This has been associated, in part, to 
the reduced intake of dietary AGEs accompanied to the reduction in food consumption (Cai, et 
al. 2008). In our previous studies we have shown that moderate calorie restriction of rat dams 
during lactation also protects their offspring against diet-induced obesity and related metabolic 
alterations, particularly dyslipidemia, insulin resistance, and hyperleptinemia (Palou, et al. 
2010a; Palou, et al. 2011; Torrens, et al. 2014). Therefore, we hypothesized that this condition 
during lactation may also result in a reduction in AGE consumption and hence a reduction in 
their circulating levels. Moreover, it might be speculated that the content of AGEs and other 
adducts in milk might also be affected, which may potentially contribute to the aforementioned 
beneficial effects in their offspring.  
Therefore, considering that i) AGE formation is a contributor of oxidative stress and 
inflammatory response, ii) calorie restriction slows the age-related processes by reduction of 
oxidant stress, and iii) moderate maternal calorie restriction in lactating dams confers some 
protection against obesity and metabolic-related alterations in the offspring, here we aimed to 
determine whether moderate (20%) maternal calorie restriction during lactation is able to 
reduce the amount of AGEs and other markers of protein damage by oxidation and nitration in 
maternal plasma, as well as in breast milk. To achieve this, we performed a quantitative 
screening of free amino acids and of a comprehensive range of free glycation, oxidation and 
nitration adducts in maternal plasma and breast milk samples from control and CRL dams by 
using chromatographic techniques with mass spectrometric detection and quantification using 
stable isotope substituted standards.  
 
Materials and Methods 
Animals and experimental design  
The animal protocol followed in this study was reviewed and approved by the Bioethical 
Committee of the University of the Balearic Islands, and guidelines for the use and care of 
laboratory animals of the university were followed.  
The study was performed in female Wistar rats weighing between 225 and 260 g (Charles 
River Laboratories, Barcelona, Spain). Animals were housed under standard conditions, that is, 
controlled temperature (22ºC), a 12 h light-dark cycle, and free access to tap water. Briefly, 22 
virgin female rats were mated with male rats (Charles River Laboratories, Barcelona, Spain). 
After matching, each female was placed in an individual cage. At day 1 after delivery, pups 
were weighed and the size of all litters was adjusted to 10 neonates with similar body weight 
per mother (5 males and 5 females, when possible) to avoid differences in milk production due 
to a different number/weight of pups per dam to feed. Dams were assigned to either control 
(n=11 dams) or calorie restricted (n=11 dams) groups. Throughout the lactating period, starting 
on day 1 after delivery until weaning (day 21), control dams were fed ad libitum with standard 
chow diet (3 kcal/g, with 8% calories from fat; Panlab, Barcelona, Spain), while calorie 
restricted (CRL) dams underwent 20% restriction of calorie intake. Calorie restriction was 
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performed by offering each dam a daily amount of food corresponding to 80% of the calories 
they should eat according to their body weight. This amount was calculated by considering the 
calories consumed daily by their control animals under ad libitum feeding conditions.  
Breast milk samples of each control and CRL dams were collected on days 5, 10 and 15 of 
lactation. Before milking, nursing rats were separated from their pups between 2-3 h to 
guarantee that mammary glands were full of milk. Milk collection was performed on 
isofluorane-anestethized rats. To induce milk letdown, approximately 5 min after anesthetizing 
the animals, an intraperitoneal injection of 0.4 IU/Kg of oxytocin was applied (Facilpart. 
Oxytocin 10 IU/mL; Laboratories Syva. León, Spain). Milk samples were collected in sterilized 
tubes and stored at -80ºC until stable isotopic dilution analysis liquid chromatography-tandem 
mass spectrometry (LC-MS/MS) was performed.  
At weaning (day 21 of lactation), control and CRL dams were killed under ad libitum feeding 
conditions by decapitation during the first 2 h at the beginning of the light cycle. Trunk blood 
samples were collected in heparinized containers. Plasma was obtained by centrifugation of 
heparinized blood at 1000 x g for 10 min and stored at -80ºC until LC-MS/MS analysis.  
 
Stable isotopic dilution analysis liquid chromatography-tandem mass spectrometry (LC-
MS/MS)  
Ultrafiltrate of maternal plasma (from day 21 of lactation) and ultrafiltrate of breast milk 
samples (from days 5, 10 and 15 of lactation) of control and CRL dams were analyzed by LC-
MS/MS to perform a quantitative screening of all the amino acids and a comprehensive range 
of protein damage biomarkers. The following free glycation adducts were determined: MG-H1, 
3DG-H, Glucosepane, G-H1, CMA, CML, CEL, Fructosyl-lysine (FL), bis(lysyl) crosslink 
derived from methylglyoxal (MOLD) and pyrraline. Concerning free oxidation adducts: 
aminoadipic semialdehyde (AASA), glutamic semialdehyde (GSA), dityrosine, MetSO and 
NFK were measured. The free nitration adduct 3-NT was also measured (Table 1).   
Ultrafiltrates of milk and plasma samples were prepared by either microspin ultrafiltration of 
50 µl of milk or 60 µl of plasma using a 3 KDa or 10 KDa cut-off filter respectively, and then 
centrifuged at 14000 x g (milk samples for 2 h and plasma samples for 30 min) at 4ºC. 
Ultrafiltrates were stored at -80ºC until preparation of vials for ultrahigh performance liquid 
chromatography (UPLC).  
UPLC vials were prepared by adding 5 µl of milk ultrafiltrate or 5 µl of plasma ultrafiltrate 
with 20 µl of 0.1% Trifluoroacetic acid (TFA) in water and 25 µl of a cocktail of stable isotope 
substituted internal standards.  
Chromatography was performed on two Hypercarb
TM
 graphic 5 µm particle size columns (2.1 x 
50 mm and 2.1 x 250 mm, respectively. Thermo Hypersil Ltd). The chromatographic procedure 
was customized to complete data collection of all analytes of each sample in a 35-minute run. 
The mobile phase was solvent A (0.1% TFA in water) and solvent B (0.1% TFA in 50% 
acetonitrile (ACN)). The two columns were initially used in series with a flow rate of 0.2 
mL/min and later (at 20 min), the second column was then switched out of the flow to facilitate 
elution of strongly hydrophobic analytes. The post-run method, for washing, used solvent A1 
(0.1% TFA in water) and solvent B2 (0.1% TFA in 50% tetrahydrofuran (THF)) for 30 
minutes. Optimised custom gradients were used for analysis and post-run column wash/re-
equilibration runs. Flow from the column in the interval 4-35 min was directed to the mass 
spectrometry (MS/MS) detector. Each analyte was detected by electrospray positive ionization 
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mass spectrometric multiple reaction monitoring (MRM). The ionization source of temperature 
was 150ºC and the desolvation gas temperature 500ºC. The cone gas and desolvation gas flow 
were 150 L/h and 1000 L/h, respectively. Each analyte was detected by selective ion 
monitoring of its molecular ion in the first mass analyser after fragmentation with argon atoms 
in the collision cell. Therefore, each analyte was detected by characteristic chromatographic 
retention time, molecular ion mass/charge ratio m/z and fragmentation ion m/z. Programmed 
molecular ion and fragment ion masses and collision energies were optimized to ± 0.1 Da and ± 
1 eV, respectively, for MRM detection of analytes. Detector response was normalized to the 
added stable isotopic standard response which has the same retention time as the normal anlyte 
and a different molecular ion or molecular ion and fragment ion m/z value. Data were collected 
sequentially and rapidly for many mass transitions (up to 32) such that multiple mass 
chromatograms may be recorded for each analyte and isotopic standard. Analyte content was 
determined from the analyte/internal standard peak response peak area ratio by reference to 
calibration curves recorded under the same conditions with the same content of internal 
standard as the samples and known amounts of normal reference standard analyte.    
 
Statistical analysis 
Data are mean ± standard error of the mean (S.E.M). Kolmogorov–Smirnov test was performed 
to determine whether the data set was normally distributed. Single comparisons between 
control and CRL dams were assessed by Student´s t test (when samples were normally 
distributed) or by Mann-Whitney U test (when samples were no normally distributed). Finally, 
Bonferroni correction was applied to prevent data from incorrectly appearing to be statistically 
significant by lowering the alpha value. Multiple comparisons were assessed by repeated 
measured analysis of variance (ANOVA). Differences between the three days of milk 
collection during lactation, in both control and CRL dams, were assessed by Bonferroni post 
hoc test. The analyses were performed with SPSS for Windows (SPSS version 19.0, Chicago, 
IL). *, p<0.05; **, p<0.01; ***, p<0.001. When Bonferroni correction was applied, alpha value 
was dived by the number of tests (p-value = α/n).  
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Table 1. Mass spectrometric multiple reaction monitoring detection of damage protein biomarkers and of their respective internal standards  
Analyte group Analyte Parent ion (Da) Fragment ion (Da) CE (eV) Rt Internal standard Parent ion (Da) Fragment ion (Da) CE (eV) Rt 
Amino acids 
Leucine 132.30 86.20 10 28.3 [2H3]Leucine 135.30 89.20 10 28.3 
Isoleucine 132.28 86.16 10 31.4 [13C6]Isoleucine 138.28 91.20 10 31.4 
Valine 118.05 72.08 10 7.8 [2H8]Valine 126.05 80.08 10 7.8 
Arginine 176.20 71.06 18 32.2 [15N2]Arginine 178.20 71.06 18 32.2 
Lysine 147.13 84.11 14 5.5 [13C6]Lysine 153.10 89.11 14 5.5 
Histidine 156.10 110.08 14 32.1 [13C6]Histidine 162.10 115.08 14 32.1 
Aspartic acid 134.04 88.03 10 7.0 [13C2-
15N]Aspartic acid 137.04 90.03 10 7.0 
Glutamic acid 148.13 102.09 10 28.3 [13C5]Glutamic acid 153.13 106.09 10 28.3 
Asparagine 133.20 87.18 8 6.6 [13C4H2O]Asparagine 137.20 90.18 8 6.6 
Glutamine 147.24 84.12 16 8.8 [13C5]Glutamine 152.20 88.10 16 8.8 
 
Serine 105.99 42.04 18 5.1 [13C3]Serine 108.99 44.04 18 5.1 
Threonine 120.07 74.02 10 6.0 [13C4-
15N]Threonine 125.07 78.02 10 6.0 
Tyrosine 182.90 137.00 12 18.4 [2H4]Tyrosine 186.90 141.00 12 18.4 
Tryptophan 206.07 159.80 15 23.7 [15N2]Tryptophan 208.70 161.08 15 23.7 
Phenylalanine 167.10 121.15 12 17.1 [D5]Phenylalanine 172.10 126.15 12 17.1 
Cysteine 122.04 76.00 22 6.3 [13C3-
15N]Cysteine 126.04 79.00 22 6.3 
Alanine 90.06 44.06 8 5.2 [D3]Alanine 93.06 47.06 8 5.2 
Proline 117.13 71.08 12 6.1 [13C5]Proline 122.13 75.08 12 6.1 
Glycine 76.23 30.16 6 4.8 [13C2-
15N]Glycine 79.23 32.16 6 4.8 
Methionine 150.00 104.04 10 32.2 [2H3]Methionine 153.00 107.04 10 32.2 
Ornithine  133.02 70.08 14 5.0 [2H6]Ornithine  139.02 76.08 14 5.0 
Glycation adducts 
MG-H1  229.16 114.10 16 11.9 [15N2]MG-H1  231.16 116.10 16 11.9 
3DG-H  319.10 70.06 28 11.7 [15N2]3DG-H  321.10 70.06 28 11.7 
Glucosepane  429.20 269.20 36 16.4 [13C6]Glucosepane  435.20 275.10 36 16.4 
G-H1  215.17 100.05 12 12.7 [15N2]G-H1  217.17 102.05 12 12.7 
CMA  233.10 70.13 28 12.3 [13C2]CMA  235.10 70.13 28 12.3 
CML  205.12 84.12 16 30.0 [13C6]CML  211.12 89.12 16 30.0 
FL  291.10 84.11 26 32.1 [2H4]FL  295.10 88.11 26 32.1 
MOLD  341.22 83.92 32 15.0 [2H8]MOLD  349.22 87.92 32 15.0 
Pyrraline 255.07 175.06 23 19.0 [2H4]Pyrraline 263.07 182.06 23 19.0 
CEL  219.17 130.04 12 32.2 [13C6]CEL  225.17 136.04 12 32.2 
Oxidation and 
nitration adducts 
AASA  128.10 82.06 12 10.7 [D3]AASA  164.96 100.79 12 10.7 
GSA  114.02 68.08 15 32.2 [D3]AASA  164.96 100.79 12 10.7 
NFK  237.08 191.10 9 23.7 [15N2]NFK  239.08 193.10 9 23.7 
Dityrosine  361.10 315.19 14 20.3 [2H6]Dityrosine  367.10 321.19 14 20.3 
MetSO  166.00 56.09 16 8.4 [2H3]MetSO  169.00 56.09 16 8.4 
3-NT  227.12 181.07 12 23.4 [2H3]3-NT  230.12 184.07 12 23.4 
Molecular weight, chromatographic retention times and mass-spectrometric multiple reaction monitoring detection of free glycation, oxidation and nitration adducts and their 
respective internal standards. Abbreviations: CE, collision energy; Rt, retention time; MG-H1, Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl)ornithine; 3DG-H, 3-
deoxyglucosone; G-H1, Nδ-(5-hydro-4-imidazolon-2-yl)ornithine; CMA, Nω-carboxymethylarginine; CML, Nε-carboxymethyl-lysine; FL, Fructosyl-lysine; MOLD, 
bis(lysyl) crosslink derived from methylglyoxal; CEL, Nε-carboxyethyl-lysine; AASA , aminoadipic semialdehyde; GSA, glutamic semialdehyde; NFK,  N-
formylkynurenine; MetSO, methionine sulfoxide; 3-NT, 3-Nitrotyrosine. 
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Results 
Amino acid composition and free glycation, oxidation and nitration adducts in the ultrafiltrate 
of plasma samples from control and CRL dams at day 21 of lactation  
Concentrations of the 21 amino acids analyzed in the ultrafiltrate of maternal plasma samples 
are shown in table 2. The concentration of total amino acids, as well as of individual amino 
acids, with the exception of aspartic acid, glutamic acid, glutamine, tryptophan, cysteine and 
glycine, in the plasma ultrafiltrate of CRL dams was significantly lower compared to that of 
control dams (p<0.0023 by Student’s t test and Mann-Whitney U test).  
Table 3 shows the quantitative screening of free glycation, oxidation and nitration adducts in 
the ultrafiltrates of maternal plasma at day 21 of lactation. Notably, plasma of CRL dams 
showed significantly lower amounts of several free glycation adducts, MG-H1, 3DG-H, FL and 
pyrraline, as well as of the free oxidation adduct AASA, compared to plasma of control dams 
(p<0.005, by Mann-Whitney U test). No significant differences were observed for the other free 
adducts analyzed.  
Table 2. Amino acid composition in the ultrafiltrate of maternal plasma samples from day 21 
of lactation  
 Amino acid Control (µM) CRL (µM) 
Branched-chain 
amino acids 
(BCAA) 
Leucine 421 ± 15 261 ± 20 ### 
Isoleucine 429 ± 13 266 ± 24 ### 
Valine 648 ± 15 418 ± 30 ### 
Sum of BCAA 1498 ± 41 945 ± 73 ### 
Basic amino acids 
Arginine 457 ± 26 282 ± 30 # 
Lysine 2095 ± 87 1224 ± 84 ### 
Histidine 264 ± 7 216 ± 10 #  
Acid amino acids 
Aspartic acid 232 ± 13 197 ± 17 
Glutamic acid 625 ± 44 628 ± 44 
Amidic amino acids 
Asparagine 174 ± 7 119 ± 7 ### 
Glutamine 2258 ± 65 1975 ± 93 
Hydroxyl amino 
acids 
Serine 1339 ± 49 1012 ± 69 # 
Threonine 882 ± 54 418 ± 39 ### 
Aromatic amino 
acids 
Tyrosine 349 ± 16 199 ± 19 ### 
Tryptophan 1295 ± 51 1612 ± 176 
Phenylalanine 200 ± 5 153 ± 9 #  
Other amino acids 
Cysteine 31.4 ± 5.2 20.7 ± 1.9 
Alanine 1842 ± 82 1039 ± 105 ### 
Proline 3951 ± 125 1392 ± 145 ### 
Glycine 772 ± 65 716 ± 78 
Methionine 205 ± 7 110 ± 8 ### 
Ornithine  9.32 ± 0.76 5.60 ± 1.00 #  
Sum Total amino acids 18478 ± 278 12263 ± 685 ### 
 
Data are mean ± S.E.M (n=11 animals per group) of control dams and moderate calorie restricted dams during 
lactation (CRL). Statistics: Kolmogorov-Smirnov test was used for testing the normality of the distribution of the 
samples. Differences between CRL and control were assessed by Mann-Whitney U test (for no normally 
distributed samples) or by Student´s t test (for normally distributed samples) and Bonferroni correction for 21 
analytes was applied: #, ## and ###, CR vs control when p<0.0023, p<0.0005 and p<0.00005 respectively. 
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Table 3. Free glycation, oxidation and nitration adduct concentration in the ultrafiltrate of 
maternal plasma samples from day 21 of lactation  
 Free adduct Control (nM) CRL (nM) 
Glycation adducts 
MG-H1  766 ± 44 396 ± 47 *** 
3DG-H  285 ± 20 195 ± 13 * 
Glucosepane  8.96 ± 1.34 10.0 ± 0.7 
G-H1  102 ± 9 89.8 ± 6.3 
CMA  95.3 ± 4.7 74.5 ± 5.5 
CML  182 ± 23 85.8 ± 8.6 ** 
FL  1860 ± 137 993 ± 127 ** 
MOLD  6.36 ± 0.97 5.13 ± 0.59 *** 
Pyrraline 1104 ± 70 329 ± 42 
CEL  1538 ± 105 2319 ± 387 
Oxidation and 
nitration adducts 
AASA  19.9 ± 1.1 11.9 ± 1.1 *** 
GSA  90.8 ± 3.5 115 ± 8 
NFK  9.43 ± 1.60 21.5 ± 4.3 
Dityrosine  12.6 ± 0.9 11.6 ± 0.7 
MetSO  2315 ± 146 1762 ± 131 
3-NT  3.06 ± 0.21 2.82 ± 0.15 
Data are mean ± S.E.M (n=11 animals per group) of control dams and moderate calorie restricted dams during 
lactation (CRL). Statistics for glycation adducts: *, ** and ***, CRL respect to control when p<0.005, p<0.001 
and p<0.0001 respectively, by Mann-Whitney U test (followed by a Bonferroni correction for 10 analytes). 
Statistics for oxidation and nitration adducts: *, ** and ***, CRL respect to control when p<0.008, p<0.002 and 
p<0.0002 respectively, by Mann-Whitney U test (followed by a Bonferroni correction for 6 analytes). 
Abbreviations: MG-H1, Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl)ornithine; 3DG-H, 3-deoxyglucosone; G-H1, 
Nδ-(5-hydro-4-imidazolon-2-yl)ornithine; CMA, Nω-carboxymethylarginine; CML, Nε-carboxymethyl-lysine; 
FL, Fructosyl-lysine; MOLD, bis(lysyl) crosslink derived from methylglyoxal; CEL, Nε-carboxyethyl-lysine; 
AASA, aminoadipic semialdehyde; GSA, glutamic semialdehyde; NFK,  N-formylkynurenine; MetSO, 
methionine sulfoxide; 3-NT, 3-Nitrotyrosine.  
 
Amino acid composition and free glycation, oxidation and nitration adducts in the ultrafiltrate 
of milk samples from control and CRL dams at days 5, 10 and 15 of lactation 
Table 4 shows the concentration of the 21 amino acids analyzed in the ultrafiltrate of milk 
samples at different time points of lactation. For most of the amino acids, differences between 
control and CRL dams were dependent on the day of lactation; in fact a significant interaction 
was found between the effect of maternal calorie restriction during lactation and the time point 
of lactation for the sum of the concentrations of all amino acids and for most of the amino acids 
with the exception of Leucine, Lysine, Tyrosine and Ornithine, which showed a significant 
effect of the lactation time (p<0.05, ANOVA repeated measures). Specifically, at days 5 and 10 
of lactation, levels of methionine and arginine, respectively, were significantly higher in milk 
from CRL dams compared to milk from control animals (p<0.0023, by Student’s t test and 
p<0.00005 by Mann-Whitney U test, respectively). In turn, at day 15 of lactation, Serine levels 
in milk from CRL dams were significantly lower compared to milk from control dams 
(p<0.00005, by Student’s t test). Notably, the concentration of most of the amino acids changed 
with the time of lactation in both control and CRL animals, with different patterns depending on 
the group of animals. Although the pattern was dependent on the specific amino acid, as a 
general trend, amino acid levels in milk increased from day 5 to 10 of lactation in both control 
and CRL animals. At day 15 of lactation, levels were maintained stable or continued to increase 
in control animals, but decreased to levels similar of those of day 5 of lactation in CRL dams. 
The sum of total amino acids also followed this trend, and milk of CRL dams at day 15 of 
lactation showed lower concentration of amino acids to that of control animals.  
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Table 4. Amino acid composition in the ultrafiltrate of breast milk samples from day 5, 10 and 
15 of lactation  
 Amino acid Dam Day 5 (µM) Day 10 (µM) Day 15 (µM) ANOVA 
Branched-
chain amino 
acids (BCAA) 
Leucine 
Control 9.25 ± 1.07 a 17.7 ± 2.4 a  25.7 ± 4.1 b 
T 
CRL 6.22 ± 0.64 x 19.1 ± 3.2 y 18.8 ± 3.8 y 
Isoleucine 
Control 11.4 ± 1.3 a 22.5 ± 2.7 b  26.1 ± 3.8 b 
TxR 
CRL 10.1 ± 0.7 x 26.0 ± 2.0 y  17.9 ± 2.4 z 
Valine 
Control 17.4 ± 1.7 a 42.5 ± 5.4 b  56.6 ± 8.1 c 
TxR 
CRL 16.6 ± 1.3 x 56.5 ± 7.4 y  34.0 ± 5.3 z 
 
Sum of BCAA 
Control 38.1 ± 3.9 a 82.7 ± 10.3 b 108 ± 14 b 
TxR 
 CRL 32.9 ± 2.4 x 102 ± 13 y 71 ± 11 z # 
Basic amino 
acids 
Arginine 
Control 39.0 ± 3.3 a  59.7 ± 2.1 b 49.6 ± 5.2 ab 
TxR 
CRL 48.5 ± 3.3 x 105 ± 7 y ### 41.5 ± 4.6 x 
Lysine 
Control 33.0 ± 4.3 a  70.2 ± 7.6 b  61.0 ± 8.7 ab 
T 
CRL 37.9 ± 5.3 xy 91.5 ± 21.6 x  51.0 ± 12.7 y 
Histidine 
Control 10.9 ± 1.1 a  17.6 ± 1.2 b  24.1 ± 2.5 c 
TxR 
CRL 11.1 ± 1.3 x 29.7 ± 6.1 y  24.1 ± 3.4 y 
Acid amino 
acids 
Aspartic acid 
Control 77.5 ± 3.9 a 183 ± 29 b  359 ± 61 c 
TxR 
CRL 111 ± 8 x 262 ± 28 y  189 ± 14 z 
Glutamic acid 
Control 278 ± 19 a 557 ± 76 b  755 ± 100 c 
TxR 
CRL 355 ± 20 x 925 ± 224 x 605 ± 107 x 
Amidic amino 
acids 
Asparagine 
Control 33.3 ± 2.2 a  75.5 ± 6.4 b 90.7 ± 8.5 b 
TxR 
CRL 44.0 ± 2.5 x 138 ± 18 y 73.3 ± 11.5 x 
Glutamine 
Control 5.52 ± 0.73 a 17.4 ± 3.8 ab 22.9 ± 5.1 b 
TxR 
CRL 9.05 ± 1.07 x 17.9 ± 3.7 x 11.6 ± 2.9 x 
Hydroxyl 
amino acids 
Serine 
Control 1377 ± 56 a 1594 ± 38 b  1167 ± 60 a 
TxR 
CRL 1309 ± 31 x 1592 ± 151 x 776 ± 37 y ### 
Threonine 
Control 29.2 ± 2.4 a  65.1 ± 5.0 b  139 ± 18 c 
TxR 
CRL 35.2 ± 4.8 x 95.5 ± 14.7 y 95.2 ± 11.3 y 
Aromatic 
amino acids 
Tyrosine 
Control 32.2 ± 3.9 a 67.6 ± 4.4 b  33.7 ± 6.3 a 
T 
CRL 24.1 ± 3.5 x 72.6 ± 5.2 y  21.2 ± 3.7 x 
Tryptophan 
Control 918 ± 22 a 1121 ± 51 b 1399 ± 143 b 
TxR 
CRL 1010 ± 43 x 1119 ± 91 x 1003 ± 45 x 
Phenylalanine 
Control 37.4 ± 1.6 a 22.7 ± 2.1 b 21.4 ± 2.6 b 
TxR 
CRL 40.1 ± 1.9 x 39.7 ± 5.4 x 21.8 ± 3.9 y 
Other amino 
acids 
Cysteine 
Control 9.38 ± 0.31 a 8.95 ± 0.53 a 8.3 ± 0.4 a 
TxR 
CRL 11.0 ± 0.5 x 6.69 ± 0.75 y 9.8 ± 0.5 x 
Alanine 
Control 152 ± 11 a 357 ± 38 b 428 ± 39 c 
TxR 
CRL 181 ± 14 x 501 ± 61 y 275 ± 44 x 
Proline 
Control 156 ± 12 a 309 ± 19 b 504 ± 69 c 
TxR 
CRL 167 ± 15 x 607 ± 105 y 366 ± 80 x 
Glycine 
Control 93.0 ± 9.4 a 190 ± 26 a 309 ± 47 b 
TxR 
CRL 87.7 ± 10.1 x 236 ± 36 y 185 ± 17 y 
Methionine 
Control 30.6 ± 1.6 a 8.13 ± 1.36 b 6.4 ± 1.6 b 
TxR 
CRL 43.2 ± 1.2 x # 3.74 ± 1.22 y 4.9 ± 1.3 y  
Ornithine  
Control 2.94 ± 0.31 a 6.80 ± 0.86 b 15.5 ± 3.1 c 
T 
CRL 3.53 ± 0.43 x 9.99 ± 1.66 y 14.1 ± 2.0 y 
Sum 
Total amino 
acids  
Control 
CRL 
3352 ± 108 a 
3560 ± 98 x 
4813 ± 265 b 
5955 ± 715 y 
5502 ± 480 b 
3838 ± 314 x ## 
TxR 
 
Data are mean ± S.E.M (n=10-11 animals per group) of control dams and moderate calorie restricted dams during 
lactation (CRL). Statistics: T, effect of lactation time; R, effect of maternal calorie restriction during lactation; TxR, 
interaction between the effect of lactation time and the effect of maternal calorie restriction during lactation 
(p<0.05, ANOVA repeated measures). Kolmogorov-Smirnov test was used for testing the normality of the 
distribution of the samples. Differences between CRL and control were assessed by Mann-Whitney U test (for no 
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normally distributed samples) or by Student’s t test (for normally distributed samples) and Bonferroni correction 
for 21 analytes was applied: #, ## and ###, CRL vs control when p<0.0023, p<0.0005 and p<0.00005, 
respectively. In both control and CRL milk samples, differences between the three days of sample collection 
during lactation were assessed by Bonferroni post hoc test: a, b, and c, for differences between day 5, 10 and 15 
respectively, in control milk samples, (p<0.05); x, y and z, for differences between day 5, 10 and 15 respectively, 
in CRL milk samples, (p<0.05).    
Figure 1 shows the concentration of free glycation adducts analyzed in milk samples at different 
days of lactation. Different levels were found for most of them between control and CRL dams, 
with the differences depending on the day of lactation. In fact an interaction between the 
maternal calorie restriction during lactation and the time of lactation was found for MG-H1, 
CEL, GH1, CMA, CML, MOLD, 3DG-H and Pyrraline adducts (p<0.05, ANOVA repeated 
measures). Levels of all of the abovementioned adducts increased from day 5 to day 10 of 
lactation, in both control and CRL dams, although the increase was generally higher in CRL 
animals; hence CRL animals showed at day 10 of lactation higher levels of CEL, GH1, CMA, 
CML, 3DG-H and pyrraline than controls (p<0.005, by Student’s t test and Mann-Whitney U 
test). However, in control animals, levels of most of them (MG-H1, CEL, GH1, CMA, CML, 
MOLD, 3DG-H) were maintained or showed further increase at day 15 of lactation, while CRL 
animals showed decreased levels compared to those of 10 days. Pyrraline was an exception 
because their levels decreased in both control and CRL animals from day 10 to day 15 of 
lactation. Thus, compared to controls, CRL animals showed, at day 15 of lactation, lower levels 
of MG-H1 and Pyrraline.  
No differences were found concerning FL and Glucosepane adducts in milk from control and 
CRL animals, but levels were also dependent on the day of lactation (p<0.05, ANOVA repeated 
measures).  
Figure 2 shows the concentration of free oxidation and nitration adducts in milk samples at 
different days of lactation. A significant interaction between the effects of maternal calorie 
restriction during lactation and the lactation time was observed for MetSO, Dityrosine, NFK, 
AASA and GSA (p<0.05, ANOVA repeated measures). At day 5 of lactation, no differences 
were observed between the levels of the aforementioned adducts in milk from control and CRL 
dams. At day 10, dityrosine and AASA levels were higher in milk from CRL dams compared to 
that of controls (p<0.0002, by Student’s t test), but differences were not sustained thereafter. In 
turn, at day 15 of lactation, the free adduct NFK was present in lower levels in CRL milk in 
comparison to control milk (p<0.002, by Mann-Whitney U test). Different patterns of MetSO 
and GSA were also observed between control and CRL dams. Both control and CRL dams 
showed increased levels of MetSO in milk from day 10 to day 15 of lactation, but the increase 
in the control group was much higher than that of CRL dams (Bonferroni post hoc test, p<0.05). 
Concerning GSA, levels in control dams increased steadily with the day of lactation, while 
levels in CRL dams peaked at day 10, but levels tended to decrease thereafter. Levels of the 
nitration adduct 3-NT in milk samples were not different between both groups, but levels were 
affected by the day of lactation (p<0.05, ANOVA repeated measures). 
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Figure 1 Concentration of free glycation adducts in the ultrafiltrate of milk samples from day 5, 10 and 15 of 
lactation. Data are mean ± S.E.M (n=11 animals per group) of control dams and moderate maternal calorie 
restricted dams during lactation (CRL). Statistics: Kolmogorov-Smirnov test was used for testing the normality of 
the distribution of the samples. Differences between CRL and control were assessed by Mann-Whitney U test (for 
no normally distributed samples) or by Student’s t test (for normally distributed samples) and Bonferroni 
correction for 10 analytes was applied: #, ## and ### CRL respect to control when p<0.005, p<0.001 and 
p<0.0001 respectively. In both control and CRL milk samples, differences between the three days of sample 
collection during lactation were assessed by Bonferroni post hoc test: a, b, and c, for differences between day 5, 10 
and 15 respectively, in control milk samples, (p<0.05); x, y and z, for differences between day 5, 10 and 15 
respectively, in CRL milk samples, (p<0.05). Abbreviations: MG-H1, Nδ-(5-hydro-5-methyl-4-imidazolon-2-
yl)ornithine; CEL, Nε-carboxyethyl-lysine; G-H1, Nδ-(5-hydro-4-imidazolon-2-yl)ornithine; CMA, Nω-
carboxymethylarginine; CML, Nε-carboxymethyl-lysine; MOLD, bis(lysyl) crosslink derived from methylglyoxal; 
FL, Fructosyl-lysine; 3DG-H, 3-deoxyglucosone.  
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Figure. 2 Concentration of free oxidation and nitration adducts in the ultrafiltrate of milk samples from day 5, 10 
and 15 of lactation. Data are mean ± S.E.M (n=11 animals per group) of control dams and moderate maternal 
calorie restricted dams during lactation (CRL). Statistics: Kolmogorov-Smirnov test was used for testing the 
normality of the distribution of the samples. Differences between CRL and control were assessed by Mann-
Whitney U test (for no normally distributed samples) or by Student’s t test (for normally distributed samples) and 
Bonferroni correction for 6 analytes was applied: ## and ### CRL respect to control when p<0.001 and p<0.0001 
respectively. In both control and CRL milk samples, differences between the three days of sample collection 
during lactation were assessed by Bonferroni post hoc test: a, b, and c, for differences between day 5, 10 and 15 
respectively, in control milk samples, (p<0.05); x, y and z, for differences between day 5, 10 and 15 respectively, 
in CRL milk samples, (p<0.05). Abbreviations: MetSO, methionine sulfoxide; NFK, N-formylkynurenine; AASA, 
aminoadipic semialdehyde; GSA, glutamic semialdehyde; 3-NT, 3-Nitrotyrosine. 
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Discussion 
Age-related chronic diseases, such as obesity, diabetes and cardiovascular and renal disorders, 
have in common elevated oxidant stress linked to a subinflammatory state (Vlassara 2005). 
Among other factors, cumulative glycoxidation or AGEs formation may be an important 
contributor to oxidant stress. In turn, a reduction of AGEs levels is associated with suppression 
of several immune defects, insulin resistance and diabetic complications (Chuyen 2006). 
Therefore, identification of ways to reduce formation of AGEs, as well as oxidation and 
nitration products, in biological systems may represent a potential key to reduce age-related 
chronic diseases. According to this, in mammals, the only major intervention that shows a 
reduction in oxidant stress and consequently an effectively slow of the age-related processes is 
calorie restriction (Vlassara 2005). In this sense, we have reported that moderate maternal 
energy restriction during lactation in rat dams has protective effects against overweight and 
related metabolic alterations in their offspring (Palou, et al. 2010a; Palou, et al. 2011; Torrens, 
et al. 2014). Here, it is shown that this condition during lactation in rat dams affects the 
concentration of free amino acids as well as AGEs and the analogous oxidation end products in 
maternal plasma and in milk depending on the day of lactation, hence affecting the supply of 
these compounds to their offspring during this critical window of development. This may be 
potentially related with the improved metabolic health of the offspring, although a direct cause-
effect of the aforementioned compounds needs to be further elucidated.   
The quantitative screening of protein damage biomarkers in maternal plasma samples at day 21 
of lactation showed significantly lower levels in CRL dams of the free glycation adducts MG-
H1, 3DG-H, FL, MOLD and the free oxidation biomarker AASA compared to control dams. 
Interestingly, when the amino acid content was measured in plasma samples of dams at 
weaning, we observed that almost all the amino acids determined, except aspartic acid, glutamic 
acid, glutamine, tryptophan, cysteine and glycine showed concentrations significantly lower in 
CRL dams than in controls. This is in concordance with the lower levels of free glycation 
adducts observed in plasma samples of CRL dams, above mentioned. Protein damage by 
glycation is implicated in protein misfolding. Misfolded proteins are degraded by the 
proteasome to ensure the high quality of biological proteins (Thornalley 2008). As a result, free 
amino acids and free glycation adducts are released into the bloodstream (Thornalley 2005). In 
this sense, as moderate calorie restriction seems to reduce glycation reactions, the number of 
glycated proteins formed is lower; hence, the turnover of these misfolded proteins is reduced 
and consequently, less free glycation adducts and less free amino acids in plasma are released 
into the bloodstream. This fact could explain the reduced levels of free glycation adducts and of 
most of the free amino acids in plasma samples from CRL dams compared to control dams. 
Milk composition is known to be affected by maternal food intake (Lonnerdal 1986). The 
results obtained in the present study show that maternal calorie restriction during lactation has a 
notable impact on the content of most of the free glycation and oxidation adducts in milk, but 
the effects are dependent on the day of lactation. It is known that breast milk changes 
dynamically during breastfeeding period to accommodate the infant’s needs (Klenovics, et al. 
2013); here it is also shown that levels of adducts in milk also change considerably throughout 
lactation, in both control and CRL dams. As a general trend, free glycation and oxidation 
adducts levels in milk increased from day 5 to 10 of lactation, the increase being higher in CRL 
dams. This trend continued in milk from control dams, while it was reverted in CRL dams, thus 
milk from CRL dams at day 15 of lactation showed lower free adduct levels than controls. 
These results at day 15 of lactation are in concordance with the quantification of protein 
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damage biomarkers in 21-day-maternal plasma samples, in which free adducts in CRL dams 
were significantly lower than in control dams. 
Levels of the AGEs FL and glucosepane, and of 3-NT, a marker of protein nitration, showed a 
similar pattern throughout lactation in control and CRL dams, but it was different compared to 
the rest of adducts. In turn, MetSO levels increased in both control and CRL dams throughout 
lactation in both groups, but the increase from day 10 to 15 was also greater in control dams. 
Pyrraline levels in milk also showed a different pattern throughout lactation compared to other 
free adducts, since levels peaked at day 10 of lactation (showing CRL milk higher levels than 
controls) but they decreased thereafter more markedly in CRL dams.  
The factors and mechanisms responsible for the increase in some of the markers of protein 
damage during the first part of lactation are not known. It would appear that the onset of 
lactation represents a situation of stress for dams which is reflected in an increase of protein 
damage markers in milk. However, this situation seems to be reverted from day 10 of lactation, 
particularly in CRL dams. Some authors have reported that exposure to high levels of AGEs 
during early childhood could be a decisive event that turns on the innate immune response to a 
proinflammatory mode; once started, such a course is likely to result in diseases such as 
diabetes, at a young age (Mericq, et al. 2010). Thus, the decrease in protein damage markers 
found in milk from CRL dams, which is more evident for AGEs, may potentially contribute to 
the beneficial effects previously described in their offspring (Palou, et al. 2010a; Palou, et al. 
2011; Torrens, et al. 2014).  
Infant formula represents a model of AGE-rich diet. Industrial processing of infant formulas 
results in the formation of substantial amounts of AGEs, especially CML, hence their content in 
infant formulas is therefore several times greater than the content in human breast milk 
(Sebekova, et al. 2008). It is known that breastfeeding, compared to formula feeding, is able to 
bring immediate and lasting programming beneficial effects, conferring protection against 
obesity and related pathologies later in life (Ip, et al. 2007; von Kries, et al. 1999). Differences 
in nutrient composition between infant formula and breast milk, such as the higher protein 
content or the lack of leptin and other biologically active substances in infant formula, may play 
a pathophysiological role and account for the higher predisposition of formula-fed infants to 
later disturbances related to the metabolic syndrome (Koletzko, et al. 2005; Palou and Picó 
2009; Savino and Liguori 2008). The presence of higher amount of AGEs in infant formulas 
compared to breast milk has also been suggested to play a role (Mericq, et al. 2010). In this 
regards, AGEs from infant formulas are at least partially absorbed from the gastrointestinal tract 
contributing to the circulating pool of AGEs. This fact may explain the reported difference in 
the serum levels of CML between breast-fed and formula-fed infants (Sebekova, et al. 2008). 
The higher amounts of AGEs in formula-fed infants may precondition to insulin resistance 
(Mericq, et al. 2010), although recent follow up study of breast-fed and formula-fed infants has 
shown that AGEs absorbed from infant formulas do not seem to be either involved in formula-
consumption-associated reduced insulin sensitivity, or accompanied by enhanced oxidative 
stress and micro-inflammation (Klenovics, et al. 2013). Nevertheless, it should be mentioned 
that although infant formulas have a substantial rise of early and advanced glycation end-
products compared to breast milk (Pischetsrieder and Henle 2012), they generally contain only 
traces of other heat-born toxic substances (Erkekoglu and Baydar 2010). It has been assumed 
that the negative health effects of thermally processed foods do not result from ingestion of 
CML per se, but rather from other AGEs, or additive effects of different heat-processing-
derived substances (Klenovics, et al. 2013). Therefore, more studies are needed to elucidate 
whether the intake of high levels of AGEs in early infancy, coming from either infant formula 
or maternal milk, may affect postnatal programming by acting at sensitive stages during 
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lactation, and contribute to increased incidence of diabetes and other pathologies later in life 
(Klenovics, et al. 2013). 
All in all, the lower content of protein damage markers in milk from CRL dams at day 15 of 
lactation compared to milk from control dams may be related with the lower propensity of their 
offspring against later metabolic diseases (Palou, et al. 2010; Palou, et al. 2011; Torrens, et al. 
2014). However, the presence of greater amounts of some of them on day 10 of lactation is 
difficult to interpret in terms of benefits in the offspring, beyond some potential effect on 
protein digestion and amino acid supply. In this sense, free amino acid content in milk through 
lactation followed a pattern similar to that observed for some free adducts. Specifically, levels 
of Isoleuicine, Valine, Histidine, Aspartic acid, Glutamic acid, Asparagine, Threonine, Alanine, 
Proline and Glycine in milk from control animals increased steadily throughout lactation, while 
in CRL animals, the content of these amino acids peaked at day 10 - reaching levels generally 
higher than those of milk from control dams - but decreased thereafter. The concentration of 
total amino acids in milk also followed the same trend as the aforementioned individual amino 
acids. It should be noted that, in rodents, the gastrointestinal tract is functionally immature for 
about the first 2 weeks of life, but extensive changes occurs during the third week (Morisset 
1993), which might represent changes in the absorptive capacity. It is precisely at this time 
when pups start to eat solid food in combination with maternal milk (Oliver, et al. 2002). 
Therefore, differences in milk composition allowing higher supply of free amino acids during 
the first part of the suckling period can be considered nutritionally convenient, when digestive 
capacity of proteins and peptides of the pups is limited. 
In conclusion, moderate maternal energy restriction during lactation in rats results in lower 
amount of glycation and oxidation free adducts in maternal plasma as well as in milk during the 
second part of lactation. Therefore, lower adduct levels in breast milk might contribute to the 
health benefits observed in the adult offspring of moderate energy restricted dams during 
lactation and could be hypothesized as potential biomarker of breast milk benefits.  
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Recapitulation 
The results obtained during the development of this PhD thesis, and organized in the presented 
manuscripts, describe some of the effects of moderate maternal energy restriction during 
critical windows of development, such as the first half of pregnancy or the whole lactating 
period, in relation to obesity propensity and metabolic health status of their offspring. Such 
characterization ― mainly throughout anthropometric measures, circulating parameters, gene 
expression analysis and histological studies ― sheds light upon the potential mechanisms 
underlying the metabolic programming under these particular nutritional environments, and 
gives some clues about potential strategies to prevent or revert programmed obesity and related 
metabolic alterations. Remarkably, the use of these animal models has made possible to 
identify potential biomarkers of metabolic health that could be used as tools to determine the 
effectiveness of nutritional interventional strategies during critical periods of development 
aimed at a better protection against obesity and its related metabolic disorders in adult life.  
Maternal nutritional conditions during gestation and lactation lead to differential programming 
on the mechanisms involved in the control of energy balance of their offspring, resulting in 
different outcomes in the propensity to suffer obesity in adult life. As previously shown by our 
group, moderate maternal calorie restriction (20%) during the first half of gestation has lasting, 
gender-dependent effects in the offspring. In particular, these animals are programmed for 
higher food intake in adulthood and show impaired ability to regulate energy homeostasis; 
hence, this concludes in higher body weight, but only in males. The results obtained here show 
that the offspring of dams that underwent a 20% calorie restriction during the first half of 
pregnancy (CRG) are programmed for insulin and central leptin resistance, favoring obesity 
development, although only manifested in males. Already at early stages of life (postnatal day 
25), CRG pups, both males and females, showed in hypothalamus lower Insr and Obrb mRNA 
expression levels than their controls; while peripherally, in rWAT and liver, only mRNA levels 
of Insr were significantly lower in CRG animals compared with their controls. This suggests 
that CRG animals display early central and peripheral insulin resistance and central leptin 
resistance, which can be responsible for the impaired control of food intake and, hence, for the 
hyperphagia observed in these animals.  
A possible determinant of the early detrimental effects observed in the offspring of moderate 
maternal calorie restriction during gestation could be an alteration in the neonatal leptin surge 
of these animals. The leptin surge is known as the rise of plasma leptin levels during the 
neonatal period (around days 9 to 10 of lactation) and is considered important for programming 
the structural and functional development of hypothalamic orexigenic and anorexigenic centers. 
In control animals, the expected peak in circulating leptin levels was observed at day 9 of 
lactation, while in CRG pups, the leptin surge was absent. Therefore, the detrimental effects in 
CRG animals by maternal calorie restriction during pregnancy could be attributed, at least in 
part, to the lack of the neonatal circulating leptin surge; fact that underscores the importance of 
leptin during lactation and the critical consequences that leptin deficiency may have during a 
critical period in postnatal life.   
Detrimental effects by maternal calorie restriction during gestation became more apparent in 
the adult offspring. Gender-dependent effects were observed concerning the expression profile 
of key genes involved in the control of energy homeostasis. Particularly, the early differences 
observed at the age of 25 days, regarding hypothalamic Obrb mRNA levels between control 
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and CRG animals, were maintained at the age of 6 months but only in females. CRG females 
also exhibited lower Pompc mRNA levels than their controls, which could be closely involved 
in their deregulated food intake control. In addition, CRG rats, unlike controls, did not show an 
increase in the Npy/Pompc mRNA ratio under fasting conditions; this suggests that CRG 
animals have a decreased capacity of the CNS to sense and respond to changes in nutrient 
availability, also contributing to explain their higher food intake.  
Regarding peripheral tissues, adult CRG animals exposed to HF-diet displayed in rWAT lower 
Insr mRNA levels (only males) and lower Obrb mRNA levels (both males and females) than 
their controls. In liver, lower mRNA levels of Obrb were observed in CRG male animals 
compared to controls but only under fed conditions. Furthermore, levels of insulin and leptin 
signaling-related proteins were decreased in CRG rats compared with controls, particularly 
under fasting conditions. Concretely, CRG female animals showed lower levels of PKCδ in 
rWAT compared with their controls, suggesting a decrease in insulin signaling and glucose 
uptake by the adipose tissue. Moreover, CRG females also displayed lower hepatic levels of 
total STAT3 (only under fed conditions) and of pSTAT3 compared to their controls. 
Conversely, CRG male animals showed higher concentration of total STAT3 in rWAT, which 
could be the result of their hyperleptinemia; this may allow certain leptin signaling in CRG 
male animals. These findings, concerning the expression levels of insulin and leptin receptors 
in peripheral tissues at early stages of life, together with the apparent impaired action of these 
hormones found in adult life, suggest that early programming of peripheral insulin resistance 
may be a direct consequence of fetal calorie restriction, while peripheral leptin resistance, 
which appears in adulthood and under HF diet might be secondary to insulin resistance or to 
central leptin resistance (manuscript 1).  
Obesity has generally been considered difficult to be reverted once it is fully established, and 
hence, development of strategies for its prevention is considered of great interest. In this thesis 
we have addressed the possibility to reverse or prevent, at early ages, programmed obesity and 
its related metabolic alterations by increasing hepatic fatty acid oxidation (FAO) through AAV-
mediated gene transference of the cDNA of Cpt1am ―encoding for a permanently active form 
of CPT1A insensitive to its physiological inhibitor malonyl-CoA―. In this regard, the results 
obtained here show that overexpression of Cpt1am at early ages prevents some of the metabolic 
disorders associated to gestational maternal calorie restriction. According to results described in 
manuscript 1, adult CRG animals present features of impaired insulin and leptin sensitivity. 
AAV-Cpt1am injection reverted the alterations in plasma insulin levels, HOMA-IR, and 
leptin/adiponectin (L/A) ratio in CRG animals. This treatment was also able to revert, at least 
partially the impairment in leptin sensitivity occurring in CRG animals, as evidenced by 
circulating levels and hepatic Obrb mRNA levels.  
CRG rats also displayed an increased adipocyte size in the rWAT and a trend to present greater 
amounts of lipid vesicles and TG content in liver, compared to control animals. Interestingly, 
AAV-Cpt1am injection in these animals resulted in a significant reduction in the adipocyte size 
to levels similar, or even lower, than controls, and also in a decreased number of hepatic lipid 
vesicles. This lower TG content in liver, which in turn may explain their relative protection to 
develop insulin resistance, could be associated in part to the lower expression levels of 
lipogenesis-related genes, such as glucose-6-phosphate dehydrogenase (G6pd) and Acetyl-CoA 
carboxylase subunit alpha (Acaca), in this tissue compared to their untreated controls. In 
addition, adult CRG animals displayed higher blood pressure, lower energy expenditure and 
lower locomotive activity than control rats; AAV-Cpt1am injection in these animals led to 
reverse the increased blood pressure, to partially recover the energy expenditure levels of 
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controls, and to restore the decreased locomotive activity. AAV-Cpt1am injection in CRG 
animals was also able to ameliorate inflammatory state, as evidenced by the lower hepatic 
TNFα mRNA expression levels of these animals in comparison to their controls.  
These findings support the possibility to revert, prevent or ameliorate programmed propensity 
to develop obesity and other features of the metabolic syndrome, which have been generally 
considered irreversible, via a strategy addressed to increase hepatic FAO by overexpression of 
Cpt1a (manuscript 2).  
Unlike the detrimental lasting effects of maternal calorie restriction during gestation on their 
offspring, we show here that moderate maternal calorie restriction during lactation protects 
their offspring from the development of obesity and other metabolic-related alterations, such as 
dyslipidemia, insulin resistance, and hyperinsulinemia, in adult life associated with HF diet 
feeding. Particularly, male and female offspring of dams that were exposed to 30% moderate 
calorie restriction during lactation (CRL) displayed lower body weight than their controls, 
already since the first days of life. This lower body weight was associated with lower food 
intake and was maintained while animals were growing, but was gradually attenuated with 
aging. The effect of maternal calorie restriction during lactation was more evident under HF 
diet feeding conditions, since the gain of body weight, accumulated body fat and also the 
increased intake of calories under HF-diet was lower in CRL animals than controls, especially 
in females. Interestingly, CRL males appeared to be more protected against HF-diet induced 
insulin resistance than controls; as evidenced, under HF-diet feeding conditions, by their 
HOMA-IR values, their higher NEFA response to fasting conditions and their lower circulating 
TG levels (under fed conditions) than their control. In females, no differences in HOMA-IR 
values were found between control and CRL animals, although neither control nor CRL rats 
showed increased HOMA-IR index under HF-diet. Concerning the leptin system, the protecting 
effect of maternal calorie restriction during lactation was especially evident under HF diet 
conditions. Notably, CRL females maintained their leptin levels under HF-diet feeding 
conditions similar to the levels of NF fed animals; this fact denotes an improvement of leptin 
sensitivity in these animals.   
Regarding the importance of leptin supply by maternal milk during lactation, we found here 
that CRL dams maintained similar levels of leptin in breast milk to those of control dams. 
Leptin in milk comes from both the maternal blood source and its production in the mammary 
gland. Plasma leptin levels between control and CRL dams were not different. Concerning its 
production by the mammary gland, although CRL dams suffered a reduction in the weight of 
this tissue, they showed higher leptin mRNA and protein levels than controls, and total leptin 
abundance estimated in the whole mammary gland was still higher than in their controls.  
All in all, these results revealed that moderate maternal calorie restriction during lactation 
confers certain protection of their offspring against diet-induced obesity and its related 
metabolic alterations, particularly insulin resistance and hyperleptinemia, although in a sex-
dependent manner (manuscript 3).   
Mechanisms underlying the developmental programming effects of maternal calorie restriction 
during lactation could involve changes in the expression of energy balance-related genes. 
Indeed, herein we found changes or adaptations at gene expression level of key genes related 
with central and peripheral leptin and insulin sensibility, which may explain, at least in part, the 
improved metabolic health in the offspring of dams exposed to moderate calorie restriction 
during lactation. Concretely, in adulthood, CRL male rats showed in hypothalamus higher 
mRNA expression levels of Obrb and a tendency to lower mRNA levels of Socs3 than controls, 
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while CRL females displayed decreased Npy/Pomc ratio (under HF-diet) and increased 
hypothalamic mRNA levels of Insr in comparison to controls. These changes at gene 
expression level in the hypothalamus illustrate the better central response to insulin action of 
CRL females and the better central leptin sensitivity of CRL males, and all in all can explain 
the improved feeding behavior and the higher resistance to develop diet-induced obesity of 
these animals. At peripheral level, CRL male animals were resistant to the decrease of mRNA 
levels of Insr and of lipogenic-related genes in rWAT under HF-diet feeding conditions, 
whereas their controls presented an impairment of these processes. These results suggest that 
CRL males have an improved response to insulin and an increased capacity to store the excess 
of fat in the adipose tissue. CRL females did not display changes concerning the expression 
levels of Insr; however, it is worth noting that CRL females presented higher Obrb and Cpt1 
mRNA levels (only under NF diet) in rWAT than their controls, suggesting that these animals 
have greater FAO capacity in adipose tissue, which is very important for the control of their 
body weight and fat reserves. In summary, these findings illustrate that maternal calorie 
restriction during lactation produces gender-dependent changes at gene expression level in the 
hypothalamus and rWAT of their offspring, programming these animals to be more resistant to 
the development of overweight/obesity and other metabolic-related alterations under HF-diet 
conditions (manuscript 4). 
The analysis of the expression profile of genes involved in energy homeostasis in animal 
models less prone to develop metabolic syndrome-related alterations could be an interesting 
strategy to identify potential biomarkers of improved metabolic health. Most of the currently 
existing biomarkers are developed for disease and are used in medicine as diagnostic tools for 
screening, diagnosis and monitoring the disease progression. However, biomarkers derived 
from disease processes do not serve to assess the potential benefits of particular nutrients or 
changes in dietary habits. Thus, identification of early biomarkers of metabolic health is of 
great interest. To achieve this, we have used the animal model consisting in the offspring of 
moderate calorie restricted dams during lactation. Although previous studies were performed 
with 30% maternal calorie restriction, here we performed a more moderate restriction, 20%, 
because this could be more representative or applicable in humans. In this regard, here we 
observed that even a less severe maternal calorie restriction during the suckling period also 
programs their offspring for a better metabolic health, as evidenced by the lower body weight, 
lower adiposity and lower cumulative food intake of adult CRL animals, under HF-diet feeding 
conditions, in comparison to their controls (being the differences more evident in females). 
Moreover, concerning circulating parameters, CRL animals displayed, at early ages, increased 
adiponectin and decreased circulating insulin and leptin levels, in comparison to their controls; 
this suggests an improved insulin and leptin sensitivity. In adulthood, CRL animals also 
maintained improved insulin and leptin sensitivity, as evidenced by their lower values of L/A 
ratio and HOMA index (particularly females) in comparison to control animals. In addition, 
CRL animals were more protected against dyslipidemia and hepatic steatosis, and showed an 
improvement of the lipid handling capacity, as evidenced by the presence of lower plasma 
levels of TG (under HF-diet) and hepatic lipid content (under NF and HF-diet) in comparison 
to controls.  
Notably, moderate maternal calorie restriction during lactation determines changes or 
adaptations in the gene expression profile of key tissues in their offspring, which are already 
manifested since early stages of life; this suggests their potential usefulness as early biomarkers 
of metabolic health. Some of these adaptations were partially maintained in adulthood and were 
even more evident when animals were exposed to an obesogenic environment. Concretely, 
CRL animals at weaning displayed higher expression levels of genes involved in insulin 
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signaling, Insr and Irs1 (rWAT); higher expression levels of genes involved in lipid 
mobilization and oxidation, Atgl and Pparα (rWAT); lower expression levels of the lipogenic-
related gene Srebp1c (liver), and higher expression levels of Obrb (liver) than controls. In 
adulthood, and under HF-diet feeding conditions, only mRNA expression levels of Irs1 
(rWAT), Atgl (rWAT), Srebp1c (only NF diet-fed males, in liver) and Obrb (only females, in 
liver) showed the same trend as was observed at weaning. Interestingly, adult HF diet-fed CRL 
animals presented greater Obrb (rWAT), Cpt1 (only females, in rWAT) and Irs1 (only females, 
in liver) mRNA levels than controls, despite no significant changes were observed at early 
ages. Remarkably, mRNA expression levels of some genes were also correlated with some 
biochemical parameters in adult animals. Concretely, mRNA levels of Irs1 (rWAT) were 
negatively correlated with hepatic lipid content and with circulating TG levels; mRNA levels of 
Obrb (liver) were also negatively correlated with hepatic lipids and circulating levels of insulin 
under ad libitum feeding conditions; and mRNA levels of Srebp1c (liver) were positively 
correlated with hepatic lipid content and also with HOMA index. These associations pinpoint 
the potential relevance of transcript levels of these genes as early biomarkers of metabolic 
health (manuscript 5).   
Extrapolation from animals into humans of the above mentioned potential biomarkers 
identified in liver and adipose tissue is really complex and presents some limitations. The main 
constraint is that tissue sample obtaining requires invasive biopsies. In this regard, PBMCs 
represent nowadays an attractive source for identifying biomarkers of health and also a 
potential way to extrapolate such biomarkers from animals into humans. This is due to the fact 
that they can be repeatedly collected in sufficient quantities from blood, in contrast to other 
tissues. Moreover, gene expression levels of PBMCs may be reflective of the gene expression 
patterns in liver, adipose tissue and/or muscle.  
Whole-genome microarray analysis of PBMCs from weaned control and CRL pups allowed to 
identify 278 genes differentially expressed by effect of 20% moderate maternal calorie 
restriction during lactation. Concretely, immune system was the most affected process in terms 
of gene expression, and was followed by processes of signaling, cell turnover and transcription 
machinery. The expression of genes involved in metabolism of proteins, carbohydrates, and 
lipids, were also notably affected. Concerning lipid metabolism-related genes, Cpt1a, Lipe and 
Star were up-regulated, and Fasn, Lrpl, and Rxrb were down-regulated in 21-day-old CRL 
pups versus control. These changes in gene expression were fully confirmed by qPCR. Among 
them, Cpt1a, Fasn, and Star emerge as particularly interesting because their expression levels 
in PBMCs correlated with their expression levels in adipose tissue or liver, or because their 
expression profile was persistent in adulthood. In particular, the expression profile of Cpt1a in 
PBMCs was correlated with that occurring in liver and adipose tissue (both at weaning and in 
adulthood). Concerning Fasn, its expression levels in PBMCs at early ages correlated with its 
expression levels in adipose tissue. In adulthood, this expression pattern was persistent in 
PBMCs but only in CRL females. The expression pattern of Star in PBMCs of 21-day-old CRL 
pups was also observed in liver samples, while in adulthood, only a trend to higher mRNA 
levels of Star was observed in PBMCs. All in all, these results reveal the possibility of using 
the transcript levels of concrete genes related with lipid metabolism in PBMCs as early 
biomarkers of metabolic health (manuscript 6). 
The nutritional environment of dams during the lactating period may produce changes in the 
composition of breast milk. Such changes could include modifications in the integrity of some 
milk proteins through glycation, oxidation or nitration reactions, which in turn generate 
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misfolded proteins. Modified proteins are then degraded into free amino acids and free 
glycation, oxidation and nitration adducts.  
Quantitative screening of free amino acids and of a comprehensive range of free glycation, 
oxidation and nitration adducts (protein damage biomarkers) in breast milk and plasma samples 
revealed the existence of different levels of these compounds between control and 20% calorie 
restricted dams during lactation (CRL) depending on the day of lactation. Regarding breast 
milk, free glycation and oxidation adducts levels increased from day 5 to 10 of lactation. This 
increase was greater in milk from CRL animals, which showed, at day 10 of lactation, levels of 
CEL, GH1, CMA, CML, 3DGH, Pyrraline, Dityrosine and AASA higher than those of 
controls. This trend was reverted from day 10 of lactation, and especially in CRL dams whose 
breast milk contained, at day 15 of lactation, lower levels of free amino acids and of MG-H1, 
Pyrraline and NFK than controls. Likewise, in plasma, 21-day old CRL dams also showed 
lower levels of free adducts and of the majority of the free amino acids studied compared to 
controls. It is suggested that the lower glycation and oxidation free adducts in breast milk from 
CRL dams during the second part of the lactating period, in comparison to milk from control 
dams, could be related with the higher protection of their offspring against later metabolic 
diseases and could be considered as potential biomarkers of breast milk benefices (manuscript 
7).  
To sum up, the results of this thesis show that moderate maternal calorie restriction during the 
first half of gestation in rats programs their offspring for a major propensity to develop obesity 
and related metabolic alterations in adulthood. Some of these programmed metabolic 
disturbances can be reverted by enhancing hepatic FAO at early ages. Conversely, moderate 
maternal calorie restriction during lactation programs their offspring for a better metabolic 
health and protection against obesity development through adaptations in the expression profile 
of energy homeostasis-related genes in key tissues, such as hypothalamus, adipose tissue and 
liver. Some of these adaptations were already observed at early stages of life in adipose tissue 
and liver. Notably, transcriptome profiling of PBMC samples revealed the possibility to use 
transcript levels of concrete genes as early biomarkers of metabolic health, but they need to be 
further validated in other animal models and, particularly, in humans. Concerning the factors 
potentially involved in the benefits of maternal calorie restriction during lactation, the analysis 
of protein damage biomarkers in milk suggests that the lower content of glycation and 
oxidation free adducts during the second part of the lactating period, in comparison to their 
controls, could contribute to the improved metabolic health in their offspring. However, a direct 
cause-effect of these compounds needs to be further elucidated.   
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Conclusions 
 
1. Moderate maternal calorie restriction of 20% in rats during the first 12 days of 
pregnancy programs their offspring for a lower capacity to respond to insulin and to 
central leptin action. This may explain the hyperphagia and other metabolic alterations 
that show these animals in adulthood, favouring obesity development. Particularly, males 
show higher and earlier harmful effects than females, who appear to be more resistant to the 
effects of this maternal condition, in terms of maintenance of body weight, in spite of the 
altered gene expression profile in energy balance-related tissues (manuscript 1).  
 
2. The lack of transient increase in plasma leptin levels during the suckling period, the so-
called “neonatal leptin surge”, in the offspring of calorie restricted dams during gestation 
appears to be closely associated with the adverse health effects observed in these animals 
in adulthood (manuscript 1). 
 
3. Increased hepatic fatty acid oxidation (FAO) at a juvenile age, through injection of 
AAV-Cpt1am vectors (adeno-associated virus containing the mutant form of carnitine 
palmitoyltransferase 1a), reverses or prevents some of the metabolic disorders observed 
in offspring of rat dams subjected to gestational calorie restriction when exposed in 
adulthood to obesogenic conditions, such as impaired insulin and leptin sensitivity, and 
increased systolic blood pressure. This treatment is also able to improve inflammatory 
markers, decrease hepatic triglyceride content, and restore the locomotive activity that was 
decreased in these animals in comparison to controls. Therefore, enhancement of hepatic FAO 
at early ages could be considered as a strategy for reverting metabolic disturbances related to 
adverse developmental programming (manuscript 2). 
 
4. Unlike calorie restriction during gestation, moderate calorie restriction of 30% in rat 
dams during lactation has lasting beneficial effects on their offspring. Particularly, these 
animals become less prone to diet-induced obesity and related metabolic alterations in adult 
life, such as dyslipidemia, insulin resistance and hyperleptinemia (manuscript 3). 
 
5. The offspring of 30% calorie restricted lactating rat dams (CRL) show enhanced 
sensitivity to insulin and leptin signalling, particularly evident under HF-diet feeding 
conditions. This effect is associated to gender-dependent adaptations at gene expression 
level in hypothalamus and visceral adipose tissue. Particularly, CRL males seem to be more 
protected against HF-diet induced peripheral insulin resistance, leading to an improved capacity 
to store the excess of fat in the adipose tissue. They also show improved capacity to respond to 
leptin at the central level. In turn, CRL females appear to be programmed for a better sensitivity 
to the peripheral actions of leptin on the adipose tissue, and display a better capacity to respond 
to insulin at central level (manuscript 4).  
 
6. A less severe food restriction (20%) during lactation in rat dams, which could be more 
easily representative or applicable in humans, also programs the offspring for a better 
metabolic health in terms of body weight and lipid handling capacity. These effects may be 
related to early adaptations in the gene expression profile in WAT and liver, affecting lipogenic 
and oxidative capacity and increasing their sensitivity to the peripheral effects of leptin and 
insulin, which suggests a better control of energy metabolism. Some of these adaptations were 
partially maintained in adulthood, but were more evident when animals were exposed to an 
obesogenic environment. Among genes that exhibit changes at the expression level in early 
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ages, insulin receptor substrate (Irs1) in rWAT and the long form of the leptin receptor (Obrb) 
and the sterol-regulatory-element-binding protein (Srebp1c) in the liver are of relevance 
because their transcript levels in adult animals were associated with hepatic lipid content and 
circulating parameters, such as triacylglycerides and insulin, and insulin resistance indexes; 
thus, they could be considered as potential biomarkers of a healthy phenotype (manuscript 5). 
 
7. Whole-genome transcriptome profiling of peripheral blood mononuclear cells (PBMCs) 
samples from the offspring of moderate (20%) calorie restricted dams during lactation 
allowed the identification of 278 known genes differentially expressed with respect to 
controls. Among lipid metabolism-related genes, carnitine palmitoyltransferase 1a (Cpt1a), 
fatty acid synthase (Fasn) and steroidogenic acute regulatory protein (Star) emerge as 
particularly interesting because their expression levels in PBMCs correlated with their 
expression levels in adipose tissue or liver, or because their expression profile was persistent in 
adulthood. These findings reveal the possibility of using transcript levels of the above 
mentioned genes in PBMCs as early biomarkers of metabolic health, which may also provide a 
valid biological readout for the study of metabolic processes in humans (manuscript 6). 
 
8. Moderate calorie restriction (20%) in rat dams during lactation results in diminished 
amounts of markers of protein damage by glycation and oxidation in maternal plasma 
and in milk during the second part of lactation, hence affecting the supply of these 
compounds to their offspring. The lower presence of protein damage markers in milk may 
contribute to the health benefits observed in the offspring, while these compounds might be 
hypothesized as potential biomarkers of this condition (manuscript 7). 
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1. Una restricción calórica materna moderada del 20% durante los 12 primeros días de 
gestación en ratas programa a la descendencia para una menor capacidad de respuesta a 
la insulina y a la acción central de la leptina. Esto explicaría la hiperfagia y otras 
alteraciones metabólicas que presentan estos animales en edad adulta, favoreciendo  a su 
vez el desarrollo de obesidad. En concreto, los machos sufren efectos nocivos más acentuados 
y con mayor anticipación que las hembras, que parecen ser más resistentes a los efectos de esta 
condición materna en relación al mantenimiento del peso corporal, a pesar de mostrar un perfil 
de expresión génica alterado en tejidos relacionados con el balance energético (manuscrito 1).  
 
2. La ausencia de un incremento transitorio en los niveles plasmáticos de leptina durante 
el periodo de lactancia, conocido como “pico de leptina neonatal”, en las crías de ratas 
sometidas a una restricción calórica durante la gestación, parece estar estrechamente 
relacionado con los efectos adversos para la salud observados en estos animales en edad 
adulta (manuscrito 1). 
 
3. El incremento de la oxidación hepática de ácidos grasos en edades tempranas, mediada 
por la inyección de vectores AAV-Cpt1am (virus adeno-asociado conteniendo una forma 
mutante de la carnitina palmitoiltransferasa 1a), revierte o previene algunas de las 
alteraciones metabólicas observadas en las crías de ratas sometidas a una restricción 
calórica gestacional cuando se exponen a un ambiente obesogénico en edad adulta, tales 
como la menor sensibilidad a la insulina y a la leptina, y el aumento de la presión arterial 
sistólica. Este tratamiento también mejora los niveles de marcadores de inflamación, desciende 
el contenido de triglicéridos hepáticos y es capaz de restaurar la actividad locomotora que 
estaba disminuida en estos animales en comparación con los controles. Por lo tanto, el aumento 
de la oxidación de los ácidos grasos en el hígado, en etapas tempranas de la vida, podría 
considerarse una estrategia para revertir alteraciones metabólicas relacionadas con una 
programación adversa durante el desarrollo (manuscrito 2). 
 
4. A diferencia de la restricción calórica durante la gestación, una restricción calórica 
moderada del 30% en ratas madre lactantes, tiene efectos beneficiosos a largo plazo sobre 
su descendencia. Particularmente, estos animales son menos propensos a desarrollar obesidad 
inducida por la dieta así como alteraciones metabólicas relacionadas en edad adulta, tales como 
la dislipidemia, resistencia a la insulina e hiperleptinemia (manuscrito 3). 
 
5. Las crías de ratas sometidas a una restricción calórica del 30% durante la lactancia 
(CRL) presentan una mayor sensibilidad a la señalización de la insulina y la leptina, 
especialmente patente en condiciones de alimentación con una dieta hiperlipídica (HL). 
Este efecto se asocia a adaptaciones dependientes del sexo en el perfil de expresión génica 
en el hipotálamo y en el tejido adiposo visceral. En concreto, los machos CRL parecen estar 
más protegidos frente al desarrollo de resistencia periférica a la insulina inducida por una dieta 
HL, lo que determina una mayor capacidad para almacenar el exceso de grasa en el tejido 
adiposo blanco. También muestran una mejorada capacidad para responder a la leptina a nivel 
central. Por otro lado, las hembras CRL parecen estar programadas para una mayor sensibilidad 
a las acciones periféricas de la leptina en el tejido adiposo, y presentan una mejor capacidad 
para responder a nivel central a la insulina (manuscrito 4).  
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6. Una restricción calórica menos severa (20%) durante la lactancia en ratas madre, que 
puede ser más fácilmente representativa o aplicable a humanos, también programa a la 
descendencia para una mejor salud metabólica, en cuanto al peso corporal y a la  
capacidad para el procesamiento de los lípidos. Estos efectos podría estar relacionado con 
adaptaciones tempranas en el perfil de expresión génica en el TAB y el hígado, afectando la 
capacidad lipogénica y oxidativa e incrementando su sensibilidad a los efectos periféricos de la 
leptina y la insulina, lo que sugiere un mejor control del metabolismo energético. Algunas de 
estas adaptaciones se mantuvieron parcialmente en edad adulta, pero fueron más evidentes 
cuando los animales se expusieron a un ambiente obesogénico. Entre los genes que exhibieron 
cambios a nivel de expresión génica en edades tempranas,  son destacables el sustrato 1 del 
receptor de insulina (Irs1) en el TAB y la forma larga del receptor de la leptina (Obrb) y la 
proteína de unión al elemento regulador de esteroles (Srebp1c) en el hígado, porque sus 
concentraciones de transcritos en edad adulta se asociaron con el contenido hepático de lípidos 
y con parámetros circulantes, tales como triacilgliceroles e insulina, así como con indicadores 
de resistencia a la insulina; por lo tanto, podrían ser considerados como potenciales 
biomarcadores de fenotipo saludable (manuscrito 5). 
 
7. El análisis transcriptómico de muestras de células mononucleares de sangre periférica 
(PBMCs) de crías de madres sometidas a una restricción calórica moderada del 20% 
durante la lactancia, permitió la identificación de 278 genes conocidos que se expresan 
diferencialmente con respecto a las controles. Entre los genes relacionados con el 
metabolismo lipídico, el de la carnitina palmitoiltransferasa 1a (Cpt1a), la ácido graso sintasa 
(Fasn) y la proteína de regulación esteroidogénica aguda (Star) destacan como particularmente 
interesantes, bien porque sus niveles de expresión en PBMCs se correlacionaron con sus 
niveles de expresión en el TAB o el hígado, o bien porque su perfil de expresión se mantuvo en 
edad adulta. Estos resultados revelan la posibilidad de utilizar la concentración de transcritos de 
los genes anteriormente mencionados en PBMCs como biomarcadores tempranos de salud 
metabólica, los cuales podrían proporcionar una potencial herramienta biológica válida para el 
estudio de procesos metabólicos en humanos (manuscrito 6). 
 
8. La restricción calórica moderada (20%) durante la lactancia en ratas determina una 
menor concentración de marcadores de daño proteico por glicación y oxidación en el 
plasma materno y en la leche durante la segunda mitad de la lactancia, afectando por 
tanto al suministro de estos compuestos a sus crías. La menor presencia de marcadores de 
daño proteico en la leche podría contribuir a los beneficios sobre la salud observados en la crías 
de estos animales, a la vez que estos compuestos podrían ser propuestos como posibles 
biomarcadores de esta condición (manuscrito 7). 
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